The	O
association	O
of	O
autism	O
prevalence	O
and	O
the	O
mean	O
annual	O
precipitation	O
received	O
by	O
a	O
county	O
between	O
1987	O
and	O
2001	O
was	O
positive	O
and	O
significant	O
(	O
p	O
=	O
0	O
.	O
0034	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
0018	O
–	O
0	O
.	O
0050	O
).	O

No	O
child	O
had	O
any	O
clinical	O
signs	O
of	O
endocrine	O
,	O
renal	O
or	O
cardiovascular	O
disease	O
.	O

The	O
seasonal	O
differences	O
outlined	O
in	O
the	O
studies	O
above	O
could	O
be	O
attributed	O
to	O
seasonal	O
25OHD	O
,	O
or	O
evolutionary	O
circannual	O
rhythms	O
to	O
protect	O
mother	O
and	O
fetus	O
.	O

Our	O
results	O
also	O
concur	O
with	O
findings	O
by	O
Morley	O
et	O
al	O
.	O

Visfatin	O
is	O
expressed	O
in	O
bovine	O
mammary	O
epithelial	O
cells	O
,	O
lactating	O
mammary	O
gland	O
,	O
and	O
milk	O
,	O
which	O
is	O
regulated	O
by	O
the	O
cAMP	O
pathway	O
(	O
24	O
).	O

It	O
may	O
be	O
hypothesised	O
that	O
during	O
winter	O
months	O
,	O
which	O
are	O
characterised	O
by	O
increased	O
darkness	O
,	O
women	O
may	O
be	O
exposed	O
to	O
melatonin	O
close	O
to	O
morning	O
and	O
evening	O
meals	O
,	O
reducing	O
their	O
ability	O
to	O
deal	O
with	O
carbohydrate	O
based	O
foods	O
.	O

Design	O
:	O
Within	O
-	O
randomization	O
group	O
analysis	O
of	O
the	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
trial	O
of	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Arachnodactyly	O
and	O
kinked	O
tail	O
in	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
).	O

Moreover	O
,	O
further	B
research	I
is	O
required	O
in	O
order	O
to	O
separate	O
the	O
effects	O
of	O
polytherapy	O
from	O
the	O
baseline	O
mental	O
illness	O
,	O
as	O
well	O
as	O
the	O
genetic	O
and	O
environmental	O
confounders	O
on	O
pregnancy	O
outcome	O
,	O
particularly	O
as	O
those	O
receiving	O
psychotropic	O
polytherapy	O
may	O
suffer	O
from	O
more	O
severe	O
and	O
persistent	O
psychiatric	O
disorders	O
.	O

This	O
finding	O
is	O
partly	O
consistent	O
with	O
previous	O
studies	O
where	O
25OHD	O
concentrations	O
of	O
25	O
–	O
30	O
nmol	O
/	O
L	O
were	O
associated	O
with	O
higher	O
probability	O
of	O
SGA	O
[	O
5	O
–	O
7	O
].	O

Low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
correlated	O
with	O
increased	O
bacterial	O
vaginosis	O
in	O
the	O
first	O
trimester	O
.	O

EDCs	O
with	O
measurements	O
below	O
the	O
limit	O
of	O
detection	O
(	O
LOD	O
)	O
were	O
assigned	O
LOD	O
/√	O
2	O
[	O
10	O
,	O
35	O
,	O
36	O
].	O

In	O
an	O
additional	O
analysis	O
of	O
the	O
association	O
between	O
alcohol	O
intake	O
and	O
psychotic	O
-	O
like	O
symptoms	O
,	O
we	O
categorized	O
women	O
into	O
never	O
drinkers	O
or	O
drinkers	O
,	O
and	O
used	O
drinkers	O
as	O
the	O
reference	O
category	O
.	O

The	O
search	O
generated	O
27	O
related	O
articles	O
in	O
the	O
following	O
categories	O
:	O
prevalence	O
—	O
2	O
,	O
treatments	O
—	O
8	O
,	O
reviews	O
—	O
6	O
,	O
interventions	O
/	O
trials	O
—	O
6	O
,	O
dosage	O
—	O
1	O
,	O
and	O
technical	O
reports	O
—	O
4	O
.	O

(	O
2015	O
)‡	O
Susiarjo	O
et	O
al	O
.	O

One	O
possibility	O
that	O
emerges	O
from	O
our	O
data	O
is	O
that	O
male	O
offspring	O
can	O
increase	O
their	O
body	O
weight	O
by	O
either	O
a	O
reduction	O
of	O
energy	O
expenditure	O
or	O
higher	O
metabolism	O
efficiency	O
.	O

They	O
were	O
impatient	O
because	O
they	O
claimed	O
they	O
had	O
other	O
preoccupations	O
.	O

The	O
mechanisms	O
protecting	O
specific	O
genomic	O
regions	O
from	O
epigenetic	O
re	O
-	O
programing	O
are	O
not	O
yet	O
well	O
-	O
understood	O
.	O

Sustained	O
effort	O
by	O
healthcare	O
leaders	O
and	O
advocates	O
at	O
all	O
levels	O
,	O
inside	O
and	O
outside	O
of	O
government	O
,	O
has	O
elevated	O
the	O
issue	O
of	O
preterm	O
birth	O
on	O
the	O
nation	O
'	O
s	O
health	O
agenda	B
,	O
contributing	O
to	O
an	O
announcement	O
of	O
new	O
federal	O
resources	O
to	O
test	O
promising	O
practices	O
in	O
February	O
2012	O
.	O

Models	O
adjusted	O
for	O
race	O
,	O
education	O
level	O
,	O
iron	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
first	O
trimester	O
;	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
iron	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
second	O
trimester	O
;	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
)	O
and	O
sex	O
of	O
the	O
baby	O
for	O
mothers	O
vaccinated	O
in	O
the	O
third	O
trimester	O
.	O

Smoking	O
status	O
was	O
categorised	O
as	O
the	O
maximum	O
exposure	O
during	O
pregnancy	O
(	O
never	O
,	O
passive	O
smoking	O
only	O
,	O
1	O
–	O
9	O
,	O
10	O
–	O
19	O
and	O
≥	O
20	O
cigarettes	O
per	O
day	O
).	O

However	O
,	O
if	O
the	O
mother	O
is	O
already	O
allergic	O
or	O
if	O
there	O
is	O
a	O
family	O
history	O
of	O
atopy	O
or	O
allergy	O
,	O
food	O
comprising	O
potential	O
allergens	O
should	B
be	I
avoided	O
.	O

Four	O
identically	O
trained	O
study	O
nurses	O
obtain	O
newborn	O
anthropometry	O
(	O
weight	O
,	O
midarm	O
circumference	O
(	O
MAC	O
),	O
crown	O
-	O
heel	O
length	O
(	O
CHL	O
),	O
head	O
circumference	O
(	O
HC	O
)	O
and	O
thoracic	O
circumference	O
(	O
TC	O
))	O
within	O
12	O
h	O
of	O
birth	O
[	O
57	O
].	O

Foetal	O
ultrasonography	O
:	O
Gestational	O
age	O
and	O
foetal	O
growth	O
Foetal	O
ultrasonography	O
examination	O
is	O
carried	O
out	O
by	O
an	O
obstetrician	O
at	O
the	O
first	O
data	O
collection	O
time	O
point	O
to	O
confirm	O
gestation	O
.	O

For	O
the	O
premature	O
baby	O
care	O
agenda	B
,	O
the	O
greatest	O
emphasis	O
is	O
on	O
development	O
and	O
delivery	O
research	O
,	O
with	O
a	O
shorter	O
timeline	O
to	O
impact	O
at	O
scale	O
.	O

For	O
example	O
,	O
chemicals	O
can	O
have	O
far	O
-	O
reaching	O
benefits	O
to	O
society	O
,	O
from	O
agriculture	O
to	O
medicine	O
and	O
food	O
/	O
product	O
safety	O
to	O
the	O
development	O
of	O
new	O
technologies	O
.	O

A	O
cohort	O
study	O
on	O
the	O
Isle	O
of	O
Wight	O
,	O
United	O
Kingdom	O
,	O
found	O
adverse	O
reactions	O
to	O
food	O
in	O
approximately	O
20	O
%	O
of	O
969	O
pregnant	O
women	O
[	O
38	O
].	O

In	O
total	O
,	O
1810	O
women	O
had	O
samples	O
collected	O
both	O
in	O
T1	O
and	O
T3	O
.	O

Though	O
,	O
the	O
interpretation	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
may	O
be	O
complicated	O
by	O
the	O
presence	O
of	O
C3	O
-	O
epimer	O
of	O
25	O
(	O
OH	O
)	O
D	O
[	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
],	O
a	O
vitamin	O
metabolite	O
that	O
may	O
be	O
erroneously	O
included	O
as	O
25	O
(	O
OH	O
)	O
D	O
by	O
LC	O
-	O
MS	O
and	O
immunoassay	O
methods	O
[	O
43	O
].	O

2009	O
).	O

Harper	O
and	O
Pethick	O
[	O
23	O
]	O
recommended	B
that	O
producers	O
focus	O
on	O
individuals	O
with	O
high	O
genetic	O
capacity	O
to	O
create	O
more	O
preadipocytes	O
within	O
animal	O
muscle	O
.	O

In	O
our	O
study	O
,	O
antenatal	O
depression	O
score	O
had	O
no	O
association	O
with	O
the	O
baseline	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
.	O

It	O
is	O
expressed	O
in	O
BAT	O
and	O
WAT	O
,	O
although	O
its	O
main	O
production	O
site	O
is	O
the	O
liver	O
(	O
Nishimura	O
et	O
al	O
.,	O
2000	O
;	O
Muise	O
et	O
al	O
.,	O
2008	O
;	O
Schulz	O
et	O
al	O
.,	O
2013	O
;	O
Zafrir	O
,	O
2013	O
).	O

The	O
focus	O
of	O
this	O
review	O
is	O
set	O
on	O
asthma	O
and	O
type	O
I	O
allergy	O
associated	O
with	O
pregnancy	O
.	O

Bodnar	O
et	O
al	O
.	O

Findings	O
of	O
a	O
study	O
revealed	O
the	O
positive	O
impact	O
on	O
reducing	O
the	O
levels	O
of	O
anemia	O
in	O
children	O
between	O
6	O
-	O
60	O
months	O
in	O
India	O
(	O
6	O
).	O

Homes	O
with	O
high	O
pet	O
activities	O
have	O
been	O
shown	O
to	O
have	O
greater	O
levels	O
of	O
pesticide	O
residues	O
in	O
sampled	O
carpet	O
dust	O
than	O
homes	O
with	O
low	O
pet	O
activities	O
[	O
31	O
,	O
32	O
].	O

Children	O
with	O
S	O
-	O
ECC	O
were	O
23	O
.	O
6	O
times	O
more	O
likely	O
to	O
have	O
elevated	O
PTH	O
levels	O
compared	O
to	O
controls	O
and	O
3	O
.	O
6	O
times	O
more	O
likely	O
to	O
have	O
abnormally	O
low	O
albumin	O
concentrations	O
(	O
Table	O
2	O
).	O

Statistical	O
analyses	O
We	O
compared	O
the	O
distributions	O
of	O
child	O
and	O
maternal	O
variables	O
across	O
maternal	O
free	O
sugar	O
intake	O
quintiles	O
using	O
F	O
-	O
statistics	O
for	O
differences	O
in	O
continuous	O
variables	O
and	O
Chi	O
-	O
squared	O
tests	O
for	O
differences	O
in	O
categorical	O
variables	O
.	O

(	O
2015	O
)	O
*	O
Polycyclic	O
aromatic	O
hydrocarbons	O
(	O
PAHs	O
)	O
AdulthoodAdulthoodPBL	O
chromosomal	O
aberrationsDNA	O
methylationYang	O
et	O
al	O
.	O

In	O
addition	O
,	O
we	O
found	O
a	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
on	O
LBW	O
among	O
those	O
vaccinated	O
in	O
the	O
second	O
trimester	O
(	O
aOR	O
:	O
0	O
.	O
80	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
64	O
–	O
0	O
.	O
97	O
)	O
using	O
PSM	O
.	O

We	O
further	O
hypothesised	O
that	O
household	O
wealth	O
and	O
maternal	O
education	O
would	O
modify	O
the	O
neonatal	O
mortality	O
responses	O
with	O
a	O
greater	O
reduction	O
for	O
women	O
from	O
the	O
poorest	O
households	O
,	O
and	O
women	O
with	O
no	O
education	O
.	O

The	O
odds	O
of	O
belonging	O
to	O
the	O
cluster	O
2	O
were	O
2	O
.	O
36	O
times	O
greater	O
for	O
each	O
additional	O
maternal	O
serving	O
of	O
dairy	O
per	O
day	O
(	O
95	O
%	O
CI	O
1	O
.	O
05	O
,	O
5	O
.	O
30	O
;	O
Fig	O
.	O

The	O
associations	O
differed	O
at	O
the	O
two	O
time	O
points	O
.	O

This	O
puzzling	O
finding	O
may	O
be	O
due	O
to	O
unknown	O
or	O
known	O
unhealthy	O
constituents	O
of	O
fatty	O
fish	O
.	O

Studies	O
of	O
protein	O
intake	O
in	O
pregnancy	O
have	O
indicated	O
that	O
higher	O
maternal	O
protein	O
intake	O
was	O
positively	O
associated	O
with	O
birth	O
weight	O
[	O
8	O
,	O
9	O
],	O
but	O
there	O
are	O
notable	O
exceptions	O
[	O
34	O
,	O
35	O
]	O
and	O
most	O
studies	O
assessed	O
diet	O
later	O
in	O
gestation	O
.	O

However	O
,	O
these	O
children	O
represent	O
a	O
small	O
proportion	O
of	O
the	O
individuals	O
with	O
a	O
suboptimal	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
.	O

The	O
husband	O
has	O
been	O
shown	O
to	O
play	O
a	O
significant	O
role	O
in	O
determining	O
the	O
choice	O
of	O
ANC	O
site	O
by	O
the	O
woman	O
in	O
a	O
Nigerian	O
[	O
19	O
]	O
and	O
Ugandan	O
study	O
[	O
20	O
]	O
where	O
they	O
accounted	O
for	O
43	O
%	O
and	O
32	O
%	O
of	O
all	O
recommendations	O
respectively	O
.	O

For	O
those	O
overrepresented	O
among	O
loci	O
associated	O
with	O
AluYb8	O
methylation	O
,	O
there	O
were	O
a	O
number	O
of	O
developmentally	O
related	O
TFBS	O
genes	O
(	O
CUX1	O
,	O
CHX10	O
,	O
PAX4	O
,	O
PPARG	O
,	O
TAL1	O
/	O
ITF2	O
heterodimer	O
,	O
HAND1	O
,	O
MYOD	O
,	O
OCT	O
),	O
as	O
well	O
as	O
those	O
involved	O
in	O
cell	O
processes	O
(	O
ACTR3B	O
,	O
S8	O
),	O
gene	O
expression	O
(	O
NFE2L	O
),	O
lipid	O
/	O
sterol	O
homeostasis	O
(	O
NR3C1	O
),	O
and	O
immune	O
modulation	O
(	O
GATA1	O
).	O

Interestingly	O
,	O
vitamin	O
D	O
status	O
at	O
T1	O
-	O
around	O
the	O
time	O
the	O
maternal	O
blood	O
flow	O
of	O
the	O
placenta	O
is	O
fully	O
developed	O
-	O
is	O
only	O
related	O
to	O
pregnancy	O
loss	O
.	O

Additionally	O
,	O
it	O
was	O
assessed	O
the	O
spontaneous	O
and	O
compulsive	O
feeding	O
behavior	O
,	O
growing	O
parameters	O
,	O
leptin	O
,	O
plasma	O
metabolites	O
,	O
and	O
adiposity	O
after	O
weaning	O
(	O
adolescence	O
and	O
adulthood	O
).	O

Japanese	O
Black	O
cattle	O
bulls	O
are	O
normally	O
castrated	O
to	O
get	O
highly	O
marbled	O
beef	O
in	O
Japan	O
[	O
61	O
].	O

This	O
prevents	O
the	O
conclusion	O
of	O
a	O
definitive	O
relationship	O
without	O
further	B
research	I
,	O
preferably	O
clinical	O
randomised	O
controlled	O
trials	O
,	O
and	O
a	O
proper	O
meta	O
-	O
analysis	O
.	O

AM251	O
(	O
Tocris	O
,	O
Bioscence	O
,	O
Bristol	O
,	O
UK	O
)	O
was	O
dissolved	O
in	O
a	O
vehicle	O
containing	O
5	O
%	O
Tween	O
80	O
and	O
95	O
%	O
saline	O
.	O

Data	O
Analysis	O
Stata	O
version	O
12	O
(	O
StataCorp	O
LP	O
,	O
College	O
Station	O
,	O
TX	O
,	O
USA	O
)	O
was	O
used	O
in	O
all	O
analyses	O
.	O

Absolute	O
values	O
from	O
each	O
sample	O
were	O
normalized	O
with	O
regard	O
to	O
the	O
housekeeping	O
gene	O
Actb	O
.	O

Then	O
,	O
the	O
sample	O
was	O
purified	O
to	O
remove	O
any	O
residual	O
tailing	O
reagents	O
.	O

The	O
uncovering	O
of	O
the	O
magnitude	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
(	O
and	O
Western	O
Europe	O
)	O
should	B
be	I
translated	O
into	O
new	O
research	O
in	O
order	O
to	O
fill	O
the	O
huge	O
knowledge	O
gap	O
concerning	O
the	O
adequate	O
amount	O
of	O
vitamin	O
D	O
to	O
prevent	O
and	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

The	O
final	O
study	O
visit	O
was	O
conducted	O
at	O
three	O
months	O
of	O
age	O
.	O

Since	O
,	O
fetus	O
and	O
baby	O
are	O
both	O
dependent	O
upon	O
mother	O
for	O
blood	O
and	O
milk	O
respectively	O
,	O
mother	O
’	O
s	O
vitamin	O
D	O
supplementation	O
is	O
highly	O
vital	O
.	O

However	O
,	O
according	O
to	O
national	O
figures	O
from	O
the	O
National	O
Food	O
Administration	O
,	O
a	O
low	O
number	O
of	O
Swedish	O
women	O
took	O
fish	O
oil	O
supplements	O
(	O
1	O
%)	O
at	O
the	O
time	O
of	O
the	O
study	O
.	O

This	O
may	O
therefore	O
be	O
affecting	O
the	O
number	O
of	O
these	O
elements	O
in	O
the	O
genome	O
and	O
the	O
functional	O
relevance	O
of	O
their	O
methylation	O
,	O
particularly	O
in	O
the	O
placenta	O
.	O

As	O
the	O
age	O
of	O
the	O
child	O
increased	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
also	O
increased	O
(	O
Fig	O
1	O
).	O

Birth	O
weight	O
is	O
an	O
independent	O
predictor	O
of	O
the	O
development	O
of	O
obesity	O
;	O
however	O
,	O
increases	O
in	O
weight	O
during	O
the	O
first	O
3	O
–	O
6	O
months	O
of	O
life	O
are	O
also	O
influential	O
on	O
long	O
-	O
term	O
increased	O
risk	O
of	O
obesity	O
[	O
47	O
,	O
48	O
].	O

Logistic	O
regression	O
for	O
S	O
-	O
ECC	O
including	O
variables	O
associated	O
at	O
the	O
bivariate	O
level	O
was	O
also	O
performed	O
.	O

Discussion	O
In	O
our	O
study	O
,	O
less	O
than	O
half	O
the	O
participants	O
used	O
folic	O
acid	O
or	O
iron	O
during	O
their	O
pregnancy	O
,	O
while	O
approximately	O
two	O
thirds	O
took	O
multivitamin	O
supplements	O
.	O

We	O
are	O
presenting	O
a	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

The	O
study	O
is	O
a	O
randomized	O
controlled	O
clinical	O
trial	O
with	O
the	O
follow	O
-	O
up	O
period	O
of	O
three	O
months	O
after	O
delivery	O
in	O
48	O
women	O
with	O
GDM	O
.	O

A	O
previous	O
expert	O
review	O
that	O
was	O
not	O
a	O
structured	O
meta	O
-	O
analysis	O
and	O
did	O
not	O
exclude	O
as	O
many	O
studies	O
as	O
the	O
Cochrane	O
review	O
concluded	O
that	O
special	O
maternal	O
lactation	O
avoidance	O
diets	O
were	O
unnecessary	O
[	O
114	O
].	O

With	O
regards	O
to	O
waiting	O
time	O
at	O
the	O
clinic	O
,	O
the	O
women	O
recognized	O
that	O
most	O
of	O
the	O
time	O
wasting	O
was	O
due	O
to	O
late	O
coming	O
of	O
their	O
fellow	O
pregnant	O
women	O
.	O

Statistical	O
Analyses	O
Treatment	O
effects	O
on	O
weight	O
gain	O
and	O
72	O
h	O
food	O
intake	O
were	O
analyzed	O
using	O
the	O
PROC	O
MIXED	O
model	O
procedure	O
in	O
SAS	O
(	O
Version	O
9	O
.	O
2	O
,	O
SAS	O
Institute	O
Inc	O
.,	O
Carey	O
,	O
NC	O
,	O
USA	O
)	O
with	O
gestational	O
diets	O
,	O
pup	O
diets	O
and	O
time	O
as	O
the	O
main	O
factors	O
.	O

As	O
was	O
mentioned	O
,	O
we	O
did	O
not	O
see	O
any	O
associations	O
of	O
healthy	O
and	O
traditional	O
dietary	O
patterns	O
with	O
consumption	O
of	O
red	O
meats	O
in	O
the	O
healthy	O
dietary	O
pattern	O
and	O
refined	O
grain	O
,	O
salt	O
,	O
and	O
sugar	O
in	O
the	O
traditional	O
dietary	O
pattern	O
.	O

OTUs	O
classified	O
to	O
the	O
genus	O
Streptococcus	O
including	O
the	O
species	O
Streptococcus	O
agalactiae	O
were	O
positively	O
associated	O
with	O
maternal	O
fish	O
and	O
seafood	O
intake	O
,	O
while	O
OTUs	O
classified	O
to	O
the	O
species	O
Bacteroides	O
uniformis	O
were	O
negatively	O
associated	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2c	O
).	O

PubMed	O
Central	O
:	O

Maternal	O
dietary	O
risk	O
factors	O
in	O
childhood	O
acute	O
lymphoblastic	O
leukemia	O
(	O
United	O
States	O
).	O

Data	O
are	O
mean	O
±	O
SD	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
pregnancy	O
outcome	O
Of	O
the	O
2800	O
women	O
present	O
in	O
this	O
study	O
,	O
1217	O
(	O
43	O
%)	O
women	O
went	O
on	O
to	O
develop	O
a	O
pregnancy	O
complication	O
and	O
included	O
5	O
.	O
8	O
%	O
(	O
n	O
=	O
161	O
)	O
who	O
developed	O
PE	O
,	O
7	O
.	O
6	O
%	O
(	O
n	O
=	O
213	O
)	O
who	O
developed	O
GH	O
,	O
3	O
.	O
3	O
%	O
(	O
n	O
=	O
92	O
)	O
who	O
developed	O
GDM	O
,	O
5	O
%	O
(	O
n	O
=	O
139	O
)	O
who	O
spontaneously	O
delivered	O
preterm	O
and	O
10	O
.	O
6	O
%	O
(	O
n	O
=	O
298	O
)	O
who	O
delivered	O
an	O
SGA	O
infant	O
.	O

The	O
field	O
team	O
consisted	O
of	O
three	O
women	O
and	O
two	O
men	O
trained	O
in	O
anthropology	O
or	O
social	O
sciences	O
,	O
who	O
had	O
experience	O
in	O
collecting	O
qualitative	O
data	O
.	O

In	O
addition	O
,	O
an	O
increasing	O
number	O
of	O
studies	O
suggest	O
that	O
gestational	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
multiple	O
adverse	O
health	O
outcomes	O
in	O
mothers	O
and	O
children	O
[	O
16	O
]–[	O
22	O
].	O

Fifty	O
-	O
four	O
per	O
cent	O
of	O
women	O
exposed	O
to	O
polytherapy	O
in	O
our	O
study	O
were	O
treated	O
with	O
both	O
an	O
SGA	O
and	O
an	O
antidepressant	O
.	O

As	O
it	O
is	O
not	O
expressed	O
in	O
mature	O
brown	O
adipocytes	O
,	O
BMP7	O
appears	O
to	O
exert	O
its	O
action	O
on	O
BAT	O
as	O
an	O
endocrine	O
factor	O
.	O

A	O
possible	O
explanation	O
for	O
this	O
might	O
be	O
a	O
U	O
-	O
shaped	O
association	O
between	O
maternal	O
vitamin	O
D	O
concentration	O
and	O
fetal	O
outcomes	O
in	O
a	O
population	O
with	O
sufficient	O
vitamin	O
D	O
status	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Mean	O
BMI	O
and	O
height	O
(	O
m	O
)	O
at	O
all	O
ages	O
for	O
children	O
and	O
for	O
lineage	O
groups	O
with	O
SD	O
and	O
rangeChild	O
age	O
0N	O
=	O
924Child	O
age	O
5N	O
=	O
568Child	O
age	O
9N	O
=	O
298MotherN	O
=	O
556FatherN	O
=	O
450MGMN	O
=	O
375MGFN	O
=	O
228PGMN	O
=	O
226PGFN	O
=	O
142Mean13	O
.	O
6016	O
.	O
6218	O
.	O
1026	O
.	O
2826	O
.	O
8928	O
.	O
7728	O
.	O
2829	O
.	O
2928	O
.	O
66BMI	O
(	O
SD	O
)(	O
1	O
.	O
78	O
)(	O
1	O
.	O
73	O
)(	O
3	O
.	O
23	O
)(	O
5	O
.	O
11	O
)(	O
3	O
.	O
68	O
)(	O
6	O
.	O
07	O
)(	O
4	O
.	O
14	O
)(	O
5	O
.	O
42	O
)(	O
4	O
.	O
47	O
)	O
Range7	O
.	O
08	O
–	O
31	O
.	O
8012	O
.	O
54	O
–	O
24	O
.	O
3311	O
.	O
88	O
–	O
38	O
.	O
4216	O
.	O
87	O
–	O
51	O
.	O
5317	O
.	O
55	O
–	O
39	O
.	O
2815	O
.	O
39	O
–	O
64	O
.	O
9119	O
.	O
19	O
–	O
41	O
.	O
5919	O
.	O
24	O
–	O
60	O
.	O
0116	O
.	O
31	O
–	O
50	O
.	O
12Mean0	O
.	O
511	O
.	O
121	O
.	O
391	O
.	O
631	O
.	O
781	O
.	O
581	O
.	O
721	O
.	O
581	O
.	O
71Height	O
(	O
SD	O
)(	O
0	O
.	O
03	O
)(	O
0	O
.	O
05	O
)(	O
0	O
.	O
08	O
)(	O
0	O
.	O
06	O
)(	O
0	O
.	O
07	O
)(	O
0	O
.	O
05	O
)(	O
0	O
.	O
06	O
)(	O
0	O
.	O
05	O
)(	O
0	O
.	O
06	O
)	O
Range0	O
.	O
36	O
–	O
0	O
.	O
620	O
.	O
97	O
–	O
1	O
.	O
271	O
.	O
19	O
–	O
1	O
.	O
581	O
.	O
45	O
–	O
1	O
.	O
851	O
.	O
52	O
–	O
2	O
.	O
081	O
.	O
39	O
–	O
1	O
.	O
761	O
.	O
55	O
–	O
1	O
.	O
881	O
.	O
44	O
–	O
1	O
.	O
731	O
.	O
56	O
–	O
1	O
.	O
94	O
BMI	O
,	O
body	O
mass	O
index	O
;	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

Pregnancy	O
outcomes	O
The	O
average	O
rates	O
of	O
miscarriage	O
(<	O
20	O
weeks	O
)	O
and	O
fetal	O
death	O
(≥	O
20	O
weeks	O
),	O
13	O
.	O
2	O
%	O
and	O
1	O
.	O
5	O
%,	O
respectively	O
,	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
two	O
groups	O
.	O

Women	O
who	O
don	O
’	O
t	O
take	O
vitamins	O
will	O
serve	O
as	O
the	O
control	O
group	O
.	O

In	O
this	O
model	O
,	O
environmental	O
exposures	O
and	O
lifestyle	O
changes	O
that	O
occur	O
afterwards	O
play	O
a	O
mainly	O
secondary	O
role	O
to	O
the	O
programming	O
or	O
imprinting	O
that	O
occurs	O
during	O
pregnancy	O
and	O
/	O
or	O
early	O
infancy	O
[	O
14	O
,	O
15	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Serum	O
levels	O
of	O
vitamin	O
D	O
in	O
three	O
categories	O
in	O
case	O
and	O
control	O
groups	O
.	O

Overall	O
,	O
we	O
did	O
not	O
observe	O
statistically	O
significant	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
after	O
adjusting	O
for	O
risk	O
factors	O
,	O
with	O
either	O
MLR	O
or	O
PSM	O
.	O

Of	O
the	O
total	O
(	O
n	O
=	O
128	O
)	O
of	O
participants	O
who	O
self	O
-	O
reported	O
not	O
receiving	O
influenza	O
vaccination	O
,	O
only	O
2	O
(	O
2	O
%),	O
had	O
evidence	O
of	O
influenza	O
vaccination	O
.	O

They	O
speculated	O
that	O
this	O
is	O
due	O
primarily	O
to	O
passive	O
absorption	O
of	O
calcium	O
at	O
this	O
age	O
.	O

Upon	O
further	O
exploration	O
through	O
GSEA	O
,	O
we	O
observed	O
an	O
overrepresentation	O
of	O
several	O
TFBSs	O
for	O
transcription	O
factors	O
critical	O
in	O
development	O
,	O
cellular	O
processes	O
,	O
immune	O
modulation	O
,	O
lipid	O
or	O
sterol	O
homeostasis	O
,	O
and	O
gene	O
expression	O
near	O
loci	O
associated	O
with	O
AluYb8	O
,	O
as	O
well	O
as	O
a	O
few	O
developmental	O
and	O
cellular	O
proliferation	O
pathways	O
for	O
LINE	O
-	O
1	O
.	O

Results	O
After	O
adjusting	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
GDM	O
risk	O
was	O
increased	O
among	O
women	O
sleeping	O
≤	O
4	O
hours	O
compared	O
with	O
those	O
sleeping	O
9	O
hours	O
per	O
night	O
(	O
RR	O
=	O
5	O
.	O
56	O
;	O
95	O
%	O
CI	O
1	O
.	O
31	O
-	O
23	O
.	O
69	O
).	O

2011	O
).	O

High	O
Prevalence	O
of	O
Vitamin	O
D	O
Deficiency	O
in	O
Pregnant	O
Women	O
:	O
A	O
National	O
Cross	O
-	O
Sectional	O
Survey	O
Abstract	O
An	O
increasing	O
number	O
of	O
studies	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
associated	O
with	O
multiple	O
adverse	O
health	O
outcomes	O
in	O
mothers	O
,	O
neonates	O
and	O
children	O
.	O

Such	O
changes	O
could	O
have	O
far	O
-	O
reaching	O
consequences	O
on	O
embryo	O
viability	O
and	O
development	O
(	O
including	O
early	O
germ	O
line	O
formation	O
),	O
and	O
thus	O
subsequent	O
future	O
health	O
and	O
fertility	O
.	O

The	O
Hosmer	O
-	O
Lemeshow	O
test	O
was	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
models	O
created	O
.	O

We	O
assessed	O
differences	O
between	O
the	O
study	O
arms	O
,	O
with	O
respect	O
to	O
observed	O
handwashing	O
with	O
soap	O
among	O
other	O
family	O
members	O
interacting	O
with	O
the	O
neonate	O
.	O

The	O
risk	O
of	O
GDM	O
was	O
particularly	O
elevated	O
among	O
overweight	O
women	O
who	O
also	O
reported	O
snoring	O
during	O
pregnancy	O
.	O

These	O
cohorts	O
often	O
have	O
limited	O
availability	O
of	O
appropriate	O
biosample	O
at	O
appropriate	O
collection	O
windows	O
(	O
Bakulski	O
&	O
Fallin2014	O
).	O

The	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
was	O
increased	O
in	O
RC	O
male	O
hypothalamus	O
,	O
but	O
a	O
down	O
-	O
expression	O
of	O
most	O
eCBs	O
-	O
metabolizing	O
enzymes	O
(	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
and	O
several	O
key	O
regulators	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1b	O
,	O
Acox1	O
),	O
mitochondrial	O
respiration	O
(	O
Cox4i1	O
),	O
and	O
lipid	O
flux	O
(	O
Ppar	O
γ	O
)	O
was	O
found	O
in	O
their	O
PAT	O
.	O

BHLM	O
uses	O
shrinkage	O
estimation	O
to	O
bias	O
the	O
regression	O
coefficient	O
estimates	O
towards	O
the	O
group	O
mean	O
parameter	O
.	O

The	O
extensive	O
training	O
and	O
community	O
education	O
program	O
was	O
another	O
positive	O
factor	O
which	O
increased	O
acceptance	O
of	O
the	O
supplements	O
as	O
a	O
valuable	O
contribution	O
to	O
women	O
'	O
s	O
health	O
.	O

Our	O
data	O
support	O
an	O
increasing	O
trend	O
in	O
the	O
use	O
of	O
SGAs	O
to	O
treat	O
a	O
variety	O
of	O
psychiatric	O
disorders	O
,	O
with	O
bipolar	O
disorder	O
and	O
depression	O
being	O
reported	O
as	O
the	O
two	O
leading	O
indications	O
and	O
quetiapine	O
being	O
the	O
one	O
most	O
commonly	O
used	O
.	O

Additional	O
studies	B
are	I
warranted	I
to	O
produce	O
beef	O
with	O
appropriate	O
levels	O
of	O
IMF	O
deposition	O
to	O
satisfy	O
beef	O
quality	O
and	O
taste	O
,	O
support	O
human	O
health	O
,	O
and	O
sustain	O
the	O
animal	O
industry	O
,	O
depending	O
on	O
the	O
situation	O
of	O
each	O
country	O
.	O

Since	O
GR	O
is	O
present	O
as	O
different	O
isoforms	O
,	O
multiple	O
bands	O
were	O
observed	O
and	O
there	O
was	O
an	O
expected	O
interpatient	O
variation	O
in	O
the	O
protein	O
expression	O
.	O

The	O
phenomenon	O
of	O
circannual	O
rhythms	O
has	O
also	O
been	O
explored	O
in	O
relation	O
to	O
gestational	O
diabetes	O
[	O
24	O
–	O
26	O
,	O
28	O
].	O

Differences	O
of	O
longitudinal	O
ontogenetic	O
regulation	O
among	O
LP	O
and	O
AP	O
offspring	O
Considering	O
two	O
adjacent	O
ontogenetic	O
stages	O
within	O
one	O
treatment	O
group	O
,	O
significantly	O
regulated	O
transcripts	O
were	O
determined	O
.	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

Then	O
,	O
we	O
observed	O
the	O
series	O
of	O
slices	O
apart	O
from	O
this	O
mean	O
size	O
to	O
avoid	O
overestimation	O
caused	O
by	O
counting	O
the	O
same	O
glomerulus	O
twice	O
.	O

The	O
immunoreactive	O
bands	O
were	O
analyzed	O
using	O
Image	O
J	O
1	O
.	O
34s	O
image	O
-	O
analysis	O
software	O
(	O
National	O
Institute	O
of	O
Health	O
,	O
USA	O
).	O

Using	O
a	O
job	O
exposure	O
matrix	O
,	O
which	O
can	O
differ	O
from	O
exposure	O
measurement	O
,	O
Birks	O
et	O
al	O
.	O

However	O
,	O
initial	O
short	O
-	O
term	O
findings	O
demonstrated	O
multiple	O
KAB	O
effects	O
[	O
23	O
],	O
and	O
this	O
study	O
demonstrated	O
a	O
behavioral	O
effect	O
on	O
alcohol	O
use	O
.	O

Two	O
lines	O
of	O
evidence	O
support	O
the	O
PAR	O
hypothesis	O
.	O

Staff	O
regularly	O
contacted	O
women	O
during	O
the	O
two	O
weeks	O
preceding	O
their	O
estimated	O
due	O
date	O
to	O
identify	O
births	O
as	O
soon	O
as	O
possible	O
after	O
delivery	O
;	O
women	O
and	O
their	O
families	O
were	O
also	O
encouraged	O
to	O
contact	O
study	O
staff	O
for	O
birth	O
notification	O
.	O

This	O
stage	O
appeared	O
as	O
a	O
phase	O
of	O
recovery	O
of	O
the	O
activity	O
of	O
genes	O
.	O

A	O
recent	O
study	O
,	O
21has	O
indicated	O
that	O
administrating	O
a	O
high	O
dose	O
of	O
vitamin	O
D	O
every	O
two	O
months	O
was	O
an	O
easy	O
and	O
comfortable	O
treatment	O
.	O

It	O
has	O
been	O
reported	O
that	O
low	O
birth	O
weight	O
is	O
related	O
to	O
modulation	O
of	O
both	O
the	O
sympathetic	O
and	O
parasympathetic	O
function	O
from	O
the	O
prenatal	O
period	O
through	O
childhood	O
and	O
adult	O
life	O
[	O
17	O
,	O
19	O
,	O
20	O
,	O
34	O
–	O
38	O
].	O

As	O
such	O
,	O
confirmation	O
of	O
these	O
findings	O
in	O
severely	O
vitamin	O
D	O
–	O
deficient	O
women	O
is	B
needed	I
as	O
it	O
is	O
possible	O
that	O
women	O
with	O
specific	O
genotypes	O
were	O
selectively	O
excluded	O
by	O
this	O
inclusion	O
criterion	O
.	O

Results	O
for	O
the	O
38	O
infants	O
(	O
19	O
Hispanic	O
and	O
19	O
Caucasian	O
),	O
with	O
the	O
values	O
obtained	O
initially	O
,	O
are	O
shown	O
in	O
Table1	O
.	O

The	O
use	O
of	O
self	O
-	O
reported	O
snoring	O
as	O
a	O
tool	O
to	O
detect	O
sleep	O
disordered	O
breathing	O
is	O
well	O
established	O
.	O

It	O
is	O
quite	O
possible	O
that	O
the	O
adverse	O
findings	O
in	O
this	O
study	O
are	O
due	O
to	O
more	O
women	O
in	O
the	O
metformin	O
group	O
having	O
a	O
greater	O
severity	O
of	O
hyperglycemia	O
early	O
in	O
the	O
pregnancy	O
.	O

T1	O
25OHD	O
was	O
also	O
investigated	O
as	O
a	O
continuous	O
variable	O
as	O
there	O
were	O
few	O
cases	O
in	O
some	O
categories	O
.	O

Independent	O
t	O
-	O
tests	O
were	O
used	O
to	O
examine	O
the	O
relationship	O
between	O
continuous	O
variables	O
and	O
each	O
outcome	O
.	O

Both	O
non	O
-	O
esterified	O
fatty	O
acids	O
(	O
NEFAs	O
)	O
and	O
a	O
glycerol	O
backbone	O
are	O
required	O
for	O
TG	O
synthesis	O
.	O

[	O
4142	O
]	O
Endocrine	O
Society	O
Issues	O
Practice	O
Guideline	O
on	O
Vitamin	O
D	O
and	O
the	O
guideline	O
recommend	B
that	O
clinicians	O
screen	O
for	O
vitamin	O
D	O
deficiency	O
in	O
people	O
at	O
risk	O
for	O
deficiency	O
,	O
including	O
obese	O
individuals	O
,	O
blacks	O
,	O
pregnant	O
and	O
lactating	O
women	O
,	O
and	O
patients	O
with	O
malabsorption	O
syndromes	O
.	O

Interventions	O
that	O
have	O
been	O
identified	O
through	O
global	O
reviews	O
of	O
the	O
evidence	O
are	O
summarised	O
elsewhere	O
[	O
4	O
-	O
6	O
]	O
and	O
shown	O
in	O
Figure1	O
.	O

After	O
the	O
filtering	O
steps	O
described	O
above	O
,	O
10	O
,	O
293	O
probe	O
-	O
sets	O
were	O
detected	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
10	O
,	O
317	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
8	O
,	O
892	O
).	O

This	O
variable	O
was	O
calculated	O
in	O
stages	O
,	O
first	O
by	O
dividing	O
the	O
number	O
of	O
positive	O
influenza	O
samples	O
by	O
the	O
total	O
number	O
of	O
samples	O
tested	O
per	O
week	O
from	O
the	O
surveillance	O
data	O
and	O
then	O
assigning	O
the	O
cumulative	O
sum	O
of	O
the	O
influenza	O
positive	O
proportions	O
per	O
week	O
to	O
the	O
weeks	O
that	O
women	O
were	O
pregnant	O
;	O
we	O
dichotomized	O
this	O
variable	O
by	O
high	O
or	O
low	O
exposure	O
using	O
the	O
median	O
cumulative	O
influenza	O
exposure	O
as	O
a	O
cutoff	O
.	O

To	O
address	O
this	O
gap	O
in	O
the	O
literature	O
,	O
the	O
aim	O
of	O
this	O
follow	O
-	O
up	O
study	O
was	O
to	O
determine	O
if	O
maternal	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
and	O
/	O
or	O
a	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
affect	O
the	O
circulating	O
concentration	O
of	O
cathelicidin	O
in	O
healthy	O
children	O
years	O
after	O
delivery	O
.	O

Based	O
on	O
aggregated	O
evidence	O
from	O
animal	O
and	O
human	O
studies	O
,	O
Witter	O
et	O
al	O
.	O

2010	O
;	O
Christensen	O
et	O
al	O
.	O

As	O
yet	O
there	O
is	O
no	O
precedent	O
for	O
epigenetically	O
mediated	O
toxicity	O
in	O
chemical	O
regulation	O
.	O

Food	O
Fortification	O
with	O
Iron	O
Iron	O
fortification	O
involves	O
the	O
addition	O
of	O
iron	O
,	O
usually	O
with	O
folic	O
acid	O
,	O
to	O
an	O
appropriate	O
food	O
vehicle	O
that	O
is	O
made	O
available	O
to	O
the	O
population	O
at	O
large	O
.	O

This	O
is	O
also	O
highly	O
topical	O
currently	O
.	O

The	O
statistical	O
analysis	O
is	O
novel	O
,	O
using	O
mixed	O
-	O
model	O
techniques	O
that	O
enable	O
all	O
the	O
data	O
to	O
be	O
utilised	O
including	O
incomplete	O
families	O
.	O

While	O
there	O
have	O
been	O
conflicting	O
reports	O
in	O
the	O
literature	O
with	O
,	O
for	O
instance	O
,	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
3reporting	O
equivalent	O
relationships	O
between	O
the	O
child	O
’	O
s	O
BMI	O
and	O
both	O
parents	O
,	O
the	O
Generation	O
R	O
study2reports	O
that	O
the	O
maternal	O
influence	O
is	O
strongest	O
.	O

Those	O
interested	O
,	O
receive	O
a	O
study	O
information	O
leaflet	O
and	O
are	O
screened	O
for	O
eligibility	O
individually	O
in	O
a	O
private	O
space	O
upon	O
which	O
a	O
booking	O
date	O
is	O
supplied	O
if	O
eligible	O
.	O

Fasting	O
glucose	O
and	O
HbA1cwere	O
lowest	O
among	O
Greek	O
patients	O
with	O
type	O
2	O
diabetes	O
during	O
August	O
and	O
September	O
[	O
23	O
].	O

The	O
ratio	O
Tpef	O
/	O
Te	O
,	O
the	O
resistance	O
of	O
the	O
respiratory	O
system	O
and	O
the	O
flow	O
of	O
tidal	O
forced	O
expiration	O
are	O
related	O
to	O
respiratory	O
function	O
in	O
infants	O
with	O
recurrent	O
wheezing	O
,	O
asthma	O
,	O
and	O
bronchiolitis	O
.	O

In	O
third	O
trimester	O
retention	O
of	O
water	O
,	O
constipation	O
is	O
seen	O
&	O
finally	O
preparation	O
of	O
genital	O
tract	O
for	O
delivery	O
is	O
needed	O
.	O

However	O
,	O
in	O
primary	O
human	O
adipose	O
stem	O
cells	O
,	O
both	O
BMP4	O
and	O
BMP7	O
induced	O
a	O
white	O
-	O
to	O
-	O
brown	O
adipocyte	O
transdifferentiation	O
(	O
Elsen	O
et	O
al	O
.,	O
2014b	O
),	O
pointing	O
to	O
the	O
occurrence	O
of	O
different	O
effects	O
,	O
depending	O
on	O
the	O
model	O
used	O
for	O
investigation	O
.	O

At	O
weaning	O
(	O
28	O
dpn	O
)	O
offspring	O
of	O
the	O
LP	O
group	O
showed	O
slight	O
but	O
significant	O
higher	O
fat	O
content	O
and	O
adipocyte	O
size	O
,	O
and	O
still	O
lower	O
muscle	O
fibre	O
numbers	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Frequency	O
of	O
distribution	O
of	O
health	O
topics	O
discussed	O
during	O
ANC	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
P	O
-	O
Value	O
of	O
the	O
different	O
service	O
satisfaction	O
rating	O
with	O
respect	O
to	O
the	O
educational	O
level	O
in	O
the	O
study	O
populationServicesFisher	O
'	O
s	O
exact	O
testp	O
-	O
valueReception0	O
.	O
091P	O
>	O
O	O
.	O
O5Sitting	O
area	O
comfort0	O
.	O
842Waiting	O
time4	O
.	O
357Staff	O
rapport1	O
.	O
838Competence	O
of	O
personnel0	O
.	O
672Health	O
talks5	O
.	O
43	O
Pregnancy	O
groups	O
There	O
was	O
a	O
statistically	O
significant	O
association	O
when	O
comparing	O
respondents	O
at	O
their	O
first	O
pregnancy	O
with	O
those	O
at	O
their	O
second	O
or	O
more	O
pregnancies	O
in	O
terms	O
of	O
their	O
satisfaction	O
ratings	O
;	O
the	O
sitting	O
area	O
comfort	O
(	O
F	O
=	O
7	O
.	O
052	O
;	O
P	O
=	O
0	O
.	O
04	O
),	O
competence	O
of	O
staff	O
(	O
F	O
=	O
8	O
.	O
92	O
,	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
health	O
talk	O
comprehensiveness	O
(	O
F	O
=	O
18	O
.	O
499	O
,	O
P	O
Number	O
of	O
Visits	O
at	O
the	O
time	O
of	O
study	O
There	O
was	O
no	O
statistically	O
significant	O
difference	O
when	O
the	O
service	O
rating	O
(	O
reception	O
,	O
sitting	O
area	O
comfort	O
,	O
waiting	O
time	O
,	O
staff	O
rapport	O
,	O
competence	O
of	O
personnel	O
and	O
health	O
talk	O
)	O
of	O
women	O
attending	O
their	O
second	O
visit	O
and	O
those	O
attending	O
subsequent	O
visits	O
was	O
compared	O
.	O

Based	O
on	O
these	O
assumptions	O
,	O
80	O
%	O
power	O
,	O
and	O
a	O
.	O
05	O
significance	O
level	O
,	O
we	O
estimated	O
that	O
we	O
would	O
need	O
to	O
conduct	O
3	O
-	O
hour	O
structured	O
observations	O
among	O
80	O
respondents	O
in	O
each	O
study	O
arm	O
.	O

Differences	O
between	O
male	O
and	O
female	O
offspring	O
(	O
CC	O
)	O
were	O
also	O
observed	O
.	O

This	O
indicates	O
that	O
there	O
may	O
be	O
a	O
window	O
of	O
opportunity	O
during	O
fetal	O
development	O
in	O
which	O
allergic	O
manifestation	O
risk	O
may	O
be	O
altered	O
.	O

The	O
AxinFu	O
mouse	O
may	O
,	O
therefore	O
,	O
represent	O
a	O
more	O
promising	O
reporter	O
model	O
in	O
the	O
development	O
of	O
regulatory	O
toxicological	O
assays	O
for	O
potential	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

Consequently	O
,	O
only	O
genes	O
whose	O
regulation	O
between	O
two	O
consecutive	O
ontogenetic	O
stages	O
(	O
period	O
I	O
:	O
94dpc	O
-	O
1dpn	O
;	O
period	O
II	O
:	O
1dpn	O
-	O
28dpn	O
;	O
period	O
III	O
:	O
28dpn	O
-	O
188dpn	O
)	O
was	O
private	O
to	O
either	O
the	O
LP	O
or	O
the	O
AP	O
group	O
were	O
analysed	O
(	O
Table1	O
).	O

By	O
contrast	O
,	O
subjects	O
were	O
generally	O
older	O
,	O
better	O
nourished	O
,	O
multiparous	O
and	O
poorly	O
educated	O
.	O

The	O
same	O
applies	O
to	O
in	O
vivo	O
tests	O
such	O
as	O
food	O
challenge	O
tests	O
and	O
patch	O
tests	O
.	O

As	O
reported	O
by	O
the	O
United	O
Nations	O
Foundation	O
,	O
Project	O
Masiluleke	O
in	O
South	O
Africa	O
reaches	O
1	O
million	O
people	O
each	O
day	O
via	O
mobile	O
phone	O
with	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
prevention	O
,	O
testing	O
,	O
and	O
treatment	O
information	O
[	O
21	O
].	O

However	O
,	O
these	O
studies	O
have	O
been	O
limited	O
by	O
the	O
relatively	O
low	O
rates	O
of	O
assessment	O
[	O
18	O
–	O
20	O
].	O

1	O
).	O

One	O
-	O
way	O
Analysis	O
of	O
Variance	O
(	O
ANOVA	O
)	O
statistical	O
tests	O
were	O
used	O
to	O
reveal	O
statistically	O
significant	O
protein	O
expression	O
differences	O
between	O
the	O
two	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

They	O
suggest	O
that	O
VD	O
changes	O
AMH	O
production	O
patterns	O
in	O
ovarian	O
granulose	O
cells	O
and	O
alters	O
follicle	O
stimulating	O
hormone	O
(	O
FHS	O
)	O
sensitivity	O
,	O
possibly	O
playing	O
a	O
role	O
in	O
ovarian	O
follicle	O
development	O
.	O

We	O
assessed	O
glucose	O
intolerance	O
by	O
analyzing	O
results	O
of	O
the	O
1	O
-	O
hour	O
oral	O
glucose	O
screening	O
test	O
results	O
.	O

Laboratory	O
studies	O
revealed	O
a	O
serum	O
sodium	O
of	O
171	O
mEq	O
/	O
L	O
,	O
potassium	O
4	O
.	O
1	O
mEq	O
/	O
L	O
,	O
chloride	O
138	O
mEq	O
/	O
L	O
,	O
bicarbonate	O
21	O
mEq	O
/	O
L	O
,	O
glucose	O
197	O
mg	O
/	O
dL	O
,	O
BUN	O
49	O
mg	O
/	O
dL	O
,	O
creatinine	O
3	O
.	O
2	O
mg	O
/	O
dL	O
,	O
calcium	O
7	O
.	O
8	O
mEq	O
/	O
L	O
,	O
total	O
protein	O
5	O
.	O
4	O
gm	O
/	O
dL	O
,	O
albumin	O
1	O
.	O
6	O
gm	O
/	O
dL	O
,	O
alkaline	O
phosphatase	O
576	O
units	O
/	O
L	O
,	O
AST	O
391	O
units	O
/	O
L	O
,	O
and	O
ALT	O
443	O
units	O
/	O
L	O
.	O

In	O
a	O
European	O
population	O
,	O
64	O
%	O
of	O
infants	O
had	O
a	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
3	O
-	O
6	O
days	O
of	O
age	O
that	O
was	O
below	O
12	O
ng	O
/	O
mL	O
[	O
12	O
].	O

More	O
than	O
70	O
%	O
of	O
mothers	O
in	O
the	O
population	O
had	O
at	O
least	O
a	O
college	O
degree	O
,	O
more	O
than	O
90	O
%	O
were	O
married	O
,	O
and	O
most	O
were	O
first	O
-	O
time	O
mothers	O
.	O

In	O
the	O
mission	O
to	O
enhance	O
and	O
compound	O
the	O
benefit	O
of	O
services	O
delivered	O
under	O
ICDS	O
,	O
Government	O
of	O
India	O
has	O
developed	O
partnerships	O
with	O
the	O
international	O
agencies	O
like	O
United	O
Nations	O
International	O
Children	O
’	O
Emergency	O
Fund	O
(	O
for	O
providing	O
technical	O
guidance	O
in	O
developing	O
need	O
-	O
based	O
training	O
plans	O
;	O
assist	O
in	O
organizing	O
scientific	O
workshops	O
;	O
and	O
in	O
impact	O
assessment	O
on	O
early	O
childhood	O
nutrition	O
and	O
development	O
),	O
Cooperative	O
for	O
Assistance	O
and	O
Relief	O
Everywhere	O
(	O
contribution	O
in	O
the	O
areas	O
of	O
maternal	O
and	O
child	O
health	O
,	O
girl	O
primary	O
education	O
,	O
etc	O
.	O

Women	O
who	O
reported	O
a	O
preference	O
for	O
shadow	O
had	O
a	O
higher	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
in	O
our	O
study	O
.	O

These	O
models	O
were	O
adjusted	O
for	O
BMI	O
,	O
season	O
of	O
conception	O
,	O
education	O
level	O
,	O
origin	O
and	O
gestational	O
age	O
at	O
registration	O
to	O
antenatal	O
care	O
(	O
based	O
on	O
last	O
menstrual	O
period	O
).	O

The	O
mutation	O
in	O
Skm2	O
(	O
S96P	O
)	O
recapitulates	O
the	O
phenotype	O
observed	O
in	O
the	O
knockout	O
mice	O
,	O
suggesting	O
that	O
this	O
residue	O
is	O
critical	O
for	O
the	O
function	O
of	O
FLNB	O
.	O

Sympathetic	O
hyperactivity	O
can	O
alter	O
glucose	O
homeostasis	O
and	O
induce	O
insulin	O
resistance	O
by	O
increasing	O
glycogen	O
breakdown	O
and	O
gluconeogenesis	O
.	O

Trial	O
Registration	O
ClincalTrials	O
.	O
govNCT00697294	O
Background	O
Vitamin	O
D	O
has	O
been	O
given	O
to	O
infants	O
to	O
prevent	O
and	O
treat	O
rickets	O
for	O
almost	O
100	O
years	O
.	O

Adverse	O
Reactions	O
to	O
Food	O
No	O
studies	O
have	O
focused	O
explicitly	O
on	O
the	O
prevalence	O
of	O
food	O
allergy	O
in	O
pregnant	O
women	O
primarily	O
because	O
often	O
the	O
immune	O
response	O
in	O
the	O
offspring	O
is	O
the	O
main	O
focus	O
of	O
research	O
.	O

When	O
BeWo	O
and	O
JEG	O
-	O
3	O
cells	O
were	O
treated	O
with	O
cortisol	O
10	O
nM	O
,	O
100	O
nM	O
,	O
or	O
1000	O
nM	O
,	O
the	O
expression	O
of	O
GAS5	O
was	O
significantly	O
upregulated	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
)	O
compared	O
with	O
their	O
corresponding	O
basal	O
levels	O
(	O
Figure	O
4	O
(	O
a	O
)).	O

Similarly	O
,	O
dietary	O
forage	O
level	O
affected	O
MS	O
.	O
Jersey	O
steers	O
fed	O
a	O
low	O
forage	O
diet	O
(	O
6	O
%	O
Sudan	O
grass	O
,	O
6	O
%	O
alfalfa	O
hay	O
and	O
63	O
.	O
15	O
%	O
steam	O
-	O
flaked	O
corn	O
,	O
dry	O
matter	O
[	O
DM	O
]	O
basis	O
)	O
in	O
a	O
feedlot	O
finishing	O
diet	O
had	O
greater	O
MS	O
in	O
the	O
strip	O
loin	O
than	O
did	O
animals	O
fed	O
a	O
high	O
forage	O
level	O
diet	O
(	O
12	O
%	O
Sudan	O
grass	O
,	O
12	O
%	O
alfalfa	O
hay	O
and	O
51	O
.	O
20	O
%	O
steam	O
-	O
flaked	O
corn	O
)	O
[	O
121	O
].	O

To	O
examine	O
predictors	O
within	O
the	O
polytherapy	O
subgroup	O
only	O
,	O
unadjusted	O
logistic	O
regression	O
models	O
(	O
due	O
to	O
the	O
small	O
sample	O
size	O
)	O
were	O
subsequently	O
tested	O
.	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

SIRTs	O
are	O
a	O
class	O
of	O
proteins	O
that	O
have	O
a	O
role	O
in	O
cellular	O
processes	O
associated	O
with	O
body	O
metabolism	O
such	O
as	O
cell	O
differentiation	O
,	O
aging	O
,	O
transcription	O
,	O
apoptosis	O
,	O
inflammation	O
,	O
and	O
stress	O
resistance	O
,	O
as	O
well	O
as	O
energy	O
efficiency	O
and	O
alertness	O
during	O
low	O
-	O
calorie	O
situations	O
.	O

Several	O
maternal	O
nutritional	O
factors	O
have	O
been	O
investigated	O
in	O
relation	O
to	O
adverse	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
offspring	O
health	O
and	O
development	O
[	O
7	O
–	O
9	O
].	O

Analysis	O
was	O
performed	O
using	O
SPSS	O
18	O
.	O
0	O
for	O
Macintosh	O
(	O
SPSS	O
,	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
).	O

For	O
missing	O
data	O
and	O
attrition	O
of	O
participants	O
,	O
a	O
t	O
test	O
was	O
used	O
to	O
compare	O
covariates	O
,	O
including	O
sociodemographic	O
and	O
other	O
variables	O
used	O
in	O
the	O
regressions	O
,	O
between	O
cases	O
with	O
and	O
without	O
missing	O
data	O
to	O
verify	O
whether	O
or	O
not	O
data	O
were	O
missing	O
completely	O
at	O
random	O
.	O

The	O
RR	O
comparing	O
growing	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
for	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
compared	O
with	O
the	O
low	O
level	O
group	O
was	O
1	O
.	O
7	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
5	O
-	O
2	O
.	O
0	O
)	O
and	O
5	O
.	O
6	O
(	O
95	O
%	O
CI	O
,	O
4	O
.	O
0	O
-	O
6	O
.	O
8	O
),	O
respectively	O
.	O

Using	O
PSM	O
,	O
we	O
observed	O
a	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
on	O
PTB	O
and	O
LBW	O
among	O
those	O
vaccinated	O
in	O
the	O
second	O
and	O
third	O
trimester	O
.	O

An	O
elevated	O
risk	O
remained	O
after	O
adjustment	O
for	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
1	O
.	O
54	O
;	O
95	O
%	O
CI	O
0	O
.	O
71	O
-	O
3	O
.	O
35	O
).	O

Regarding	O
the	O
time	O
exposure	O
to	O
diet	O
,	O
Palou	O
et	O
al	O
.	O

For	O
both	O
measurements	O
,	O
the	O
tape	O
was	O
positioned	O
at	O
a	O
level	O
parallel	O
to	O
the	O
floor	O
,	O
and	O
the	O
waist	O
-	O
to	O
-	O
hip	O
ratio	O
was	O
calculated	O
.	O

Chailurkit	O
et	O
al	O
.	O

Iron	O
-	O
deficiency	O
is	O
the	O
most	O
common	O
nutritional	O
deficiency	O
globally	O
.	O

Patients	O
’	O
vitamin	O
D	O
status	O
was	O
determined	O
by	O
measuring	O
serum	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
concentration	O
.	O

Pregnant	O
women	O
(<	O
18	O
weeks	O
’	O
gestation	O
)	O
(	O
n	O
=	O
250	O
)	O
are	O
being	O
recruited	O
from	O
primary	O
healthcare	O
clinics	O
in	O
Johannesburg	O
and	O
are	O
followed	O
-	O
up	O
at	O
a	O
provincial	O
hospital	O
.	O

Furthermore	O
,	O
there	O
are	O
new	O
therapeutic	O
approaches	O
under	O
validation	O
for	O
advanced	O
or	O
recurrent	O
disease46	O
-	O
48	O
.	O

Long	O
-	O
term	O
concerns	O
regarding	O
glyburide	O
and	O
metformin	O
therapy	O
for	O
GDM	O
Although	O
the	O
above	O
randomized	O
trials	O
have	O
demonstrated	O
non	O
-	O
inferiority	O
of	O
glyburide	O
and	O
metformin	O
in	O
achieving	O
glycemic	O
control	O
,	O
and	O
satisfactory	O
birth	O
outcomes	O
compared	O
to	O
insulin	O
therapy	O
,	O
concerns	O
must	O
remain	O
as	O
long	O
-	O
term	O
issues	O
have	O
not	O
yet	O
been	O
addressed	O
.	O

(	O
2015	O
)*/†	O
Takeda	O
et	O
al	O
.	O

There	O
was	O
no	O
association	O
with	O
eczema	O
,	O
hay	O
fever	O
,	O
total	O
IgE	O
,	O
FEV1	O
,	O
FVC	O
or	O
FEF25	O
–	O
75	O
(	O
table	O
2and	O
supplementary	O
table	O
E2	O
).	O

We	O
also	O
report	O
unadjusted	O
estimates	O
for	O
analyses	O
and	O
analyses	O
further	O
adjusted	O
for	O
infant	O
age	O
at	O
sample	O
collection	O
in	O
the	O
supplemental	O
information	O
.	O

These	O
authors	O
estimate	O
that	O
the	O
productivity	O
gains	O
for	O
an	O
individual	O
removed	O
from	O
anaemia	O
are	O
5	O
%	O
in	O
manual	O
occupations	O
(	O
70	O
%	O
of	O
employment	O
in	O
a	O
country	O
such	O
as	O
Viet	O
Nam	O
),	O
and	O
17	O
%	O
in	O
heavy	O
manual	O
occupations	O
(	O
which	O
form	O
12	O
.	O
7	O
%	O
of	O
employment	O
in	O
manual	O
occupations	O
in	O
Viet	O
Nam	O
:	O
the	O
share	O
of	O
agriculture	O
in	O
GDP	O
is	O
22	O
.	O
1	O
%)[	O
16	O
].	O

Decreasing	O
slaughter	O
age	O
may	O
be	O
better	O
for	O
reducing	O
production	O
costs	O
when	O
feed	O
prices	O
are	O
high	O
.	O

All	O
studies	O
were	O
found	O
to	O
be	O
either	O
positive	O
or	O
neutral	O
in	O
regards	O
to	O
quality	O
rating	O
.	O

The	O
measles	O
immunisation	O
in	O
South	O
Africa	O
forms	O
part	O
of	O
the	O
National	O
Expanded	O
Programme	O
for	O
Immunisation	O
and	O
permission	O
to	O
administer	O
it	O
at	O
the	O
study	O
site	O
has	O
been	O
granted	O
by	O
the	O
Department	O
of	O
Health	O
of	O
Gauteng	O
Province	O
and	O
the	O
City	O
of	O
Johannesburg	O
.	O

It	O
is	O
not	O
necessarily	O
important	O
whether	O
an	O
environmental	O
exposure	O
induces	O
adverse	O
outcomes	O
in	O
multiple	O
exposed	O
or	O
non	O
-	O
exposed	O
generations	O
.	O

However	O
,	O
at	O
childbirth	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
in	O
comparison	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

In	O
a	O
study	O
in	O
a	O
private	O
center	O
in	O
Brazil	O
,	O
the	O
prevalence	O
of	O
antenatal	O
depression	O
was	O
19	O
.	O
6	O
%	O
with	O
the	O
Beck	O
tool	O
[	O
61	O
].	O

Vitamin	O
D	O
is	O
definitely	O
not	O
a	O
Trojan	O
Horse	O
in	O
reproductive	O
health	O
since	O
there	O
were	O
no	O
adverse	O
effects	O
reported	O
for	O
vitamin	O
D	O
intake	O
of	O
up	O
to	O
10	O
,	O
000	O
IU	O
/	O
d	O
[	O
66	O
],	O
but	O
to	O
proclaim	O
it	O
the	O
Golden	O
Fleece	O
,	O
more	B
evidence	I
is	I
still	O-
required	I
.	O

Generalized	O
UniFrac	O
unifies	O
weighted	O
and	O
unweighted	O
UniFrac	O
to	O
detect	O
differences	O
in	O
moderately	O
abundant	O
lineages	O
instead	O
of	O
those	O
exclusively	O
in	O
highly	O
abundant	O
or	O
rare	O
lineages	O
[	O
43	O
,	O
44	O
].	O

This	O
was	O
an	O
important	O
focus	O
of	O
text4baby	O
messages	O
,	O
including	O
both	O
recommendations	O
not	O
to	O
drink	O
and	O
also	O
warnings	O
about	O
the	O
health	O
risks	O
of	O
fetal	O
alcohol	O
syndrome	O
for	O
unborn	O
babies	O
.	O

Finally	O
,	O
as	O
a	O
retrospective	O
study	O
,	O
we	O
were	O
limited	O
by	O
available	O
data	O
and	O
the	O
amount	O
of	O
cord	O
blood	O
available	O
for	O
further	O
testing	O
.	O

This	O
study	O
focuses	O
on	O
the	O
F1	O
and	O
F2	O
generations	O
after	O
F0	O
maternal	O
vitamin	O
D	O
restriction	O
.	O

This	O
study	O
reports	O
on	O
analysis	O
of	O
the	O
full	O
dataset	O
from	O
baseline	O
to	O
postpartum	O
follow	O
-	O
up	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

Stata	O
V	O
.	O
14	O
(	O
StataCorp	O
.	O

Women	O
living	O
in	O
a	O
nursing	O
home	O
have	O
a	O
higher	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
than	O
in	O
free	O
-	O
living	O
women	O
,	O
39	O
.	O
8	O
%	O
compared	O
to	O
30	O
%,	O
respectively	O
[	O
13	O
].	O

As	O
S	O
-	O
ECC	O
is	O
influenced	O
by	O
the	O
social	O
determinants	O
of	O
health	O
,	O
there	O
were	O
differences	O
in	O
parental	O
education	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
household	O
income	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
between	O
groups	O
,	O
with	O
lower	O
levels	O
of	O
both	O
education	O
and	O
household	O
income	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

After	O
delivery	O
,	O
thyroxine	O
dose	O
can	O
be	O
gradually	O
reduced	O
to	O
pre	O
-	O
pregnancy	O
levels	O
,	O
while	O
TSH	O
levels	O
should	O
be	O
constantly	O
monitored1015	O
.	O

During	O
the	O
final	O
stage	O
,	O
from	O
18	O
months	O
to	O
slaughter	O
(	O
28	O
to	O
30	O
months	O
of	O
age	O
),	O
the	O
concentrate	O
is	O
84	O
.	O
2	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
,	O
and	O
the	O
rest	O
is	O
roughage	O
(	O
rice	O
straw	O
).	O

The	O
same	O
results	O
were	O
obtained	O
after	O
adjusting	O
for	O
potential	O
confounding	O
variables	O
in	O
model	O
1	O
[	O
OR	O
2	O
.	O
05	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
1	O
.	O
01	O
-	O
4	O
.	O
15	O
),	O
P	O
=	O
0	O
.	O
05	O
]	O
and	O
model	O
2	O
[	O
OR	O
2	O
.	O
04	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
97	O
-	O
4	O
.	O
32	O
),	O
P	O
=	O
0	O
.	O
06	O
].	O

The	O
mean	O
body	O
weight	O
and	O
body	O
length	O
at	O
birth	O
were	O
3	O
.	O
0	O
±	O
0	O
.	O
6	O
kg	O
and	O
48	O
.	O
4	O
±	O
9	O
.	O
9	O
cm	O
respectively	O
.	O

Maternal	O
caloric	O
restriction	O
induces	O
sex	O
-	O
dimorphic	O
alterations	O
in	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
lipid	O
metabolism	O
Sexual	O
dimorphism	O
in	O
offspring	O
after	O
maternal	O
caloric	O
restriction	O
was	O
also	O
observed	O
in	O
the	O
gene	O
expression	O
of	O
key	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
that	O
include	O
elements	O
of	O
the	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
.	O

During	O
lactation	O
,	O
a	O
special	O
diet	O
for	O
the	O
mother	O
(	O
or	O
,	O
if	O
not	O
breast	O
-	O
feeding	O
,	O
hypoallergenic	O
formula	O
nutrition	O
for	O
the	O
infant	O
)	O
should	B
be	I
considered	B
only	O
in	O
individuals	O
with	O
an	O
established	O
atopy	O
risk	O
or	O
existing	O
allergy	O
[	O
82	O
,	O
115	O
].	O

The	O
mortality	O
rate	O
in	O
our	O
study	O
cohort	O
was	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
95	O
%	O
CI	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
):	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
;	O
ten	O
cases	O
)	O
in	O
our	O
vitamin	O
D	O
group	O
and	O
3	O
·	O
4	O
per	O
1000	O
child	O
years	O
(	O
1	O
·	O
3	O
–	O
7	O
·	O
1	O
;	O
seven	O
cases	O
)	O
in	O
our	O
placebo	O
group	O
.	O

2011	O
[	O
26	O
]	O
to	O
prevent	O
attenuation	O
.	O

These	O
birds	O
,	O
which	O
lived	O
in	O
northeastern	O
Siberia	O
,	O
northern	O
Alaska	O
,	O
and	O
northern	O
Greenland	O
,	O
are	O
believed	O
to	O
have	O
had	O
no	O
contact	O
with	O
humans	O
.	O

(	O
2005	O
).	O

Women	O
presenting	O
for	O
other	O
services	O
than	O
ANC	O
visits	O
were	O
excluded	O
on	O
the	O
grounds	O
that	O
they	O
did	O
not	O
have	O
any	O
experience	O
of	O
a	O
particular	O
health	O
centre	O
and	O
so	O
could	O
not	O
give	O
an	O
opinion	O
on	O
the	O
ANC	O
services	O
.	O

Each	O
data	O
collector	O
will	O
be	O
responsible	O
for	O
one	O
cluster	O
.	O

Podolian	O
bulls	O
fed	O
grazing	O
pasture	O
and	O
fed	O
a	O
high	O
protein	O
(	O
15	O
%	O
CP	O
,	O
DM	O
basis	O
)	O
supplement	O
had	O
higher	O
IMF	O
content	O
in	O
the	O
LM	O
than	O
did	O
animals	O
grazing	O
pasture	O
and	O
fed	O
a	O
low	O
protein	O
(	O
12	O
%	O
CP	O
)	O
supplement	O
[	O
126	O
].	O

The	O
serum	O
osmolality	O
was	O
356	O
mOsm	O
/	O
kg	O
;	O
urine	O
sodium	O
21	O
mEq	O
/	O
L	O
and	O
urine	O
osmolality	O
was	O
inappropriately	O
low	O
(	O
225	O
mOsm	O
/	O
kg	O
).	O

Thus	O
,	O
the	O
cost	O
-	O
effectiveness	O
of	O
the	O
project	O
is	O
assessed	O
at	O
USD	O
4	O
.	O
24	O
per	O
anaemia	O
case	O
prevented	O
per	O
year	O
.	O

Apart	O
from	O
the	O
inconvenience	O
of	O
taking	O
time	O
to	O
answer	O
the	O
research	O
questionnaire	O
,	O
participants	O
were	O
not	O
exposed	O
to	O
undue	O
risk	O
.	O

However	O
,	O
such	O
management	O
may	O
lead	O
to	O
an	O
increased	O
risk	O
of	O
adverse	O
pregnancy	O
outcomes	O
.	O

Multivariate	O
linear	O
regression	O
was	O
used	O
to	O
determine	O
the	O
association	O
of	O
GRS	O
with	O
25	O
(	O
OH	O
)	O
D	O
,	O
using	O
the	O
same	O
confounding	O
factors	O
as	O
before	O
.	O

It	O
can	O
be	O
argued	O
that	O
a	O
steady	O
-	O
state	O
adequate	O
vitamin	O
D	O
concentration	O
was	O
not	O
reached	O
in	O
some	O
children	O
because	O
of	O
fluctuations	O
in	O
serum	O
concentrations	O
due	O
to	O
our	O
study	O
regimen	O
.	O

Whether	O
women	O
treated	O
for	O
thyroid	O
cancer	O
should	O
become	O
pregnant	O
was	O
once	O
a	O
matter	O
of	O
concern	O
,	O
but	O
current	O
evidence	O
suggests	O
that	O
DTC	O
should	B
not	O
discourage	O
intended	O
pregnancy	O
,	O
with	O
the	O
usual	O
recommendation	B
to	O
postpone	O
it	O
to	O
at	O
least	O
6	O
months	O
after	O
radioiodine	O
therapy	O
.	O

Of	O
the	O
10	O
term	O
placentas	O
4	O
were	O
nonlabor	O
and	O
all	O
CS	O
,	O
and	O
6	O
were	O
from	O
laboring	O
tissues	O
(	O
mode	O
of	O
delivery	O
:	O
3	O
CS	O
,	O
3	O
vaginal	O
deliveries	O
).	O

Our	O
hypothesis	O
was	O
that	O
lack	O
of	O
prenatal	O
vitamin	O
(	O
PNV	O
)	O
use	O
would	O
be	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
defined	O
as	O
<	O
50	O
nmol	O
/).	O

PubMed	O
Central	O
:	O

Sampling	O
during	O
pregnancy	O
and	O
delivery	O
showed	O
that	O
the	O
women	O
had	O
unusually	O
high	O
serum	O
levels	O
of	O
PFOA	O
—	O
twice	O
the	O
U	O
.	O
S	O
.	O
average	O
—	O
possibly	O
due	O
to	O
the	O
presence	O
of	O
a	O
chemical	O
plant	O
nearby	O
.	O

The	O
observation	O
that	O
lactational	O
undernutrition	O
can	O
lead	O
to	O
a	O
modification	O
of	O
the	O
adult	O
metabolic	O
phenotype	O
is	O
compatible	O
with	O
work	O
by	O
others	O
showing	O
that	O
postnatal	O
undernutrition	O
can	O
modify	O
metabolic	O
programming	O
[	O
52	O
],[	O
53	O
].	O

We	O
suggest	O
further	B
clinical	O-
trial	I
in	O
pregnant	O
mothers	O
who	O
are	O
at	O
risk	O
for	O
postnatal	O
depression	O
.	O

No	O
umbilical	O
cord	O
care	O
events	O
were	O
observed	O
,	O
given	O
that	O
observations	O
were	O
conducted	O
after	O
the	O
typical	O
time	O
of	O
cord	O
separation	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g009	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
9	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
weaning	O
and	O
6	O
months	O
of	O
age	O
for	O
AT1	O
receptor	O
expression	O
.	O

To	O
our	O
knowledge	O
,	O
ours	O
is	O
one	O
of	O
the	O
first	O
studies	O
to	O
find	O
associations	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
loss	O
.	O

These	O
results	O
are	O
similar	O
to	O
ours	O
:	O
we	O
found	O
that	O
women	O
aged	O
over	O
18	O
years	O
,	O
with	O
parity	O
less	O
than	O
two	O
,	O
with	O
more	O
than	O
9	O
years	O
of	O
education	O
,	O
from	O
urban	O
areas	O
with	O
a	O
wanted	O
pregnancy	O
or	O
who	O
were	O
married	O
were	O
significantly	O
more	O
likely	O
to	O
use	O
iron	O
supplements	O
.	O

Recruitment	O
took	O
place	O
over	O
this	O
time	O
period	O
until	O
the	O
targeted	O
sample	O
was	O
reached	O
.	O

“	O
We	O
’	O
re	O
still	O
analyzing	O
data	O
—	O
it	O
generated	O
just	O
an	O
enormous	O
amount	O
of	O
data	O
,”	O
Lewis	O
says	O
.	O

There	O
were	O
no	O
differences	O
in	O
maternal	O
weight	O
gain	O
in	O
pregnancy	O
between	O
the	O
exposed	O
and	O
comparison	O
groups	O
and	O
between	O
the	O
monotherapy	O
-	O
exposed	O
and	O
polytherapy	O
-	O
exposed	O
subgroups	O
.	O

Infants	O
reported	O
to	O
have	O
never	O
been	O
introduced	O
to	O
formula	O
and	O
to	O
be	O
breastfed	O
were	O
considered	O
to	O
be	O
exclusively	O
breastfed	O
,	O
while	O
those	O
who	O
were	O
ever	O
breastfed	O
and	O
ever	O
formula	O
-	O
fed	O
were	O
considered	O
to	O
be	O
fed	O
with	O
a	O
combination	O
of	O
breast	O
milk	O
and	O
formula	O
regardless	O
of	O
whether	O
or	O
not	O
the	O
infant	O
was	O
still	O
breastfed	O
at	O
the	O
time	O
of	O
stool	O
collection	O
.	O

The	O
mitochondria	O
of	O
BAT	O
are	O
characterized	O
by	O
the	O
presence	O
of	O
uncoupling	O
protein	O
-	O
1	O
(	O
UCP1	O
)	O
in	O
the	O
inner	O
mitochondrial	O
membrane	O
.	O

The	O
effects	O
of	O
roughage	O
/	O
concentrate	O
ratio	O
on	O
body	O
fat	O
deposition	O
and	O
the	O
expression	O
of	O
angiogenic	O
and	O
adipogenic	O
factors	O
in	O
adipose	O
tissue	O
have	O
been	O
examined	O
in	O
fattening	O
Wagyu	O
steers	O
[	O
122	O
].	O

Each	O
adult	O
egg	O
-	O
laying	O
hen	O
consumes	O
100	O
–	O
115	O
g	O
/	O
day	O
feeds	O
fortified	O
with	O
1600	O
IU	O
/	O
kg	O
Vitamin	O
D	O
(	O
both	O
Vitamin	O
D2	O
and	O
Vitamin	O
D3	O
),	O
as	O
indicated	O
by	O
Chinese	O
nutrition	O
standards	O
for	O
feeding	O
egg	O
-	O
laying	O
hens	O
.	O

The	O
mean	O
GD	O
was	O
12	O
%	O
smaller	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
43	O
.	O
3	O
±	O
0	O
.	O
3	O
µm	O
for	O
F1	O
-	O
VitD	O
-	O
mice	O
vs	O
.	O
49	O
.	O
3	O
±	O
0	O
.	O
6	O
µm	O
for	O
F1	O
-	O
SC	O
mice	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
)	O
and	O
8	O
%	O
smaller	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F2	O
-	O
SC	O
(	O
46	O
.	O
0	O
±	O
0	O
.	O
8	O
µm	O
and	O
50	O
.	O
2	O
±	O
1	O
.	O
2	O
µm	O
,	O
respectively	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

There	O
are	O
other	O
more	O
time	O
and	O
financially	O
economical	O
ways	O
in	O
which	O
lifetime	O
,	O
multigenerational	O
and	O
/	O
or	O
transgenerational	O
toxicity	O
could	O
be	O
assessed	B
,	O
for	O
example	O
using	O
zebrafish	O
models	O
,	O
both	O
respecting	O
the	O
3Rs	O
and	O
satisfying	O
sufficient	O
statistical	O
power	O
.	O

These	O
can	O
cause	O
vitamin	O
D	O
deficiency	O
in	O
mothers	O
’	O
milk	O
as	O
the	O
only	O
source	O
of	O
vitamin	O
D	O
for	O
babies	O
.	O
6	O
There	O
are	O
evidences	O
showing	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
keeping	O
normal	O
glucose	O
homeostasis	O
.	O
7	O
-	O
10Resistance	O
to	O
insulin	O
and	O
destruction	O
of	O
insulin	O
secretion	O
in	O
human	O
and	O
animal	O
models	O
has	O
considerably	O
been	O
related	O
to	O
vitamin	O
D	O
deficiency	O
.	O

Questionnaire	O
The	O
questionnaire	O
included	O
demographic	O
information	O
(	O
age	O
,	O
race	O
,	O
living	O
environment	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
persons	O
in	O
the	O
household	O
,	O
delivery	O
hospital	O
),	O
antenatal	O
care	O
(	O
number	O
of	O
antenatal	O
visits	O
,	O
vaccinations	O
received	O
during	O
pregnancy	O
,	O
consumption	O
of	O
antenatal	O
supplements	O
),	O
presence	O
of	O
medical	O
conditions	O
prior	O
to	O
pregnancy	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
any	O
complications	O
during	O
pregnancy	O
(	O
hospitalization	O
for	O
any	O
specific	O
complication	O
such	O
as	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
,	O
or	O
influenza	O
-	O
like	O
illness	O
),	O
other	O
risk	O
factors	O
for	O
adverse	O
pregnancy	O
outcomes	O
(	O
alcohol	O
consumption	O
and	O
smoking	O
before	O
and	O
during	O
pregnancy	O
),	O
obstetric	O
characteristics	O
of	O
the	O
mother	O
(	O
number	O
of	O
parturitions	O
,	O
number	O
of	O
abortions	O
,	O
number	O
of	O
livebirths	O
and	O
stillbirths	O
,	O
type	O
of	O
delivery	O
),	O
and	O
characteristics	O
of	O
the	O
offspring	O
(	O
sex	O
,	O
weight	O
,	O
gestational	O
age	O
at	O
delivery	O
).	O

A	O
potential	O
limitation	O
of	O
our	O
follow	O
-	O
up	O
study	O
is	O
the	O
risk	O
of	O
selection	O
bias	O
,	O
with	O
only	O
82	O
%	O
of	O
the	O
available	O
cohort	O
contributing	O
data	O
at	O
6	O
-	O
month	O
follow	O
-	O
up	O
assessments	O
.	O

Postoperatively	O
,	O
the	O
mother	O
continued	O
to	O
be	O
hypernatremic	O
despite	O
IV	O
infusion	O
of	O
hypotonic	O
fluids	O
.	O

Preterm	O
birth	O
is	O
not	O
a	O
single	O
condition	O
,	O
but	O
a	O
single	O
outcome	O
(	O
birth	O
before	O
37	O
completed	O
weeks	O
)	O
due	O
to	O
multiple	O
causes	O
.	O

Discussion	O
In	O
this	O
population	O
-	O
based	O
birth	O
cohort	O
study	O
,	O
we	O
found	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
,	O
independently	O
of	O
sugar	O
intake	O
in	O
early	O
childhood	O
.	O

In	O
juvenile	O
piglets	O
(	O
stage	O
28	O
dpn	O
)	O
483	O
probe	O
-	O
sets	O
differed	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

(	O
2016	O
),	O
found	O
an	O
association	O
between	O
PCB	O
153	O
and	O
low	O
birth	O
weight	O
[	O
21	O
]	O
whereas	O
Lenters	O
et	O
al	O
.	O

(	O
2003	O
)	O
demonstrated	O
a	O
decrease	O
in	O
the	O
hypothalamic	O
levels	O
of	O
AEA	O
(	O
confirmed	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
)	O
and	O
an	O
absence	O
of	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Faah	O
in	O
the	O
hypothalamus	O
of	O
weaned	O
pups	O
after	O
a	O
maternal	O
undernutrition	O
throughout	O
the	O
last	O
part	O
of	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

For	O
the	O
quantitative	O
PCR	O
,	O
the	O
following	O
equations	O
were	O
used	O
:	O
ΔCt	O
=	O
Ct	O
(	O
gene	O
of	O
interest	O
)−	O
Ct	O
(	O
house	O
keeping	O
gene	O
),	O
ΔΔCt	O
=	O
ΔCt	O
(	O
sample	O
)−	O
ΔCt	O
(	O
calibrator	O
),	O
and	O
Relative	O
Quantity	O
(	O
RQ	O
)	O
=	O
2	O
−	O
ΔΔCtas	O
previously	O
described	O
[	O
12	O
].	O

This	O
was	O
the	O
first	O
study	O
to	O
suggest	O
that	O
smoking	O
during	O
pregnancy	O
is	O
linked	O
to	O
adverse	O
changes	O
in	O
the	O
lipoprotein	O
levels	O
of	O
children	O
(	O
19	O
).	O

In	O
addition	O
,	O
adjustments	O
for	O
multiple	O
testing	O
were	O
made	O
in	O
this	O
model	O
.	O

An	O
intake	O
of	O
fish	O
may	O
reflect	O
a	O
health	O
conscious	O
diet	O
and	O
thus	O
the	O
positive	O
effects	O
may	O
not	O
be	O
directly	O
attributed	O
to	O
the	O
fish	O
but	O
rather	O
to	O
the	O
diet	O
as	O
a	O
whole	O
.	O

Written	O
informed	O
consent	O
was	O
obtained	O
from	O
all	O
participants	O
.	O

Caption	O
(	O
FIG	O
)	O
The	O
western	O
sandpiper	O
,	O
one	O
of	O
the	O
Arctic	O
species	O
studied	O
UK	O
Organic	O
Certifier	O
Says	O
No	O
to	O
Nanomaterials	O
The	O
Soil	O
Association	O
,	O
a	O
nonprofit	O
UK	O
organization	O
that	O
certifies	O
the	O
majority	O
of	O
that	O
nation	O
’	O
s	O
organic	O
products	O
,	O
announced	O
in	O
January	O
2008	O
it	O
will	O
no	O
longer	O
allow	O
man	O
-	O
made	O
nanomaterials	O
(	O
materials	O
with	O
a	O
mean	O
size	O
of	O
less	O
than	O
200	O
nm	O
)	O
to	O
be	O
used	O
in	O
goods	O
carrying	O
its	O
certification	O
label	O
.	O

However	O
,	O
such	O
associations	O
were	O
not	O
seen	O
in	O
women	O
taking	O
healthy	O
and	O
traditional	O
dietary	O
patterns	O
.	O

While	O
there	O
is	O
interest	O
in	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
prevention	O
of	O
multiple	O
sclerosis	O
,	O
following	O
epidemiological	O
studies	O
demonstrating	O
an	O
association	O
between	O
vitamin	O
D	O
supplementation	O
and	O
reduced	O
prevalence	O
of	O
the	O
disease	O
,	O
future	B
research	I
,	O
including	O
randomized	O
controlled	O
trials	O
in	O
pregnant	O
or	O
nonpregnant	O
individuals	O
,	O
is	O
awaited	B
to	B
confirm	I
or	O
refute	O
such	O
benefit	O
.	O

The	O
characteristics	O
of	O
subjects	O
used	O
in	O
these	O
analyses	O
(	O
n	O
=	O
380	O
)	O
are	O
shown	O
in	O
Supplemental	O
Material	O
,	O
Table	O
1	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
).	O

Thyroid	O
hormones	O
are	O
major	O
factors	O
for	O
the	O
normal	O
development	O
of	O
foetal	O
brain	O
,	O
and	O
until	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
when	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
thyroid	O
axis	O
becomes	O
functional	O
,	O
the	O
foetal	O
brain	O
is	O
strictly	O
dependent	O
on	O
local	O
deiodination	O
of	O
maternal	O
thyroxine7	O
-	O
12	O
.	O

Luckily	O
,	O
for	O
the	O
time	O
being	O
the	O
in	O
vitro	O
experiments	O
did	O
not	O
prove	O
cross	O
-	O
reaction	O
of	O
specific	O
immunoglobulin	O
with	O
VDBP	O
[	O
50	O
].	O

Discussion	O
This	O
clinical	O
trial	O
evaluated	O
the	O
effect	O
of	O
2000	O
IU	O
of	O
vitamin	O
D3supplement	O
per	O
day	O
during	O
late	O
pregnancy	O
on	O
perinatal	O
depression	O
.	O

Samples	O
were	O
immediately	O
collected	O
from	O
lobus	O
sinister	O
hepaticus	O
(	O
approximately	O
500	O
mg	O
),	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

The	O
COPSAC2000study	O
have	O
failed	O
to	O
show	O
an	O
association	O
between	O
cord	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
lung	O
function	O
at	O
7	O
years	O
of	O
age	O
[	O
33	O
].	O

Study	O
Limitations	O
This	O
study	O
provides	O
useful	O
data	O
of	O
the	O
relationship	O
between	O
serum	O
visfatin	O
and	O
the	O
children	O
’	O
s	O
anthropometric	O
markers	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

A	O
community	O
-	O
based	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
rural	O
Bangladesh	O
to	O
evaluate	O
the	O
impact	O
of	O
the	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
early	O
in	O
pregnancy	O
on	O
the	O
risk	O
of	O
neonatal	O
mortality	O
:	O
the	O
Shonjibon	O
trial	O
Abstract	O
Background	O
Iron	O
-	O
deficiency	O
is	O
the	O
most	O
common	O
nutritional	O
deficiency	O
globally	O
.	O

Plasma	O
cathelicidin	O
was	O
measured	O
from	O
the	O
children	O
’	O
s	O
samples	O
by	O
ELISA	O
(	O
Hycult	O
Biotech	O
,	O
the	O
Netherlands	O
),	O
in	O
which	O
each	O
sample	O
was	O
diluted	O
24	O
times	O
and	O
analyzed	O
in	O
duplicate	O
.	O

Although	O
,	O
only	O
hypothesis	O
generating	O
,	O
two	O
ecological	O
studies	O
support	O
the	O
hypothesis	O
by	O
reporting	O
the	O
ratio	O
of	O
saturated	O
fat	O
to	O
PUFA	O
in	O
the	O
diet	O
is	O
a	O
strong	O
predictor	O
of	O
schizophrenia	O
outcome	O
,	O
measured	O
as	O
according	O
to	O
either	O
clinical	O
or	O
to	O
social	O
variables	O
[	O
6	O
,	O
14	O
].	O

Saki	O
et	O
al	O
.,	O
showed	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
southern	O
Iranian	O
children	O
,	O
more	O
than	O
80	O
%	O
were	O
deficient	O
[	O
53	O
].	O

in	O
taxonomy	O
labels	O
indicate	O
that	O
the	O
level	O
of	O
taxonomy	O
is	O
family	O
,	O
genus	O
,	O
or	O
species	O
Discussion	O
We	O
observed	O
differences	O
in	O
both	O
overall	O
infant	O
gut	O
microbial	O
community	O
structure	O
and	O
specific	O
microbes	O
in	O
relation	O
to	O
maternal	O
dietary	O
factors	O
,	O
often	O
in	O
a	O
delivery	O
mode	O
-	O
dependent	O
pattern	O
.	O

Given	O
that	O
73	O
%	O
of	O
children	O
had	O
vitamin	O
D	O
deficiency	O
in	O
the	O
study	O
region	O
in	O
2005	O
,	O
12and	O
that	O
the	O
incidence	O
of	O
pneumonia	O
was	O
ten	O
-	O
times	O
higher	O
in	O
vitamin	O
D	O
deficient	O
children	O
than	O
in	O
children	O
without	O
a	O
deficiency	O
in	O
case	O
-	O
control	O
studies1	O
,	O
2we	O
postulated	O
that	O
there	O
would	O
be	O
at	O
least	O
a	O
35	O
%	O
reduction	O
in	O
pneumonia	O
incidence	O
in	O
the	O
vitamin	O
D	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

PubMed	O
Central	O
:	O

However	O
this	O
recommended	B
level	O
,	O
which	O
was	O
largely	O
arbitrarily	O
set	O
,	O
seems	O
to	O
be	O
less	O
helpful	O
to	O
improve	O
the	O
nutritional	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
.	O

Black	O
infants	O
with	O
vitamin	O
D	O
deficiency	O
had	O
2	O
.	O
4	O
greater	O
odds	O
of	O
SGA	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
0	O
,	O
5	O
.	O
8	O
)	O
after	O
adjusting	O
for	O
maternal	O
history	O
of	O
PIH	O
and	O
maternal	O
BMI	O
,	O
two	O
significant	O
confounding	O
variables	O
in	O
our	O
model	O
(	O
Table	O
3	O
).	O

Follow	O
-	O
up	O
of	O
a	O
smaller	O
proportion	O
of	O
child	O
participants	O
at	O
2	O
to	O
3	O
years	O
of	O
age	O
[	O
42	O
,	O
43	O
]	O
demonstrated	O
no	O
significant	O
differences	O
in	O
the	O
metabolic	O
profile	O
of	O
children	O
[	O
42	O
],	O
or	O
on	O
measures	O
of	O
growth	O
and	O
adiposity	O
[	O
43	O
].	O

In	O
our	O
study	O
,	O
the	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
of	O
the	O
maternal	O
serum	O
was	O
low	O
,	O
at	O
15	O
ng	O
/	O
ml	O
,	O
which	O
might	O
hinder	O
our	O
investigation	O
.	O

Conclusions	O
Antenatal	O
dietary	O
and	O
lifestyle	O
advice	O
did	O
not	O
alter	O
infant	O
growth	O
and	O
adiposity	O
at	O
6	O
-	O
months	O
of	O
age	O
.	O

It	O
would	O
be	O
of	B
interest	I
to	O
repeat	O
these	O
experiments	O
in	O
primary	O
cell	O
lines	O
of	O
syncytialised	O
trophoblasts	O
.	O

There	O
is	O
variation	O
in	O
haemoglobin	O
levels	O
during	O
pregnancy	O
;	O
at	O
the	O
beginning	O
of	O
a	O
pregnancy	O
,	O
there	O
is	O
a	O
normal	O
reduction	O
in	O
haemoglobin	O
level	O
followed	O
by	O
a	O
slight	O
rise	O
towards	O
the	O
end	O
of	O
pregnancy	O
[	O
2	O
].	O

This	O
study	O
was	O
conducted	O
to	O
evaluate	O
early	O
life	O
bone	O
mineral	O
content	O
(	O
BMC	O
)	O
and	O
the	O
effects	O
of	O
three	O
months	O
of	O
vitamin	O
D	O
supplementation	O
in	O
breast	O
-	O
fed	O
Hispanic	O
and	O
non	O
-	O
Hispanic	O
Caucasian	O
(	O
henceforth	O
,	O
"	O
Caucasian	O
")	O
infants	O
on	O
vitamin	O
D	O
levels	O
.	O

However	O
,	O
recent	O
animal	O
and	O
human	O
studies	O
indicate	O
that	O
acid	O
suppression	O
and	O
the	O
resulting	O
elevated	O
pH	O
in	O
the	O
stomach	O
may	O
lead	O
to	O
an	O
increased	O
risk	O
of	O
sensitization	O
to	O
food	O
[	O
86	O
,	O
87	O
].	O

On	O
the	O
other	O
hand	O
,	O
resting	O
HR	O
values	O
were	O
positive	O
correlated	O
with	O
BMI	O
(	O
r	O
=	O
0	O
.	O
300	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
blood	O
pressure	O
levels	O
(	O
SBP	O
:	O
r	O
=	O
0	O
.	O
382	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
DBP	O
:	O
r	O
=	O
0	O
.	O
317	O
,	O
P	O
=	O
0	O
.	O
001	O
).	O

Reducing	O
anaemia	O
rates	O
by	O
18	O
.	O
2	O
%	O
for	O
women	O
of	O
reproductive	O
age	O
therefore	O
constitutes	O
a	O
6	O
.	O
7	O
%	O
reduction	O
in	O
anaemia	O
on	O
average	O
in	O
the	O
labour	O
force	O
(	O
using	O
the	O
proportion	O
of	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
overall	O
labour	O
force	O
in	O
Vietnam	O
:	O
women	O
'	O
s	O
labour	O
force	O
participation	O
rate	O
is	O
similar	O
to	O
men	O
'	O
s	O
).	O

Regarding	O
female	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
a	O
main	O
effect	O
of	O
prenatal	O
diet	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
7	O
.	O
517	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
and	O
an	O
almost	O
significant	O
effect	O
of	O
treatment	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
3	O
.	O
928	O
,	O
P	O
=	O
0	O
.	O
056	O
]	O
on	O
chocolate	O
intake	O
(	O
Figure3G	O
).	O

Marked	O
improvement	O
was	O
seen	O
in	O
the	O
patient	O
'	O
s	O
hypernatremia	O
,	O
in	O
which	O
her	O
serum	O
sodium	O
concentrations	O
decreased	O
from	O
158	O
mEq	O
/	O
L	O
to143	O
mEq	O
/	O
L	O
within	O
30	O
hours	O
from	O
the	O
initial	O
DDAVP	O
dose	O
(	O
Figure	O
1	O
),	O
and	O
normalization	O
of	O
her	O
serum	O
osmolality	O
(	O
Figure	O
2	O
).	O

Cardiac	O
glycosides	O
in	O
the	O
venom	O
are	O
thought	O
to	O
inhibit	O
proteins	O
that	O
promote	O
cancer	O
cell	O
growth	O
,	O
thereby	O
causing	O
cancer	O
cell	O
death	O
.	O

The	O
authors	O
suggested	O
that	O
mild	O
heat	O
stress	O
in	O
summer	O
and	O
mild	O
cold	O
stress	O
in	O
winter	O
may	O
be	O
beneficial	O
to	O
fat	O
deposition	O
under	O
ad	O
libitum	O
feeding	O
conditions	O
for	O
cattle	O
fed	O
in	O
an	O
unprotected	O
,	O
unsheltered	O
area	O
.	O

Handwashing	O
behavior	O
may	O
have	O
been	O
different	O
earlier	O
in	O
the	O
newborn	O
period	O
,	O
when	O
threat	O
perceptions	O
may	O
have	O
been	O
higher	O
but	O
household	O
routines	O
may	O
have	O
been	O
disrupted	O
by	O
the	O
arrival	O
of	O
the	O
new	O
baby	O
.	O

Management	O
and	O
follow	O
-	O
up	O
of	O
thyroid	O
cancer	O
in	O
pregnant	O
women	O
AbstractSUMMARY	O
Thyroid	O
cancer	O
,	O
the	O
most	O
common	O
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
female	O
patients	O
.	O

However	O
,	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
bone	O
-	O
related	O
outcomes	O
in	O
supplemented	O
infants	O
provides	O
information	O
about	O
the	O
effects	O
of	O
these	O
cord	O
levels	O
and	O
vitamin	O
D	O
supplementation	O
in	O
early	O
infancy	O
.	O

The	O
coordination	O
of	O
several	O
factors	O
affects	O
IMF	O
deposition	O
.	O

Exposure	O
to	O
a	O
high	O
level	O
of	O
testosterone	O
during	O
the	O
earlier	O
part	O
of	O
pregnancy	O
is	O
thought	O
to	O
promote	O
right	O
brain	O
development	O
and	O
influence	O
hand	O
preference	O
,	O
although	O
the	O
evidence	O
in	O
support	O
of	O
a	O
relationship	O
is	O
not	O
conclusive	O
[	O
191	O
].	O

This	O
study	O
demonstrated	O
that	O
as	O
children	O
age	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
increases	O
.	O

Pre	O
-	O
eclampsia	O
is	O
a	O
known	O
independent	O
risk	O
factor	O
for	O
SGA	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
case	O
is	O
the	O
first	O
report	O
of	O
AAOC	O
in	O
pregnancy	O
.	O

Proteins	O
symbols	O
in	O
red	O
were	O
up	O
-	O
regulated	O
,	O
while	O
green	O
were	O
down	O
-	O
regulated	O
.	O

[	O
Mean	O
±	O
SD	O
or	O
Median	O
(	O
interquartile	O
range	O
)	O
or	O
n	O
(%)]	O
PPBMI	O
(	O
kg	O
/	O
m2	O
)	O
p	O
**	O
Total	O
(	O
n	O
=	O
76	O
)	O
<	O
25	O
(	O
n	O
=	O
21	O
)	O
≥	O
25	O
(	O
n	O
=	O
25	O
)	O
≥	O
30	O
(	O
n	O
=	O
30	O
)	O
Feature	O
Weight	O
gain	O
before	O
diagnosis	O
(	O
kg	O
)	O
8	O
,	O
1	O
(	O
2	O
,	O
2	O
–	O
11	O
,	O
1	O
)	O
9	O
.	O
0	O
(	O
7	O
,	O
6	O
-	O
11	O
,	O
1	O
)	O
a9	O
,	O
2	O
(	O
2	O
,	O
5	O
-	O
13	O
,	O
9	O
)	O
a3	O
,	O
4	O
(	O
0	O
,	O
1	O
-	O
9	O
.	O
0	O
)	O
b0	O
.	O
002	O
Below	O
the	O
recommended	O
26	O
(	O
34	O
,	O
2	O
)	O
4	O
(	O
19	O
.	O
0	O
)	O
7	O
(	O
28	O
.	O
0	O
)	O
15	O
(	O
50	O
.	O
0	O
)	O
0	O
,	O
166	O
Adequate	O
4	O
(	O
5	O
,	O
3	O
)	O
2	O
(	O
9	O
,	O
5	O
)	O
1	O
(	O
4	O
.	O
0	O
)	O
1	O
(	O
3	O
,	O
3	O
)	O
Above	O
the	O
recommended	O
46	O
(	O
60	O
,	O
5	O
)	O
15	O
(	O
71	O
,	O
4	O
)	O
17	O
(	O
68	O
.	O
0	O
)	O
14	O
(	O
46	O
,	O
7	O
)	O
BMI	O
at	O
diagnosis	O
(	O
kg	O
/	O
m2	O
)	O
32	O
,	O
2	O
±	O
5	O
,	O
826	O
,	O
1	O
±	O
2	O
.	O
0a30	O
,	O
9	O
±	O
3	O
,	O
1b37	O
,	O
5	O
±	O
4	O
,	O
5c	O
<	O
0	O
.	O
001	O
Low	O
weight	O
1	O
(	O
1	O
,	O
3	O
)	O
1	O
(	O
4	O
,	O
8	O
)	O
0	O
(	O
0	O
)	O
0	O
(	O
0	O
)<	O
0	O
.	O
001	O
Normal	O
weight	O
16	O
(	O
21	O
,	O
1	O
)	O
14	O
(	O
66	O
,	O
7	O
)*	O
2	O
(	O
8	O
.	O
0	O
)	O
0	O
(	O
0	O
)	O
Overweight	O
22	O
(	O
28	O
,	O
9	O
)	O
6	O
(	O
28	O
,	O
6	O
)	O
14	O
(	O
56	O
.	O
0	O
)*	O
2	O
(	O
6	O
,	O
7	O
)	O
Obesity	O
37	O
(	O
48	O
,	O
7	O
)	O
0	O
(	O
0	O
)	O
9	O
(	O
36	O
.	O
0	O
)	O
28	O
(	O
93	O
,	O
3	O
)*	O
a	O
,	O
b	O
,	O
c	O
=	O
mean	O
/	O
median	O
significantly	O
different	O
between	O
groups	O
*=	O
association	O
found	O
p	O
**=	O
comparison	O
between	O
groups	O
BMI	O
=	O
Body	O
Mass	O
Index	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Graphical	O
analysis	O
on	O
Bland	O
-	O
Altman	O
showing	O
agreement	O
between	O
the	O
average	O
of	O
energy	O
intake	O
and	O
recommendation	O
(	O
kcal	O
)	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
gestational	O
diabetes	O
mellitus	O
.	O

In	O
the	O
case	O
of	O
asthma	O
,	O
the	O
risk	O
of	O
uncontrolled	O
severe	O
asthma	O
(	O
which	O
may	O
include	O
maternal	O
or	O
fetal	O
mortality	O
)	O
would	O
usually	O
be	O
the	O
greater	O
risk	O
,	O
suggesting	O
that	O
oral	O
corticosteroids	O
must	O
still	O
be	O
used	O
when	O
indicated	O
for	O
the	O
management	O
of	O
severe	O
gestational	O
asthma	O
.	O

To	O
determine	O
the	O
effect	O
of	O
birth	O
weight	O
on	O
HRV	O
parameters	O
,	O
we	O
perform	O
multivariate	O
linear	O
regression	O
analysis	O
adjusted	O
for	O
potentially	O
confounding	O
factors	O
(	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
).	O

In	O
addition	O
,	O
microarray	O
analyses	O
demonstrated	O
that	O
many	O
transcripts	O
were	O
differentially	O
expressed	O
between	O
JEG	O
-	O
3	O
and	O
BeWo	O
cells	O
[	O
25	O
].	O

Conclusions	O
The	O
transcriptomic	O
modulations	O
point	O
to	O
persistent	O
functional	O
demand	O
on	O
the	O
liver	O
towards	O
cell	O
proliferation	O
in	O
the	O
LP	O
group	O
but	O
not	O
in	O
the	O
AP	O
group	O
at	O
identical	O
nutritional	O
conditions	O
during	O
postnatal	O
life	O
due	O
to	O
divergent	O
'	O
programming	O
'	O
of	O
the	O
genome	O
.	O

Whether	O
a	O
food	O
tastes	O
good	O
or	O
bad	O
and	O
the	O
pleasure	O
of	O
eating	O
is	O
a	O
complex	O
process	O
mediated	O
by	O
chemical	O
senses	O
in	O
the	O
periphery	O
and	O
multiple	O
brain	O
substrates	O
,	O
which	O
are	O
remarkably	O
well	O
conserved	O
phylogenetically	O
(	O
24	O
).	O

During	O
rapid	O
assessments	O
conducted	O
on	O
postnatal	O
days	O
4	O
-	O
5	O
,	O
the	O
proportion	O
of	O
households	O
observed	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
place	O
was	O
77	O
%	O
in	O
the	O
intervention	O
arm	O
and	O
27	O
%	O
in	O
the	O
control	O
arm	O
(	O
RR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
2	O
.	O
11	O
–	O
4	O
.	O
15	O
,	O
p	O
<	O
.	O
0001	O
)	O
(	O
Figure	O
3	O
).	O

In	O
addition	O
to	O
this	O
,	O
a	O
special	O
call	O
centre	O
will	O
be	O
set	O
up	O
centrally	O
where	O
trained	O
nutrition	O
counsellors	O
will	O
systematically	O
make	O
bi	O
-	O
weekly	O
calls	O
to	O
monitor	O
compliance	O
with	O
the	O
supplementation	O
regime	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Schedule	O
of	O
enrolment	O
,	O
interventions	O
,	O
and	O
assessments	O
Electronic	O
data	O
collection	O
tool	O
Data	O
will	O
be	O
captured	O
using	O
an	O
android	O
application	O
developed	O
using	O
Java	O
.	O

A	O
total	O
of	O
25	O
%	O
of	O
the	O
women	O
had	O
25OHD	O
concentrations	O
≥	O
100	O
nmol	O
/	O
L	O
at	O
T3	O
.	O

The	O
aim	O
was	O
to	O
include	O
22	O
women	O
in	O
each	O
cluster	O
of	O
which	O
11	O
in	O
the	O
first	O
trimester	O
and	O
11	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

While	O
DEP	O
was	O
associated	O
with	O
a	O
14	O
g	O
increase	O
in	O
birth	O
weight	O
in	O
the	O
combined	O
analysis	O
,	O
it	O
was	O
associated	O
with	O
a	O
51	O
g	O
increase	O
in	O
males	O
and	O
a	O
9	O
g	O
decrease	O
in	O
females	O
in	O
the	O
sex	O
stratified	O
analysis	O
.	O

Mice	O
were	O
outcrossed	O
to	O
DBA	O
/	O
2J	O
at	O
the	O
first	O
generation	O
(	O
G1	O
)	O
to	O
facilitate	O
mapping	O
using	O
a	O
panel	O
of	O
markers	O
polymorphic	O
between	O
129S1	O
and	O
DBA	O
/	O
2J	O
strains	O
,	O
and	O
second	O
generation	O
(	O
G2	O
)	O
progeny	O
were	O
backcrossed	O
to	O
G1	O
mice	O
to	O
generate	O
homozygosity	O
.	O

The	O
corresponding	O
RR	O
for	O
lean	O
women	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
was	O
3	O
.	O
23	O
(	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
30	O
.	O
41	O
)	O
and	O
9	O
.	O
83	O
(	O
95	O
%	O
CI	O
1	O
.	O
12	O
-	O
86	O
.	O
32	O
)	O
for	O
overweight	O
women	O
(≥	O
25	O
kg	O
/	O
m2	O
).	O

In	O
many	O
high	O
-	O
income	O
countries	O
and	O
those	O
with	O
emerging	O
economies	O
,	O
there	O
is	O
evidence	O
of	O
an	O
increase	O
in	O
late	O
preterm	O
deliveries	O
due	O
to	O
elective	O
inductions	O
and	O
caesareans	O
without	O
clear	O
medical	O
indication	O
[	O
38	O
].	O

The	O
participants	O
who	O
had	O
depression	O
scores	O
of	O
>	O
13	O
were	O
exited	O
from	O
this	O
clinical	O
trial	O
and	O
referred	O
to	O
psychiatrist	O
for	O
further	O
assessment	O
and	O
treatment	O
,	O
because	O
,	O
the	O
nature	O
of	O
our	O
study	O
was	O
preventative	O
than	O
management	O
.	O

Apart	O
from	O
the	O
long	O
-	O
term	O
health	O
consequences	O
,	O
severe	O
growth	O
-	O
restricted	O
foetuses	O
are	O
at	O
increased	O
risk	O
of	O
stillbirth	O
,	O
and	O
the	O
live	O
births	O
have	O
an	O
increased	O
risk	O
of	O
neonatal	O
death	O
,	O
morbidity	O
and	O
permanent	O
deficits	O
in	O
growth	O
and	O
neurocognitive	O
development	O
[	O
5	O
,	O
6	O
].	O

Both	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
corrected	O
by	O
applying	O
a	O
linear	O
regression	O
equation	O
(	O
Oct	O
2014	O
value	O
(	O
nmol	O
/	O
L	O
)	O
=	O
[(	O
early	O
2014	O
value	O
)	O
–	O
8	O
.	O
2	O
]	O
/	O
0	O
.	O
99	O
)	O
provided	O
by	O
the	O
manufacturer	O
because	O
of	O
methodological	O
changes	O
in	O
the	O
IDS	O
-	O
iSYS	O
system	O
between	O
2014	O
and	O
2016	O
(	O
see	O
Additional	O
file	O
1	O
).	O

Data	O
sources	O
for	O
UK	O
and	O
US	O
historical	O
data	O
:	O
(	O
CDC	O
,	O
2012	O
,	O
Office	O
for	O
National	O
Statistics	O
,	O
2012	O
,	O
NIH	O
,	O
1985	O
,	O
Smith	O
et	O
al	O
.,	O
1983	O
,	O
Jamison	O
et	O
al	O
.,	O
2006	O
,	O
Lissauer	O
and	O
Fanaroff	O
,	O
2006	O
,	O
Baker	O
,	O
2000	O
,	O
Philip	O
,	O
2005	O
,	O
Wegman	O
,	O
2001	O
)	O
[	O
54	O
-	O
62	O
].	O

The	O
protocol	O
was	O
also	O
reviewed	O
at	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
and	O
was	O
determined	O
to	O
be	O
public	O
health	O
practice	O
-	O
program	O
evaluation	O
.	O

We	O
will	O
use	O
physician	O
-	O
certified	O
verbal	O
autopsy	O
method	O
to	O
identify	O
cases	O
of	O
death	O
related	O
to	O
preterm	O
delivery	O
and	O
birth	O
asphyxia	O
using	O
the	O
hierarchical	O
assignment	O
of	O
causes	O
of	O
death	O
.	O

RPMM	O
was	O
selected	O
for	O
this	O
analysis	O
because	O
we	O
have	O
demonstrated	O
that	O
RPMM	O
provides	O
more	O
consistent	O
clustering	O
and	O
more	O
robustness	O
in	O
the	O
selection	O
of	O
the	O
number	O
of	O
classes	O
because	O
of	O
its	O
hierarchical	O
presentation	O
of	O
classes	O
,	O
compared	O
with	O
metric	O
hierarchical	O
clustering	O
,	O
for	O
this	O
data	O
set	O
[	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

Suzuki	O
et	O
al	O
.	O

One	O
child	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
above	O
four	O
SD	O
from	O
the	O
mean	O
and	O
was	O
excluded	O
from	O
subsequent	O
analyses	O
.	O

Any	O
medication	O
and	O
supplementation	O
use	O
is	O
also	O
recorded	O
daily	O
.	O

In	O
tandem	O
with	O
living	O
on	O
a	O
farm	O
,	O
infants	O
have	O
unique	O
vulnerabilities	O
that	O
may	O
lead	O
to	O
higher	O
levels	O
of	O
exposures	O
in	O
the	O
same	O
environment	O
than	O
adults	O
[	O
9	O
].	O

Autism	O
and	O
autism	O
spectrum	O
disorders	O
(	O
ASDs	O
),	O
including	O
Asperger	O
'	O
s	O
syndrome	O
and	O
pervasive	O
developmental	O
disorder	O
,	O
have	O
become	O
increasingly	O
diagnosed	O
over	O
the	O
past	O
decade	O
.	O

The	O
same	O
was	O
seen	O
for	O
the	O
father	O
and	O
his	O
mother	O
(	O
p	O
=	O
0	O
.	O
008	O
).	O

With	O
this	O
,	O
there	O
was	O
a	O
1	O
%	O
incidence	O
of	O
serious	O
perinatal	O
outcomes	O
(	O
death	O
,	O
shoulder	O
dystocia	O
,	O
fracture	O
,	O
and	O
nerve	O
palsy	O
)	O
compared	O
to	O
4	O
%	O
amongst	O
women	O
provided	O
with	O
standard	O
pregnancy	O
care	O
only	O
(	O
adjusted	O
risk	O
reduction	O
0	O
.	O
33	O
,	O
p	O
=	O
0	O
.	O
01	O
).	O

In	O
2002	O
/	O
2003	O
a	O
follow	O
-	O
up	O
study	O
was	O
initiated	O
,	O
and	O
women	O
who	O
had	O
responded	O
to	O
the	O
1991	O
/	O
1992	O
questionnaire	O
and	O
who	O
were	O
alive	O
and	O
living	O
in	O
Sweden	O
in	O
October	O
2002	O
were	O
contacted	O
.	O

Multilinear	O
regression	O
analysis	O
was	O
used	O
to	O
identify	O
significant	O
predictors	O
for	O
pre	O
-	O
pregnancy	O
maternal	O
weight	O
gain	O
.	O

Thus	O
,	O
managing	O
maternal	O
nutrition	O
is	O
a	O
potentially	O
effective	O
way	O
to	O
promote	O
adipogenesis	O
in	O
fetal	O
muscle	O
[	O
16	O
].	O

This	O
Zinc	O
-	O
finger	O
transcription	O
factor	O
induces	O
differentiation	O
of	O
brown	O
adipocytes	O
(	O
Seale	O
et	O
al	O
.,	O
2011	O
).	O

We	O
also	O
found	O
a	O
sex	O
effect	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Cnr2	O
,	O
and	O
Faah	O
in	O
liver	O
and	O
PAT	O
,	O
Mgll	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
in	O
liver	O
,	O
and	O
Dagl	O
α	O
and	O
Dagl	O
β	O
in	O
PAT	O
.	O

Those	O
identified	O
as	O
at	O
-	O
risk	O
include	O
:	O
Women	O
from	O
black	O
and	O
ethnic	O
minorities	O
who	O
are	O
socially	O
-	O
excluded	O
,	O
women	O
with	O
limited	O
exposure	O
to	O
sunlight	O
,	O
especially	O
those	O
who	O
are	O
housebound	O
and	O
obese	O
women	O
with	O
prepregnancy	O
BMI	O
>	O
30	O
.	O

At	O
10	O
days	O
of	O
age	O
,	O
generation	O
contributed	O
significantly	O
to	O
KM	O
(	O
P	O
<	O
0	O
.	O
0001	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

Furthermore	O
,	O
a	O
higher	O
proportion	O
of	O
the	O
women	O
in	O
the	O
middle	O
and	O
high	O
level	O
symptoms	O
groups	O
had	O
grown	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
than	O
women	O
in	O
the	O
low	O
level	O
symptoms	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

In	O
the	O
second	O
trimester	O
,	O
blood	O
volume	O
increases	O
by	O
45	O
%	O
with	O
an	O
increase	O
in	O
plasma	O
volume	O
of	O
50	O
%;	O
red	O
cell	O
mass	O
is	O
raised	O
by	O
35	O
%	O
which	O
amounts	O
to	O
about	O
450	O
mg	O
of	O
iron	O
in	O
a	O
55	O
kg	O
woman	O
[	O
4	O
].	O

The	O
selective	O
knock	O
-	O
out	O
of	O
SIRT1	O
in	O
hypothalamic	O
AgRP	O
neurons	O
diminished	O
response	O
to	O
hunger	O
-	O
inducing	O
hormone	O
ghrelin	O
,	O
reduced	O
food	O
intake	O
,	O
consequently	O
causing	O
decreased	O
lean	O
mass	O
and	O
body	O
weight	O
(	O
23	O
).	O

We	O
selected	O
infants	O
considered	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
;	O
<	O
10th	O
percentile	O
of	O
birth	O
weight	O
)	O
and	O
matched	O
non	O
-	O
SGA	O
infants	O
to	O
these	O
for	O
infant	O
sex	O
,	O
maternal	O
age	O
(±	O
3	O
years	O
),	O
and	O
gestational	O
age	O
(±	O
2	O
days	O
).	O

It	O
is	O
also	O
possible	O
that	O
the	O
milieu	O
of	O
higher	O
melatonin	O
and	O
insulin	O
resistance	O
during	O
winter	O
in	O
early	O
pregnancy	O
may	O
set	O
the	O
scene	O
for	O
glucose	O
homeostasis	O
throughout	O
the	O
remaining	O
months	O
of	O
pregnancy	O
.	O

Multiple	O
regression	O
analyses	O
were	O
then	O
conducted	O
to	O
determine	O
the	O
most	O
robust	O
set	O
of	O
predictors	O
of	O
offspring	O
weight	O
parameters	O
after	O
adjustment	O
for	O
treatment	O
group	O
,	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
(	O
in	O
6	O
-	O
month	O
analyses	O
).	O

Biochemical	O
analyses	O
Haemoglobin	O
is	O
determined	O
on	O
site	O
in	O
whole	O
blood	O
(	O
20	O
μL	O
)	O
using	O
HemoCue	O
(	O
Hb	O
201	O
+,	O
Ängelholm	O
,	O
Sweden	O
).	O

The	O
major	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
glomerular	O
development	O
and	O
renal	O
structure	O
at	O
birth	O
,	O
10	O
days	O
and	O
adulthood	O
in	O
mice	O
born	O
to	O
mothers	O
fed	O
a	O
diet	O
restricted	O
in	O
vitamin	O
D	O
.	O
Although	O
,	O
we	O
examined	O
other	O
variables	O
,	O
such	O
as	O
body	O
mass	O
and	O
24	O
h	O
urine	O
,	O
the	O
present	O
study	O
was	O
not	O
designed	O
to	O
investigate	O
renal	O
functional	O
and	O
metabolic	O
consequences	O
but	O
rather	O
was	O
designed	O
to	O
answer	O
the	O
question	O
of	O
whether	O
there	O
were	O
structural	O
,	O
glomerular	O
alterations	O
or	O
transgenerational	O
effects	O
.	O

The	O
risk	O
was	O
also	O
lower	O
for	O
women	O
with	O
a	O
high	O
intake	O
of	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
PUFA	O
compared	O
to	O
women	O
with	O
a	O
lower	O
intake	O
of	O
these	O
fatty	O
acids	O
.	O

Leukotriene	O
modifiers	O
may	O
be	O
used	O
as	O
alternative	O
add	O
-	O
on	O
treatment	O
;	O
montelukast	O
and	O
zafirlukast	O
are	O
the	O
preferred	O
antileukotriene	O
drugs	O
(	O
but	O
zileuton	O
is	O
not	O
).	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	O
that	O
metformin	O
is	O
superior	O
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	O
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	O
on	O
fetal	O
insulin	O
resistance	O
might	O
even	O
provide	O
further	O
benefit	O
in	O
light	O
of	O
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	O
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	O
be	O
viewed	O
with	O
caution	O
as	O
there	O
always	O
remains	O
the	O
possibility	O
of	O
unexpected	O
long	O
-	O
term	O
effects	O
.	O

Both	O
the	O
tails	O
and	O
globular	O
domains	O
of	O
histones	O
can	O
undergo	O
multiple	O
posttranslational	O
modifications	O
,	O
including	O
acetylation	O
,	O
methylation	O
,	O
phosphorylation	O
,	O
ADP	O
ribosylation	O
,	O
ubiquitination	O
and	O
sumoylation	O
,	O
giving	O
rise	O
to	O
the	O
so	O
-	O
called	O
histone	O
code	O
(	O
Strahl	O
&	O
Allis2000	O
;	O
Turner2000	O
;	O
Jenuwein	O
&	O
Allis2001	O
;	O
Bhaumik	O
et	O
al	O
.	O
2007	O
;	O
Kouzarides2007	O
;	O
Suganuma	O
&	O
Workman2011	O
).	O

*	O
Studies	O
directly	O
sampling	O
the	O
target	O
tissue	O
or	O
validating	O
the	O
same	O
change	O
in	O
the	O
blood	O
and	O
target	O
tissue	O
of	O
an	O
appropriate	O
in	O
vivo	O
model	O
.	O

Staying	O
on	O
vitamin	O
D	O
consumption	O
until	O
childbirth	O
resulted	O
in	O
higher	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
that	O
induced	O
the	O
effect	O
on	O
postnatal	O
depression	O
exceeding	O
than	O
prenatal	O
depression	O
.	O

Potentially	O
the	O
most	O
significant	O
nutritional	O
intervention	O
has	O
been	O
the	O
prenatal	O
supplementation	O
of	O
folate	O
,	O
which	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
neural	O
tube	O
defects	O
[	O
3	O
],	O
limb	O
malformations	O
,	O
urogenital	O
abnormalities	O
,	O
cardiovascular	O
malformations	O
[	O
4	O
],	O
and	O
cleft	O
lip	O
or	O
palate	O
[	O
5	O
].	O

CHL	O
is	O
measured	O
by	O
placing	O
the	O
newborn	O
in	O
supine	O
position	O
on	O
the	O
tape	O
measure	O
on	O
a	O
flat	O
surface	O
with	O
all	O
limbs	O
extended	O
and	O
measurement	O
taken	O
from	O
vertex	O
to	O
heel	O
of	O
foot	O
,	O
with	O
foot	O
held	O
in	O
a	O
perpendicular	O
position	O
to	O
the	O
leg	O
.	O

Innovate	O
•	O
Generate	O
and	O
disseminate	O
evidence	O
on	O
preterm	O
birth	O
and	O
provide	O
a	O
platform	O
for	O
sharing	O
best	O
practices	O
,	O
and	O
use	O
the	O
UN	O
Commodities	O
Commission	O
to	O
address	O
gaps	O
for	O
essential	O
equipment	O
and	O
medicines	O
(	O
e	O
.	O
g	O
.,	O
antenatal	O
corticosteroids	O
).	O

Children	O
were	O
asked	O
to	O
avoid	O
physical	O
activity	O
and	O
to	O
consume	O
liquids	O
2	O
hours	O
before	O
evaluation	O
to	O
prevent	O
errors	O
in	O
measurement	O
due	O
to	O
fluid	O
imbalances	O
.	O

We	O
excluded	O
stillbirths	O
,	O
those	O
who	O
declined	O
to	O
participate	O
,	O
those	O
with	O
obstetric	O
pathology	O
,	O
or	O
psychiatric	O
,	O
cognitive	O
or	O
other	O
disease	O
that	O
might	O
adversely	O
affect	O
understanding	O
of	O
the	O
study	O
objectives	O
or	O
the	O
ability	O
to	O
provide	O
accurate	O
information	O
.	O

The	O
BPA	O
,	O
TCDD	O
,	O
alcohol	O
and	O
smoking	O
-	O
related	O
evidence	O
is	O
particularly	O
compelling	O
as	O
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	O
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

Questionnaire	O
data	O
were	O
systematically	O
checked	O
for	O
errors	O
during	O
data	O
entry	O
by	O
using	O
legal	O
values	O
and	O
specified	O
ranges	O
in	O
Epi	O
-	O
info	O
.	O

White	O
children	O
had	O
a	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
35	O
.	O
1	O
ng	O
/	O
mL	O
(	O
87	O
.	O
8	O
nmol	O
/	O
L	O
)	O
at	O
the	O
follow	O
-	O
up	O
visit	O
,	O
which	O
was	O
also	O
found	O
to	O
be	O
significantly	O
higher	O
than	O
both	O
Black	O
and	O
Hispanic	O
children	O
with	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
22	O
.	O
5	O
ng	O
/	O
mL	O
(	O
56	O
.	O
3	O
nmol	O
/	O
L	O
)	O
and	O
25	O
.	O
4	O
ng	O
/	O
mL	O
(	O
63	O
.	O
5	O
nmol	O
/	O
L	O
),	O
respectively	O
(	O
p	O
≤	O
0	O
.	O
0001	O
and	O
≤	O
0	O
.	O
0001	O
,	O
respectively	O
).	O

In	O
summary	O
,	O
some	O
investigations	B
have	O
shown	O
an	O
association	O
between	O
length	O
of	O
labor	O
and	O
autism	O
,	O
but	O
findings	O
have	O
been	O
inconsistent	O
owing	O
to	O
differences	O
in	O
sampling	O
and	O
methods	O
.	O

Sensible	O
sun	O
exposure	O
and	O
education	O
of	O
the	O
public	O
about	O
the	O
beneficial	O
effects	O
of	O
some	O
limited	O
sun	O
exposure	O
to	O
satisfy	O
their	O
body	O
'	O
s	O
vitamin	O
D	O
requirements	O
should	B
be	I
implemented	O
.	O

Findings	O
from	O
the	O
present	O
study	O
demonstrated	O
that	O
children	O
with	O
low	O
birth	O
weight	O
have	O
abnormal	O
autonomic	O
modulation	O
,	O
suggesting	O
that	O
variation	O
in	O
birth	O
weight	O
seems	O
associated	O
with	O
the	O
differences	O
in	O
autonomic	O
function	O
observed	O
in	O
later	O
childhood	O
.	O

Vitamin	O
D	O
status	O
of	O
children	O
with	O
severe	O
early	O
childhood	O
caries	O
:	O
a	O
case	O
–	O
control	O
study	O
Abstract	O
Background	O
Severe	O
Early	O
Childhood	O
Caries	O
(	O
S	O
-	O
ECC	O
)	O
affects	O
the	O
health	O
and	O
well	O
-	O
being	O
of	O
young	O
children	O
.	O

Serum	O
was	O
stored	O
at	O
−	O
70	O
°	O
C	O
until	O
analysis	O
of	O
25OHD	O
.	O

One	O
ecological	O
study	O
reported	O
a	O
correlation	O
between	O
perinatal	O
consumption	O
of	O
sugar	O
and	O
severe	O
childhood	O
asthma	O
symptoms	O
[	O
9	O
],	O
but	O
could	O
not	O
specifically	O
address	O
maternal	O
sugar	O
intake	O
in	O
pregnancy	O
.	O

Visible	O
skeletal	O
malformations	O
in	O
Skm1	O
(	O
B	O
)	O
mice	O
and	O
Skm2	O
(	O
C	O
)	O
mice	O
.	O

Offspring	O
then	O
were	O
fed	O
either	O
a	O
control	O
or	O
a	O
high	O
fat	O
diet	O
from	O
the	O
time	O
of	O
weaning	O
to	O
adulthood	O
.	O

Information	O
from	O
a	O
questionnaire	O
at	O
recruitment	O
and	O
from	O
the	O
obstetric	O
records	O
was	O
used	O
to	O
classify	O
women	O
into	O
four	O
mutually	O
exclusive	O
categories	O
:	O
no	O
evidence	O
of	O
glycosuria	O
or	O
diabetes	O
,	O
existing	O
diabetes	O
mellitus	O
before	O
the	O
pregnancy	O
,	O
gestational	O
diabetes	O
and	O
persistent	O
glycosuria	O
during	O
pregnancy	O
.	O

Statistical	O
analysis	O
Data	O
was	O
blinded	O
until	O
completion	O
of	O
the	O
analysis	O
,	O
which	O
was	O
performed	O
on	O
an	O
intention	O
-	O
to	O
-	O
treat	O
basis	O
.	O

Although	O
not	O
contraindicated	O
,	O
skin	O
prick	O
testing	O
should	B
be	I
postponed	O
until	O
after	O
birth	O
because	O
of	O
possible	O
,	O
although	O
rare	O
,	O
anaphylactic	O
reactions	O
to	O
skin	O
prick	O
testing	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
MelbourneTraining	O
of	O
trainers	O
amortized	O
over	O
5	O
years	O
:	O
USD85	O
.	O
67	O
/	O
year	O
;	O
training	O
of	O
local	O
health	O
staff	O
USD10	O
/	O
person	O
,	O
2000	O
staff	O
,	O
amortized	O
over	O
5	O
years	O
.	O

Average	O
hours	O
of	O
sunlight	O
per	O
day	O
in	O
Adelaide	O
from	O
September	O
2005	O
to	O
September	O
2008	O
were	O
obtained	O
from	O
the	O
Australian	O
Government	O
Bureau	O
of	O
Meteorology	O
and	O
compared	O
against	O
serum	O
vitamin	O
D	O
measured	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Fig	O
.	O

Simultaneous	O
with	O
the	O
above	O
two	O
Acta	O
Paediatrica	O
publications	O
,	O
a	O
paper	O
elsewhere	O
reported	O
that	O
among	O
117	O
adult	O
psychiatric	O
outpatients	O
is	O
Sweden	O
with	O
various	O
diagnoses	O
,	O
the	O
10	O
patients	O
with	O
autism	O
had	O
the	O
lowest	O
vitamin	O
D	O
levels	O
of	O
any	O
of	O
the	O
groups	O
studied	O
,	O
a	O
mean	O
of	O
12	O
ng	O
/	O
mL	O
(	O
31	O
nM	O
),	O
approaching	O
the	O
osteomalacic	O
range	O
for	O
adults	O
and	O
the	O
rachitic	O
range	O
for	O
children	O
(	O
6	O
).	O

BMI	O
Table	O
3displays	O
raw	O
BMI	O
correlations	O
for	O
the	O
index	O
child	O
with	O
family	O
members	O
together	O
with	O
the	O
sample	O
size	O
.	O

However	O
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

Maternal	O
average	O
nightly	O
sleep	O
duration	O
during	O
pregnancy	O
was	O
ascertained	O
by	O
asking	O
women	O
the	O
following	O
question	O
:	O
"	O
Since	O
becoming	O
pregnant	O
,	O
how	O
many	O
hours	O
per	O
night	O
do	O
you	O
sleep	O
?"	O

Risk	O
for	O
glioma	O
also	O
is	O
nearly	O
equal	O
for	O
left	O
-	O
handed	O
and	O
ambidextrous	O
individuals	O
but	O
higher	O
for	O
right	O
-	O
handers	O
.	O

The	O
transfer	O
of	O
maternal	O
cytokines	O
was	O
confirmed	O
in	O
a	O
study	O
of	O
suckling	O
piglets	O
[	O
65	O
].	O

Twelve	O
mothers	O
of	O
our	O
13	O
infants	O
with	O
IIH	O
received	O
antenatal	O
vitamin	O
D3supplementation	O
.	O

In	O
accordance	O
to	O
a	O
guideline	O
by	O
Holick	O
et	O
al	O
.,	O
6	O
–	O
8	O
weeks	O
consumption	O
of	O
a	O
high	O
dose	O
vitamin	O
D	O
supplement	O
are	O
essential	O
to	O
obtain	O
an	O
adequate	O
blood	O
reserves	O
of	O
vitamin	O
D	O
[	O
19	O
].	O

EDC	O
concentrations	O
were	O
quantified	O
in	O
blood	O
and	O
urine	O
samples	O
collected	O
at	O
16	O
and	O
26	O
weeks	O
gestation	O
.	O

In	O
fact	O
,	O
children	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
below	O
this	O
threshold	O
were	O
twice	O
as	O
likely	O
to	O
have	O
S	O
-	O
ECC	O
.	O

There	O
was	O
no	O
significant	O
relationship	O
between	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
BMC	O
or	O
BMD	O
in	O
the	O
first	O
week	O
of	O
life	O
(	O
n	O
=	O
49	O
)	O
or	O
after	O
3	O
months	O
of	O
vitamin	O
D	O
supplementation	O
.	O

Both	O
papers	O
describe	O
‘	O
weak	O
mindedness	O
,’‘	O
feeble	O
minds	O
,’‘	O
mental	O
dullness	O
,’	O
unresponsiveness	O
and	O
developmental	O
delays	O
.	O

Lives	O
saved	O
modelling	O
for	O
preterm	O
mortality	O
reduction	O
A	O
Lives	O
Saved	O
Tool	O
(	O
LiST	O
)	O
analysis	O
examining	O
projected	O
lives	O
saved	O
with	O
interventions	O
for	O
preterm	O
birth	O
was	O
conducted	O
for	O
75	O
Countdown	O
to	O
2015	O
priority	O
countries	O
(	O
These	O
countries	O
are	O
:	O
Afghanistan	O
,	O
Angola	O
,	O
Azerbaijan	O
,	O
Bangladesh	O
,	O
Benin	O
,	O
Bolivia	O
,	O
Botswana	O
,	O
Brazil	O
,	O
Burkina	O
Faso	O
,	O
Burundi	O
,	O
Cambodia	O
,	O
Cameroon	O
,	O
Central	O
African	O
Republic	O
,	O
Chad	O
,	O
China	O
,	O
Comoros	O
,	O
Congo	O
,	O
Democratic	O
Republic	O
of	O
the	O
Congo	O
,	O
Côte	O
d	O
'	O
Ivoire	O
,	O
Djibouti	O
,	O
Egypt	O
,	O
Equatorial	O
Guinea	O
,	O
Eritrea	O
,	O
Ethiopia	O
,	O
Gabon	O
,	O
The	O
Gambia	O
,	O
Ghana	O
,	O
Guatemala	O
,	O
Guinea	O
,	O
Guinea	O
-	O
Bissau	O
,	O
Haiti	O
,	O
India	O
,	O
Indonesia	O
,	O
Iraq	O
,	O
Kenya	O
,	O
Democratic	O
Republic	O
of	O
Korea	O
,	O
Kyrgyz	O
Republic	O
,	O
Lao	O
People	O
'	O
s	O
Democratic	O
Republic	O
,	O
Lesotho	O
,	O
Liberia	O
,	O
Madagascar	O
,	O
Malawi	O
,	O
Mali	O
,	O
Mauritania	O
,	O
Mexico	O
,	O
Morocco	O
,	O
Mozambique	O
,	O
Myanmar	O
,	O
Nepal	O
,	O
Niger	O
,	O
Nigeria	O
,	O
Pakistan	O
,	O
Papua	O
New	O
Guinea	O
,	O
Peru	O
,	O
Philippines	O
,	O
Rwanda	O
,	O
Sao	O
Tome	O
and	O
Principe	O
,	O
Senegal	O
,	O
Sierra	O
Leone	O
,	O
Solomon	O
Islands	O
,	O
Somalia	O
,	O
South	O
Africa	O
,	O
South	O
Sudan	O
,	O
Sudan	O
,	O
Swaziland	O
,	O
Tajikistan	O
,	O
United	O
Republic	O
of	O
Tanzania	O
,	O
Togo	O
,	O
Turkmenistan	O
,	O
Uganda	O
,	O
Uzbekistan	O
,	O
Vietnam	O
,	O
Yemen	O
,	O
Zambia	O
,	O
and	O
Zimbabwe	O
.).	O

Furthermore	O
,	O
the	O
transcriptional	O
adaptations	O
may	O
have	O
consequences	O
for	O
the	O
offspring	O
'	O
s	O
phenotype	O
,	O
including	O
alterations	O
of	O
plasma	O
parameters	O
[	O
44	O
-	O
46	O
,	O
50	O
],	O
hepatic	O
histology	O
[	O
46	O
]	O
and	O
body	O
composition	O
[	O
47	O
].	O

A	O
strong	O
,	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
VD	O
and	O
sperm	O
motility	O
and	O
morphology	O
was	O
also	O
found	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

It	O
is	O
known	O
that	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D	O
is	O
responsible	O
for	O
increasing	O
intracellular	O
Ca	O
+	O
2concentration	O
and	O
the	O
activity	O
of	O
acrosine	O
,	O
which	O
is	O
accountable	O
for	O
acrosome	O
reactions	O
that	O
are	O
essential	O
for	O
the	O
fertilization	O
process	O
.	O

It	O
is	O
important	O
to	O
recognize	O
that	O
many	O
individuals	O
who	O
use	O
text	O
messages	O
receive	O
large	O
numbers	O
of	O
texts	O
per	O
day	O
.	O

Dietary	O
sources	O
of	O
vitamin	O
D	O
include	O
:	O
Fatty	O
fish	O
species	O
,	O
such	O
as	O
Catfish	O
,	O
Salmon	O
,	O
Mackerel	O
,	O
Tuna	O
etc	O
.,	O
egg	O
,	O
beef	O
and	O
fish	O
liver	O
oils	O
.	O

(	O
a	O
).	O

Linoleic	O
acid	O
is	O
the	O
parent	O
fatty	O
acid	O
of	O
the	O
omega	O
-	O
6	O
family	O
,	O
and	O
the	O
main	O
source	O
in	O
a	O
typical	O
Swedish	O
diet	O
is	O
vegetable	O
oil	O
(	O
such	O
as	O
corn	O
oil	O
,	O
sunflower	O
oil	O
,	O
soy	O
oil	O
,	O
rapeseed	O
oil	O
and	O
margarine	O
).	O

For	O
fatty	O
fish	O
(	O
herring	O
/	O
mackerel	O
,	O
salmon	O
-	O
type	O
fish	O
),	O
the	O
strongest	O
inverse	O
association	O
was	O
found	O
for	O
an	O
intermediate	O
intake	O
(	O
RR	O
:	O
0	O
.	O
81	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
66	O
-	O
0	O
.	O
98	O
),	O
whereas	O
a	O
high	O
intake	O
of	O
fatty	O
fish	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(	O
RR	O
:	O
1	O
.	O
90	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
34	O
-	O
2	O
.	O
70	O
).	O

Some	O
of	O
the	O
results	O
presented	O
above	O
suggest	O
restricted	O
nutrition	O
at	O
certain	O
stages	O
of	O
pregnancy	O
has	O
more	O
favourable	O
outcomes	O
.	O

The	O
mean	O
score	O
was	O
11	O
.	O
0	O
(	O
95	O
%	O
CI	O
,	O
10	O
.	O
5	O
-	O
11	O
.	O
5	O
)	O
and	O
standard	O
deviation	O
was	O
4	O
.	O
8	O
(	O
Table	O
1	O
).	O

However	O
,	O
when	O
LMP	O
was	O
determined	O
to	O
be	O
unreliable	O
,	O
we	O
calculated	O
gestational	O
age	O
at	O
delivery	O
using	O
data	O
from	O
an	O
ultrasound	O
.	O

When	O
the	O
data	O
were	O
stratified	O
by	O
gender	O
in	O
post	O
-	O
hoc	O
analyses	O
,	O
only	O
the	O
male	O
population	O
continued	O
to	O
demonstrate	O
this	O
correlation	O
(	O
ρ	O
=	O
0	O
.	O
292	O
,	O
p	O
=	O
0	O
.	O
014	O
),	O
while	O
females	O
did	O
not	O
(	O
ρ	O
=	O
0	O
.	O
103	O
,	O
p	O
=	O
0	O
.	O
425	O
).	O

It	O
should	B
also	O
be	O
noted	O
that	O
,	O
despite	O
ongoing	O
research	O
efforts	O
,	O
relatively	O
little	O
has	O
yet	O
been	O
divulged	O
regarding	O
delivery	O
-	O
room	O
attributes	O
that	O
may	O
be	O
directly	O
or	O
indirectly	O
associated	O
with	O
the	O
incidence	O
of	O
autism	O
.	O

Results	O
:	O
Only	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
[	O
β	O
=	O
3	O
.	O
1	O
nmol	O
/	O
L	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
<	O
0	O
.	O
004	O
].	O

The	O
study	O
was	O
approved	O
as	O
minimal	O
risk	O
research	O
by	O
the	O
Madigan	O
Institutional	O
Review	O
Board	O
(	O
IRB	O
)	O
on	O
July	O
26	O
,	O
2011	O
.	O

Information	O
on	O
medical	O
and	O
reproductive	O
histories	O
and	O
sociodemographic	O
and	O
lifestyle	O
characteristics	O
including	O
average	O
number	O
of	O
hours	O
of	O
sleep	O
before	O
and	O
during	O
early	O
pregnancy	O
was	O
collected	O
.	O

Randomisation	O
was	O
by	O
use	O
of	O
a	O
computer	O
-	O
generated	O
list	O
.	O

In	O
this	O
study	O
,	O
data	O
collection	O
lasted	O
from	O
November	O
2014	O
until	O
early	O
October	O
2015	O
.	O

The	O
serum	O
Phosphorus	O
before	O
and	O
after	O
the	O
intervention	O
in	O
each	O
group	O
or	O
between	O
the	O
two	O
groups	O
was	O
not	O
significant	O
.	O

Others	O
have	O
also	O
reported	O
that	O
rampant	O
caries	O
can	O
negatively	O
impact	O
nutritional	O
health	O
status	O
and	O
well	O
-	O
being	O
[	O
3	O
,	O
10	O
,	O
13	O
,	O
35	O
].	O

Several	O
maternal	O
demographic	O
characteristics	O
predicted	O
birth	O
weight	O
,	O
including	O
age	O
,	O
race	O
,	O
marital	O
status	O
,	O
annual	O
household	O
income	O
,	O
public	O
or	O
no	O
insurance	O
and	O
other	O
SES	O
variables	O
.	O

The	O
result	O
was	O
that	O
196	O
participants	O
will	O
be	O
required	O
.	O

Therefore	O
,	O
the	O
high	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
in	O
infants	O
may	O
explain	O
that	O
low	O
cord	O
—	O
but	O
not	O
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	O
to	O
poor	O
lung	O
function	O
and	O
increased	O
risk	O
of	O
respiratory	O
infection	O
in	O
this	O
study	O
.	O

Although	O
their	O
safety	O
has	O
not	O
been	O
proven	O
,	O
it	O
is	O
often	O
rationalized	O
that	O
a	O
change	O
in	O
the	O
basal	O
insulin	O
will	O
result	O
in	O
deterioration	O
in	O
glycemic	O
control	O
,	O
and	O
therefore	O
the	O
risk	O
of	O
continuing	O
glargine	O
is	O
less	O
than	O
the	O
risk	O
from	O
changing	O
insulins	O
.	O

Overall	O
,	O
the	O
sample	O
was	O
predominantly	O
white	O
(	O
69	O
.	O
6	O
%,	O
656	O
/	O
943	O
),	O
with	O
a	O
mean	O
age	O
of	O
26	O
.	O
5	O
(	O
SD	O
74	O
.	O
4	O
)	O
years	O
.	O

In	O
addition	O
,	O
large	O
human	O
cohorts	O
that	O
have	O
recruited	O
participants	O
at	O
birth	O
for	O
long	O
-	O
term	O
follow	O
up	O
with	O
comprehensive	O
data	O
and	O
sample	O
collection	O
,	O
such	O
as	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
cohort	O
(	O
Boyd	O
et	O
al	O
.	O
2013	O
),	O
provide	O
a	O
wealth	O
of	O
information	O
to	O
investigate	O
epidemiological	O
links	O
between	O
specific	O
environmental	O
exposures	O
and	O
public	O
health	O
outcomes	O
.	O

Bodnar	O
et	O
al	O
.	O

It	O
can	O
be	O
concluded	O
that	O
women	O
with	O
low	O
socioeconomic	O
status	O
need	B
specific	O
dietary	O
intervention	O
programs	O
due	O
to	O
increase	O
in	O
nutritional	O
demands	O
during	O
pregnancy	O
.	O

Authors	O
reported	O
that	O
fish	O
consumption	O
two	O
to	O
three	O
times	O
per	O
week	O
during	O
pregnancy	O
was	O
beneficial	O
for	O
children	O
who	O
were	O
breastfed	O
for	O
less	O
than	O
six	O
months	O
.	O

It	O
was	O
also	O
used	O
previously	O
to	O
assess	O
individual	O
and	O
total	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
fatty	O
acid	O
intake	O
in	O
a	O
rural	O
and	O
urban	O
South	O
-	O
African	O
population	O
[	O
42	O
].	O

In	O
summary	O
,	O
we	O
found	O
some	O
evidence	O
of	O
a	O
protective	O
effect	O
of	O
influenza	O
vaccination	O
by	O
trimester	O
on	O
birth	O
outcomes	O
;	O
however	O
,	O
we	O
encourage	B
further	B
investigation	I
by	O
prioritizing	O
prospective	O
cohort	O
designs	O
over	O
retrospective	O
studies	O
to	O
minimize	O
selection	O
and	O
recall	O
biases	O
.	O

The	O
exclusion	O
of	O
17	O
women	O
with	O
implausible	O
energy	O
intake	O
estimates	O
did	O
not	O
alter	O
the	O
main	O
results	O
nor	O
did	O
exclusion	O
of	O
mothers	O
with	O
diabetes	O
.	O

Previous	O
researches	O
have	O
demonstrated	O
metabolic	O
alterations	O
after	O
undernutrition	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

Any	O
drug	O
may	O
carry	O
a	O
small	O
risk	O
that	O
must	O
be	O
balanced	O
against	O
the	O
benefits	O
of	O
keeping	O
the	O
mother	O
and	O
baby	O
healthy	O
.	O

Thus	O
,	O
all	O
the	O
machinery	O
involved	O
in	O
these	O
pathways	O
,	O
including	O
DNA	O
and	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
,	O
are	O
epigenetically	O
important	O
.	O

This	O
study	O
finds	O
that	O
85	O
.	O
7	O
%	O
of	O
pregnant	O
women	O
received	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
Their	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
those	O
without	O
supplement	O
use	O
.	O

The	O
independent	O
and	O
paired	O
t	O
-	O
test	O
were	O
used	O
for	O
normally	O
distributed	O
quantitative	O
variables	O
,	O
the	O
chi	O
-	O
square	O
test	O
was	O
used	O
for	O
qualitative	O
variables	O
,	O
and	O
the	O
Mann	O
-	O
Whitney	O
U	O
and	O
Wilcoxon	O
Signed	O
-	O
Rank	O
tests	O
were	O
used	O
for	O
non	O
-	O
normally	O
distributed	O
variables	O
.	O

In	O
a	O
recently	O
published	O
meta	O
-	O
analysis	O
,[	O
12	O
]	O
6	O
cohort	O
studies	O
evaluating	O
the	O
relationship	O
between	O
first	O
trimester	O
maternal	O
use	O
of	O
oral	O
corticosteroids	O
and	O
congenital	O
malformations	O
did	O
not	O
show	O
an	O
increased	O
risk	O
of	O
congenital	O
malformations	O
(	O
summary	O
odds	O
ratio	O
,	O
1	O
.	O
45	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
08	O
-	O
2	O
.	O
60	O
).	O

Similarly	O
,	O
indoor	O
-	O
outdoor	O
pets	O
are	O
efficient	O
carriers	O
of	O
agents	O
into	O
the	O
home	O
,	O
and	O
also	O
pose	O
an	O
exposure	O
source	O
for	O
pesticides	O
from	O
anti	O
flea	O
/	O
tick	O
collars	O
,	O
sprays	O
,	O
and	O
shampoos	O
.	O

In	O
this	O
way	O
,	O
hundreds	O
of	O
thousands	O
of	O
lives	O
could	O
be	O
saved	O
with	O
the	O
application	O
of	O
current	O
knowledge	O
.	O

DNMT1	O
,	O
the	O
maintenance	O
DNMT	O
,	O
preferentially	O
methylates	O
hemimethylated	O
DNA	O
and	O
thus	O
maintains	O
DNA	O
methylation	O
following	O
DNA	O
replication	O
.	O

DISCUSSION	O
We	O
found	O
the	O
same	O
results	O
as	O
studies	O
in	O
Europe	O
and	O
North	O
America	O
,	O
which	O
implicates	O
lower	O
serum	O
vitamin	O
D	O
level	O
in	O
MS	O
patients	O
than	O
in	O
normal	O
population	O
,	O
in	O
spite	O
of	O
sufficient	O
sun	O
exposure	O
in	O
Isfahan	O
region	O
.	O
23815The	O
hypothesis	O
that	O
vitamin	O
D	O
deficiency	O
is	O
a	O
risk	O
factor	O
for	O
MS	O
was	O
first	O
proposed	O
over	O
30	O
years	O
ago4and	O
gained	O
credibility	O
after	O
the	O
discovery	O
of	O
the	O
immunomodulatory	O
effects	O
of	O
vitamin	O
D	O
.	O
5Moreover	O
,	O
in	O
the	O
past	O
few	O
years	O
,	O
the	O
epidemiological	O
evidence	O
of	O
an	O
increased	O
MS	O
risk	O
among	O
individuals	O
with	O
low	O
vitamin	O
D	O
concentrations	O
has	O
achieved	O
substantial	O
strength	O
.	O

Vitamin	O
D	O
metabolism	O
in	O
the	O
placenta	O
has	O
been	O
shown	O
to	O
be	O
influenced	O
by	O
testosterone	O
production	O
and	O
thus	O
varies	O
by	O
fetal	O
sex	O
[	O
35	O
].	O

T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
(	O
equal	O
to	O
40	O
ng	O
/	O
ml	O
)	O
was	O
associated	O
with	O
lower	O
odds	O
of	O
SGA	O
(	O
OR	O
0	O
.	O
3	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
and	O
LBW	O
(	O
OR	O
0	O
.	O
2	O
,	O
p	O
=	O
0	O
.	O
046	O
),	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
(	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
,	O
or	O
12	O
ng	O
/	O
ml	O
).	O

The	O
ncRNA	O
superfamily	O
encompasses	O
a	O
number	O
of	O
families	O
broadly	O
classified	O
according	O
to	O
their	O
length	O
:	O
long	O
non	O
-	O
coding	O
RNAs	O
(	O
lncRNAs	O
)	O
(>	O
200	O
nt	O
)	O
and	O
short	O
non	O
coding	O
RNAs	O
(	O
sncRNAs	O
)	O
(<	O
200	O
nt	O
),	O
which	O
include	O
microRNAs	O
(	O
miRNAs	O
,	O
single	O
stranded	O
,	O
∼	O
19	O
–	O
25	O
nt	O
),	O
piwi	O
-	O
interacting	O
RNAs	O
(	O
piRNAs	O
,	O
single	O
stranded	O
,	O
∼	O
24	O
–	O
30	O
nt	O
)	O
and	O
endogenous	O
short	O
interfering	O
RNAs	O
(	O
esiRNAs	O
,	O
double	O
stranded	O
,	O
∼	O
21	O
–	O
22	O
nt	O
).	O

In	O
addition	O
,	O
studies	O
in	O
humans	O
and	O
humanized	O
gnotobiotic	O
mice	O
show	O
that	O
diets	O
with	O
reduced	O
carbohydrates	O
[	O
4	O
],	O
or	O
high	O
in	O
polysaccharides	O
,	O
alter	O
gut	O
microbiome	O
composition	O
[	O
5	O
].	O

Structured	O
questionnaires	O
were	O
administered	O
to	O
assess	O
the	O
availability	O
of	O
supplements	O
at	O
each	O
level	O
of	O
the	O
distribution	O
chain	O
and	O
women	O
'	O
s	O
attitude	O
about	O
,	O
and	O
their	O
history	O
of	O
,	O
taking	O
the	O
supplements	O
[	O
13	O
].	O

In	O
addition	O
,	O
not	O
all	O
of	O
the	O
spermatozoal	O
histones	O
are	O
replaced	O
with	O
protamines	O
during	O
spermiogenesis	O
,	O
up	O
to	O
15	O
%	O
of	O
histones	O
within	O
human	O
spermatozoa	O
and	O
1	O
%	O
in	O
mouse	O
spermatozoa	O
are	O
retained	O
(	O
Miller	O
et	O
al	O
.	O
2010	O
;	O
Carrell2012	O
).	O

The	O
study	O
nurses	O
obtain	O
maternal	O
weight	O
before	O
birth	O
with	O
a	O
calibrated	O
digital	O
scale	O
.	O

Like	O
the	O
early	O
zygote	O
,	O
mature	O
gametes	O
are	O
transcriptionally	O
quiescent	O
.	O

In	O
addition	O
,	O
the	O
Ministry	O
is	O
planning	B
to	O
improve	O
the	O
supplementary	O
nutrition	O
services	O
;	O
creating	O
Anganwadi	O
based	O
crèches	O
centers	O
;	O
intensify	O
monitoring	O
,	O
and	O
training	O
activities	O
;	O
to	O
develop	O
linkages	O
with	O
different	O
stakeholders	O
such	O
as	O
Pan	O
-	O
chayati	O
Raj	O
Institutions	O
and	O
ministry	O
of	O
rural	O
development	O
(	O
1	O
).	O

Further	O
investigation	O
of	O
potential	O
confounding	O
/	O
mediation	O
of	O
main	O
findings	O
and	O
sensitivity	O
analyses	O
Additional	O
separate	O
adjustment	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
BMI	O
,	O
gestational	O
age	O
at	O
delivery	O
,	O
birthweight	O
,	O
maternal	O
weight	O
gain	O
during	O
pregnancy	O
and	O
child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
did	O
not	O
substantially	O
alter	O
the	O
main	O
findings	O
and	O
therefore	O
no	O
further	O
formal	O
mediation	O
analysis	O
was	O
conducted	O
(	O
supplementary	O
table	O
E3	O
).	O

Neither	O
BMI	O
,	O
nor	O
percent	O
fat	O
were	O
found	O
to	O
correlate	O
with	O
cathelicidin	O
concentration	O
.	O

To	O
study	O
the	O
Vitamin	O
D	O
nutritional	O
status	O
of	O
pregnant	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
and	O
analyze	O
the	O
different	O
sources	O
of	O
Vitamin	O
D	O
intake	O
.	O

However	O
,	O
the	O
mechanisms	O
of	O
action	O
and	O
protective	O
abilities	O
of	O
PUFA	O
could	O
differ	O
between	O
different	O
diseases	O
.	O

Recently	O
,	O
a	O
meta	O
-	O
analysis	O
reported	O
that	O
vitamin	O
D	O
supplementation	O
in	O
childhood	O
can	O
help	O
prevent	O
caries	O
[	O
30	O
],	O
and	O
it	O
has	O
also	O
been	O
suggested	O
that	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
between	O
75	O
–	O
100	O
nmol	O
/	O
L	O
may	O
reduce	O
the	O
risk	O
for	O
caries	O
[	O
22	O
].	O

Offspring	O
of	O
mothers	O
enrolled	O
in	O
an	O
NICHD	O
pregnancy	O
vitamin	O
D	O
supplementation	O
trial	O
(	O
results	O
of	O
which	O
were	O
previously	O
published	O
[	O
21	O
,	O
22	O
])	O
were	O
seen	O
in	O
follow	O
-	O
up	O
from	O
ages	O
2	O
–	O
7	O
years	O
during	O
a	O
three	O
-	O
year	O
study	O
period	O
.	O

We	O
computed	O
generalized	O
UniFrac	O
distances	O
between	O
pairs	O
of	O
samples	O
using	O
OTU	O
tables	O
and	O
the	O
midpoint	O
rooted	O
phylogenetic	O
tree	O
.	O

Furthermore	O
,	O
it	O
has	O
been	O
established	O
that	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
is	O
recommended	B
during	O
pregnancy	O
and	O
lactation	O
[	O
7	O
].	O

Phalanges	O
are	O
indicated	O
by	O
arrowheads	O
.	O

The	O
group	O
cites	O
insufficient	O
evidence	O
on	O
the	O
impact	O
of	O
nanomaterials	O
on	O
the	O
environment	O
and	O
human	O
health	O
.	O

For	O
children	O
aged	O
24	O
to	O
47	O
months	O
,	O
only	O
maternal	O
prepregnancy	O
obesity	O
had	O
a	O
significant	O
effect	O
;	O
for	O
children	O
aged	O
48	O
to	O
71	O
months	O
,	O
either	O
maternal	O
prepregnancy	O
overweight	O
or	O
obesity	O
increased	O
risk	O
;	O
and	O
in	O
children	O
aged	O
72	O
to	O
95	O
months	O
,	O
maternal	O
overweight	O
or	O
obesity	O
imparted	O
an	O
even	O
higher	O
risk	O
(	O
21	O
,	O
22	O
).	O

Fasting	O
serum	O
blood	O
samples	O
were	O
collected	O
at	O
the	O
first	O
antenatal	O
visit	O
(	O
early	O
pregnancy	O
)	O
and	O
at	O
the	O
28	O
-	O
week	O
gestation	O
visit	O
(	O
late	O
pregnancy	O
)	O
for	O
the	O
measurement	O
of	O
insulin	O
and	O
25OHD	O
.	O

Children	O
born	O
to	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
are	O
more	O
likely	O
to	O
be	O
identified	O
with	O
moderate	O
to	O
severe	O
cognitive	O
,	O
motor	O
and	O
global	O
developmental	O
delay	O
at	O
3	O
years	O
of	O
age	O
[	O
46	O
],	O
as	O
well	O
as	O
poorer	O
academic	O
achievement	O
extending	O
to	O
14	O
years	O
of	O
age	O
[	O
44	O
,	O
45	O
].	O

CONCLUSIONS	O
In	O
conclusion	O
,	O
this	O
study	O
showed	O
that	O
serum	O
vitamin	O
D	O
deficiency	O
might	O
be	O
a	O
potential	O
environmental	O
predisposing	O
factor	O
for	O
developing	O
multiple	O
sclerosis	O
in	O
our	O
region	O
,	O
and	O
need	O
to	O
follow	O
factors	O
that	O
cause	O
this	O
problem	O
including	O
dietary	O
,	O
genetic	O
,	O
and	O
other	O
ones	O
.	O

The	O
expression	O
and	O
activity	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
CYP27B1	O
)	O
was	O
evaluated	O
in	O
in	O
vitro	O
experiments	O
on	O
decidua	O
cell	O
cultures	O
collected	O
in	O
the	O
1st	O
and	O
3rd	O
trimesters	O
[	O
15	O
].	O

Since	O
the	O
mid	O
-	O
1990s	O
,	O
the	O
use	O
of	O
SGAs	O
has	O
increased	O
drastically	O
and	O
expanded	O
rapidly	O
to	O
the	O
treatment	O
of	O
depressive	O
and	O
anxiety	O
disorders	O
.	O
10	O
–	O
13Furthermore	O
,	O
deinstitutionalisation	O
,	O
the	O
destigmatisation	O
of	O
mental	O
illness	O
and	O
the	O
improved	O
side	O
effect	O
profile	O
of	O
SGAs	O
,	O
particularly	O
the	O
reduced	O
incidence	O
of	O
hyperprolactinaemia	O
in	O
most	O
SGAs	O
,	O
have	O
all	O
contributed	O
to	O
increased	O
fertility	O
rates	O
among	O
treated	O
women	O
.	O
9The	O
rise	O
in	O
birth	O
rate	O
in	O
women	O
with	O
psychiatric	O
disorders	O
,	O
combined	O
with	O
the	O
increase	O
in	O
off	O
-	O
label	O
usage	O
of	O
these	O
medications	O
,	O
has	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
fetuses	O
exposed	O
to	O
this	O
newer	O
class	O
of	O
antipsychotics	O
.	O

Nutritional	O
factors	O
,	O
including	O
fat	O
metabolism	O
,	O
digestion	O
and	O
absorption	O
of	O
feed	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
and	O
vitamin	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
are	O
important	O
for	O
IMF	O
deposition	O
.	O

Therefore	O
,	O
understanding	B
the	I
differences	I
between	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
dietary	O
patterns	O
and	O
usual	O
Iranian	O
dietary	O
pattern	O
might	O
help	O
interpreting	O
the	O
importance	O
of	O
the	O
findings	O
we	O
reached	O
.	O

Anaphylaxis	O
associated	O
with	O
folic	O
acid	O
:	O
domestic	O
case	O
review	O
Background	O
Synthetic	O
folic	O
acid	O
has	O
been	O
shown	O
to	O
cause	O
serious	O
,	O
potentially	O
life	O
-	O
threatening	O
IgE	O
mediated	O
anaphylaxis	O
[	O
1	O
-	O
3	O
].	O

(	O
9	O
)	O
did	O
not	O
identify	O
these	O
associations	O
.	O

Actions	O
taken	O
during	O
labour	O
and	O
birth	O
,	O
and	O
particularly	O
improved	O
care	O
of	O
the	O
neonate	O
have	O
been	O
shown	O
to	O
have	O
major	O
impact	O
[	O
5	O
,	O
6	O
].	O

Children	O
with	O
S	O
-	O
ECC	O
had	O
significantly	O
lower	O
mean	O
calcium	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
mean	O
albumin	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
as	O
well	O
as	O
higher	O
mean	O
PTH	O
concentrations	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
than	O
controls	O
.	O

Maternal	O
medical	O
records	O
were	O
reviewed	O
for	O
the	O
following	O
information	O
:	O
race	O
,	O
prepregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
and	O
BMI	O
at	O
delivery	O
,	O
insurance	O
status	O
,	O
prenatal	O
vitamin	O
use	O
and	O
maternal	O
complications	O
including	O
smoking	O
,	O
hypertension	O
,	O
diabetes	O
,	O
chorioamnionitis	O
,	O
preterm	O
labor	O
and	O
premature	O
rupture	O
of	O
membranes	O
.	O

Recruitment	O
Recruitment	O
and	O
enrollment	O
took	O
place	O
at	O
various	O
obstetric	O
clinics	O
in	O
an	O
urban	O
area	O
of	O
the	O
South	O
East	O
from	O
January	O
–	O
April	O
2011	O
.	O

Each	O
membrane	O
was	O
blocked	O
by	O
incubation	O
in	O
6	O
%	O
(	O
w	O
/	O
v	O
)	O
non	O
-	O
fat	O
dry	O
milk	O
in	O
Tris	O
-	O
buffered	O
saline	O
(	O
20	O
mM	O
Tris	O
/	O
HCL	O
[	O
pH	O
7	O
.	O
4	O
]	O
and	O
500	O
mM	O
NaCl	O
)	O
containing	O
0	O
.	O
05	O
%	O
Tween	O
20	O
(	O
TBS	O
-	O
T	O
).	O

The	O
comparison	O
of	O
neonatal	O
height	O
in	O
different	O
categories	O
of	O
maternal	O
dietary	O
patterns	O
showed	O
maternal	O
dietary	O
patterns	O
were	O
not	O
related	O
to	O
neonatal	O
height	O
in	O
all	O
crude	O
and	O
adjusted	O
models	O
.	O

PubMed	O
Central	O
:	O

3	O
.	O
4	O
.	O
4	O
.	O

in	O
taxonomy	O
labels	O
indicate	O
that	O
the	O
level	O
of	O
taxonomy	O
is	O
family	O
,	O
genus	O
,	O
or	O
species	O
,	O
respectively	O
Infant	O
gut	O
microbiome	O
clusters	O
We	O
identified	O
three	O
distinct	O
clusters	O
of	O
the	O
infant	O
gut	O
microbiome	O
in	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
),	O
with	O
cluster	O
1	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
the	O
genus	O
Bifidobacterium	O
,	O
cluster	O
2	O
by	O
the	O
genera	O
Streptococcus	O
and	O
Clostridium	O
,	O
and	O
cluster	O
3	O
by	O
the	O
genus	O
Bacteroides	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S1	O
,	O
Table	O
S1	O
).	O

Children	O
of	O
school	O
age	O
are	O
highly	O
susceptible	O
to	O
environmental	O
stimuli	O
such	O
as	O
marketing	O
and	O
food	O
availability	O
.	O

Methods	O
Survey	O
Sample	O
size	O
calculation	O
Sample	O
size	O
planning	O
was	O
informed	O
by	O
calculating	O
sample	O
needs	O
in	O
order	O
to	O
detect	O
a	O
40	O
%	O
reduction	O
of	O
low	O
birth	O
weight	O
among	O
newborns	O
of	O
vaccinated	O
(	O
regardless	O
of	O
vaccination	O
trimester	O
)	O
compared	O
to	O
unvaccinated	O
mothers	O
[	O
20	O
],[	O
21	O
],	O
assuming	O
a	O
two	O
-	O
sided	O
95	O
%	O
confidence	O
level	O
,	O
80	O
%	O
power	O
,	O
and	O
a	O
ratio	O
of	O
unvaccinated	O
to	O
vaccinated	O
of	O
2	O
:	O
5	O
[	O
33	O
].	O

It	O
is	O
noteworthy	O
,	O
however	O
,	O
that	O
complementary	O
researches	B
are	O
necessary	B
to	O
determine	O
the	O
mechanisms	O
involved	O
as	O
well	O
as	O
the	O
potential	O
influence	O
of	O
birth	O
weight	O
on	O
the	O
cardiac	O
autonomic	O
modulation	O
.	O

Except	O
for	O
the	O
age	O
factor	O
,	O
anti	O
-	O
Müllerian	O
hormone	O
(	O
AMH	O
)	O
is	O
well	O
recognized	O
as	O
the	O
biochemical	O
marker	O
of	O
this	O
syndrome	O
[	O
41	O
].	O

In	O
addition	O
,	O
many	O
of	O
these	O
interventions	O
,	O
such	O
as	O
obstetric	O
care	O
and	O
antibiotics	O
for	O
prelabour	O
premature	O
rupture	O
of	O
membranes	O
(	O
pPROM	O
),	O
also	O
benefit	O
maternal	O
health	O
and	O
prevent	O
stillbirths	O
[	O
8	O
].	O

Finally	O
,	O
a	O
2008	O
paper	O
reported	O
that	O
autism	O
was	O
more	O
common	O
among	O
mothers	O
who	O
took	O
antiepileptic	O
drugs	O
(	O
19	O
).	O

2010	O
).	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

study	O
which	O
showed	O
that	O
“	O
health	O
conscious	O
”	O
dietary	O
patterns	O
were	O
negatively	O
associated	O
with	O
decreasing	O
educational	O
level	O
,	O
age	O
,	O
and	O
socioeconomic	O
status	O
[	O
21	O
].	O

Congenital	O
spine	O
deformities	O
occur	O
with	O
an	O
approximate	O
frequency	O
of	O
0	O
.	O
5	O
–	O
1	O
per	O
1000	O
live	O
births	O
(	O
Sparrow	O
et	O
al	O
.	O

At	O
follow	O
-	O
up	O
,	O
44	O
%	O
(	O
47	O
/	O
106	O
)	O
in	O
the	O
control	O
arm	O
and	O
70	O
%	O
in	O
the	O
intervention	O
arm	O
(	O
77	O
/	O
110	O
)	O
reported	O
doing	O
so	O
.	O

Controlling	O
for	O
mediators	O
may	O
attenuate	O
the	O
total	O
effect	O
of	O
EDCs	O
on	O
birth	O
weight	O
.	O

Maternal	O
characteristics	O
which	O
differed	O
across	O
quintiles	O
of	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
included	O
age	O
,	O
parity	O
,	O
pregnancy	O
size	O
,	O
season	O
of	O
birth	O
,	O
breastfeeding	O
duration	O
,	O
educational	O
level	O
,	O
ethnicity	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
anxiety	O
level	O
,	O
tobacco	O
exposure	O
and	O
infection	O
during	O
pregnancy	O
.	O

Secondary	O
outcomes	O
Infant	O
Anthropometric	O
Measurements	O
:	O
We	O
have	O
an	O
established	O
and	O
validated	O
method	O
of	O
conducting	O
anthropometric	O
measurements	O
in	O
infants	O
[	O
28	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Number	O
of	O
regulated	O
probe	O
-	O
sets	O
in	O
liver	O
tissue	O
.	O

The	O
IMF	O
content	O
in	O
the	O
LM	O
of	O
somatic	O
-	O
cell	O
-	O
cloned	O
Japanese	O
black	O
steers	O
increased	O
with	O
age	O
at	O
slaughter	O
:	O
20	O
(	O
23	O
.	O
7	O
%),	O
25	O
(	O
38	O
.	O
7	O
%),	O
and	O
30	O
months	O
(	O
41	O
.	O
1	O
%)	O
[	O
65	O
].	O

In	O
sheep	O
,	O
the	O
mother	O
'	O
s	O
diet	O
during	O
pregnancy	O
determines	O
the	O
size	O
of	O
the	O
placenta	O
and	O
can	O
affect	O
both	O
the	O
BAT	O
and	O
WAT	O
mass	O
,	O
depending	O
on	O
the	O
timing	O
and	O
the	O
nature	O
of	O
the	O
diet	O
perturbation	O
.	O

These	O
probe	O
-	O
sets	O
represent	O
7	O
,	O
697	O
genes	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
7	O
,	O
758	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
6	O
,	O
879	O
).	O

Therefore	O
,	O
there	O
is	O
a	O
need	B
to	O
establish	O
effective	O
and	O
safe	O
doses	O
of	O
supplemental	O
iron	O
with	O
folic	O
acid	O
either	O
as	O
daily	O
or	O
weekly	O
supplementation	O
;	O
this	O
should	B
take	O
into	O
consideration	B
nutritional	O
and	O
haematological	O
status	O
of	O
women	O
in	O
developing	O
countries	O
.	O

Muscle	O
and	O
fat	O
cell	O
growth	O
typically	O
occur	O
as	O
mass	O
increases	O
due	O
to	O
both	O
hyperplasia	O
(	O
increase	O
in	O
cell	O
number	O
)	O
and	O
hypertrophy	O
(	O
increase	O
in	O
cell	O
size	O
)	O
[	O
14	O
,	O
15	O
].	O

Additionally	O
,	O
fewer	O
caregivers	O
of	O
children	O
with	O
S	O
-	O
ECC	O
indicated	O
that	O
their	O
child	O
’	O
s	O
overall	O
health	O
was	O
very	O
good	O
compared	O
to	O
those	O
whose	O
children	O
were	O
caries	O
-	O
free	O
(	O
58	O
.	O
3	O
%	O
vs	O
.	O
82	O
.	O
8	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

At	O
baseline	O
,	O
40	O
%	O
of	O
control	O
(	O
50	O
/	O
124	O
)	O
and	O
46	O
%	O
of	O
intervention	O
(	O
57	O
/	O
125	O
)	O
participants	O
said	O
they	O
reminded	O
someone	O
else	O
to	O
wash	O
hands	O
on	O
a	O
typical	O
day	O
.	O

GDM	O
is	O
the	O
most	O
common	O
pregnancy	O
complication	O
in	O
Europe	O
[	O
11	O
].	O

Consistent	O
with	O
this	O
finding	O
,	O
expression	O
of	O
genes	O
associated	O
with	O
an	O
impaired	O
immunity	O
were	O
found	O
to	O
be	O
altered	O
in	O
offspring	O
of	O
protein	O
malnourished	O
dams	O
[	O
62	O
,	O
63	O
].	O

The	O
best	O
treatment	O
for	O
nearly	O
all	O
identified	O
malignant	O
thyroid	O
neoplasm	O
is	O
surgery	O
.	O

Wistar	O
rats	O
(	O
age	O
100	O
±	O
5	O
days	O
)	O
were	O
time	O
mated	O
using	O
a	O
rat	O
estrous	O
cycle	O
monitor	O
to	O
assess	O
the	O
stage	O
of	O
estrous	O
before	O
introducing	O
the	O
male	O
.	O

Excessive	O
rebound	O
and	O
early	O
rebound	O
(	O
before	O
age	O
5	O
)	O
are	O
related	O
to	O
higher	O
BMI	O
in	O
adulthood	O
(	O
83	O
).	O

In	O
addition	O
,	O
there	O
were	O
no	O
significant	O
correlations	O
found	O
between	O
concentration	O
of	O
cathelicidin	O
and	O
the	O
child	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
at	O
birth	O
,	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
,	O
or	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
area	O
under	O
the	O
curve	O
from	O
pregnancy	O
visits	O
3	O
–	O
7	O
.	O

A	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Primer	O
used	O
to	O
verify	O
microarray	O
experiments	O
in	O
liver	O
tissue	O
by	O
qRT	O
-	O
PCRGene	O
nameProbe	O
-	O
set	O
IDSequence	O
5	O
'	O
-	O
3	O
'	O
T	O
(°	O
C	O
)	O
Size	O
(	O
bp	O
)	O
CCND2Ssc	O
.	O
15749	O
.	O
1	O
.	O
S1_atFor	O
AGGAGCAGATTGAGGTCGTG86185Rev	O
CAACCAGAGAGAAGGAAGGAGANCAPGSsc	O
.	O
28512	O
.	O
1	O
.	O
S1_atFor	O
CTTGTAGATTTGACGAGACCA60156Rev	O
GGCTTTAGTATAGACCCGAACMGMTSsc	O
.	O
19639	O
.	O
1	O
.	O
A1_atFor	O
GCAACTACTCGGGAGGAATG88171Rev	O
CTGCGAACGCTCAGTCTTGGADD45BSsc	O
.	O
14764	O
.	O
1	O
.	O
A1_atFor	O
GGACTTAGACTTTGGGACTTG60140Rev	O
GTAAGCCTCCCATCTCTCTTSDHBSsc	O
.	O
8939	O
.	O
1	O
.	O
S1_atFor	O
GCAGGACCCGTTCTCTCTGT60170Rev	O
GGTTACAGTCACGTTAGGTTGGPPARGC1ASsc	O
.	O
16864	O
.	O
1	O
.	O
S1_atFor	O
GTAAATCTGCGGGATGATGG60208Rev	O
TGGTGGAAGCAGGATCAAAGPRKAA1Ssc	O
.	O
8107	O
.	O
1	O
.	O
A1_atFor	O
TTGTTAATTTCATAAACTTTGCTTC60193Rev	O
GTGCAGCCTTGACATACTCPRKAA2Ssc	O
.	O
16257	O
.	O
1	O
.	O
S1_atFor	O
TCTGTAATTCTGTTTTGCCTACGA60168Rev	O
AGCAAGAAGGTGATGCCAAGRPL10	O
*	O
Ssc	O
.	O
9130	O
.	O
1	O
.	O
A1_atFor	O
CTGTGTTCGTCTTTTCTTCC60199Rev	O
TCATCCACTTTTGCCTTCT	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
;	O
RPL10	O
-	O
Ribosomal	O
protein	O
10	O
;	O
*	O
house	O
keeping	O
gene	O
.	O

One	O
hundred	O
children	O
aged	O
5	O
and	O
14	O
years	O
had	O
anthropometric	O
parameters	O
,	O
body	O
composition	O
and	O
blood	O
pressure	O
levels	O
determined	O
.	O

Even	O
after	O
controlling	O
for	O
seasonal	O
influence	O
on	O
endogenous	O
synthesis	O
,	O
low	O
household	O
income	O
,	O
and	O
infrequent	O
consumption	O
of	O
vitamin	O
D	O
drops	O
and	O
milk	O
,	O
the	O
significant	O
association	O
remained	O
.	O

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
sleep	O
disturbances	O
may	O
augment	O
pro	O
-	O
inflammatory	O
responses	O
that	O
may	O
then	O
contribute	O
to	O
altered	O
glucose	O
metabolism	O
.	O

When	O
studied	O
under	O
thermoneutral	O
conditions	O
,	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
increased	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
.	O

Future	B
research	I
should	B
include	O
more	O
discrete	O
and	O
refined	O
dosage	O
and	O
other	B
optimization	O-
studies	I
.	O

Vitamin	O
D	O
status	O
trajectory	O
from	O
early	O
to	O
late	O
pregnancy	O
was	O
inversely	O
associated	O
with	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
with	O
the	O
lowest	O
odds	O
among	O
women	O
with	O
the	O
highest	O
increment	O
in	O
25OHD	O
.	O

For	O
instance	O
,	O
infection	O
with	O
influenza	O
virus	O
during	O
pregnancy	O
may	O
prompt	O
an	O
inflammatory	O
[	O
cascade	O
]	O
response	O
that	O
is	O
associated	O
with	O
preterm	O
birth	O
[	O
3	O
],[	O
4	O
].	O

These	O
costs	O
were	O
identified	O
through	O
the	O
accounts	O
of	O
the	O
relevant	O
agencies	O
and	O
structured	O
interviews	O
with	O
health	O
staff	O
at	O
each	O
level	O
of	O
the	O
distribution	O
chain	O
.	O

In	O
the	O
longest	O
follow	O
-	O
up	O
of	O
women	O
who	O
have	O
had	O
GDM	O
36	O
%	O
of	O
women	O
had	O
developed	O
diabetes	O
within	O
22	O
–	O
28	O
years	O
(	O
by	O
WHO	O
criteria	O
).	O
21This	O
was	O
in	O
a	O
predominantly	O
white	O
population	O
in	O
Boston	O
from	O
the	O
1960s	O
.	O

Influenza	O
vaccination	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
risk	O
of	O
influenza	O
virus	O
disease	O
and	O
its	O
complications	O
among	O
pregnant	O
women	O
and	O
their	O
infants	O
[	O
5	O
],[	O
6	O
],[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],[	O
12	O
],[	O
13	O
],[	O
14	O
],[	O
15	O
].	O

Wells	O
,	O
in	O
a	O
recent	O
commentary	O
,	O
indicates	O
the	O
need	O
for	O
such	O
cross	O
-	O
generational	O
grandparental	O
data	O
to	O
understand	O
more	O
fully	O
the	O
influence	O
of	O
maternal	O
and	O
paternal	O
lineages	O
on	O
growth	O
and	O
development	O
.	O
19	O
In	O
a	O
previous	O
study	O
employing	O
primarily	O
self	O
-	O
reported	O
data	O
,	O
we	O
showed	O
that	O
BMI	O
appeared	O
to	O
be	O
strongly	O
familial	O
in	O
the	O
maternal	O
line	O
,	O
23and	O
we	O
have	O
shown	O
that	O
familial	O
dietary	O
patterns	O
are	O
also	O
stronger	O
in	O
the	O
maternal	O
line	O
.	O
2425The	O
present	O
analysis	O
of	O
BMI	O
has	O
extended	O
this	O
to	O
include	O
both	O
birth	O
weight	O
and	O
data	O
when	O
the	O
children	O
were	O
aged	O
9	O
years	O
and	O
shows	O
this	O
strong	O
maternal	O
pattern	O
consistently	O
for	O
children	O
while	O
height	O
,	O
by	O
comparison	O
,	O
is	O
heritable	O
across	O
lineages	O
.	O

Familial	O
cases	O
account	O
for	O
about	O
30	O
%	O
of	O
MTCs	O
.	O

Vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
has	O
been	O
shown	O
to	O
positively	O
affect	O
cord	O
blood	O
vitamin	O
D	O
levels	O
at	O
birth	O
.	O
43	O
,	O
44Studies	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
thus	O
far	O
have	O
shown	O
conflicting	O
results	O
with	O
respect	O
to	O
birth	O
weight	O
and	O
reduction	O
of	O
SGA	O
.	O
43	O
,	O
45	O
,	O
46	O
,	O
47	O
,	O
48Adequately	O
powered	O
and	O
randomized	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
during	O
pregnancy	O
are	B
needed	I
to	B
assess	I
the	O
impact	O
of	O
supplementation	O
on	O
SGA	O
as	O
well	O
as	O
the	O
appropriate	O
dose	O
and	O
timing	O
of	O
supplementation	O
.	O

Statistical	O
Analysis	O
Analysis	O
was	O
completed	O
using	O
the	O
cathelicidin	O
concentration	O
values	O
obtained	O
from	O
each	O
child	O
’	O
s	O
yearly	O
follow	O
-	O
up	O
visit	O
.	O

Results	O
Cord	O
blood	O
and	O
initial	O
bone	O
mineralization	O
values	O
A	O
total	O
of	O
49	O
singleton	O
infants	O
were	O
enrolled	O
at	O
one	O
week	O
of	O
age	O
for	O
this	O
research	O
project	O
.	O

Packs	O
of	O
study	O
treatment	O
were	O
randomly	O
assigned	O
in	O
a	O
1	O
:	O
1	O
ratio	O
by	O
Sharp	O
Clinical	O
Services	O
by	O
a	O
computer	O
-	O
generated	O
sequence	O
in	O
randomly	O
permuted	O
blocks	O
of	O
10	O
,	O
starting	O
randomly	O
midway	O
through	O
the	O
block	O
,	O
and	O
sequentially	O
numbered	O
,	O
before	O
delivery	O
to	O
the	O
study	O
sites	O
,	O
and	O
then	O
dispensed	O
in	O
order	O
by	O
each	O
study	O
pharmacist	O
.	O

Fatty	O
acids	O
of	O
dietary	O
origin	O
are	O
obtained	O
from	O
transporta	O
tion	O
of	O
TG	O
lipoprotein	O
and	O
subsequent	O
uptake	O
after	O
lipoprotein	O
lipase	O
hydrolysis	O
into	O
tissues	O
from	O
the	O
circulation	O
[	O
92	O
,	O
93	O
].	O

The	O
monotherapy	O
and	O
polytherapy	O
groups	O
did	O
not	O
differ	O
with	O
respect	O
to	O
the	O
rate	O
of	O
preterm	O
deliveries	O
,	O
birth	O
weight	O
or	O
proportion	O
of	O
small	O
for	O
gestational	O
age	O
neonates	O
.	O

[	O
37	O
]	O
expanded	O
on	O
this	O
and	O
illustrated	O
a	O
case	O
control	O
study	O
of	O
4429	O
children	O
with	O
autism	O
.	O

The	O
primary	O
form	O
of	O
vitamin	O
D	O
,	O
colecalciferol	O
(	O
vitamin	O
D3	O
),	O
is	O
available	O
from	O
two	O
sources	O
:	O
skin	O
exposure	O
to	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
in	O
sunlight	O
and	O
diet	O
.	O

There	O
are	O
a	O
number	O
of	O
limitations	O
to	O
our	O
findings	O
.	O

Constraints	O
to	O
Successful	O
Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
3	O
.	O
4	O
.	O
1	O
.	O

A	O
10	O
-	O
fold	O
increase	O
in	O
Pb	O
exposure	O
was	O
associated	O
with	O
a	O
45	O
g	O
birth	O
weight	O
reduction	O
(	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
),	O
while	O
increased	O
exposure	O
to	O
DMP	O
was	O
associated	O
with	O
a	O
-	O
57	O
g	O
(	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
))	O
change	O
in	O
birth	O
weight	O
.	O

3	O
.	O

Sampling	O
and	O
laboratory	O
analyses	O
have	O
been	O
described	O
previously	O
[	O
3	O
].	O

1	O
.	O

(	O
E	O
)	O
Radiograph	O
of	O
the	O
tail	O
of	O
Skm1	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
.	O

Another	O
study	O
showed	O
that	O
a	O
higher	O
level	O
of	O
nutritional	O
knowledge	O
was	O
associated	O
with	O
vitamin	O
/	O
mineral	O
supplementation	O
use	O
[	O
21	O
].	O

The	O
most	O
complete	O
data	O
were	O
available	O
for	O
the	O
latter	O
at	O
these	O
time	O
points	O
.	O

We	O
also	O
collected	O
samples	O
at	O
other	O
times	O
(	O
appendix	O
)	O
from	O
a	O
different	O
set	O
of	O
randomly	O
selected	O
children	O
to	O
check	O
fluctuations	O
in	O
serum	O
concentrations	O
.	O

In	O
contrast	O
,	O
our	O
data	O
support	O
investigation	B
into	O
higher	O
doses	O
of	O
vitamin	O
D	O
in	O
subgroups	O
at	O
high	O
risk	O
if	O
benefits	O
are	O
demonstrated	O
by	O
ongoing	O
trials	O
in	O
pregnancy	O
of	O
achieving	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

In	O
addition	O
to	O
a	O
lower	O
birth	O
weight	O
population	O
,	O
a	O
secondary	O
analysis	O
longitudinal	O
design	O
study	O
using	O
cranial	O
ultrasound	O
evidence	O
of	O
14	O
study	O
participants	O
diagnosed	O
with	O
ASD	O
identified	O
that	O
children	O
with	O
ventricular	O
enlargement	O
were	O
strong	O
indicators	O
of	O
the	O
potential	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
50	O
].	O

The	O
gestation	O
period	O
is	O
very	O
important	O
because	O
it	O
determines	O
the	O
fate	O
of	O
progenitor	O
cells	O
that	O
will	O
become	O
muscle	O
cells	O
,	O
fibroblasts	O
,	O
or	O
adipocytes	O
[	O
16	O
].	O

The	O
characteristics	O
of	O
the	O
pregnant	O
women	O
included	O
in	O
the	O
study	O
are	O
shown	O
inTable	O
2	O
.	O

For	O
categorical	O
analysis	O
of	O
vitamin	O
D	O
levels	O
,	O
we	O
used	O
cutoff	O
values	O
of	O
:	O
sufficient	O
(⩾	O
50	O
nmol	O
l	O
−	O
1	O
)	O
and	O
deficient	O
(<	O
50	O
nmol	O
l	O
−	O
1	O
).	O
28	O
,	O
29	O
,	O
30	O
,	O
31	O
Statistical	O
analysis	O
Distributions	O
of	O
continuous	O
variables	O
were	O
evaluated	O
for	O
normality	O
graphically	O
using	O
histogram	O
and	O
box	O
plots	O
and	O
are	O
described	O
using	O
means	O
and	O
s	O
.	O
d	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Background	O
characteristics	O
of	O
the	O
participantsBackground	O
characteristics	O
Age	O
,	O
years	O
(	O
mean	O
±	O
SD	O
)	O
27	O
.	O
5	O
±	O
5	O
.	O
59Urban	O
environment	O
,	O
N	O
(%)	O
218	O
(	O
54	O
.	O
3	O
)	O
Formal	O
education	O
,	O
number	O
of	O
years	O
≤	O
8	O
(%)	O
25	O
.	O
5	O
9	O
-	O
12	O
(%)	O
40	O
.	O
5	O
>	O
12	O
(%)	O
34Married	O
,	O
N	O
(%)	O
323	O
(	O
80	O
.	O
8	O
)	O
Number	O
of	O
births	O
,	O
N	O
(%)	O
Primiparous198	O
(	O
49	O
.	O
5	O
)	O
Secundiparous129	O
(	O
32	O
.	O
3	O
)	O
Multiparous73	O
(	O
18	O
.	O
2	O
)	O
Wanted	O
pregnancy	O
,	O
N	O
(%)	O
360	O
(	O
90	O
)	O
Gestational	O
age	O
at	O
first	O
prenatal	O
visit	O
,	O
mean	O
±	O
SD2	O
.	O
59	O
±	O
1	O
.	O
23First	O
prenatal	O
visit	O
at	O
≤	O
4	O
months	O
of	O
pregnancy	O
,	O
N	O
(%)	O
364	O
(	O
91	O
)	O
Number	O
of	O
prenatal	O
visits	O
at	O
general	O
practitioner	O
,	O
mean	O
±	O
SD4	O
.	O
82	O
±	O
2	O
.	O
54Number	O
of	O
prenatal	O
visits	O
at	O
obstetrician	O
,	O
mean	O
±	O
SD4	O
.	O
76	O
±	O
3	O
.	O
07Total	O
number	O
of	O
prenatal	O
visits	O
,	O
mean	O
±	O
SD9	O
.	O
58	O
±	O
4	O
.	O
88Nutritional	O
knowledge	O
score	O
,	O
mean	O
±	O
SD11	O
±	O
4	O
.	O
8Advice	O
on	O
diet	O
,	O
YES	O
(	O
N	O
,%)	O
168	O
(	O
42	O
)	O
Advice	O
on	O
breastfeeding	O
,	O
YES	O
(	O
N	O
,%)	O
334	O
(	O
83	O
.	O
5	O
)	O
Use	O
of	O
folic	O
acid	O
(	O
N	O
,%)	O
192	O
(	O
48	O
)	O
Use	O
of	O
iron	O
(	O
N	O
,%)	O
181	O
(	O
45	O
.	O
3	O
)	O
Use	O
of	O
multivitamins	O
(	O
N	O
,%)	O
272	O
(	O
68	O
)	O
Statistical	O
analysis	O
Associations	O
between	O
socio	O
-	O
demographic	O
factors	O
,	O
prenatal	O
care	O
,	O
the	O
level	O
of	O
nutritional	O
knowledge	O
and	O
the	O
intake	O
of	O
nutritional	O
supplements	O
were	O
evaluated	O
using	O
the	O
Chi	O
-	O
square	O
test	O
(	O
χ2	O
)	O
and	O
binomial	O
logistical	O
regression	O
[	O
24	O
].	O

For	O
example	O
,	O
studies	O
have	O
examined	O
point	O
-	O
of	O
-	O
decision	O
prompts	O
to	O
increase	O
exercise	O
and	O
nutrition	O
[	O
43	O
],	O
and	O
use	O
of	O
mobile	O
technologies	O
for	O
health	O
interventions	O
[	O
11	O
,	O
44	O
],	O
but	O
no	O
study	O
has	O
combined	O
both	O
.	O

Our	O
results	O
could	O
also	O
indicate	O
that	O
it	O
takes	O
time	O
for	O
changes	O
in	O
vitamin	O
D	O
metabolism	O
to	O
manifest	O
as	O
changes	O
in	O
circulating	O
25OHD	O
.	O

We	O
considered	O
infants	O
with	O
cord	O
25	O
(	O
OH	O
)	O
D	O
below	O
20	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
above	O
20	O
ng	O
/	O
mL	O
regardless	O
of	O
ethnicity	O
.	O

Mass	O
fortification	O
programme	O
of	O
common	O
local	O
staple	O
foods	O
with	O
iron	O
and	O
folic	O
acid	O
is	O
a	O
long	O
-	O
term	O
goal	O
,	O
which	O
national	O
governments	O
in	O
developing	O
countries	O
should	B
consider	B
as	O
a	O
strategy	B
aimed	O
at	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
the	O
general	O
population	O
.	O

Therefore	O
,	O
it	O
seems	O
reasonable	O
to	O
recommend	B
that	O
when	O
there	O
is	O
no	O
medical	O
or	O
obstetric	O
contraindication	O
,	O
women	O
with	O
GDM	O
should	B
maintain	O
a	O
sensible	O
level	O
of	O
light	O
and	O
moderate	O
intensity	O
physical	O
activity	O
until	O
the	O
latter	O
stages	O
of	O
the	O
pregnancy	O
.	O

Providers	O
may	O
need	B
to	O
re	O
-	O
emphasize	O
their	O
recommendations	O
with	O
overweight	O
and	O
obese	O
patients	O
to	O
help	O
align	O
their	O
personal	O
weight	O
gain	O
targets	O
with	O
current	O
clinical	O
recommendations	O
.	O

In	O
another	O
study	O
,	O
Graugnard	O
et	O
al	O
[	O
56	O
]	O
reported	O
that	O
a	O
high	O
-	O
starch	O
diet	O
induced	O
precocious	O
upregulation	O
of	O
the	O
adipogenic	O
gene	O
network	O
in	O
the	O
longissimus	O
lumborum	O
of	O
early	O
-	O
weaned	O
(	O
average	O
155	O
d	O
)	O
Angus	O
cattle	O
.	O

Similarly	O
,	O
maternal	O
prenatal	O
behaviors	O
may	O
differentially	O
impact	O
birth	O
and	O
6	O
months	O
offspring	O
weights	O
(	O
e	O
.	O
g	O
.,	O
protein	O
impacting	O
6	O
month	O
but	O
not	O
birth	O
weight	O
in	O
the	O
current	O
study	O
).	O

In	O
general	O
,	O
Stanford	O
type	O
A	O
dissections	O
involve	O
the	O
ascending	O
aorta	O
and	O
are	O
managed	O
surgically	O
while	O
type	O
B	O
dissections	O
involved	O
the	O
descending	O
aorta	O
and	O
are	O
managed	O
medically	O
.	O

Consolidated	O
Standards	O
of	O
Reporting	O
Trials	O
diagram	O
.	O

[	O
20	O
]	O
reported	O
that	O
only	O
1	O
.	O
7	O
%	O
of	O
women	O
consumed	O
fish	O
oil	O
supplements	O
not	O
affecting	O
outcomes	O
,	O
however	O
,	O
this	O
study	O
did	O
not	O
consider	O
supplements	O
other	O
than	O
fish	O
oil	O
.	O

For	O
example	O
,	O
a	O
meta	O
-	O
analysis	O
by	O
Govarts	O
et	O
al	O
.	O

On	O
a	O
broader	O
scale	O
the	O
reduced	O
capacity	O
for	O
work	O
and	O
education	O
due	O
to	O
anaemia	O
and	O
iron	O
deficiency	O
can	O
adversely	O
impact	O
a	O
population	O
'	O
s	O
social	O
and	O
economic	O
development	O
[	O
6	O
].	O

Usually	O
the	O
dosage	O
needs	O
to	O
be	O
increased	O
as	O
early	O
as	O
during	O
the	O
fifth	O
week	O
of	O
gestation	O
,	O
and	O
fT4	O
TSH	O
monitoring	O
is	O
recommended	B
every	O
6	O
weeks	O
for	O
adequate	O
adjustment	O
of	O
dosage	O
.	O

In	O
inherited	O
forms	O
,	O
the	O
initial	O
germline	O
mutation	O
produces	O
multiple	O
foci	O
of	O
cells	O
–	O
the	O
so	O
-	O
called	O
C	O
-	O
cell	O
hyperplasia	O
–	O
that	O
are	O
susceptible	O
to	O
tumour	O
formation	O
,	O
and	O
each	O
MTC	O
is	O
the	O
result	O
of	O
a	O
second	O
cell	O
transformation	O
in	O
one	O
of	O
these	O
susceptible	O
clones	O
.	O

#	O
Beta	O
(	O
s	O
.	O
e	O
.	O

Overall	O
,	O
differences	O
in	O
study	O
design	O
,	O
populations	O
,	O
influenza	O
virus	O
and	O
circulation	O
variability	O
make	O
it	O
a	O
challenge	O
to	O
compare	O
results	O
[	O
31	O
].	O

Third	O
,	O
BHLM	O
results	O
are	O
sensitive	O
to	O
the	O
assigned	O
prior	O
distributions	O
of	O
hyperparameters	O
μβand	O
σβ	O
.	O

Additionally	O
,	O
RC	O
females	O
showed	O
lower	O
plasma	O
levels	O
of	O
leptin	O
,	O
total	O
cholesterol	O
,	O
LDL	O
,	O
and	O
bilirubin	O
than	O
RC	O
males	O
.	O

Discussion	O
The	O
importance	O
of	O
perinatal	O
nutrition	O
and	O
its	O
role	O
in	O
offspring	O
health	O
,	O
is	O
recognised	O
[	O
79	O
].	O

CONCLUSION	O
In	O
this	O
article	O
,	O
we	O
reviewed	O
several	O
factors	O
(	O
genetic	O
,	O
management	O
,	O
and	O
nutritional	O
factors	O
)	O
affecting	O
IMF	O
deposition	O
in	O
cattle	O
(	O
Table	O
2	O
).	O

These	O
features	O
were	O
also	O
linked	O
to	O
an	O
impairment	O
of	O
the	O
browning	O
process	O
of	O
the	O
white	O
adipose	O
tissue	O
(	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

Based	O
on	O
a	O
False	O
Discovery	O
Rate	O
of	O
28	O
%,	O
we	O
predict	O
that	O
nine	O
of	O
these	O
spots	O
would	O
be	O
false	O
positives	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Altered	O
proteins	O
in	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
DVD	O
-	O
deficient	O
and	O
control	O
male	O
rats	O
.	O

Glucose	O
response	O
to	O
a	O
glucose	O
load	O
was	O
measured	O
at	O
18	O
weeks	O
post	O
-	O
weaning	O
.	O

At	O
weaning	O
,	O
HF	O
offspring	O
weights	O
were	O
significantly	O
increased	O
compared	O
to	O
controls	O
(	O
Cont	O
59	O
.	O
1	O
±	O
0	O
.	O
7	O
g	O
,	O
MHF	O
66	O
.	O
3	O
±	O
0	O
.	O
9	O
g	O
,	O
PLHF	O
63	O
.	O
8	O
±	O
0	O
.	O
7	O
g	O
,	O
p	O
<	O
0	O
.	O
0001	O
and	O
p	O
<	O
0	O
.	O
05	O
versus	O
controls	O
respectively	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Offspring	O
birth	O
weights	O
and	O
neonatal	O
growth	O
curves	O
in	O
all	O
groups	O
.	O

The	O
sample	O
size	O
required	O
was	O
estimated	O
to	O
be	O
2769	O
(	O
1938	O
vaccinated	O
and	O
831	O
unvaccinated	O
pregnant	O
women	O
).	O

We	O
didn	O
’	O
t	O
consider	O
placebo	O
because	O
WHO	O
and	O
Government	O
of	O
Bangladesh	O
have	O
a	O
recommendation	B
that	O
pregnant	O
women	O
should	B
receive	O
60	O
mg	O
of	O
iron	O
supplementation	O
.	O

Measurement	O
of	O
metabolites	O
,	O
hepatic	O
enzymes	O
,	O
and	O
leptin	O
in	O
plasma	O
The	O
following	O
plasma	O
metabolites	O
and	O
enzymes	O
were	O
measured	O
:	O
basal	O
glucose	O
,	O
triglycerides	O
,	O
total	O
cholesterol	O
,	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
),	O
urea	O
,	O
bilirubin	O
,	O
alkaline	O
phosphatase	O
(	O
ALKP	O
),	O
and	O
the	O
hepatic	O
enzymes	O
alanine	O
aminotransferase	O
(	O
ALT	O
),	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
and	O
gamma	O
-	O
glutamyl	O
transpeptidase	O
(	O
γGT	O
).	O

These	O
supplements	O
are	O
not	O
necessary	O
in	O
most	O
pregnancies	O
,	O
which	O
raises	O
questions	O
about	O
women	O
’	O
s	O
motivation	O
to	O
use	O
them	O
in	O
the	O
absence	O
of	O
formal	O
recommendations	B
.	O

The	O
doses	O
for	O
adults	O
and	O
elderly	O
people	O
of	O
proper	O
body	O
weight	O
,	O
and	O
pregnant	O
and	O
lactating	O
women	O
should	B
not	O
exceed	O
4000	O
IU	O
daily	O
,	O
and	O
the	O
supplementation	O
dosage	O
recommended	B
for	O
pregnant	O
women	O
in	O
winter	O
and	O
less	O
sunny	O
countries	O
is	O
1500	O
–	O
4000	O
IU	O
per	O
day	O
(	O
37	O
.	O
5	O
–	O
50	O
.	O
0	O
μg	O
/	O
day	O
)	O
[	O
10	O
,	O
66	O
,	O
70	O
].	O

The	O
impact	O
of	O
the	O
program	O
on	O
women	O
'	O
s	O
iron	O
and	O
helminth	O
infection	O
status	O
in	O
the	O
first	O
12	O
months	O
was	O
assessed	O
using	O
structured	O
questionnaires	O
,	O
stool	O
examination	O
and	O
haemoglobin	O
assessment	O
at	O
the	O
field	O
site	O
,	O
and	O
blood	O
sample	O
analysis	O
for	O
ferritin	O
,	O
soluble	O
Transferrin	O
Receptor	O
and	O
C	O
-	O
Reactive	O
Protein	O
(	O
to	O
identify	O
the	O
presence	O
of	O
acute	O
infection	O
).	O

Furthermore	O
,	O
a	O
large	O
study	O
utilising	O
data	O
from	O
the	O
Swedish	O
Medical	O
Birth	O
Register	O
reported	O
an	O
increased	O
risk	O
of	O
congenital	O
malformations	O
associated	O
with	O
exposure	O
to	O
either	O
a	O
typical	O
antipsychotic	O
or	O
SGA	O
;	O
however	O
,	O
this	O
finding	O
failed	O
to	O
reach	O
statistical	O
significance	O
after	O
controlling	O
for	O
exposure	O
to	O
anticonvulsants	O
.	O
18	O
Another	O
growing	O
concern	O
is	O
the	O
increased	O
use	O
of	O
multiple	O
psychotropic	O
medications	O
in	O
the	O
treatment	O
of	O
mental	O
illness	O
.	O

At	O
adult	O
age	O
(	O
stage	O
188	O
dpn	O
)	O
2	O
,	O
084	O
probe	O
-	O
sets	O
were	O
significantly	O
different	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

Results	O
3	O
.	O
1	O
.	O

Forty	O
two	O
females	O
and	O
8	O
males	O
were	O
included	O
in	O
each	O
group	O
.	O

Canaries	O
in	O
the	O
Uranium	O
Mines	O
The	O
arrival	O
of	O
prospectors	O
signified	O
the	O
Navajo	O
Nation	O
’	O
s	O
entrance	O
into	O
the	O
modern	O
wage	O
economy	O
.	O
7Some	O
welcomed	O
the	O
potential	O
income	O
.	O

Results	O
The	O
incidence	O
rate	O
of	O
Vitamin	O
D	O
deficiency	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
was	O
20	O
.	O
4	O
%.	O

In	O
a	O
cohort	O
study	O
by	O
Evans	O
et	O
al	O
.	O

A	O
developmental	O
perspective	O
considers	O
family	O
,	O
school	O
,	O
and	O
community	O
context	O
.	O

In	O
order	O
to	O
further	O
investigate	O
the	O
effect	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
we	O
performed	O
a	O
compulsive	O
feeding	O
test	O
in	O
the	O
adult	O
offspring	O
.	O

2	O
-	O
D	O
gel	O
electrophoresis	O
-	O
based	O
proteomics	O
and	O
mass	O
spectroscopy	O
were	O
used	O
to	O
investigate	O
differential	O
protein	O
expression	O
.	O

Although	O
not	O
prespecified	O
,	O
we	O
also	O
generated	O
rate	O
ratios	O
to	O
compare	O
the	O
proportion	O
of	O
intervention	O
-	O
recommended	O
times	O
at	O
which	O
hands	O
were	O
washed	O
in	O
the	O
two	O
study	O
arms	O
;	O
we	O
used	O
log	O
binomial	O
regression	O
,	O
accounting	O
for	O
repeated	O
measures	O
at	O
the	O
caregiver	O
level	O
to	O
adjust	O
standard	O
errors	O
.	O

There	O
was	O
a	O
trend	O
for	O
lower	O
DopaR1	O
expression	O
in	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
HV	O
pup	O
diet	O
compared	O
to	O
the	O
RV	O
offspring	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
(	O
Figure	O
5b	O
).	O

(	O
2014	O
)*	O
Smoking	O
:	O
Cigarette	O
smokeMouse	O
RatInhalation	O
(	O
exposure	O
chamber	O
)	O
(	O
1	O
–	O
2	O
h	O
/	O
d	O
,	O
1	O
h	O
/	O
2	O
d	O
or	O
8	O
–	O
10	O
cigarettes	O
/	O
d	O
)	O
Combinations	O
of	O
:	O
Neonatal	O
Adolescence	O
Early	O
adulthoodAdolescence	O
AdulthoodPulmonary	O
inflammation	O
and	O
abnormalitiesHistone	O
modification	O
miRNAsHalappanavar	O
et	O
al	O
.	O

Groups	O
The	O
exogenous	O
Vitamin	O
D	O
came	O
from	O
Vitamin	O
D	O
supplement	O
or	O
Vitamin	O
D	O
rich	O
food	O
.	O

Dams	O
(	O
and	O
corresponding	O
litters	O
)	O
were	O
placed	O
under	O
control	O
conditions	O
for	O
the	O
remainder	O
of	O
the	O
experiment	O
.	O

It	O
is	O
also	O
important	O
to	O
consider	O
,	O
however	O
,	O
early	O
ex	O
utero	O
exposures	O
.	O

Body	O
weight	O
and	O
caloric	O
intake	O
of	O
offspring	O
were	O
monitored	O
from	O
birth	O
(	O
PND0	O
)	O
to	O
adulthood	O
(	O
postnatal	O
weeks	O
21	O
–	O
23	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
.	O

Liver	O
tissue	O
was	O
immediately	O
collected	O
from	O
lobus	O
sinister	O
hepaticus	O
,	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
use	O
for	O
RNA	O
isolation	O
.	O

Four	O
major	O
adipose	O
tissue	O
depots	O
exist	O
in	O
animals	O
:	O
ab	O
dominal	O
,	O
subcutaneous	O
,	O
intermuscular	O
,	O
and	O
intramuscular	O
.	O

The	O
sample	O
was	O
diverse	O
but	O
self	O
-	O
selected	O
and	O
free	O
of	O
diseases	O
that	O
might	O
contraindicate	O
participation	O
in	O
a	O
lifestyle	O
intervention	O
study	O
;	O
thus	O
,	O
findings	O
may	O
not	O
generalize	O
to	O
the	O
population	O
at	O
large	O
.	O

These	O
animals	O
were	O
from	O
four	O
separate	O
litters	O
per	O
experimental	O
group	O
.	O

Vitamin	O
D	O
is	O
present	O
in	O
a	O
small	O
number	O
of	O
foods	O
,	O
although	O
,	O
for	O
an	O
average	O
person	O
food	O
will	O
only	O
supply	O
about	O
10	O
%	O
of	O
the	O
amount	O
needed	O
.	O

The	O
few	O
available	O
studies	O
investigating	O
the	O
reproductive	O
safety	O
of	O
SGAs	O
did	O
not	O
reach	O
conclusive	O
results	O
,	O
and	O
none	O
have	O
compared	O
monotherapy	O
with	O
polytherapy	O
involving	O
other	O
psychotropic	O
medications	O
.	O

Neither	O
of	O
these	O
results	O
changed	O
after	O
adjustment	O
for	O
tobacco	O
use	O
and	O
vitamin	O
D	O
supplementation	O
at	O
T3	O
or	O
after	O
excluding	O
cases	O
of	O
preeclampsia	O
.	O

We	O
used	O
Bayesian	O
Hierarchical	O
Linear	O
Models	O
(	O
BHLM	O
)	O
to	O
examine	O
the	O
associations	O
between	O
newborn	O
birth	O
weight	O
and	O
53	O
EDCs	O
,	O
2	O
organochlorine	O
pesticides	O
(	O
OPPs	O
)	O
and	O
2	O
heavy	O
metals	O
.	O

Furthermore	O
,	O
it	O
has	O
been	O
hypothesized	O
that	O
prenatal	O
vitamin	O
D	O
deficiency	O
is	O
a	O
risk	O
factor	O
for	O
schizophrenia	O
,	O
supported	O
by	O
the	O
role	O
of	O
this	O
vitamin	O
in	O
cell	O
growth	O
and	O
differentiation	O
,	O
the	O
excess	O
of	O
winter	O
births	O
in	O
schizophrenia	O
(	O
a	O
period	O
when	O
vitamin	O
D	O
levels	O
are	O
low	O
),	O
and	O
increased	O
births	O
of	O
pre	O
-	O
schizophrenic	O
subjects	O
in	O
urban	O
areas	O
,	O
where	O
vitamin	O
D	O
deficiency	O
is	O
higher	O
[	O
12	O
,	O
18	O
].	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
Melbourne	O
/	O
NIMPE	O
.	O

SIRT	O
Nampt	O
expression	O
increased	O
in	O
both	O
cell	O
models	O
in	O
the	O
course	O
of	O
bone	O
tissue	O
differentiation	O
from	O
multipotent	O
fibroblast	O
and	O
monopotent	O
pre	O
-	O
osteoblast	O
in	O
rats	O
.	O

Data	O
will	O
be	O
analysed	O
prospectively	O
to	O
determine	O
associations	O
between	O
variables	O
at	O
different	O
time	O
points	O
(	O
longitudinally	O
)	O
by	O
using	O
appropriate	O
statistical	O
methods	O
(	O
e	O
.	O
g	O
.	O

3	O
.	O
4	O
.	O

Although	O
relatively	O
rare	O
,	O
clinicians	O
must	O
maintain	O
a	O
high	O
index	O
of	O
suspicion	O
for	O
aortic	O
dissection	O
in	O
any	O
pregnant	O
female	O
who	O
presents	O
with	O
acute	O
onset	O
chest	O
pain	O
.	O

Participants	O
took	O
a	O
survey	O
about	O
their	O
Vitamin	O
D	O
supplement	O
intake	O
history	O
,	O
including	O
brand	O
,	O
gestational	O
week	O
when	O
starting	O
the	O
intake	O
,	O
frequency	O
and	O
dose	O
,	O
and	O
calculation	O
of	O
non	O
-	O
dietary	O
Vitamin	O
D	O
daily	O
intake	O
.	O

recently	O
reported	O
that	O
2	O
-	O
3	O
weekly	O
servings	O
of	O
fatty	O
fish	O
increased	O
25	O
(	O
OH	O
)	O
D	O
by	O
45	O
%	O
in	O
a	O
population	O
of	O
Swedish	O
women	O
[	O
35	O
].	O

However	O
,	O
fat	O
weights	O
in	O
the	O
subcutaneous	O
,	O
mesenteric	O
,	O
and	O
intermuscular	O
regions	O
were	O
not	O
different	O
between	O
the	O
groups	O
.	O

In	O
this	O
study	O
,	O
VD	O
levels	O
were	O
estimated	O
in	O
donor	O
’	O
s	O
serum	O
before	O
the	O
embryo	O
transfer	O
.	O

(	O
2011	O
)*	O
UrethaneMouseInjection	O
(	O
ip	O
)	O
(	O
1	O
mg	O
/	O
g	O
/	O
wk	O
)	O
Late	O
childhood	O
/	O
adolescence	O
+	O
early	O
adulthoodAdulthoodHepatic	O
tumorsHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsPandey	O
et	O
al	O
.	O

For	O
example	O
,	O
the	O
increased	O
prevalence	O
of	O
the	O
use	O
of	O
anticonvulsant	O
medications	O
during	O
pregnancy	O
is	O
correlated	O
with	O
an	O
increased	O
risk	O
of	O
autism	O
.	O

After	O
this	O
incubation	O
,	O
three	O
10	O
-	O
minute	O
washes	O
were	O
followed	O
in	O
2xSSC	O
at	O
37	O
°	O
C	O
.	O

Discussion	O
Normal	O
Vitamin	O
D	O
level	O
is	O
one	O
of	O
the	O
nutritional	O
management	O
goals	O
for	O
women	O
with	O
GDM	O
.	O

Propensity	O
Score	O
Models	O
adjusted	O
for	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
Fe	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
).	O

It	O
cannot	O
,	O
however	O
,	O
correct	O
for	O
potential	O
bias	O
and	O
confounding	O
of	O
the	O
studies	O
included	O
;	O
we	O
addressed	O
this	O
issue	O
in	O
our	O
review	O
(	O
Martin	O
et	O
al	O
.	O

In	O
2000	O
she	O
received	O
an	O
environmental	O
justice	O
grant	O
from	O
the	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
to	O
collect	O
clinical	O
and	O
survey	O
data	O
from	O
people	O
living	O
on	O
the	O
Eastern	O
Navajo	O
Nation	O
.	O

We	O
find	O
no	O
support	O
for	O
this	O
in	O
our	O
results	O
,	O
since	O
,	O
the	O
effect	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
psychotic	O
-	O
like	O
symptoms	O
were	O
almost	O
similar	O
to	O
those	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
.	O

Women	O
who	O
reported	O
no	O
PNV	O
use	O
(	O
versus	O
any	O
reported	O
PNV	O
use	O
)	O
had	O
significantly	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
at	O
the	O
time	O
of	O
the	O
first	O
sample	O
(	O
OR	O
3	O
.	O
9	O
,	O
95	O
%	O
CI	O
2	O
.	O
9	O
,	O
5	O
.	O
2	O
)	O
and	O
second	O
sample	O
(	O
OR	O
2	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
6	O
,	O
2	O
.	O
9	O
)	O
(	O
Table	O
3	O
)	O
in	O
models	O
adjusting	O
for	O
season	O
.	O

Even	O
more	O
importantly	O
,	O
the	O
body	O
grew	O
faster	O
than	O
the	O
head	O
for	O
those	O
with	O
ASD	O
by	O
the	O
end	O
of	O
the	O
first	O
year	O
of	O
life	O
,	O
suggesting	O
a	O
closer	O
following	O
of	O
length	O
to	O
circumference	O
during	O
development	O
.	O

Table2shows	O
the	O
interventions	O
included	O
in	O
the	O
LiST	O
analysis	O
that	O
prevent	O
preterm	O
births	O
and	O
improve	O
survival	O
of	O
premature	O
babies	O
.	O

A	O
control	O
group	O
of	O
offspring	O
from	O
dams	O
fed	O
the	O
RV	O
diet	O
was	O
weaned	O
to	O
the	O
RV	O
pup	O
diet	O
for	O
29	O
weeks	O
.	O

WT1	O
expression	O
(	O
Figure	O
11	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g011	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
11	O
Western	O
blotting	O
analysis	O
of	O
renal	O
tissue	O
at	O
birth	O
for	O
WT1	O
expression	O
.	O

While	O
lncRNAs	O
do	O
this	O
in	O
a	O
variety	O
of	O
ways	O
,	O
including	O
chromosome	O
remodeling	O
,	O
and	O
transcriptional	O
or	O
post	O
-	O
transcriptional	O
regulation	O
(	O
Galupa	O
&	O
Heard2015	O
;	O
Kanduri2016	O
;	O
Taylor	O
et	O
al	O
.	O
2015	O
),	O
sncRNAs	O
predominantly	O
mediate	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
).	O

No	O
interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
hypothalamus	O
,	O
but	O
it	O
was	O
found	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
and	O
Dagl	O
β	O
in	O
PAT	O
(	O
TableS2	O
).	O

Regular	O
assessments	O
of	O
TSH	O
and	O
fT4	O
levels	O
every	O
6	O
/	O
8	O
weeks	O
during	O
pregnancy	O
and	O
breast	O
-	O
feeding	O
are	O
required	O
to	O
ensure	O
an	O
adequate	O
dose	O
of	O
levothyroxine	O
.	O

Phylogenetic	O
trees	O
were	O
constructed	O
using	O
the	O
FastTree	O
method	O
[	O
41	O
].	O

Finally	O
,	O
Monteagudo	O
et	O
al	O
.	O

Thus	O
,	O
a	O
total	O
of	O
33	O
623	O
women	O
were	O
included	O
in	O
the	O
analysis	O
.	O

RNA	O
Fluorescent	O
In	O
Situ	O
Hybridization	O
(	O
FISH	O
)	O
The	O
slides	O
of	O
the	O
paraffin	O
embedded	O
placental	O
tissue	O
samples	O
were	O
placed	O
in	O
a	O
coplin	O
jar	O
and	O
deparaffinised	O
for	O
30	O
minutes	O
at	O
37	O
°	O
C	O
using	O
Histo	O
-	O
Clear	O
(	O
Fisher	O
Scientific	O
,	O
UK	O
).	O

Urine	O
parameters	O
(	O
Table	O
2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Urine	O
parameters	O
.	O
ParametersF1	O
-	O
SCF1	O
-	O
VitD	O
-	O
F2	O
-	O
SCF2	O
-	O
VitD	O
-	O
WI	O
,	O
g	O
/	O
100	O
g	O
BM	O
/	O
day	O
16	O
.	O
3	O
±	O
1	O
.	O
014	O
.	O
4	O
±	O
1	O
.	O
615	O
.	O
2	O
±	O
1	O
.	O
113	O
.	O
3	O
±	O
1	O
.	O
3	O
Urine	O
output	O
0	O
.	O
05	O
±	O
0	O
.	O
0020	O
.	O
02	O
±	O
0	O
.	O
004	O
†	O
0	O
.	O
04	O
±	O
0	O
.	O
0060	O
.	O
04	O
±	O
0	O
.	O
004	O
Urea	O
,	O
mg	O
/	O
dL	O
36	O
.	O
5	O
±	O
3	O
.	O
8194	O
.	O
7	O
±	O
23	O
.	O
2	O
†	O
45	O
.	O
5	O
±	O
8	O
.	O
158	O
.	O
2	O
±	O
8	O
.	O
5	O
‡	O
Creatinine	O
,	O
mg	O
/	O
dL	O
1	O
.	O
2	O
±	O
0	O
.	O
13	O
.	O
3	O
±	O
0	O
.	O
2	O
†	O
1	O
.	O
0	O
±	O
0	O
.	O
11	O
.	O
4	O
±	O
0	O
.	O
1	O
‡	O
Uric	O
acid	O
,	O
mg	O
/	O
dL	O
0	O
.	O
6	O
±	O
0	O
.	O
21	O
.	O
2	O
±	O
0	O
.	O
60	O
.	O
5	O
±	O
0	O
.	O
10	O
.	O
9	O
±	O
0	O
.	O
3	O
Proteinuria	O
,	O
g	O
/	O
L	O
0	O
.	O
43	O
±	O
0	O
.	O
10	O
.	O
55	O
±	O
0	O
.	O
10	O
.	O
40	O
±	O
0	O
.	O
10	O
.	O
44	O
±	O
0	O
.	O
1	O
Data	O
were	O
kept	O
for	O
six	O
-	O
month	O
-	O
old	O
male	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

These	O
findings	O
are	O
more	O
pronounced	O
in	O
F1	O
progeny	O
,	O
but	O
F2	O
progeny	O
are	O
also	O
affected	O
.	O

Anthropometric	O
indicators	O
(	O
birth	O
height	O
,	O
weight	O
,	O
and	O
head	O
circumference	O
)	O
were	O
measured	O
.	O

The	O
elimination	O
of	O
the	O
problem	O
at	O
this	O
short	O
period	O
is	O
valuable	O
in	O
the	O
health	O
of	O
mothers	O
’	O
and	O
their	O
breast	O
–	O
fed	O
children	O
.	O

The	O
sampling	O
flow	O
chart	O
was	O
presented	O
in	O
Fig	O
.	O

The	O
basis	O
for	O
these	O
recommendations	B
was	O
made	O
before	O
it	O
was	O
possible	O
to	O
measure	O
the	O
circulating	O
concentration	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
],	O
the	O
indicator	O
of	O
nutritional	O
vitamin	O
D	O
status	O
.	O

Because	O
the	O
G	O
allele	O
at	O
rs10741657	O
,	O
which	O
was	O
more	O
frequent	O
in	O
our	O
population	O
,	O
was	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
following	O
supplementation	O
,	O
it	O
could	O
be	O
postulated	O
that	O
this	O
allele	O
previously	O
conferred	O
an	O
evolutionary	O
advantage	O
to	O
prevent	O
vitamin	O
D	O
toxicity	O
.	O

Thus	O
,	O
metabolism	O
of	O
the	O
parent	O
environmental	O
compound	O
can	O
vary	O
greatly	O
between	O
models	O
,	O
resulting	O
in	O
the	O
production	O
of	O
different	O
types	O
and	O
levels	O
of	O
metabolites	O
.	O

However	O
,	O
higher	O
yearly	O
household	O
incomes	O
were	O
associated	O
with	O
higher	O
mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
and	O
having	O
concentrations	O
≥	O
75	O
nmol	O
/	O
L	O
(	O
p	O
=	O
0	O
.	O
002	O
and	O
p	O
=	O
0	O
.	O
002	O
,	O
respectively	O
).	O

Seventy	O
-	O
six	O
per	O
cent	O
of	O
women	O
reported	O
using	O
an	O
SGA	O
throughout	O
their	O
entire	O
pregnancy	O
(	O
n	O
=	O
101	O
),	O
while	O
the	O
remaining	O
reported	O
exposure	O
in	O
at	O
least	O
one	O
trimester	O
.	O

Caption	O
(	O
FIG	O
)	O
Many	O
studies	O
on	O
DDT	O
exposures	O
and	O
lactation	O
have	O
been	O
conducted	O
with	O
populations	O
of	O
Hispanic	O
women	O
who	O
work	O
on	O
farms	O
or	O
live	O
in	O
agricultural	O
areas	O
.	O

Skm1	O
homozygous	O
mutant	O
mice	O
were	O
born	O
with	O
expected	O
Mendelian	O
frequency	O
and	O
were	O
easily	O
distinguished	O
from	O
their	O
wild	O
-	O
type	O
littermates	O
at	O
weaning	O
.	O

Prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
were	O
tested	O
with	O
Fisher	O
’	O
s	O
Exact	O
test	O
.	O

Survival	O
analysis	O
could	O
therefore	O
not	O
be	O
performed	O
,	O
as	O
time	O
to	O
event	O
data	O
were	O
missing	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Mapping	O
of	O
the	O
mutant	O
pedigrees	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
the	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
(	O
Table	O
3	O
).	O

As	O
a	O
result	O
,	O
GRs	O
cannot	O
bind	O
to	O
their	O
DNA	O
GRE	O
and	O
subsequently	O
their	O
function	O
is	O
compromised	O
[	O
8	O
].	O

Besides	O
the	O
role	O
of	O
genetic	O
predisposition	O
,	O
some	O
factors	O
have	O
been	O
identified	O
that	O
may	O
either	O
contribute	O
to	O
sensitization	O
of	O
the	O
mother	O
and	O
to	O
the	O
subsequent	O
transfer	O
of	O
a	O
predisposition	O
for	O
allergy	O
to	O
the	O
offspring	O
,	O
or	O
that	O
directly	O
induce	O
sensitization	O
in	O
offspring	O
that	O
manifests	O
shortly	O
after	O
birth	O
or	O
at	O
a	O
young	O
age	O
.	O

Two	O
weeks	O
before	O
mating	O
female	O
rats	O
were	O
exposed	O
to	O
20	O
%	O
caloric	O
restriction	O
up	O
to	O
the	O
gestational	O
day	O
20	O
(	O
GD20	O
).	O

Parents	O
,	O
advocates	O
and	O
civil	O
society	O
have	O
captured	O
the	O
attention	O
of	O
governments	O
and	O
monitored	O
progress	O
in	O
the	O
United	O
States	O
through	O
support	O
of	O
an	O
annual	O
Premature	O
Birth	O
Report	O
Card	O
.	O

Program	O
dosage	O
and	O
optimization	O
research	B
should	B
be	I
included	O
to	O
address	O
other	O
features	O
of	O
the	O
mobile	O
phone	O
,	O
such	O
as	O
ubiquity	O
,	O
constant	O
use	O
,	O
and	O
potential	O
to	O
act	O
as	O
a	O
point	O
of	O
decision	O
prompt	O
.	O

Although	O
there	O
are	O
contradicting	O
epidemiological	O
and	O
experimental	O
results	O
regarding	O
the	O
direct	O
influence	O
of	O
smoking	O
on	O
total	O
and	O
specific	O
IgE	O
production	O
,[	O
97	O
,	O
98	O
]	O
smoking	O
should	B
nevertheless	O
be	O
avoided	O
for	O
obvious	O
reasons	O
,	O
such	O
as	O
carcinogenic	O
smoke	O
constituents	O
and	O
the	O
vasoconstrictive	O
effect	O
of	O
nicotine	O
.	O

Information	O
on	O
BMI	O
at	O
T1	O
and	O
season	O
of	O
conception	O
(	O
December	O
–	O
May	O
or	O
June	O
–	O
November	O
)	O
was	O
obtained	O
from	O
the	O
medical	O
records	O
.	O

The	O
resources	O
to	O
assist	O
with	O
this	O
include	O
the	O
Condensed	O
Food	O
Composition	O
Tables	O
for	O
South	O
Africa	O
[	O
43	O
]	O
and	O
the	O
South	O
African	O
Medical	O
Research	O
Council	O
(	O
SAMRC	O
)	O
Food	O
Quantities	O
Manual	O
[	O
44	O
].	O

To	O
estimate	O
the	O
total	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
we	O
combined	O
the	O
intake	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
.	O

Finally	O
,	O
adverse	O
birth	O
outcomes	O
were	O
infrequent	O
among	O
the	O
participants	O
and	O
did	O
not	O
differ	O
by	O
vaccination	O
status	O
(	O
p	O
-	O
value	O
>	O
0	O
.	O
05	O
);	O
the	O
percentage	O
with	O
preterm	O
birth	O
was	O
5	O
%,	O
small	O
for	O
gestational	O
age	O
was	O
10	O
%	O
and	O
low	O
birth	O
weight	O
was	O
6	O
%	O
(	O
Table	O
1	O
).	O

Sunscreen	O
lotions	O
prevent	O
UV	O
radiation	O
from	O
reaching	O
the	O
skin	O
and	O
might	O
therefore	O
reduce	O
the	O
skin	O
’	O
s	O
vitamin	O
D	O
production	O
[	O
56	O
].	O

Its	O
chemical	O
structure	O
resembles	O
steroid	O
hormones	O
and	O
it	O
acts	O
likewise	O
via	O
nuclear	O
receptor	O
(	O
VDR	O
,	O
vitamin	O
D	O
receptor	O
).	O

Global	O
Methylation	O
Status	O
Neither	O
the	O
gestational	O
nor	O
post	O
-	O
weaning	O
diet	O
had	O
any	O
effect	O
on	O
the	O
global	O
methylation	O
status	O
in	O
the	O
offspring	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
(	O
Figure	O
6c	O
).	O

In	O
addition	O
,	O
studies	O
within	O
categories	O
1	O
and	O
2	O
may	O
also	O
enable	O
identification	O
of	O
markers	O
and	O
/	O
or	O
mechanisms	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
through	O
a	O
weight	O
of	O
evidence	O
approach	O
(	O
e	O
.	O
g	O
.	O

Each	O
strip	O
will	O
consist	O
of	O
15	O
capsules	O
.	O

Records	O
included	O
ethnicity	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
socioeconomic	O
index	O
(	O
SEI	O
)	O
and	O
multivitamin	O
use	O
[	O
29	O
].	O

We	O
think	O
that	O
confounding	O
of	O
the	O
main	O
findings	O
by	O
lifestyle	O
or	O
other	O
aspects	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
is	O
unlikely	O
,	O
as	O
we	O
controlled	O
for	O
numerous	O
potential	O
confounders	O
in	O
the	O
analyses	O
,	O
including	O
nutrients	O
and	O
foods	O
that	O
have	O
been	O
previously	O
linked	O
to	O
childhood	O
asthma	O
and	O
atopy	O
.	O

Pregnant	O
women	O
with	O
thyroid	O
cancer	O
have	O
been	O
shown	O
to	O
have	O
favourable	O
outcomes	O
regardless	O
of	O
the	O
timing	O
of	O
diagnosis13233	O
.	O

However	O
,	O
as	O
misclassification	O
of	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
is	O
likely	O
to	O
have	O
been	O
random	O
with	O
respect	O
to	O
childhood	O
outcomes	O
,	O
the	O
strength	O
of	O
associations	O
may	O
have	O
been	O
underestimated	O
.	O

Elastic	O
Net	O
selected	O
the	O
same	O
variables	O
as	O
LASSO	O
,	O
as	O
well	O
as	O
an	O
additional	O
5	O
PCBs	O
and	O
1	O
PBDE	O
.	O

However	O
,	O
dissatisfaction	O
abounded	O
with	O
respect	O
to	O
this	O
aspect	O
,	O
especially	O
for	O
women	O
of	O
higher	O
educational	O
levels	O
.	O

Increasion	O
of	O
nerve	O
growth	O
factor	O
in	O
PC12	O
cells	O
by	O
Cytoplasmic	O
SIRT1	O
Induced	O
neuritogenesis	O
(	O
18	O
).	O

The	O
red	O
dashed	O
lines	O
represent	O
the	O
null	O
limits	O
for	O
the	O
permutation	O
distribution	O
of	O
regression	O
coefficient	O
t	O
-	O
statistics	O
(	O
t	O
-	O
stat	O
),	O
adjusted	O
for	O
multiple	O
comparisons	O
.	O

Although	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
black	O
mothers	O
and	O
neonates	O
is	O
well	O
known	O
,	O
debate	O
exists	O
as	O
to	O
the	O
relationship	O
between	O
race	O
,	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O
12	O
,	O
14	O
,	O
15	O
,	O
17	O
,	O
18We	O
examined	O
this	O
relationship	O
in	O
conjunction	O
with	O
additional	O
maternal	O
characteristics	O
in	O
order	O
to	O
identify	O
groups	O
of	O
pregnant	O
women	O
who	O
could	O
benefit	O
most	O
from	O
vitamin	O
D	O
supplementation	O
.	O

Generally	O
,	O
there	O
is	O
a	O
lack	O
of	O
evidence	O
for	O
maternal	O
pregnancy	O
restriction	O
diets	O
.	O

MUSC	O
is	O
a	O
comprehensive	O
,	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
(~	O
3000	O
deliveries	O
/	O
year	O
).	O

Between	O
1970	O
and	O
2000	O
,	O
there	O
was	O
a	O
25	O
%	O
increase	O
in	O
the	O
per	O
capita	O
consumption	O
of	O
all	O
refined	O
sugars	O
in	O
the	O
USA	O
,	O
matching	O
a	O
worldwide	O
trend	O
[	O
3	O
].	O

The	O
modification	O
of	O
insulin	O
sensitivity	O
occurs	O
via	O
the	O
effect	O
of	O
the	O
PTEN	O
/	O
AKT	O
-	O
mediated	O
regulation	O
of	O
adipose	O
tissue	O
lipolysis	O
.	O

Any	O
unexpected	O
test	O
result	O
and	O
any	O
symptoms	O
that	O
change	O
over	O
time	O
should	B
be	I
reevaluated	O
after	O
pregnancy	O
.	O

At	O
T1	O
,	O
10	O
%	O
had	O
25OHD	O
concentrations	O
<	O
30	O
nmol	O
/	O
L	O
and	O
9	O
%	O
at	O
T3	O
(	O
Table	O
2	O
).	O

Dietary	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
polyunsaturated	O
fatty	O
acids	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
cohort	O
of	O
33	O
000	O
women	O
from	O
the	O
general	O
population	O
Abstract	O
Background	O
Low	O
intake	O
of	O
fish	O
,	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
)	O
and	O
vitamin	O
D	O
deficiency	O
has	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
schizophrenia	O
.	O

Fetuses	O
originated	O
from	O
litters	O
of	O
at	O
least	O
11	O
viable	O
piglets	O
.	O

At	O
six	O
months	O
,	O
both	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
groups	O
were	O
heavier	O
than	O
their	O
SC	O
counterparts	O
(+	O
17	O
%	O
in	O
F1	O
,	O
+	O
15	O
%	O
in	O
F2	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

Alternatively	O
,	O
maternal	O
diet	O
may	O
affect	O
fetal	O
development	O
and	O
subsequent	O
host	O
response	O
to	O
microbial	O
populations	O
at	O
and	O
after	O
birth	O
.	O

However	O
,	O
if	O
an	O
epigenetic	O
change	O
becomes	O
permanently	O
established	O
in	O
the	O
germ	O
line	O
,	O
it	O
will	O
be	O
transmitted	O
across	O
future	O
generations	O
,	O
even	O
in	O
the	O
absence	O
of	O
the	O
original	O
stimulus	O
.	O

There	O
are	O
some	O
potential	O
limitations	O
to	O
our	O
findings	O
.	O

Obesity	O
was	O
defined	O
as	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
,	O
overweight	O
as	O
BMI	O
≥	O
25	O
and	O
<	O
30	O
kg	O
/	O
m2	O
,	O
normal	O
weight	O
as	O
BMI	O
>	O
20	O
and	O
<	O
25	O
kg	O
/	O
m2and	O
underweight	O
as	O
BMI	O
≤	O
20	O
kg	O
/	O
m2	O
.	O

Handwashing	O
with	O
soap	O
was	O
significantly	O
higher	O
before	O
breastfeeding	O
and	O
after	O
fecal	O
contact	O
among	O
intervention	O
mothers	O
than	O
among	O
controls	O
;	O
however	O
,	O
washing	O
with	O
soap	O
after	O
fecal	O
contact	O
was	O
less	O
common	O
than	O
the	O
prevalence	O
of	O
this	O
behavior	O
observed	O
among	O
mothers	O
of	O
young	O
children	O
in	O
Bangladesh	O
and	O
elsewhere	O
,	O
underscoring	O
the	O
substantial	O
barriers	O
to	O
handwashing	O
faced	O
by	O
mothers	O
of	O
neonates	O
[	O
21	O
].	O

Finding	O
about	O
neonatal	O
weight	O
showed	O
that	O
those	O
in	O
the	O
top	O
quartile	O
of	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
marginally	O
significant	O
chance	O
of	O
having	O
low	O
weight	O
infant	O
compared	O
with	O
those	O
in	O
the	O
bottom	O
quartile	O
in	O
the	O
crude	O
model	O
[	O
OR	O
1	O
.	O
84	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
94	O
-	O
3	O
.	O
60	O
),	O
P	O
=	O
0	O
.	O
05	O
].	O

There	O
is	O
significant	O
interest	O
in	O
what	O
influences	O
weight	O
gain	O
over	O
the	O
life	O
course	O
and	O
the	O
degree	O
to	O
which	O
risk	O
of	O
overweight	O
or	O
obesity	O
is	O
transmitted	O
across	O
generations	O
of	O
families	O
.	O
1	O
–	O
3From	O
studies	O
that	O
have	O
examined	O
the	O
heritability	O
of	O
BMI	O
,	O
45it	O
is	O
clear	O
that	O
BMI	O
does	O
have	O
a	O
heritable	O
component	O
.	O

They	O
were	O
randomized	O
to	O
receive	O
treatment	O
for	O
GDM	O
,	O
including	O
dietary	O
advice	O
,	O
blood	O
glucose	O
monitoring	O
,	O
and	O
insulin	O
as	O
required	O
,	O
or	O
standard	O
pregnancy	O
care	O
.	O

Parenteral	O
iron	O
sucrose	O
complex	O
is	O
known	O
to	O
have	O
several	O
advantages	O
because	O
of	O
its	O
low	O
-	O
allergenic	O
properties	O
and	O
consequently	O
,	O
an	O
extremely	O
low	O
incidence	O
of	O
severe	O
side	O
effects	O
such	O
as	O
anaphylactic	O
reactions	O
[	O
47	O
,	O
48	O
];	O
however	O
,	O
its	O
use	O
requires	O
caution	O
as	O
it	O
may	O
not	O
be	O
completely	O
devoid	O
of	O
side	O
effect	O
.	O

Both	O
adjusted	O
and	O
unadjusted	O
analyses	O
were	O
performed	O
,	O
with	O
adjustment	O
for	O
variables	O
used	O
to	O
stratify	O
randomisation	O
(	O
maternal	O
early	O
pregnancy	O
BMI	O
category	O
,	O
parity	O
,	O
and	O
centre	O
of	O
birth	O
),	O
in	O
addition	O
to	O
maternal	O
socioeconomic	O
status	O
,	O
age	O
,	O
and	O
smoking	O
status	O
.	O

Moreover	O
,	O
we	O
observed	O
a	O
sex	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perigonadal	O
fat	O
relative	O
to	O
body	O
weight	O
.	O

2	O
Associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
in	O
infants	O
delivered	O
vaginally	O
.	O

Covariate	O
data	O
.	O

The	O
remaining	O
piglets	O
were	O
cross	O
-	O
fostered	O
to	O
non	O
-	O
experimental	O
sows	O
of	O
2ndto	O
4thparities	O
,	O
which	O
were	O
on	O
the	O
AP	O
diet	O
during	O
gestation	O
.	O

Ørskov	O
[	O
110	O
]	O
reported	O
that	O
up	O
to	O
42	O
%	O
of	O
dietary	O
starch	O
may	O
escape	O
ruminal	O
fermentation	O
and	O
reach	O
the	O
small	O
intestine	O
.	O

Bonferrroni	O
analysis	O
indicated	O
that	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
).	O

Four	O
weeks	O
later	O
,	O
once	O
she	O
was	O
well	O
into	O
the	O
second	O
trimester	O
of	O
her	O
pregnancy	O
,	O
a	O
shave	O
removal	O
with	O
electrodessication	O
of	O
the	O
base	O
was	O
performed	O
after	O
reflecting	O
the	O
nail	O
plate	O
proximally	O
to	O
expose	O
the	O
lesion	O
.	O

The	O
lower	O
serum	O
VD	O
level	O
was	O
also	O
related	O
to	O
worse	O
sperm	O
parameters	O
[	O
52	O
].	O

In	O
contrast	O
,	O
“	O
brite	O
”	O
adipocytes	O
have	O
been	O
shown	O
to	O
originate	O
from	O
Myf	O
-	O
negative	O
(	O
Myf	O
5	O
−)	O
progenitor	O
cells	O
,	O
much	O
like	O
white	O
adipocytes	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
;	O
Long	O
et	O
al	O
.,	O
2014	O
).	O

Thus	O
,	O
with	O
differing	O
results	O
it	O
is	O
evident	O
that	O
more	B
specific	O-
studies	I
need	B
to	I
be	I
conducted	O
on	O
infertility	O
treatments	O
keeping	O
in	O
mind	O
specific	O
subtypes	O
and	O
their	O
effect	O
on	O
autism	O
in	O
children	O
.	O

Sampling	O
The	O
target	O
population	O
of	O
the	O
survey	O
comprised	O
all	O
pregnant	O
women	O
in	O
Belgium	O
during	O
the	O
first	O
and	O
the	O
third	O
trimester	O
of	O
pregnancy	O
in	O
the	O
period	O
from	O
September	O
2010	O
to	O
June	O
2011	O
.	O

The	O
average	O
daily	O
Vitamin	O
D	O
intake	O
dose	O
in	O
the	O
rest	O
eighty	O
-	O
four	O
participants	O
was	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

However	O
,	O
although	O
bitter	O
tastes	O
are	O
innately	O
disliked	O
,	O
with	O
repeated	O
exposure	O
,	O
infants	O
can	O
come	O
to	O
like	O
certain	O
foods	O
that	O
are	O
bitter	O
,	O
particularly	O
some	O
vegetables	O
(	O
31	O
-	O
34	O
).	O

The	O
dissection	O
started	O
at	O
the	O
aortic	O
root	O
and	O
extended	O
inferiorly	O
into	O
the	O
descending	O
aorta	O
and	O
upper	O
abdomen	O
.	O

In	O
1	O
study	O
,	O
at	O
least	O
half	O
of	O
food	O
advertisements	O
during	O
children	O
'	O
s	O
television	O
programming	O
were	O
for	O
energy	O
-	O
dense	O
,	O
low	O
-	O
nutrient	O
foods	O
such	O
as	O
cereal	O
,	O
candy	O
,	O
snacks	O
,	O
soda	O
,	O
and	O
fast	O
food	O
(	O
87	O
).	O

There	O
are	O
very	O
few	O
human	O
studies	O
which	O
include	O
three	O
generations	O
of	O
family	O
members	O
and	O
which	O
also	O
collect	O
anthropometric	O
data	O
or	O
study	O
heritability	O
patterns	O
.	O

[	O
37	O
–	O
39	O
]	O
The	O
concept	O
that	O
maternal	O
nutritional	O
status	O
influences	O
the	O
risk	O
of	O
chronic	O
disorders	O
in	O
the	O
offspring	O
has	O
attracted	O
interest	O
over	O
the	O
past	O
2	O
decades	O
.	O

The	O
data	O
was	O
entered	O
into	O
Microsoft	O
Excel	O
and	O
exported	O
toEpi	O
-	O
Info	O
(	O
Version	O
3	O
.	O
5	O
.	O
1	O
)	O
for	O
analysis	O
.	O

It	O
is	O
essential	O
for	O
the	O
generation	O
of	O
subsequent	O
germ	O
cells	O
(	O
and	O
thus	O
the	O
successful	O
production	O
of	O
future	O
generations	O
)	O
that	O
parental	O
imprints	O
within	O
PGCs	O
are	O
removed	O
and	O
new	O
imprints	O
are	O
re	O
-	O
established	O
according	O
to	O
the	O
gender	O
of	O
the	O
embryo	O
.	O

This	O
belief	O
among	O
public	O
health	O
and	O
medical	O
professional	O
is	O
justifiable	O
,	O
says	O
Nommsen	O
-	O
Rivers	O
,	O
because	O
formula	O
companies	O
have	O
a	O
long	O
history	O
of	O
dubious	O
marketing	O
practices	O
that	O
can	O
undermine	O
a	O
woman	O
’	O
s	O
confidence	O
in	O
her	O
ability	O
to	O
nourish	O
her	O
baby	O
without	O
the	O
use	O
of	O
their	O
products	O
.	O
4	O
,	O
5Breastfeeding	O
rates	O
began	O
to	O
dwindle	O
worldwide	O
with	O
the	O
advent	O
of	O
infant	O
formula	O
in	O
the	O
1860s	O
.	O
4They	O
reached	O
an	O
all	O
-	O
time	O
low	O
in	O
the	O
United	O
States	O
in	O
1971	O
,	O
when	O
fewer	O
than	O
25	O
%	O
of	O
new	O
mothers	O
initiated	O
breastfeeding	O
at	O
all	O
,	O
and	O
only	O
5	O
%	O
of	O
mothers	O
were	O
still	O
breastfeeding	O
at	O
6	O
months	O
.	O
6Today	O
,	O
largely	O
due	O
to	O
parent	O
education	O
efforts	O
and	O
improved	O
support	O
for	O
lactating	O
mothers	O
,	O
more	O
than	O
75	O
%	O
of	O
U	O
.	O
S	O
.	O
mothers	O
initiate	O
breastfeeding	O
,	O
and	O
about	O
20	O
%	O
of	O
U	O
.	O
S	O
.	O
babies	O
are	O
breastfed	O
exclusively	O
through	O
6	O
months	O
.	O
7	O
Robust	O
milk	O
production	O
depends	O
on	O
frequent	O
and	O
thorough	O
draining	O
of	O
the	O
breast	O
through	O
suckling	O
or	O
pumping	O
.	O

Education	O
about	O
asthma	O
and	O
its	O
interaction	O
with	O
pregnancy	O
reduces	O
anxiety	O
and	O
improves	O
compliance	O
.	O

[	O
17	O
]	O
New	O
research	O
suggests	O
that	O
women	O
who	O
take	O
high	O
doses	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
have	O
a	O
greatly	O
reduced	O
risk	O
of	O
complications	O
,	O
including	O
gestational	O
diabetes	O
,	O
preterm	O
birth	O
,	O
and	O
infection	O
.	O

Abstract	O
Cryptorchidism	O
and	O
retention	O
of	O
Müllerian	O
duct	O
structures	O
occur	O
with	O
high	O
frequency	O
among	O
the	O
male	O
offspring	O
of	O
CD	O
-	O
1	O
mice	O
treated	O
with	O
100	O
micrograms	O
diethylstilbestrol	O
/	O
kg	O
body	O
weight	O
on	O
days	O
9	O
through	O
16	O
of	O
pregnancy	O
.	O

American	O
Wagyu	O
steers	O
fed	O
a	O
high	O
-	O
corn	O
diet	O
had	O
greater	O
fat	O
accumulation	O
than	O
did	O
animals	O
fed	O
a	O
hay	O
-	O
based	O
diet	O
[	O
120	O
].	O

Excess	O
weight	O
is	O
usually	O
defined	O
by	O
the	O
body	O
mass	O
index	O
or	O
BMI	O
.	O

3	O
).	O

Neither	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
nor	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
related	O
to	O
birth	O
length	O
or	O
ponderal	O
index	O
.	O

Primordial	O
germ	O
cells	O
(	O
PGCs	O
)	O
undergo	O
a	O
second	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
to	O
ensure	O
correct	O
imprinting	O
and	O
development	O
of	O
mature	O
germ	O
cells	O
according	O
to	O
the	O
gender	O
of	O
the	O
embryo	O
,	O
and	O
enable	O
the	O
successful	O
production	O
of	O
subsequent	O
generations	O
in	O
a	O
continuous	O
cycle	O
.	O

The	O
nail	O
plate	O
was	O
subsequently	O
reflected	O
back	O
into	O
place	O
.	O

During	O
pregnancy	O
.	O

Homocysteine	O
is	O
an	O
amino	O
acid	O
,	O
which	O
plays	O
several	O
important	O
roles	O
in	O
human	O
physiology	O
.	O

In	O
their	O
study	O
,	O
early	O
weaning	O
calves	O
(	O
123	O
d	O
of	O
age	O
;	O
145	O
kg	O
of	O
body	O
weight	O
)	O
were	O
compared	O
with	O
conventional	O
weaning	O
animals	O
(	O
259	O
d	O
of	O
age	O
;	O
273	O
kg	O
of	O
body	O
weight	O
)	O
in	O
contemporary	O
feeding	O
management	O
.	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

Income	O
was	O
categorized	O
as	O
>$	O
25	O
,	O
000	O
per	O
year	O
versus	O
≤$	O
25	O
,	O
000	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Comparison	O
of	O
demographic	O
data	O
in	O
the	O
intervention	O
and	O
control	O
groupVariablesVitamin	O
DControl	O
p	O
-	O
valueAge	O
(	O
year	O
)	O
Mean	O
±	O
sd26	O
.	O
40	O
±	O
4	O
.	O
8826	O
.	O
22	O
±	O
4	O
.	O
330	O
.	O
80Job	O
N	O
(%)	O
0	O
.	O
96	O
Housewife72	O
(	O
96	O
)	O
75	O
(	O
96	O
.	O
2	O
)	O
Employed3	O
(	O
4	O
)	O
3	O
(	O
3	O
.	O
8	O
)	O
Education	O
N	O
(%)	O
0	O
.	O
55	O
High	O
school26	O
(	O
34	O
.	O
7	O
)	O
21	O
(	O
26	O
.	O
9	O
)	O
High	O
school	O
diploma34	O
(	O
45	O
.	O
3	O
)	O
38	O
(	O
48	O
.	O
7	O
)	O
University15	O
(	O
20	O
.	O
0	O
)	O
19	O
(	O
24	O
.	O
4	O
)	O
Parity0	O
.	O
17	O
Nullipara41	O
(	O
54	O
.	O
7	O
)	O
51	O
(	O
65	O
.	O
4	O
)	O
Multipara34	O
(	O
45	O
.	O
3	O
)	O
27	O
(	O
34	O
.	O
6	O
)	O
Using	O
others	O
supplements0	O
.	O
017	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Planned	O
pregnancy0	O
.	O
01	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Seasonal	O
distribution	O
in	O
onset	O
N	O
(%)	O
0	O
.	O
32	O
Autumn9	O
(	O
12	O
)	O
6	O
(	O
7	O
.	O
7	O
)	O
Winter11	O
(	O
14	O
.	O
7	O
)	O
7	O
(	O
9	O
)	O
Spring55	O
(	O
73	O
.	O
3	O
)	O
65	O
(	O
83	O
.	O
3	O
)	O
Sun	O
exposure	O
(	O
minutes	O
)	O
0	O
.	O
55	O
<	O
1514	O
(	O
21	O
.	O
9	O
)	O
12	O
(	O
16	O
.	O
7	O
)	O
15	O
–	O
3028	O
(	O
43	O
.	O
8	O
)	O
33	O
(	O
45	O
.	O
8	O
)	O
30	O
–	O
6010	O
(	O
15	O
.	O
6	O
)	O
17	O
(	O
23	O
.	O
6	O
)	O
>	O
6012	O
(	O
18	O
.	O
8	O
)	O
10	O
(	O
13	O
.	O
9	O
)	O
At	O
baseline	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
had	O
a	O
mean	O
value	O
of	O
12	O
.	O
35	O
±	O
7	O
.	O
17	O
ng	O
/	O
with	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
4	O
and	O
49	O
.	O
30	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

In	O
each	O
of	O
the	O
models	O
,	O
however	O
,	O
the	O
child	O
’	O
s	O
age	O
at	O
their	O
first	O
follow	O
-	O
up	O
visit	O
was	O
significantly	O
and	O
independently	O
positively	O
correlated	O
with	O
cathelicidin	O
.	O

Therefore	O
,	O
examining	O
childhood	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
is	B
warranted	I
.	O

1	O
.	O

These	O
Results	O
emphasize	O
the	O
need	O
for	O
pregnant	O
women	O
to	O
be	O
professionally	O
monitored	O
so	O
that	O
modifiable	O
risk	O
factors	O
can	O
be	O
managed	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
combined	O
or	O
system	O
-	O
specific	O
morbidity	O
profiles	O
between	O
study	O
groups	O
(	O
data	O
not	O
shown	O
).	O

Owing	O
to	O
the	O
lack	O
of	O
other	O
available	O
data	O
,	O
we	O
used	O
the	O
annual	O
number	O
of	O
live	O
births	O
in	O
Iaşi	O
county	O
reported	O
on	O
01	O
July	O
2009	O
(	O
n	O
=	O
9	O
,	O
499	O
)	O
to	O
define	O
the	O
size	O
of	O
the	O
reference	O
group	O
[	O
23	O
].	O

Having	O
many	O
exposure	O
variables	O
complicates	O
the	O
interpretation	O
of	O
associations	O
between	O
the	O
5	O
EDC	O
classes	O
and	O
birth	O
weight	O
when	O
using	O
traditional	O
multi	O
-	O
variable	O
linear	O
methods	O
.	O

Female	O
service	O
members	O
and	O
spouses	O
of	O
active	O
duty	O
soldiers	O
are	O
a	O
group	O
exposed	O
to	O
multiple	O
stressors	O
that	O
may	O
increase	O
health	O
risks	O
during	O
pregnancy	O
[	O
33	O
-	O
35	O
].	O

Future	B
interventions	I
can	O
tailor	O
text	O
message	O
and	O
other	O
mHealth	O
message	O
content	O
(	O
eg	O
,	O
through	O
social	O
media	O
or	O
apps	O
)	O
both	O
to	O
a	O
specific	O
target	O
audience	O
and	O
to	O
an	O
optimal	O
time	O
for	O
delivery	O
.	O

Similarly	O
,	O
there	O
were	O
no	O
significant	O
differences	O
identified	O
with	O
regards	O
to	O
general	O
health	O
or	O
health	O
service	O
utilisation	O
(	O
Table	O
4	O
).	O

RMMCH	O
is	O
a	O
provincial	O
hospital	O
focusing	O
on	O
maternal	O
and	O
paediatric	O
healthcare	O
,	O
delivering	O
more	O
than	O
10	O
,	O
000	O
babies	O
annually	O
.	O

The	O
reason	O
why	O
low	O
birth	O
weight	O
promotes	O
alterations	O
in	O
cardiac	O
ANS	O
activity	O
among	O
health	O
individuals	O
is	O
unknown	O
.	O

The	O
mean	O
time	O
of	O
follow	O
up	O
was	O
similar	O
in	O
both	O
groups	O
(	O
MMN	O
:	O
14	O
.	O
1	O
±	O
1	O
.	O
2	O
months	O
,	O
placebo	O
14	O
.	O
0	O
±	O
1	O
.	O
2	O
months	O
).	O

OVERVIEW	O
OF	O
MUSCLE	O
AND	O
FAT	O
CELL	O
GROWTH	O
IN	O
RUMINANTS	O
Skeletal	O
muscle	O
including	O
the	O
LM	O
mainly	O
consists	O
of	O
skeletal	O
muscle	O
fibres	O
(	O
myofibres	O
),	O
but	O
it	O
also	O
contains	O
fat	O
cells	O
,	O
connective	O
tissue	O
or	O
extracellular	O
matrix	O
,	O
and	O
various	O
other	O
cell	O
types	O
including	O
satellite	O
cells	O
,	O
immune	O
cells	O
and	O
blood	O
vessels	O
.	O

In	O
a	O
study	O
by	O
Mozafari	O
-	O
Khosravi	O
et	O
al	O
.,	O
300	O
,	O
000	O
and	O
150	O
,	O
000	O
IU	O
vitamin	O
D	O
were	O
administered	O
by	O
injection	O
to	O
the	O
two	O
groups	O
who	O
suffered	O
depression	O
and	O
the	O
third	O
group	O
did	O
not	O
receive	O
vitamin	O
D	O
.	O
High	O
doses	O
of	O
vitamin	O
D	O
were	O
effective	O
in	O
decreasing	O
depression	O
levels	O
after	O
3	O
months	O
[	O
30	O
].	O

PubMed	O
Central	O
:	O

EAH	O
is	O
seen	O
more	O
often	O
in	O
children	O
who	O
are	O
overweight	O
(	O
39	O
,	O
47	O
,	O
49	O
,	O
52	O
)	O
and	O
in	O
children	O
with	O
higher	O
1	O
-	O
year	O
weight	O
gains	O
(	O
53	O
).	O

(	O
2014	O
)*/†	O
Nutrition	O
:	O
High	O
fat	O
dietMouse	O
RatOral	O
(	O
diet	O
)	O
(	O
60	O
%	O
fat	O
)	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
to	O
lactation	O
Early	O
adulthoodAdulthood	O
F0	O
-	O
F1generationsWeight	O
-,	O
glucose	O
-	O
and	O
lipid	O
-	O
related	O
metabolic	O
and	O
food	O
preference	O
abnormalitiesDNA	O
methylation	O
miRNAsBaselga	O
-	O
Escudero	O
et	O
al	O
.	O

Database	O
searching	O
and	O
secondary	O
analyses	O
Data	O
generated	O
from	O
peptide	O
mass	O
mapping	O
(	O
PMM	O
)	O
of	O
each	O
spot	O
were	O
used	O
to	O
perform	O
searches	O
of	O
the	O
SWISS	O
-	O
PROT	O
,	O
NCBI	O
and	O
TrEMBL	O
databases	O
using	O
the	O
programs	O
Aldente	O
(	O
www	O
.	O
expasy	O
.	O
ch	O
)	O
and	O
MASCOT	O
(	O
www	O
.	O
matrixscience	O
.	O
com	O
).	O

Recommendations	O
The	O
World	O
Health	O
Organization	O
has	O
recommended	B
that	O
weekly	O
iron	O
and	O
folic	O
acid	O
supplementation	O
should	B
be	I
considered	O
as	O
a	O
strategy	B
for	O
prevention	O
of	O
iron	O
deficiency	O
in	O
population	O
groups	O
.	O

Maternal	O
diet	O
during	O
pregnancy	O
is	O
related	O
with	O
the	O
infant	O
stool	O
microbiome	O
in	O
a	O
delivery	O
mode	O
-	O
dependent	O
manner	O
Abstract	O
Background	O
The	O
gut	O
microbiome	O
has	O
an	O
important	O
role	O
in	O
infant	O
health	O
and	O
immune	O
development	O
and	O
may	O
be	O
affected	O
by	O
early	O
-	O
life	O
exposures	O
.	O

However	O
,	O
the	O
suitability	O
of	O
the	O
Avy	O
mouse	O
as	O
a	O
true	O
reporter	O
model	O
has	O
since	O
been	O
questioned	O
following	O
both	O
lack	O
of	O
reproducibility	O
(	O
Rosenfeld	O
et	O
al	O
.	O
2013	O
),	O
and	O
the	O
suggestion	O
that	O
it	O
may	O
possess	O
a	O
“	O
thrifty	O
”	O
genotype	O
,	O
naturally	O
predisposing	O
offspring	O
to	O
a	O
metabolic	O
syndrome	O
when	O
food	O
is	O
plentiful	O
,	O
thus	O
confounding	O
results	O
following	O
environmental	O
exposures	O
(	O
Greally	O
&	O
Jacobs2013	O
).	O

Maternal	O
Anthropometrics	O
Maternal	O
pregravid	O
weight	O
was	O
based	O
on	O
self	O
-	O
report	O
at	O
time	O
of	O
study	O
enrollment	O
and	O
was	O
shown	O
to	O
be	O
valid	O
compared	O
with	O
physician	O
documented	O
prepregnancy	O
weight	O
[	O
16	O
].	O

Overall	O
,	O
these	O
birth	O
weight	O
studies	O
illustrate	O
that	O
more	B
research	I
with	O
larger	O
populations	O
needs	B
to	O
be	O
conducted	O
to	O
determine	O
whether	O
autism	O
etiology	O
is	O
genetic	O
in	O
relation	O
to	O
birth	O
weight	O
,	O
whether	O
birth	O
weight	O
is	O
a	O
risk	O
factor	O
or	O
a	O
cause	O
of	O
autism	O
,	O
how	O
much	O
mother	O
'	O
s	O
gestational	O
age	O
plays	O
a	O
role	O
,	O
and	O
whether	O
pre	O
-	O
or	O
postpregnancy	O
weight	O
of	O
the	O
mother	O
has	O
a	O
larger	O
effect	O
on	O
prevalence	O
of	O
autism	O
and	O
ASD	O
as	O
research	O
currently	O
supports	O
a	O
variety	O
of	O
findings	O
.	O

This	O
interpretation	O
also	O
agrees	O
with	O
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
metabolism	O
in	O
peripheral	O
tissues	O
.	O

The	O
remaining	O
seven	O
deaths	O
were	O
due	O
to	O
accidental	O
or	O
congenital	O
causes	O
.	O

The	O
importance	O
of	O
age	O
of	O
exposure	O
and	O
seasonality	O
is	O
uncertain	O
.	O

Hematoxylin	O
and	O
eosin	O
stain	O
,	O
same	O
magnification	O
in	O
all	O
pictures	O
.	O

Both	O
methods	O
are	O
interviewer	O
administered	O
by	O
using	O
standardised	O
probing	O
questions	O
[	O
37	O
].	O

We	O
also	O
obtained	O
anthropometric	O
data	O
(	O
height	O
and	O
weight	O
),	O
demographic	O
data	O
(	O
occupation	O
and	O
education	O
),	O
and	O
clinical	O
data	O
(	O
delivery	O
status	O
,	O
IUGR	O
and	O
history	O
of	O
preterm	O
birth	O
,	O
abortion	O
,	O
delivery	O
status	O
,	O
and	O
stillbirth	O
)	O
of	O
the	O
pregnant	O
women	O
.	O

Expanding	O
on	O
this	O
,	O
a	O
matched	O
case	O
control	O
studies	O
of	O
children	O
in	O
Stockholm	O
county	O
showed	O
a	O
correlation	O
between	O
low	O
growth	O
for	O
gestation	O
age	O
and	O
preterm	O
birth	O
with	O
ASD	O
combined	O
with	O
intellectual	O
disabilities	O
.	O

Skm1	O
mice	O
were	O
visibly	O
leaner	O
than	O
their	O
littermate	O
controls	O
and	O
presented	O
with	O
either	O
an	O
elongated	O
body	O
or	O
a	O
thoracolumbar	O
kyphosis	O
and	O
a	O
kinked	O
tail	O
(	O
Figure	O
1B	O
).	O

The	O
obvious	O
explanations	O
to	O
the	O
higher	O
body	O
weight	O
found	O
in	O
RC	O
males	O
after	O
weaning	O
could	O
be	O
as	O
a	O
consequence	O
of	O
an	O
increased	O
food	O
intake	O
,	O
decreased	O
energy	O
expenditure	O
or	O
higher	O
metabolic	O
efficiency	O
.	O

A	O
Cochrane	O
review	O
of	O
a	O
randomized	O
control	O
trial	O
conducted	O
in	O
Pakistan	O
reported	O
that	O
daily	O
iron	O
treatment	O
is	O
better	O
than	O
intermittent	O
iron	O
supplementation	O
in	O
increasing	O
haemoglobin	O
level	O
at	O
delivery	O
among	O
pregnant	O
women	O
in	O
developing	O
countries	O
[	O
2	O
].	O

Evidence	O
-	O
Based	O
Preventive	O
Treatment	O
Options	O
3	O
.	O
2	O
.	O
1	O
.	O

One	O
of	O
the	O
mechanisms	O
responsible	O
for	O
the	O
effect	O
of	O
fetal	O
nutritional	O
programming	O
on	O
growth	O
and	O
adiposity	O
of	O
progeny	O
is	O
epigenetic	O
modification	O
(	O
DNA	O
methylation	O
,	O
histone	O
modification	O
,	O
and	O
microRNA	O
)	O
of	O
gene	O
expression	O
during	O
early	O
development	O
and	O
permanent	O
changes	O
in	O
offspring	O
phenotypes	O
in	O
later	O
life	O
.	O

In	O
pairwise	O
comparison	O
,	O
the	O
baseline	O
depression	O
score	O
and	O
the	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
were	O
not	O
different	O
significantly	O
(	O
p	O
=	O
0	O
.	O
142	O
).	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	O
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	O
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
[	O
1	O
-	O
6	O
].	O

Pre	O
-	O
cast	O
immobilised	O
pH	O
gradient	O
strips	O
(	O
IPG	O
,	O
11	O
cm	O
,	O
pH	O
3	O
–	O
10	O
,	O
Proteome	O
Systems	O
,	O
North	O
Ryde	O
,	O
Australia	O
)	O
were	O
passively	O
rehydrated	O
in	O
200	O
µg	O
sample	O
protein	O
extract	O
for	O
6	O
hr	O
at	O
room	O
temperature	O
.	O

Maternal	O
Diet	O
During	O
Lactation	O
Regarding	O
maternal	O
lactation	O
diets	O
,	O
a	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
[	O
99	O
]	O
found	O
some	O
evidence	O
of	O
reduced	O
atopic	O
dermatitis	O
,	O
but	O
suggested	O
that	O
more	B
studies	B
are	I
needed	I
.	O

P	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
.	O

Linear	O
models	O
indicated	O
a	O
positive	O
association	O
of	O
maternal	O
dairy	O
intake	O
with	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
and	O
the	O
species	O
Escherichia	O
coli	O
and	O
negative	O
association	O
with	O
the	O
OTUs	O
that	O
belong	O
to	O
the	O
genera	O
Bifidobacterium	O
,	O
Pseudomonas	O
,	O
and	O
Bacteroides	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5b	O
).	O

These	O
include	O
both	O
direct	O
and	O
indirect	O
processes	O
that	O
ultimately	O
lead	O
to	O
alterations	O
in	O
DNA	O
methylation	O
,	O
histone	O
modification	O
and	O
/	O
or	O
ncRNA	O
expression	O
.	O

The	O
data	O
included	O
partially	O
missing	O
information	O
.	O

Conclusions	O
In	O
a	O
large	O
ethnically	O
diverse	O
cohort	O
of	O
newborns	O
,	O
the	O
presence	O
of	O
a	O
pet	O
in	O
the	O
home	O
during	O
the	O
prenatal	O
time	O
period	O
was	O
associated	O
with	O
higher	O
cord	O
blood	O
vitamin	O
D	O
,	O
but	O
only	O
among	O
Whites	O
.	O

Particularly	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
male	O
offspring	O
were	O
born	O
normoweight	O
but	O
displayed	O
higher	O
body	O
weight	O
than	O
CC	O
male	O
offspring	O
in	O
several	O
days	O
of	O
the	O
lactation	O
period	O
(	O
PND	O
1	O
–	O
2	O
and	O
PND	O
9	O
–	O
11	O
).	O

These	O
data	O
also	O
further	O
the	O
hypothesis	O
that	O
the	O
intrauterine	O
environment	O
acting	O
through	O
epigenetic	O
alteration	O
of	O
the	O
placenta	O
is	O
a	O
key	O
mechanism	O
to	O
explain	O
the	O
developmental	O
origins	O
of	O
health	O
and	O
disease	O
and	O
suggest	O
that	O
enhanced	O
examinations	O
of	O
the	O
importance	O
of	O
placental	O
epigenetic	O
variation	O
in	O
health	O
outcomes	O
should	B
be	I
undertaken	O
.	O

Several	O
small	O
studies	O
comparing	O
metformin	O
to	O
insulin	O
for	O
the	O
treatment	O
of	O
GDM	O
have	O
also	O
been	O
performed	O
(	O
Table	O
5	O
).	O

Dosage	O
in	O
excess	O
of	O
50	O
mcg	O
(	O
2000	O
units	O
)	O
per	O
day	O
are	O
not	O
recommended	B
,	O
thus	O
the	O
treatment	O
of	O
postsurgical	O
hypoparatithyroid	O
patient	O
calcium	O
supplementation	O
may	O
be	O
required	O
at	O
dosage	O
as	O
high	O
as	O
4	O
g	O
/	O
day	O
together	O
with	O
D	O
vitamin	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
show	O
that	O
low	O
cord	O
—	O
and	O
not	O
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	O
to	O
relatively	O
poor	O
lung	O
performance	O
at	O
6	O
months	O
of	O
age	O
.	O

There	O
may	O
also	O
be	O
a	O
role	O
for	O
hand	O
cleansing	O
options	O
that	O
are	O
waterless	O
or	O
that	O
can	O
confer	O
residual	O
bacteriostatic	O
benefit	O
to	O
improve	O
the	O
convenience	O
and	O
thereby	O
the	O
frequency	O
of	O
hand	O
cleansing	O
,	O
or	O
the	O
effects	O
of	O
even	O
infrequent	O
hand	O
cleansing	O
.	O

The	O
relatively	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
may	O
have	O
important	O
health	O
implications	O
for	O
Thai	O
people	O
as	O
the	O
science	O
of	O
vitamin	O
D	O
continues	O
to	O
be	O
unraveled	O
.	O

1	O
.	O

Overall	O
,	O
however	O
,	O
the	O
current	O
study	O
'	O
s	O
findings	O
suggest	O
that	O
dietary	O
variables	O
may	O
exert	O
more	O
of	O
an	O
effect	O
than	O
maternal	O
psychosocial	O
variables	O
on	O
offspring	O
weight	O
outcomes	O
.	O

Two	O
-	O
way	O
ANOVA	O
and	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
RC	O
males	O
;	O
ns	O
,	O
non	O
-	O
significant	O
.	O

The	O
effectiveness	O
of	O
calcium	O
supplementation	O
on	O
prevention	O
of	O
perinatal	O
depression	O
has	O
been	O
shown	O
in	O
a	O
previous	O
study	O
[	O
65	O
].	O

This	O
is	O
in	O
keeping	O
with	O
the	O
observation	O
of	O
increased	O
plasma	O
IL	O
-	O
6	O
levels	O
in	O
obese	O
patients	O
(	O
Cottam	O
et	O
al	O
.,	O
2004	O
).	O

Mechanisms	O
regulating	O
pubertal	O
onset	O
are	O
no	O
doubt	O
multifactorial	O
.	O

Therefore	O
,	O
'	O
mTOR	O
signaling	O
'	O
might	O
be	O
involved	O
in	O
compensatory	O
growth	O
processes	O
at	O
adult	O
stage	O
in	O
LP	O
offspring	O
.	O

3	O
.	O
2	O
.	O

Much	O
like	O
anticonvulsants	O
and	O
other	O
drug	O
exposures	O
,	O
the	O
use	O
of	O
SSRIs	O
in	O
pregnant	O
women	O
and	O
its	O
association	O
to	O
autism	O
have	O
been	O
explored	O
.	O

Established	O
risk	O
factors	O
include	O
ionizing	O
radiation	O
and	O
a	O
few	O
genetic	O
syndromes	O
[	O
2	O
].	O

Pregnancy	O
itself	O
may	O
also	O
affect	O
the	O
course	O
of	O
asthma	O
and	O
other	O
diseases	O
[	O
10	O
].	O

Western	O
blotting	O
analysis	O
After	O
euthanasia	O
,	O
the	O
right	O
kidneys	O
were	O
taken	O
at	O
birth	O
,	O
weaning	O
and	O
6	O
months	O
in	O
both	O
generations	O
to	O
determine	O
total	O
proteins	O
.	O

Thus	O
,	O
Model	O
1	O
indicates	O
that	O
every	O
1	O
-	O
year	O
increase	O
in	O
a	O
child	O
’	O
s	O
age	O
is	O
associated	O
with	O
a	O
0	O
.	O
145	O
unit	O
increase	O
in	O
their	O
log	O
cathelicidin	O
concentration	O
,	O
equivalent	O
to	O
a	O
e0	O
.	O
145	O
=	O
1	O
.	O
2	O
-	O
fold	O
increase	O
from	O
1	O
year	O
to	O
the	O
next	O
.	O

However	O
,	O
mothers	O
with	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
had	O
newborns	O
with	O
smaller	O
head	O
circumference	O
than	O
those	O
with	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
003	O
),	O
which	O
was	O
further	O
confirmed	O
as	O
a	O
linear	O
association	O
(	O
P	O
=	O
0	O
.	O
024	O
).	O

Fat	O
digestion	O
and	O
absorption	O
Many	O
of	O
the	O
FAs	O
generated	O
by	O
digestion	O
in	O
the	O
rumen	O
pass	O
into	O
the	O
small	O
intestine	O
,	O
where	O
they	O
are	O
absorbed	O
into	O
circulation	O
via	O
the	O
lymph	O
and	O
blood	O
.	O

We	O
also	O
report	O
the	O
proportion	O
of	O
mothers	O
who	O
maintained	O
soap	O
and	O
water	O
at	O
at	O
least	O
one	O
handwashing	O
station	O
in	O
the	O
home	O
and	O
at	O
a	O
handwashing	O
station	O
in	O
the	O
room	O
where	O
the	O
neonate	O
was	O
cared	O
for	O
and	O
compare	O
the	O
intervention	O
and	O
control	O
groups	O
at	O
each	O
time	O
point	O
that	O
this	O
outcome	O
was	O
observed	O
.	O

Ratings	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
follow	O
-	O
up	O
questionnaire	O
contained	O
20	O
questions	O
on	O
psychotic	O
-	O
like	O
symptoms	O
,	O
(	O
Additional	O
file1	O
),	O
constituting	O
the	O
positive	O
symptoms	O
of	O
the	O
CAPE	O
(	O
Community	O
Assessment	O
of	O
Psychic	O
Experiences	O
)	O
questionnaire	O
,	O
a	O
modified	O
version	O
of	O
the	O
Peters	O
et	O
al	O
.	O

The	O
exposed	O
neonates	O
were	O
more	O
likely	O
to	O
be	O
born	O
premature	O
,	O
were	O
admitted	O
more	O
often	O
to	O
the	O
neonatal	O
intensive	O
care	O
unit	O
,	O
presented	O
with	O
poor	O
neonatal	O
adaptation	O
signs	O
and	O
had	O
higher	O
rates	O
of	O
congenital	O
malformations	O
.	O

However	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
in	O
Japan	O
,	O
higher	O
dietary	O
vitamin	O
D	O
intake	O
was	O
independently	O
associated	O
with	O
a	O
lower	O
prevalence	O
of	O
depressive	O
symptoms	O
during	O
pregnancy	O
[	O
66	O
].	O

Also	O
,	O
using	O
a	O
questionnaire	O
,	O
data	O
were	O
collected	O
on	O
age	O
,	O
literacy	O
level	O
,	O
occupation	O
,	O
type	O
of	O
therapy	O
for	O
diabetes	O
,	O
and	O
type	O
of	O
delivery	O
using	O
medical	O
history	O
and	O
interview	O
with	O
the	O
patients	O
.	O

Models	O
were	O
adjusted	O
for	O
age	O
,	O
physical	O
activity	O
,	O
smoking	O
status	O
,	O
educational	O
attainment	O
,	O
season	O
of	O
blood	O
sampling	O
,	O
compliance	O
,	O
and	O
pregnancy	O
weight	O
gain	O
.	O

The	O
commonly	O
used	O
organophospate	O
pesticide	O
chlorpyrifos	O
(	O
CPF	O
)	O
is	O
known	O
to	O
specifically	O
target	O
the	O
immature	O
brain	O
,	O
from	O
the	O
early	O
embryonic	O
stage	O
to	O
the	O
postweaning	O
period	O
,	O
and	O
it	O
causes	O
a	O
host	O
of	O
irreversible	O
changes	O
to	O
developing	O
brain	O
cells	O
[	O
39	O
].	O

Discussion	O
Exposure	O
to	O
extended	O
winter	O
in	O
early	O
pregnancy	O
is	O
associated	O
with	O
increased	O
insulin	O
resistance	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
and	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
status	O
.	O

Established	O
as	O
the	O
chorioallantoic	O
placenta	O
at	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
villous	O
tissues	O
secrete	O
multiple	O
hormones	O
that	O
maintain	O
pregnancy	O
and	O
regulate	O
placental	O
physiology	O
.	O

We	O
used	O
the	O
elbow	O
method	O
to	O
determine	O
the	O
optimal	O
number	O
of	O
clusters	O
,	O
which	O
is	O
based	O
on	O
the	O
within	O
-	O
cluster	O
sum	O
of	O
squares	O
.	O

A	O
burgeoning	O
body	O
of	O
research	O
—	O
from	O
rodent	O
toxicology	O
to	O
human	O
epidemiology	O
studies	O
—	O
suggests	O
that	O
certain	O
environmental	O
exposures	O
may	O
impair	O
a	O
mother	O
’	O
s	O
ability	O
to	O
nurse	O
her	O
child	O
.	O

per	O
quintile	O
effect	O
).	O

LASSO	O
and	O
Elastic	O
Net	O
regression	O
coefficients	O
were	O
larger	O
in	O
size	O
but	O
with	O
less	O
precise	O
95	O
%	O
intervals	O
compared	O
to	O
BHLM	O
.	O

It	O
is	O
worth	O
mentioning	O
that	O
their	O
tools	O
for	O
determining	O
depression	O
were	O
different	O
than	O
ours	O
.	O

Scenario	O
1	O
:	O
"	O
Business	O
as	O
usual	O
"	O
Should	O
governments	O
and	O
the	O
global	O
community	O
take	O
no	O
further	O
direct	O
action	B
to	O
address	O
deaths	O
due	O
to	O
preterm	O
birth	O
,	O
mortality	O
will	O
decline	O
by	O
24	O
%	O
by	O
2025	O
according	O
to	O
an	O
analysis	O
of	O
regional	O
trends	O
over	O
the	O
past	O
decade	O
and	O
forward	O
projection	O
(	O
or	O
16	O
%,	O
if	O
the	O
projection	O
is	O
based	O
on	O
forecasted	O
GNI	O
change	O
)	O
(	O
Figure4	O
).	O

In	O
addition	O
,	O
each	O
situation	O
must	O
be	O
considered	O
in	O
development	O
,	O
nothing	O
is	O
static	O
,	O
mainly	O
in	O
the	O
first	O
trimester	O
.	O

The	O
a	O
priori	O
goal	O
was	O
the	O
achievement	O
of	O
a	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
≥	O
40	O
ng	O
/	O
mL	O
to	O
achieve	O
maximal	O
production	O
of	O
the	O
active	O
hormone	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
[	O
13	O
].	O

Tertiary	O
prevention	O
is	O
directed	O
at	O
patients	O
with	O
a	O
chronic	O
disease	O
to	O
prevent	O
additional	O
problems	O
related	O
to	O
the	O
disease	O
.	O

Thus	O
,	O
increasing	O
vitamin	O
D	O
intake	O
from	O
vitamin	O
D	O
fortified	O
foods	O
,	O
and	O
vitamin	O
D	O
supplements	O
,	O
in	O
combination	O
with	O
sensible	O
sun	O
exposure	O
,	O
maximize	O
a	O
person	O
'	O
s	O
vitamin	O
D	O
status	O
to	O
promote	O
good	O
health	O
.	O

Signals	O
were	O
visualized	O
by	O
chemiluminescence	O
,	O
and	O
the	O
digital	O
images	O
were	O
quantitatively	O
analyzed	O
(	O
Image	O
-	O
Pro	O
Plus	O
version	O
7	O
.	O
01	O
,	O
Media	O
Cybernetics	O
,	O
Silver	O
Spring	O
,	O
MD	O
,	O
USA	O
).	O

Evidence	O
shows	O
that	O
postnatal	O
depression	O
is	O
an	O
extension	O
of	O
antenatal	O
depression	O
which	O
continues	O
postpartum	O
.	O

Compared	O
with	O
lean	O
women	O
who	O
did	O
not	O
snore	O
,	O
those	O
who	O
were	O
overweight	O
and	O
snored	O
had	O
a	O
6	O
.	O
9	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

Ultimately	O
,	O
the	O
mature	O
gametes	O
come	O
together	O
to	O
enable	O
the	O
cycle	O
to	O
begin	O
again	O
and	O
so	O
on	O
.	O

In	O
calorie	O
restricted	O
offspring	O
(	O
UNP	O
,	O
UNL	O
,	O
UNPL	O
),	O
a	O
post	O
-	O
weaning	O
HF	O
diet	O
further	O
advanced	O
the	O
age	O
at	O
puberty	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Figure	O
2B	O
,	O
C	O
,	O
D	O
;	O
Table	O
1	O
)	O
compared	O
to	O
those	O
offspring	O
who	O
were	O
normally	O
nourished	O
in	O
utero	O
and	O
fed	O
a	O
HF	O
diet	O
post	O
-	O
weaning	O
(	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Percentage	O
of	O
offspring	O
entering	O
puberty	O
over	O
time	O
in	O
animals	O
whose	O
dams	O
received	O
50	O
%	O
of	O
normal	O
nutrition	O
.	O

In	O
clinical	O
studies	O
,	O
researchers	O
from	O
Kaiser	O
Permanente	O
Northern	O
California	O
Hospitals	O
examined	O
291	O
children	O
born	O
from	O
1995	O
to	O
1999	O
,	O
compared	O
to	O
284	O
controls	O
.	O

In	O
addition	O
,	O
3	O
-	O
month	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
not	O
closely	O
related	O
to	O
BMC	O
at	O
3	O
months	O
,	O
r	O
=	O
0	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
18	O
.	O

Therefore	O
,	O
the	O
transcriptional	O
control	O
of	O
cyclins	O
provides	O
an	O
additional	O
level	O
of	O
growth	O
regulation	O
.	O

Only	O
6	O
%	O
of	O
women	O
started	O
visits	O
in	O
the	O
first	O
trimester	O
while	O
14	O
.	O
5	O
%	O
began	O
in	O
the	O
third	O
trimester	O
.	O

The	O
supernatant	O
was	O
removed	O
to	O
a	O
new	O
tube	O
then	O
dried	O
in	O
a	O
centrifugal	O
vacuum	O
drier	O
.	O

The	O
lines	O
represent	O
the	O
weighted	O
regression	O
with	O
its	O
95	O
%	O
confidence	O
interval	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Multiple	O
Linear	O
Regression	O
Analyses	O
for	O
the	O
Dependent	O
Variables	O
RMSSD	O
,	O
PNN50	O
and	O
HF	O
index	O
.	O
βSECI	O
(	O
95	O
%)	O
P	O
Value	O
RMSSD	O
(	O
ms	O
)	O
Birth	O
Weight0	O
.	O
0110	O
.	O
004	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
019	O
)	O
0	O
.	O
018	O
PNN50	O
(%)	O
Birth	O
Weight0	O
.	O
0080	O
.	O
003	O
(	O
0	O
.	O
002	O
to	O
0	O
.	O
012	O
)	O
0	O
.	O
007Age1	O
.	O
3650	O
.	O
677	O
(	O
0	O
.	O
019	O
to	O
2	O
.	O
710	O
)	O
0	O
.	O
047BMI	O
-	O
0	O
.	O
7530	O
.	O
308	O
(-	O
1	O
.	O
364	O
to	O
-	O
0	O
.	O
142	O
)	O
0	O
.	O
016	O
HF	O
(	O
n	O
.	O
u	O
.)	O

We	O
encouraged	O
families	O
to	O
bring	O
their	O
children	O
to	O
the	O
study	O
hospital	O
for	O
any	O
illness	O
for	O
which	O
quality	O
treatment	O
was	O
offered	O
free	O
of	O
charge	O
.	O

Maternal	O
consumption	O
of	O
a	O
HF	O
diet	O
resulted	O
in	O
adult	O
offspring	O
progesterone	O
concentrations	O
that	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
offspring	O
born	O
to	O
Cont	O
dams	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Figure	O
4B	O
),	O
although	O
in	O
MHF	O
offspring	O
these	O
differences	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
determinants	O
of	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamins	O
supplements	O
by	O
expectant	O
mothers	O
in	O
Romania	O
,	O
in	O
terms	O
of	O
nutritional	O
knowledge	O
evaluated	O
by	O
a	O
structured	O
questionnaire	O
,	O
socio	O
-	O
demographic	O
factors	O
and	O
engagement	O
with	O
prenatal	O
care	O
.	O

It	O
is	O
the	O
first	O
study	O
to	O
capture	O
mothers	O
’	O
overall	O
dietary	O
patterns	O
and	O
relate	O
them	O
to	O
child	O
leukemia	O
.	O

Thus	O
,	O
the	O
total	O
number	O
of	O
subjects	O
was	O
723	O
.	O

We	O
are	O
not	O
basing	O
our	O
conclusion	O
that	O
the	O
maternal	O
line	O
is	O
stronger	O
solely	O
on	O
the	O
fact	O
that	O
the	O
mother	O
–	O
child	O
correlations	O
at	O
age	O
5	O
are	O
significant	O
.	O

This	O
holds	O
true	O
for	O
the	O
existing	O
inequalities	O
in	O
care	O
within	O
and	O
across	O
high	O
-	O
income	O
as	O
well	O
as	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
.	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
was	O
determined	O
on	O
average	O
at	O
11	O
weeks	O
of	O
gestation	O
in	O
pregnancy	O
and	O
in	O
umbilical	O
cord	O
blood	O
(	O
UCB	O
)	O
at	O
birth	O
.	O

Frequency	O
of	O
the	O
type	O
of	O
food	O
eaten	O
during	O
the	O
past	O
month	O
can	O
be	O
reported	O
by	O
the	O
mother	O
as	O
every	O
day	O
;	O
most	O
days	O
(	O
not	O
every	O
day	O
,	O
but	O
at	O
least	O
4	O
times	O
per	O
week	O
);	O
once	O
a	O
week	O
(	O
less	O
than	O
4	O
times	O
per	O
week	O
,	O
but	O
at	O
least	O
once	O
per	O
week	O
)	O
or	O
never	O
.	O

This	O
was	O
also	O
observed	O
in	O
response	O
to	O
irisin	O
,	O
a	O
hormone	O
secreted	O
by	O
skeletal	O
muscles	O
.	O

122	O
caries	O
-	O
free	O
controls	O
were	O
recruited	O
from	O
the	O
community	O
.	O

In	O
life	O
history	O
terms	O
,	O
the	O
trade	O
-	O
off	O
for	O
those	O
born	O
to	O
dams	O
undernourished	O
during	O
pregnancy	O
may	O
be	O
an	O
earlier	O
maturation	O
but	O
a	O
faster	O
decline	O
in	O
ovarian	O
function	O
with	O
aging	O
,	O
associated	O
with	O
significantly	O
reduced	O
adult	O
progesterone	O
levels	O
.	O

proposed	O
that	O
permanent	O
changes	O
in	O
autonomic	O
tone	O
could	O
result	O
in	O
neurological	O
changes	O
in	O
the	O
fetus	O
,	O
especially	O
after	O
two	O
or	O
more	O
weeks	O
of	O
high	O
dose	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
.	O

Vitamin	O
D3	O
also	O
comes	O
from	O
endogenous	O
sources	O
where	O
it	O
can	O
be	O
synthesized	O
by	O
skin	O
when	O
exposed	O
to	O
ultraviolet	O
irradiation	O
.	O

Although	O
they	O
did	O
not	O
start	O
early	O
,	O
these	O
figures	O
indicate	O
there	O
is	O
a	O
substantial	O
opportunity	B
to	O
improve	O
IFA	O
supplements	O
distribution	O
in	O
rural	O
Bangladesh	O
.	O

Only	O
POU2F1	O
was	O
found	O
to	O
be	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
.	O

Future	B
studies	I
should	B
compare	O
placebo	O
,	O
iron	O
-	O
folate	O
and	O
UNIMMAP	O
supplementation	O
in	O
order	O
to	O
assess	O
the	O
efficacy	O
and	O
effectiveness	O
of	O
pre	O
-	O
or	O
inter	O
-	O
pregnancy	O
supplementation	O
on	O
later	O
maternal	O
anaemia	O
and	O
pregnancy	O
outcome	O
,	O
as	O
well	O
as	O
the	O
impact	O
on	O
broader	O
micronutrient	O
status	O
and	O
other	O
functional	O
outcomes	O
in	O
this	O
vulnerable	O
group	O
.	O

Additionally	O
,	O
those	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
are	O
more	O
likely	O
to	O
have	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
season	O
.	O

Cattle	O
management	O
factors	O
are	O
also	O
important	O
for	O
IMF	O
deposition	O
.	O

We	O
observed	O
no	O
association	O
between	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
and	O
fasting	O
plasma	O
glucose	O
(	O
B	O
-	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
00	O
,	O
0	O
.	O
00	O
;	O
P	O
=	O
0	O
.	O
54	O
),	O
1	O
-	O
h	O
glucose	O
(	O
B	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
01	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
53	O
)	O
or	O
2	O
-	O
h	O
glucose	O
(	O
B	O
-	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
01	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
54	O
).	O

Methods	O
/	O
design	O
The	O
effect	O
of	O
the	O
early	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
neonatal	O
mortality	O
will	O
be	O
examined	O
using	O
a	O
community	O
based	O
,	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
five	O
districts	O
with	O
30	O
,	O
000	O
live	O
births	O
.	O

Vitamin	O
D	O
status	O
will	O
be	O
determined	O
by	O
measuring	O
total	O
25	O
-	O
Hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentrations	O
in	O
serum	O
using	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LCMSMS	O
)	O
[	O
72	O
].	O

The	O
mother	O
is	O
given	O
medical	O
advice	O
and	O
referred	O
if	O
necessary	O
.	O

We	O
acknowledge	O
that	O
measurement	O
of	O
GR	O
polymorphisms	O
posed	O
certain	O
limitations	O
,	O
for	O
example	O
,	O
the	O
use	O
of	O
cell	O
lines	O
as	O
in	O
vitro	O
experimental	O
models	O
.	O

Similarly	O
,	O
exposure	O
to	O
asbestos	O
70	O
years	O
prior	O
to	O
the	O
development	O
of	O
mesothelioma	O
[	O
4	O
],	O
suggests	O
a	O
“	O
one	O
insult	O
,	O
co	O
-	O
carcinogenic	O
model	O
”	O
of	O
cancer	O
development	O
[	O
5	O
].	O

Low	O
25OHD	O
at	O
the	O
first	O
antenatal	O
visit	O
was	O
not	O
associated	O
with	O
insulin	O
resistance	O
in	O
early	O
or	O
late	O
pregnancy	O
when	O
controlling	O
for	O
season	O
and	O
confounders	O
.	O

This	O
subtle	O
difference	O
may	O
indicate	O
some	O
alterations	O
in	O
the	O
central	O
rewarding	O
functions	O
of	O
the	O
ECS	O
,	O
as	O
was	O
previously	O
described	O
in	O
animals	O
with	O
reduced	O
preference	O
for	O
highly	O
palatable	O
foods	O
(	O
Brand	O
et	O
al	O
.,	O
2012	O
).	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
no	O
significant	O
effects	O
were	O
observed	O
.	O

The	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O
Visfatin	O
has	O
extensive	O
effects	O
on	O
pregnancy	O
physiology	O
and	O
pathology	O
,	O
maternal	O
and	O
especially	O
neonatal	O
outcomes	O
,	O
and	O
its	O
effect	O
is	O
different	O
in	O
normal	O
weight	O
and	O
overweight	O
women	O
.	O

Whatever	O
their	O
developmental	O
origin	O
,	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
seem	O
to	O
greatly	O
differ	O
in	O
their	O
function	O
.	O

The	O
pressure	O
to	O
thinness	O
in	O
western	O
societies	O
associated	O
to	O
a	O
higher	O
prevalence	O
of	O
women	O
with	O
a	O
past	O
of	O
eating	O
disorders	O
or	O
a	O
worry	O
in	O
excess	O
about	O
body	O
changing	O
during	O
pregnancy	O
and	O
postpartum	O
have	O
raised	O
the	O
risk	O
for	O
giving	O
birth	O
underweight	O
babies	O
(	O
Easter	O
et	O
al	O
.,	O
2013	O
;	O
Linna	O
et	O
al	O
.,	O
2014	O
).	O

Following	O
medical	O
consultation	O
,	O
the	O
health	O
care	O
provider	O
asked	O
if	O
the	O
patient	O
would	O
be	O
willing	O
to	O
participate	O
in	O
the	O
research	O
study	O
and	O
those	O
who	O
agreed	O
underwent	O
informed	O
consent	O
and	O
then	O
were	O
offered	O
the	O
opportunity	O
to	O
complete	O
a	O
baseline	O
survey	O
on	O
a	O
secure	O
computer	O
in	O
a	O
private	O
setting	O
in	O
the	O
clinic	O
.	O

In	O
a	O
previous	O
genome	O
-	O
wide	O
association	O
study	O
(	O
GWAS	O
),	O
we	O
demonstrated	O
that	O
a	O
number	O
of	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
or	O
near	O
to	O
genes	O
encoding	O
key	O
components	O
of	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
are	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
8	O
).	O

However	O
,	O
they	O
showed	O
that	O
the	O
decrease	O
of	O
PTH	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

This	O
bioinformatic	O
classification	O
resulted	O
in	O
41	O
distinct	O
bioinformatic	O
classes	O
containing	O
at	O
least	O
one	O
CpG	O
(	O
see	O
Supplemental	O
Material	O
,	O
Table	O
2	O
).	O

RPMM	O
classes	O
were	O
labeled	O
using	O
a	O
series	O
of	O
numbers	O
,	O
ranging	O
from	O
1	O
to	O
16	O
(	O
with	O
class	O
1	O
having	O
the	O
lowest	O
methylation	O
level	O
and	O
class	O
16	O
having	O
the	O
highest	O
methylation	O
level	O
).	O

Conclusion	O
The	O
importance	O
of	O
nutritional	O
counseling	O
before	O
conception	O
and	O
during	O
pregnancy	O
should	B
be	I
emphasized	O
in	O
order	O
to	O
encourage	B
proper	O
PPBMI	O
and	O
avoidance	O
of	O
excessive	O
gestational	O
weight	O
gain	O
,	O
since	O
both	O
are	O
related	O
to	O
risk	O
for	O
GDM	O
.	O

Lower	O
vitamin	O
D	O
status	O
has	O
also	O
been	O
associated	O
with	O
a	O
medical	O
history	O
of	O
recurrent	O
miscarriage	O
[	O
12	O
]	O
but	O
only	O
two	O
prospective	O
studies	O
have	O
investigated	O
this	O
,	O
without	O
finding	O
that	O
lower	O
25OHD	O
concentrations	O
increases	O
the	O
risk	O
of	O
pregnancy	O
loss	O
[	O
5	O
,	O
13	O
].	O

The	O
first	O
section	O
comprises	O
10	O
chapters	O
on	O
various	O
aspects	O
of	O
nutrition	O
such	O
as	O
nutrition	O
adequacy	O
to	O
dietary	O
supplements	O
.	O

Potential	O
confounders	O
We	O
selected	O
potential	O
confounding	O
factors	O
which	O
are	O
known	O
(	O
from	O
existing	O
literature	O
)	O
to	O
be	O
associated	O
with	O
one	O
or	O
more	O
of	O
the	O
outcomes	O
of	O
interest	O
[	O
20	O
].	O

Among	O
all	O
the	O
predicted	O
miRNAs	O
,	O
4	O
miRNAs	O
targeting	O
GR	O
were	O
quantitated	O
by	O
real	O
-	O
time	O
PCR	O
.	O

•	O
Ensure	O
that	O
every	O
family	O
has	O
the	O
support	O
they	O
need	O
,	O
immediately	O
after	O
birth	O
of	O
a	O
premature	O
baby	O
,	O
following	O
its	O
loss	O
,	O
or	O
living	O
with	O
a	O
child	O
with	O
prematurity	O
-	O
associated	O
disability	O
.	O

With	O
respect	O
to	O
partial	O
implementation	O
of	O
preventive	O
treatment	O
,	O
local	O
health	O
staff	O
should	B
be	I
encouraged	B
on	O
adherence	O
to	O
the	O
guidelines	O
on	O
antenatal	O
care	O
package	O
at	O
any	O
given	O
antenatal	O
visit	O
so	O
that	O
partial	O
implementation	O
of	O
preventive	O
treatments	O
is	O
minimized	O
.	O

Research	O
assistants	O
used	O
Harpenden	O
skin	O
-	O
fold	O
callipers	O
to	O
obtain	O
skinfold	O
thickness	O
measurements	O
,	O
and	O
received	O
ongoing	O
standardised	O
training	O
[	O
29	O
].	O

Interestingly	O
,	O
the	O
CB2	O
receptor	O
activation	O
was	O
associated	O
with	O
anti	O
-	O
obesity	O
effects	O
(	O
Verty	O
et	O
al	O
.,	O
2015	O
)	O
and	O
a	O
decreased	O
risk	O
for	O
cardiovascular	O
diseases	O
.	O

No	O
monetary	O
value	O
was	O
assigned	O
to	O
the	O
women	O
'	O
s	O
time	O
since	O
the	O
time	O
required	O
per	O
person	O
was	O
very	O
modest	O
and	O
respondents	O
stated	O
that	O
this	O
did	O
not	O
involve	O
loss	O
of	O
work	O
time	O
or	O
incur	O
a	O
financial	O
cost	O
.	O

An	O
information	O
sheet	O
in	O
English	O
was	O
provided	O
for	O
women	O
to	O
take	O
away	O
.	O

We	O
also	O
consider	O
research	O
gaps	O
since	O
advancing	O
the	O
research	B
agenda	I
is	O
a	O
critical	O
need	B
to	O
reduce	O
the	O
global	O
burden	O
of	O
preterm	O
birth	O
,	O
requiring	O
innovations	O
for	O
both	O
prevention	O
and	O
care	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

Logistic	O
regression	O
analysis	O
was	O
performed	O
in	O
order	O
to	O
identify	O
the	O
significant	O
predictors	O
for	O
the	O
LGA	O
outcome	O
.	O

In	O
Finland	O
,	O
maternal	O
vitamin	O
D	O
status	O
has	O
improved	O
considerably	O
due	O
to	O
national	O
health	O
policies	O
.	O

There	O
were	O
no	O
differences	O
in	O
haematological	O
parameters	O
.	O

Measurement	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
Non	O
-	O
fasting	O
whole	O
peripheral	O
blood	O
samples	O
were	O
collected	O
into	O
non	O
-	O
heparinised	O
tubes	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
.	O

Note	O
that	O
values	O
in	O
ng	O
/	O
mL	O
can	O
be	O
converted	O
to	O
nmol	O
/	O
L	O
by	O
multiplying	O
by	O
2	O
.	O
5	O
.	O

A	O
recent	O
study	O
conducted	O
in	O
Sweden	O
by	O
Rai	O
et	O
al	O
.	O

Methods	O
The	O
methods	O
and	O
primary	O
clinical	O
findings	O
of	O
the	O
LIMIT	O
randomised	O
trial	O
have	O
been	O
published	O
[	O
21	O
–	O
23	O
],	O
with	O
the	O
trial	O
registered	O
on	O
the	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

Serum	O
vitamin	O
D3	O
level	O
was	O
found	O
to	O
be	O
low	O
(	O
4	O
.	O
7	O
ng	O
/	O
ml	O
).	O

Further	O
analyses	O
including	O
those	O
who	O
self	O
-	O
reported	O
vaccination	O
showed	O
similar	O
trends	O
(	O
seeSupplementary	O
materials	O
A3	O
-	O
A5	O
).	O

In	O
general	O
,	O
these	O
indicate	O
that	O
glyburide	O
is	O
effective	O
in	O
achieving	O
glycemic	O
control	O
in	O
the	O
majority	O
of	O
patients	O
.	O

When	O
surgery	O
is	O
planned	O
during	O
pregnancy	O
,	O
it	O
is	O
important	O
to	O
consider	O
both	O
gestational	O
age	O
and	O
the	O
type	O
of	O
general	O
anaesthesia	O
.	O

Methods	O
We	O
interviewed	O
women	O
from	O
the	O
inpatient	O
post	O
-	O
natal	O
unit	O
at	O
BMC	O
about	O
what	O
herbs	O
they	O
used	O
during	O
pregnancy	O
,	O
socioeconomic	O
factors	O
,	O
changes	O
to	O
diet	O
,	O
and	O
use	O
of	O
prenatal	O
vitamins	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
class	O
methylation	O
.	O

Snoring	O
that	O
is	O
infrequent	O
or	O
non	O
-	O
habitual	O
has	O
not	O
been	O
shown	O
to	O
be	O
a	O
useful	O
screen	O
for	O
sleep	O
disordered	O
breathing	O
in	O
large	O
epidemiologic	O
studies	O
[	O
41	O
,	O
42	O
].	O

UNIMMAP	O
is	O
a	O
balanced	O
preparation	O
of	O
15	O
vitamins	O
and	O
minerals	O
formulated	O
by	O
an	O
Expert	O
Committee	O
of	O
the	O
United	O
Nations	O
Children	O
'	O
s	O
Fund	O
,	O
World	O
Health	O
Organization	O
and	O
the	O
United	O
Nations	O
University	O
,	O
primarily	O
for	O
use	O
by	O
pregnant	O
and	O
lactating	O
women	O
.	O

In	O
addition	O
,	O
Skm2	O
mutants	O
were	O
dehydrated	O
and	O
presented	O
with	O
tachypnea	O
,	O
likely	O
as	O
a	O
consequence	O
of	O
thoracic	O
deformities	O
.	O

Data	O
were	O
processed	O
and	O
analysed	O
using	O
SPSS	O
for	O
Windows	O
v15	O
.	O

Proteins	O
were	O
extracted	O
in	O
homogenizing	O
buffer	O
with	O
protease	O
inhibitors	O
.	O

Authors	O
'	O
contributions	O
EW	O
was	O
responsible	O
for	O
the	O
recruitment	O
,	O
data	O
collection	O
and	O
funding	O
.	O

Despite	O
these	O
limitations	O
,	O
the	O
strengths	O
of	O
our	O
study	O
include	O
having	O
access	O
to	O
birth	O
outcomes	O
from	O
medical	O
records	O
as	O
well	O
as	O
having	O
available	O
influenza	O
surveillance	O
data	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Associations	O
between	O
infant	O
growth	O
and	O
repetitive	O
element	O
methylation	O
.	O
Covariate	O
(	O
n	O
=	O
380	O
)	O
Linear	O
regression	O
effect	O
estimate	O
(	O
95	O
%	O
CI	O
)	O
p	O
-	O
ValueMean	O
LINE	O
-	O
1	O
(	O
per	O
10	O
%)	O
9	O
.	O
7	O
(	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
)	O
0	O
.	O
01Infant	O
sex12	O
.	O
81	O
(	O
6	O
.	O
54	O
,	O
19	O
.	O
09	O
)<	O
0	O
.	O
0001White	O
maternal	O
ethnicity7	O
.	O
06	O
(	O
0	O
.	O
59	O
,	O
13	O
.	O
53	O
)	O
0	O
.	O
03Mean	O
AluYb8	O
(	O
per	O
10	O
%)	O
14	O
.	O
5	O
(	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)<	O
0	O
.	O
0001Infant	O
sex12	O
.	O
05	O
(	O
5	O
.	O
76	O
,	O
18	O
.	O
33	O
)<	O
0	O
.	O
0001White	O
maternal	O
ethnicity6	O
.	O
91	O
(	O
0	O
.	O
46	O
,	O
13	O
.	O
36	O
)	O
0	O
.	O
04All	O
models	O
were	O
also	O
adjusted	O
for	O
maternal	O
age	O
,	O
BMI	O
before	O
pregnancy	O
,	O
tobacco	O
,	O
alcohol	O
,	O
and	O
prenatal	O
vitamin	O
use	O
during	O
pregnancy	O
.	O

Perinatal	O
risk	O
factors	O
that	O
have	O
a	O
suggested	O
association	O
include	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
,	O
labor	O
induction	O
and	O
augmentation	O
,	O
maternal	O
infection	O
and	O
disease	O
(	O
i	O
.	O
e	O
.,	O
antiphospholipid	O
syndrome	O
),	O
antiepileptic	O
drugs	O
,	O
cocaine	O
use	O
,	O
and	O
oral	O
supplements	O
.	O

The	O
literature	O
also	O
contains	O
many	O
in	O
vitro	O
studies	O
investigating	O
the	O
role	O
of	O
specific	O
epigenetic	O
mechanisms	O
in	O
adverse	O
outcomes	O
induced	O
by	O
environmental	O
exposures	O
.	O

In	O
another	O
study	O
,	O
the	O
cold	O
-	O
induced	O
increase	O
in	O
thermogenesis	O
was	O
accompanied	O
by	O
a	O
decrease	O
in	O
body	O
weight	O
,	O
mainly	O
affecting	O
the	O
fat	O
mass	O
compartment	O
(	O
Yoneshiro	O
et	O
al	O
.,	O
2013	O
).	O

It	O
should	O
be	O
emphasized	O
that	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
included	O
a	O
fairly	O
homogeneous	O
cohort	O
of	O
Mediterranean	O
patients	O
from	O
Crete	O
.	O

The	O
study	O
is	O
part	O
of	O
the	O
longitudinal	O
Vitamin	O
D	O
Intervention	O
in	O
Infants	O
(	O
VIDI	O
)	O
study	O
.	O

Japanese	O
Black	O
steers	O
fed	O
a	O
16	O
%	O
CP	O
diet	O
had	O
greater	O
backfat	O
thickness	O
than	O
those	O
fed	O
a	O
12	O
%	O
CP	O
diet	O
[	O
127	O
].	O

Despite	O
small	O
cell	O
sizes	O
,	O
it	O
should	O
be	O
noted	O
that	O
all	O
of	O
the	O
children	O
with	O
low	O
calcium	O
concentrations	O
belonged	O
to	O
the	O
S	O
-	O
ECC	O
group	O
.	O

We	O
studied	O
kidney	O
stereology	O
at	O
birth	O
,	O
10	O
days	O
and	O
6	O
months	O
of	O
age	O
in	O
each	O
generation	O
(	O
n	O
=	O
6	O
for	O
each	O
group	O
).	O

There	O
was	O
a	O
significant	O
positive	O
correlation	O
between	O
maternal	O
and	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
r2	O
=	O
0	O
.	O
457	O
,	O
p	O
<	O
0	O
.	O
0001	O
;	O
Fig	O
2	O
).	O

However	O
,	O
the	O
present	O
study	O
has	O
some	O
limitations	O
.	O

Blood	O
lead	O
concentration	O
was	O
associated	O
with	O
a	O
45	O
g	O
decrease	O
in	O
birth	O
weight	O
(	O
95	O
%	O
CI	O
(-	O
110	O
,	O
22	O
),	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
)),	O
while	O
mercury	O
exposure	O
was	O
associated	O
with	O
a	O
5	O
g	O
,	O
95	O
%	O
CI	O
(-	O
56	O
,	O
66	O
)	O
increase	O
in	O
birth	O
weight	O
.	O

Follow	O
-	O
up	O
participants	O
answered	O
additional	O
questions	O
on	O
recall	O
,	O
reactions	O
,	O
and	O
receptivity	O
to	O
the	O
texts	O
.	O

Nonetheless	O
,	O
folic	O
acid	O
supplementation	O
might	O
address	O
other	O
forms	O
of	O
anaemia	O
,	O
and	O
the	O
advice	B
might	O
also	O
increase	O
the	O
likelihood	O
of	O
folic	O
acid	O
use	O
before	O
and	O
during	O
future	O
pregnancies	O
.	O

Interestingly	O
,	O
the	O
decreased	O
gene	O
expression	O
of	O
Ppar	O
γ	O
has	O
been	O
linked	O
to	O
inflammatory	O
processes	O
associated	O
with	O
obesity	O
and	O
insulin	O
resistance	O
(	O
Odegaard	O
et	O
al	O
.,	O
2007	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
),	O
an	O
issue	O
that	O
enhances	O
the	O
importance	O
of	O
the	O
inflammatory	O
responses	O
in	O
the	O
developmental	O
programming	O
.	O

Similar	O
results	O
have	O
been	O
reported	O
in	O
human	O
subjects	O
.	O

Another	O
independent	O
determinant	O
of	O
offspring	O
weight	O
status	O
is	O
gestational	O
weight	O
gain	O
(	O
GWG	O
).	O

The	O
plasma	O
levels	O
of	O
LDL	O
were	O
significantly	O
increased	O
in	O
RC	O
males	O
and	O
females	O
.	O

Placental	O
Tissue	O
Placental	O
tissues	O
were	O
obtained	O
from	O
women	O
delivering	O
at	O
term	O
(>	O
37	O
weeks	O
of	O
gestation	O
)	O
and	O
preterm	O
(<	O
37	O
weeks	O
of	O
gestation	O
)	O
(	O
total	O
n	O
=	O
23	O
).	O

There	O
are	O
very	O
few	O
data	O
on	O
25	O
(	O
OH	O
)	O
D	O
in	O
cord	O
blood	O
in	O
the	O
Hispanic	O
population	O
and	O
no	O
data	O
looking	O
specifically	O
at	O
the	O
relative	O
increase	O
over	O
time	O
based	O
on	O
cord	O
25	O
(	O
OH	O
)	O
D	O
[	O
11	O
].	O

Almost	O
all	O
participants	O
were	O
found	O
to	O
have	O
water	O
,	O
but	O
just	O
15	O
(	O
12	O
%)	O
in	O
each	O
arm	O
were	O
observed	O
to	O
have	O
bar	O
soap	O
at	O
the	O
main	O
handwashing	O
station	O
;	O
other	O
types	O
of	O
soap	O
were	O
rarely	O
observed	O
.	O

The	O
above	O
studies	O
provide	O
reassurance	O
that	O
moderate	O
intensity	O
activities	O
such	O
as	O
walking	O
for	O
20	O
–	O
30	O
minutes	O
each	O
day	O
,	O
and	O
attendance	O
at	O
antenatal	O
exercise	O
classes	O
can	O
be	O
safely	O
encouraged	B
,	O
and	O
that	O
modest	O
improvements	O
in	O
glycemic	O
control	O
might	O
be	O
achieved	O
.	O

These	O
results	O
likely	O
indicate	O
that	O
the	O
up	O
-	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
in	O
the	O
hypothalamus	O
at	O
adulthood	O
may	O
result	O
from	O
a	O
lower	O
long	O
-	O
term	O
cannabinoid	O
activity	O
that	O
,	O
in	O
turn	O
,	O
could	O
be	O
produced	O
by	O
lower	O
levels	O
of	O
eCBs	O
and	O
N	O
-	O
acylethanolamines	O
(	O
NAEs	O
)	O
in	O
the	O
hypothalamus	O
of	O
male	O
offspring	O
as	O
was	O
previous	O
described	O
at	O
birth	O
(	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

As	O
,	O
in	O
the	O
two	O
subgroups	O
,	O
the	O
depression	O
scores	O
were	O
not	O
significantly	O
lower	O
in	O
vitamin	O
D	O
group	O
compared	O
to	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
reproductive	O
system	O
(	O
after	O
:	O
Grzechocinska	O
B	O
,	O
Dabrowski	O
FA	O
,	O
Cyganek	O
A	O
,	O
Wielgos	O
M	O
.	O
The	O
role	O
of	O
vitamin	O
D	O
in	O
impaired	O
fertility	O
treatment	O
[	O
2	O
]).	O

This	O
information	O
,	O
filtered	O
according	O
to	O
the	O
geographical	O
area	O
,	O
comes	O
from	O
the	O
registration	O
data	O
collected	O
by	O
the	O
Field	O
Implementers	O
.	O

Estimated	O
BMI	O
correlations	O
,	O
employing	O
the	O
mixed	O
models	O
,	O
and	O
adjusting	O
for	O
age	O
,	O
are	O
shown	O
at	O
each	O
time	O
point	O
for	O
the	O
children	O
and	O
across	O
generations	O
are	O
then	O
displayed	O
intable	O
4	O
.	O

There	O
was	O
no	O
difference	O
in	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
(	O
82	O
vs	O
82	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
99	O
).	O

We	O
will	O
conduct	O
analyses	O
at	O
the	O
infant	O
level	O
adjusted	O
for	O
the	O
cluster	O
randomisation	O
.	O

Additionally	O
,	O
16	O
(	O
6	O
.	O
1	O
%)	O
had	O
deficient	O
vitamin	O
D	O
concentrations	O
(<	O
35	O
nmol	O
/	O
L	O
).	O

Survival	O
and	O
disease	O
-	O
free	O
intervals	O
identical	O
in	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
The	O
effects	O
of	O
management	O
modalities	O
on	O
pregnancy	O
outcome	O
:	O
No	O
I	O
-	O
131	O
,	O
tailored	O
therapy	O
.	O

Behrman	O
,	O
Alderman	O
and	O
Hoddinott	O
,	O
2004	O
[	O
23	O
],	O
cite	O
estimates	O
for	O
Nepal	O
of	O
$	O
13	O
.	O
14	O
per	O
pregnancy	O
(	O
based	O
on	O
program	O
estimates	O
extrapolated	O
from	O
a	O
research	O
study	O
).	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
vs	O
.	O
respective	O
vehicle	O
males	O
;#/##	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
(	O
vehicle	O
)	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
;§	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
AM251	O
-	O
treated	O
CC	O
females	O
.	O

These	O
neuroendocrine	O
cells	O
are	O
believed	O
to	O
be	O
of	O
neural	O
crest	O
origin	O
,	O
thus	O
having	O
a	O
separate	O
lineage	O
from	O
the	O
endoderm	O
-	O
derived	O
follicular	O
thyroid	O
cells	O
.	O

Pre	O
-	O
and	O
Postnatal	O
Nutritional	O
Histories	O
Influence	O
Reproductive	O
Maturation	O
and	O
Ovarian	O
Function	O
in	O
the	O
Rat	O
Abstract	O
Background	O
While	O
prepubertal	O
nutritional	O
influences	O
appear	O
to	O
play	O
a	O
role	O
in	O
sexual	O
maturation	O
,	O
there	O
is	O
a	O
need	B
to	B
clarify	I
the	O
potential	O
contributions	O
of	O
maternal	O
and	O
childhood	O
influences	O
in	O
setting	O
the	O
tempo	O
of	O
reproductive	O
maturation	O
.	O

Extending	O
the	O
time	O
between	O
two	O
consecutive	O
episodes	O
of	O
pneumonia	O
to	O
30	O
days	O
to	O
define	O
a	O
new	O
repeat	O
episode	O
of	O
pneumonia	O
(	O
used	O
by	O
the	O
WHO	O
Vaccine	O
Trials	O
group	O
),	O
19gave	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Integrated	O
service	O
delivery	O
packages	O
for	O
maternal	O
,	O
newborn	O
and	O
child	O
health	O
.	O

Reverse	O
transcription	O
was	O
carried	O
out	O
from	O
1	O
μg	O
of	O
RNA	O
using	O
the	O
Transcriptor	O
Reverse	O
Transcriptase	O
kit	O
and	O
random	O
hexamer	O
primers	O
(	O
Transcriptor	O
RT	O
,	O
Roche	O
).	O

The	O
membranes	O
were	O
washed	O
thoroughly	O
for	O
30	O
min	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
,	O
before	O
incubation	O
with	O
the	O
secondary	O
HRP	O
-	O
conjugated	O
immunoglobulin	O
(	O
1	O
:	O
2000	O
)	O
for	O
1	O
hr	O
at	O
room	O
temperature	O
and	O
further	O
washing	O
for	O
30	O
min	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
.	O

Specific	O
pharmacological	O
agents	O
for	O
treatment	O
of	O
asthma	O
or	O
allergic	O
diseases	O
must	O
be	O
cautiously	O
selected	O
and	O
are	O
discussed	O
here	O
with	O
respect	O
to	O
safety	O
considerations	O
in	O
pregnancy	O
.	O

2	O
.	O
9	O
.	O

Community	O
antenatal	O
and	O
paediatric	O
clinics	O
,	O
which	O
often	O
already	O
serve	O
these	O
populations	O
,	O
can	O
readily	O
be	O
used	O
to	O
identify	O
those	O
at	O
particular	O
risk	O
on	O
finger	O
-	O
prick	O
testing	O
and	O
target	B
them	O
for	O
supplementation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Subject	O
characteristics	O
by	O
delivery	O
mode	O
(	O
n	O
=	O
145	O
)	O
n	O
(%)	O
or	O
mean	O
[	O
range	O
]	O
p	O
value1All	O
(	O
n	O
=	O
145	O
)	O
Vaginal	O
(	O
n	O
=	O
97	O
)	O
Cesarean	O
(	O
n	O
=	O
48	O
)	O
Maternal	O
characteristics	O
Maternal	O
age31	O
.	O
9	O
[	O
22	O
–	O
44	O
]	O
31	O
.	O
8	O
[	O
22	O
–	O
44	O
]	O
32	O
.	O
2	O
[	O
23	O
–	O
42	O
]	O
0	O
.	O
65	O
Education	O
level0	O
.	O
14	O
Less	O
than	O
11th	O
grade1	O
(	O
0	O
.	O
7	O
)	O
1	O
(	O
1	O
.	O
0	O
)	O
0	O
(	O
0	O
.	O
0	O
)	O
High	O
school	O
graduate	O
or	O
equivalent15	O
(	O
10	O
.	O
3	O
)	O
7	O
(	O
7	O
.	O
2	O
)	O
8	O
(	O
16	O
.	O
7	O
)	O
Junior	O
college	O
graduate	O
or	O
some	O
college25	O
(	O
17	O
.	O
2	O
)	O
16	O
(	O
16	O
.	O
5	O
)	O
9	O
(	O
18	O
.	O
8	O
)	O
College	O
graduate54	O
(	O
37	O
.	O
2	O
)	O
34	O
(	O
35	O
.	O
1	O
)	O
20	O
(	O
41	O
.	O
7	O
)	O
Any	O
post	O
-	O
graduate	O
schooling50	O
(	O
34	O
.	O
5	O
)	O
39	O
(	O
40	O
.	O
2	O
)	O
11	O
(	O
22	O
.	O
9	O
)	O
Relationship	O
status0	O
.	O
29	O
Married133	O
(	O
91	O
.	O
7	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
42	O
(	O
87	O
.	O
5	O
)	O
Separated	O
or	O
divorced3	O
(	O
2	O
.	O
1	O
)	O
1	O
(	O
1	O
.	O
0	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
Single	O
and	O
never	O
married9	O
(	O
6	O
.	O
2	O
)	O
5	O
(	O
5	O
.	O
2	O
)	O
4	O
(	O
8	O
.	O
3	O
)	O
Smoking0	O
.	O
43	O
No138	O
(	O
95	O
.	O
2	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
47	O
(	O
97	O
.	O
9	O
)	O
Yes7	O
(	O
4	O
.	O
8	O
)	O
6	O
(	O
6	O
.	O
2	O
)	O
1	O
(	O
2	O
.	O
1	O
)	O
Parity0	O
.	O
8	O
[	O
0	O
–	O
4	O
]	O
0	O
.	O
9	O
[	O
0	O
–	O
4	O
]	O
0	O
.	O
7	O
[	O
0	O
–	O
2	O
]	O
0	O
.	O
07	O
Maternal	O
BMI25	O
.	O
6	O
[	O
17	O
.	O
4	O
–	O
47	O
.	O
8	O
]	O
26	O
.	O
0	O
[	O
17	O
.	O
4	O
–	O
47	O
.	O
8	O
]	O
24	O
.	O
7	O
[	O
18	O
.	O
4	O
–	O
42	O
.	O
1	O
]	O
0	O
.	O
22	O
Gestational	O
diabetes20	O
.	O
58	O
No121	O
(	O
83	O
.	O
4	O
)	O
84	O
(	O
86	O
.	O
6	O
)	O
37	O
(	O
77	O
.	O
1	O
)	O
Yes16	O
(	O
11	O
.	O
0	O
)	O
10	O
(	O
10	O
.	O
3	O
)	O
6	O
(	O
12	O
.	O
5	O
)	O
Dietary	O
factors	O
(	O
servings	O
/	O
day	O
)	O
3	O
aMED	O
score3	O
.	O
67	O
[	O
0	O
–	O
7	O
]	O
3	O
.	O
8	O
[	O
0	O
–	O
7	O
]	O
3	O
.	O
5	O
[	O
0	O
–	O
7	O
]	O
0	O
.	O
32	O
Dairy3	O
.	O
6	O
[	O
0	O
.	O
0	O
–	O
8	O
.	O
5	O
]	O
3	O
.	O
7	O
[	O
0	O
.	O
0	O
–	O
8	O
.	O
5	O
]	O
3	O
.	O
5	O
[	O
0	O
.	O
8	O
–	O
6	O
.	O
8	O
]	O
0	O
.	O
40	O
Fruit2	O
.	O
3	O
[	O
0	O
.	O
0	O
–	O
5	O
.	O
9	O
]	O
2	O
.	O
3	O
[	O
0	O
.	O
2	O
–	O
5	O
.	O
9	O
]	O
2	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
5	O
.	O
6	O
]	O
0	O
.	O
52	O
Vegetables3	O
.	O
3	O
[	O
0	O
.	O
0	O
–	O
9	O
.	O
6	O
]	O
3	O
.	O
3	O
[	O
0	O
.	O
5	O
–	O
9	O
.	O
6	O
]	O
3	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
7	O
.	O
6	O
]	O
0	O
.	O
78	O
Whole	O
grains1	O
.	O
0	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
1	O
]	O
1	O
.	O
2	O
[	O
0	O
.	O
1	O
–	O
4	O
.	O
1	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
3	O
.	O
1	O
]	O
0	O
.	O
03	O
Fish	O
and	O
seafood0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
1	O
.	O
0	O
]	O
0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
1	O
.	O
0	O
]	O
0	O
.	O
2	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
56	O
Nuts	O
,	O
legumes	O
,	O
and	O
soy0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
5	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
3	O
.	O
1	O
]	O
0	O
.	O
9	O
[	O
0	O
.	O
0	O
–	O
4	O
.	O
5	O
]	O
1	O
.	O
00	O
Red	O
and	O
processed	O
meat0	O
.	O
8	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
7	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
0	O
]	O
0	O
.	O
8	O
[	O
0	O
.	O
0	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
21	O
Polyunsaturated	O
fat	O
(	O
g	O
/	O
day	O
)	O
13	O
.	O
9	O
[	O
8	O
.	O
67	O
–	O
23	O
.	O
7	O
]	O
13	O
.	O
6	O
[	O
8	O
.	O
7	O
–	O
21	O
.	O
0	O
]	O
14	O
.	O
5	O
[	O
9	O
.	O
2	O
–	O
23	O
.	O
7	O
]	O
0	O
.	O
12	O
EPA	O
(	O
g	O
/	O
day	O
)	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
28	O
DHA	O
(	O
g	O
/	O
day	O
)	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
6	O
]	O
0	O
.	O
1	O
[	O
0	O
.	O
0	O
–	O
0	O
.	O
5	O
]	O
0	O
.	O
79	O
Monounsaturated	O
:	O
saturated	O
fatty	O
acid	O
ratio1	O
.	O
1	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
3	O
]	O
1	O
.	O
1	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
1	O
]	O
1	O
.	O
2	O
[	O
0	O
.	O
7	O
–	O
2	O
.	O
3	O
]	O
0	O
.	O
35Infant	O
characteristics	O
Sex0	O
.	O
38	O
Female62	O
(	O
42	O
.	O
8	O
)	O
44	O
(	O
45	O
.	O
4	O
)	O
18	O
(	O
37	O
.	O
5	O
)	O
Male83	O
(	O
57	O
.	O
2	O
)	O
53	O
(	O
54	O
.	O
6	O
)	O
30	O
(	O
62	O
.	O
5	O
)	O
Birth	O
weight	O
(	O
g	O
)	O
43427	O
.	O
4	O
[	O
1960	O
–	O
4710	O
]	O
3466	O
.	O
3	O
[	O
2030	O
–	O
4565	O
]	O
3348	O
.	O
9	O
[	O
1960	O
–	O
4710	O
]	O
0	O
.	O
18	O
Gestational	O
age	O
(	O
weeks	O
)	O
39	O
.	O
3	O
[	O
30	O
.	O
4	O
–	O
43	O
.	O
4	O
]	O
39	O
.	O
5	O
[	O
30	O
.	O
4	O
–	O
42	O
.	O
1	O
]	O
39	O
.	O
1	O
[	O
33	O
.	O
4	O
–	O
43	O
.	O
4	O
]	O
0	O
.	O
21	O
Feeding	O
method0	O
.	O
04	O
Exclusively	O
breastfed102	O
(	O
70	O
.	O
3	O
)	O
74	O
(	O
76	O
.	O
3	O
)	O
28	O
(	O
58	O
.	O
3	O
)	O
Combination37	O
(	O
25	O
.	O
5	O
)	O
21	O
(	O
21	O
.	O
7	O
)	O
16	O
(	O
33	O
.	O
3	O
)	O
Exclusively	O
formula	O
fed6	O
(	O
4	O
.	O
1	O
)	O
2	O
(	O
2	O
.	O
1	O
)	O
4	O
(	O
8	O
.	O
3	O
)	O
Antibiotics	O
by	O
4	O
months	O
old50	O
.	O
66	O
No135	O
(	O
93	O
.	O
1	O
)	O
91	O
(	O
93	O
.	O
8	O
)	O
44	O
(	O
91	O
.	O
7	O
)	O
Yes5	O
(	O
3	O
.	O
5	O
)	O
3	O
(	O
3	O
.	O
1	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
1p	O
value	O
determined	O
by	O
two	O
-	O
sided	O
Welch	O
’	O
s	O
t	O
test	O
or	O
Fisher	O
’	O
s	O
exact	O
test	O
2Missing	O
data	O
on	O
eight	O
subjects	O
3All	O
dietary	O
factors	O
are	O
standardized	O
to	O
a	O
2000	O
cal	O
/	O
day	O
diet	O
,	O
excluding	O
aMED	O
score	O
and	O
monounsaturated	O
:	O
saturated	O
fatty	O
acid	O
ratio	O
4Missing	O
data	O
on	O
three	O
subjects	O
5Missing	O
data	O
on	O
five	O
subjects	O
Microbial	O
community	O
composition	O
and	O
maternal	O
dietary	O
factors	O
We	O
identified	O
11	O
,	O
029	O
,	O
093	O
bacterial	O
sequences	O
in	O
145	O
6	O
-	O
week	O
infant	O
stool	O
samples	O
passing	O
quality	O
control	O
.	O

No	O
specific	O
etiologic	O
agent	O
to	O
date	O
has	O
been	O
identified	O
to	O
support	O
such	O
a	O
long	O
induction	O
period	O
for	O
this	O
cancer	O
.	O

In	O
contrast	O
,	O
the	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
show	O
changes	O
in	O
body	O
weight	O
and	O
adiposity	O
,	O
but	O
exhibited	O
higher	O
levels	O
of	O
LDL	O
and	O
glucose	O
in	O
plasma	O
,	O
and	O
a	O
reduction	O
in	O
chocolate	O
preference	O
at	O
adolescence	O
and	O
total	O
caloric	O
intake	O
at	O
adulthood	O
.	O

Low	O
Utilization	O
of	O
Maternal	O
Health	O
Service	O
in	O
Developing	O
Countries	O
It	O
is	O
well	O
established	O
that	O
antenatal	O
care	O
provides	O
pregnant	O
women	O
with	O
opportunities	O
to	O
receive	O
cost	O
-	O
effective	O
interventions	O
which	O
are	O
beneficial	O
to	O
mother	O
and	O
child	O
;	O
these	O
interventions	O
include	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anemia	O
.	O

Assessment	O
of	O
25	O
(	O
OH	O
)	O
D	O
On	O
the	O
day	O
that	O
the	O
study	O
medication	O
was	O
dispensed	O
and	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
a	O
nonfasted	O
venous	O
blood	O
sample	O
was	O
obtained	O
and	O
serum	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Intervention	O
We	O
trained	O
female	O
behavior	O
change	O
communicators	O
,	O
who	O
typically	O
have	O
Master	O
'	O
s	O
degrees	O
and	O
experience	O
in	O
data	O
collection	O
,	O
to	O
implement	O
the	O
intervention	O
.	O

They	O
were	O
originally	O
thought	O
to	O
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

S	O
-	O
ECC	O
,	O
infrequent	O
milk	O
intake	O
,	O
and	O
winter	O
season	O
were	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
but	O
not	O
household	O
income	O
or	O
vitamin	O
D	O
drop	O
use	O
.	O

After	O
PSM	O
,	O
we	O
evaluated	O
these	O
variables	O
for	O
significant	O
differences	O
between	O
the	O
vaccination	O
status	O
groups	O
in	O
order	O
to	O
know	O
how	O
well	O
matching	O
occurred	O
.	O

Only	O
expression	O
of	O
GAS5	O
was	O
significantly	O
upregulated	O
by	O
cortisol	O
in	O
all	O
treatments	O
compared	O
with	O
basal	O
levels	O
,	O
but	O
none	O
of	O
the	O
GRs	O
changed	O
expression	O
significantly	O
.	O

2	O
.	O
2	O
.	O

Prepregnancy	O
weight	O
and	O
weight	O
recorded	O
in	O
prenatal	O
clinics	O
were	O
utilised	O
to	O
calculate	O
gestational	O
weight	O
gain	O
(	O
GWG	O
)	O
(	O
kg	O
).	O

INTRODUCTION	O
Vitamin	O
D	O
has	O
been	O
a	O
hot	O
topic	O
in	O
the	O
medical	O
world	O
for	O
the	O
past	O
10	O
years	O
.	O

For	O
these	O
analyses	O
,	O
we	O
classified	O
women	O
by	O
the	O
joint	O
distribution	O
of	O
pre	O
-	O
pregnancy	O
lean	O
or	O
overweight	O
status	O
(<	O
25	O
vs	O
.	O
≥	O
25	O
kg	O
/	O
m2	O
)	O
and	O
snoring	O
during	O
early	O
pregnancy	O
(	O
no	O
vs	O
.	O
yes	O
)	O
thus	O
resulting	O
in	O
the	O
following	O
categories	O
:	O
lean	O
and	O
non	O
-	O
snorer	O
(	O
the	O
reference	O
group	O
);	O
lean	O
and	O
snorer	O
;	O
overweight	O
and	O
non	O
-	O
snorer	O
;	O
and	O
overweight	O
and	O
snorer	O
.	O

Long	O
-	O
term	O
effects	O
of	O
ECS	O
activation	O
could	O
finally	O
increase	O
the	O
risk	O
from	O
suffering	O
metabolic	O
diseases	O
that	O
lead	O
to	O
obesity	O
and	O
metabolic	O
syndrome	O
(	O
Tibirica	O
,	O
2010	O
;	O
Cristino	O
et	O
al	O
.,	O
2014	O
).	O

The	O
level	O
of	O
this	O
evidence	O
is	O
Grade	O
C	O
as	O
per	O
the	O
ratings	O
outlined	O
inTable	O
3	O
,	O
adapted	O
from	O
Williams	O
et	O
al	O
.	O

Of	O
PNV	O
users	O
,	O
477	O
(	O
62	O
.	O
5	O
%)	O
reported	O
use	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
,	O
238	O
(	O
31	O
.	O
2	O
%)	O
reported	O
use	O
only	O
after	O
pregnancy	O
was	O
diagnosed	O
,	O
and	O
just	O
48	O
(	O
6	O
.	O
3	O
%)	O
of	O
women	O
reported	O
using	O
PNVs	O
prior	O
to	O
pregnancy	O
but	O
discontinuing	O
PNV	O
use	O
after	O
diagnosis	O
of	O
pregnancy	O
.	O

In	O
22	O
.	O
6	O
%	O
of	O
221	O
infertile	O
patients	O
,	O
the	O
VD	O
serum	O
concentration	O
was	O
lesser	O
than	O
25	O
nmol	O
/	O
L	O
,	O
in	O
70	O
.	O
1	O
%	O
it	O
was	O
within	O
the	O
range	O
of	O
25	O
–	O
72	O
.	O
3	O
nmol	O
/	O
L	O
,	O
while	O
in	O
the	O
remaining	O
7	O
.	O
2	O
%	O
it	O
was	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
.	O

In	O
this	O
study	O
using	O
C57BL	O
/	O
6	O
male	O
mice	O
,	O
stress	O
induced	O
GAS5	O
RNA	O
levels	O
in	O
the	O
hippocampus	O
and	O
this	O
increase	O
was	O
accompanied	O
by	O
a	O
rise	O
of	O
corticosterone	O
levels	O
[	O
22	O
].	O

Pre	O
-	O
pregnancy	O
nutritional	O
status	O
and	O
weight	O
gain	O
were	O
classified	O
according	O
to	O
guidelines	O
by	O
the	O
Institute	O
of	O
Medicine	O
.	O

(	O
A	O
)	O
female	O
offspring	O
in	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

The	O
influence	O
of	O
the	O
educational	O
level	O
of	O
respondents	O
is	O
predominant	O
here	O
as	O
it	O
is	O
noticed	O
that	O
those	O
at	O
a	O
high	O
educational	O
level	O
are	O
more	O
likely	O
to	O
be	O
critical	O
about	O
care	O
received	O
and	O
defer	O
a	O
positive	O
satisfaction	O
.	O

Recent	O
nationwide	O
shortages	O
of	O
low	O
-	O
calcium	O
formula	O
(	O
LCF	O
)	O
suggest	O
this	O
problem	O
may	O
be	O
widespread	O
.	O

There	O
are	O
few	O
data	O
from	O
India	O
about	O
the	O
prevalence	O
of	O
hypovitaminosis	O
D	O
in	O
pregnancy	O
and	O
in	O
the	O
newborn	O
.	O

In	O
addition	O
,	O
treating	O
the	O
infant	O
with	O
DDAVP	O
besides	O
intravenous	O
fluids	O
may	O
also	O
be	O
beneficial	O
.	O

The	O
consumptions	O
of	O
pills	O
were	O
assessed	O
in	O
later	O
prenatal	O
care	O
visits	O
and	O
over	O
the	O
phone	O
.	O

The	O
vast	O
majority	O
of	O
published	O
studies	O
on	O
neonatal	O
care	O
relate	O
to	O
high	O
-	O
technology	O
care	O
in	O
high	O
-	O
income	O
settings	O
[	O
39	O
].	O

White	O
perirenal	O
and	O
perigonadal	O
fat	O
were	O
completely	O
dissected	O
out	O
,	O
weighed	O
,	O
frozen	O
,	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
until	O
RT	O
-	O
qPCR	O
analyses	O
.	O

Both	O
the	O
Diabetes	O
Prevention	O
Program86and	O
the	O
Finnish	O
Diabetes	O
Prevention	O
Study87demonstrated	O
this	O
,	O
with	O
an	O
intensive	O
intervention	O
including	O
lifestyle	O
coaches	O
,	O
strict	O
supervised	O
exercise	O
regimes	O
and	O
caloric	O
restriction	O
.	O

Immature	O
glomeruli	O
normally	O
begin	O
to	O
disappear	O
at	O
this	O
age	O
,	O
but	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
had	O
150	O
%	O
more	O
immature	O
glomeruli	O
and	O
25	O
%	O
more	O
mature	O
glomeruli	O
than	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

In	O
another	O
study	O
,	O
15administration	O
of	O
600	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
was	O
associated	O
with	O
a	O
significant	O
increase	O
in	O
serum	O
vitamin	O
D	O
,	O
a	O
significant	O
decrease	O
in	O
serum	O
PTH	O
,	O
and	O
hypercalcemia	O
occurring	O
in	O
4	O
%	O
of	O
the	O
subjects	O
during	O
4	O
and	O
12	O
months	O
of	O
intervention	O
.	O

2	O
.	O
2	O
.	O
4	O
.	O

PubMed	O
Central	O
:	O

Several	O
studies	O
emphasize	O
the	O
importance	O
of	O
the	O
relationship	O
between	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
intake	O
and	O
socio	O
-	O
demographic	O
factors	O
such	O
as	O
age	O
,	O
level	O
of	O
education	O
,	O
area	O
of	O
residence	O
,	O
marital	O
status	O
,	O
parity	O
,	O
economical	O
status	O
and	O
characteristics	O
of	O
prenatal	O
care	O
(	O
including	O
gestational	O
age	O
at	O
the	O
beginning	O
of	O
prenatal	O
care	O
and	O
the	O
number	O
of	O
prenatal	O
consultations	O
)	O
[	O
15	O
-	O
19	O
].	O

Ethics	O
Approval	O
was	O
granted	O
by	O
the	O
Women	O
’	O
s	O
and	O
Children	O
’	O
s	O
Local	O
Health	O
Network	O
Human	O
Research	O
and	O
Ethics	O
Committee	O
at	O
the	O
Women	O
’	O
s	O
and	O
Children	O
’	O
s	O
Hospital	O
,	O
the	O
Central	O
Northern	O
Adelaide	O
Health	O
Service	O
Ethics	O
of	O
Human	O
Research	O
Committee	O
(	O
Lyell	O
McEwin	O
Hospital	O
)	O
and	O
the	O
Flinders	O
Clinical	O
Research	O
Ethics	O
Committee	O
(	O
Flinders	O
Medical	O
Centre	O
).	O

Furthermore	O
,	O
recent	O
studies	O
have	O
shown	O
that	O
this	O
restriction	O
can	O
generate	O
“	O
genomic	O
imprinting	O
”	O
in	O
the	O
fetus	O
,	O
which	O
is	O
related	O
to	O
the	O
genesis	O
of	O
chronic	O
diseases	O
in	O
adulthood	O
[	O
9	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

This	O
experiment	O
would	O
provide	O
a	O
better	O
insight	O
into	O
the	O
regulation	O
of	O
GAS5	O
by	O
cortisol	O
.	O

(	O
2013	O
)*	O
Phthalates	O
:	O
Dibutylphthalate	O
(	O
DBP	O
)	O
RatOral	O
(	O
gavage	O
)	O
(	O
500	O
mg	O
/	O
kg	O
/	O
d	O
)	O
In	O
uteroIn	O
utero	O
to	O
early	O
adulthood	O
F1male	O
offspring	O
↓	O
testicular	O
testosterone	O
and	O
Leydig	O
stem	O
cellsHistone	O
modificationKilcoyne	O
et	O
al	O
.	O

Sample	O
collection	O
At	O
21	O
–	O
23	O
postnatal	O
weeks	O
,	O
adult	O
offspring	O
were	O
sacrificed	O
by	O
decapitation	O
after	O
the	O
administration	O
of	O
Equitesin	O
®	O
(	O
3	O
mg	O
/	O
kg	O
).	O

The	O
incidence	O
of	O
PTB	O
across	O
25	O
(	O
OH	O
)	O
D	O
groups	O
was	O
tested	O
for	O
trend	O
.	O

Immediate	O
-	O
phase	O
type	O
I	O
allergic	O
symptoms	O
usually	O
occur	O
within	O
several	O
minutes	O
after	O
allergen	O
contact	O
.	O

Our	O
sample	O
testing	O
suggest	O
that	O
the	O
vitamin	O
D	O
group	O
maintained	O
above	O
mean	O
adequate	O
vitamin	O
D	O
concetrations	O
verses	O
consistently	O
low	O
concentrations	O
in	O
the	O
placebo	O
group	O
.	O

Author	O
contributions	O
FR	O
,	O
JS	O
,	O
and	O
RG	O
conceived	O
the	O
study	O
and	O
got	O
financial	O
support	O
.	O

SIRTs	O
have	O
an	O
important	O
role	O
in	O
the	O
process	O
of	O
synapse	O
promotion	O
and	O
modulation	O
of	O
their	O
strength	O
,	O
which	O
is	O
important	O
for	O
memory	O
formation	O
.	O

Quartiles	O
,	O
based	O
on	O
the	O
distribution	O
amongst	O
the	O
population	O
of	O
women	O
studied	O
,	O
in	O
the	O
standardised	O
concentrations	O
were	O
then	O
used	O
to	O
create	O
cut	O
-	O
points	O
and	O
designated	O
‘	O
low	O
’	O
(<	O
44	O
nmol	O
/	O
L	O
),	O
‘	O
low	O
-	O
moderate	O
’	O
(	O
44	O
–	O
63	O
nmol	O
/	O
L	O
),	O
‘	O
moderate	O
-	O
high	O
’	O
(	O
63	O
–	O
81	O
nmol	O
/	O
L	O
)	O
and	O
‘	O
high	O
’	O
(>	O
81	O
nmol	O
/	O
L	O
)	O
categories	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
.	O
Generalised	O
linear	O
models	O
(	O
Poisson	O
with	O
log	O
link	O
and	O
robust	O
variance	O
estimates	O
)	O
were	O
used	O
to	O
calculate	O
the	O
risk	O
ratios	O
for	O
pregnancy	O
complications	O
by	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
calculated	O
among	O
the	O
women	O
who	O
had	O
an	O
uncomplicated	O
pregnancy	O
.	O

The	O
fold	O
changes	O
were	O
uniformly	O
small	O
,	O
with	O
the	O
largest	O
FC	O
being	O
−	O
1	O
.	O
67	O
.	O

These	O
findings	O
suggest	O
that	O
pathways	O
associated	O
to	O
lipid	O
metabolism	O
are	O
part	O
of	O
postnatal	O
adaptive	O
responses	O
to	O
the	O
prenatal	O
nutritional	O
environment	O
in	O
LP	O
offspring	O
.	O

Angus	O
crossbred	O
cattle	O
exposed	O
to	O
greater	O
heat	O
stress	O
tend	O
to	O
have	O
a	O
greater	O
MS	O
[	O
82	O
].	O

This	O
may	O
be	O
because	O
reported	O
data	O
were	O
exaggerated	O
by	O
the	O
partner	O
or	O
because	O
,	O
for	O
some	O
reason	O
,	O
reported	O
is	O
a	O
healthier	O
group	O
than	O
measured	O
height	O
.	O

Birth	O
size	O
,	O
including	O
birth	O
weight	O
(	O
kg	O
),	O
length	O
(	O
cm	O
),	O
and	O
head	O
circumference	O
(	O
cm	O
),	O
was	O
measured	O
by	O
midwives	O
according	O
to	O
standard	O
procedure	O
.	O

Few	O
clinical	O
trial	O
intervention	O
studies	O
have	O
specifically	O
measured	O
changes	O
in	O
physical	O
activity	O
during	O
pregnancy	O
,	O
but	O
available	O
evidence	O
suggests	O
little	O
to	O
no	O
effect	O
on	O
maternal	O
GWG	O
[	O
16	O
,	O
43	O
].	O

The	O
composition	O
of	O
the	O
various	O
multivitamin	O
compounds	O
taken	O
also	O
varied	O
:	O
the	O
daily	O
dose	O
of	O
vitamin	O
C	O
ranged	O
from	O
0	O
to	O
600	O
mg	O
,	O
vitamin	O
E	O
ranged	O
from	O
0	O
to	O
70	O
mg	O
,	O
vitamin	O
A	O
ranged	O
from	O
0	O
to	O
30	O
,	O
000	O
IU	O
,	O
and	O
folate	O
ranged	O
from	O
0	O
to	O
2000	O
micrograms	O
.	O

Data	O
from	O
gene	O
expression	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
with	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

Once	O
transcription	O
within	O
the	O
embryo	O
genome	O
is	O
activated	O
,	O
however	O
,	O
there	O
is	O
rapid	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
processes	O
for	O
which	O
miRNA	O
-	O
mediated	O
regulation	O
is	O
essential	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
hence	O
increased	O
expression	O
of	O
miRNAs	O
.	O

The	O
subjects	O
with	O
the	O
three	O
highest	O
cathelicidin	O
concentration	O
values	O
had	O
characteristics	O
including	O
25	O
(	O
OH	O
)	O
D	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
age	O
,	O
which	O
were	O
comparable	O
to	O
the	O
corresponding	O
variable	O
represented	O
in	O
the	O
entire	O
cohort	O
.	O

trials	O
,	O
the	O
Medical	O
University	O
of	O
South	O
Carolina	O
(	O
MUSC	O
)	O
initiated	O
a	O
new	O
standard	O
of	O
care	O
for	O
pregnant	O
women	O
that	O
included	O
routine	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
in	O
September	O
2015	O
.	O

Evaluations	O
of	O
these	O
programs	O
using	O
maternal	O
anaemia	O
as	O
the	O
outcome	O
report	O
little	O
or	O
no	O
impact	O
because	O
of	O
the	O
multiple	O
causes	O
of	O
maternal	O
anaemia	O
,	O
low	O
compliance	O
,	O
and	O
inadequate	O
distribution	O
programs	O
.	O

Especially	O
notable	O
is	O
the	O
considerably	O
lower	O
PTB	O
rate	O
for	O
those	O
who	O
reached	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
those	O
who	O
did	O
not	O
(	O
78	O
%)	O
among	O
non	O
-	O
white	O
women	O
.	O

BeWo	O
cells	O
were	O
cultured	O
in	O
Ham	O
F12	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
)	O
containing	O
10	O
%	O
heat	O
-	O
inactivated	O
fetal	O
bovine	O
serum	O
(	O
FBS	O
)	O
and	O
0	O
.	O
5	O
%	O
penicillin	O
streptomycin	O
,	O
whereas	O
JEG	O
-	O
3	O
cells	O
were	O
maintained	O
in	O
MEME	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
UK	O
)	O
containing	O
10	O
%	O
heat	O
-	O
inactivated	O
FBS	O
and	O
0	O
.	O
5	O
%	O
penicillin	O
streptomycin	O
,	O
0	O
.	O
5	O
%	O
L	O
-	O
glutamine	O
,	O
0	O
.	O
5	O
%	O
sodium	O
pyruvate	O
,	O
and	O
0	O
.	O
5	O
%	O
MEM	O
nonessential	O
amino	O
acids	O
.	O

In	O
addition	O
,	O
researchers	O
find	O
dairy	O
products	O
in	O
China	O
are	O
mainly	O
fortified	O
with	O
Vitamin	O
D3	O
,	O
which	O
will	O
not	O
translate	O
into	O
higher	O
Vitamin	O
D2	O
detection	O
rate	O
among	O
participants	O
.	O

Assignment	O
of	O
treatments	O
An	O
investigator	O
remote	O
from	O
the	O
field	O
area	O
will	O
assign	O
the	O
interventions	O
to	O
eligible	O
clusters	O
using	O
a	O
fixed	O
randomisation	O
scheme	O
with	O
a	O
uniform	O
allocation	O
ratio	O
of	O
treatments	O
,	O
stratified	O
by	O
subdistrict	O
or	O
Upazila	O
.	O

We	O
additionally	O
considered	O
each	O
of	O
those	O
dietary	O
components	O
and	O
maternal	O
dairy	O
,	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
),	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
intakes	O
separately	O
.	O

3	O
.	O

Risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
,	O
in	O
addition	O
to	O
geographic	O
and	O
seasonal	O
variation	O
,	O
are	O
well	O
established	O
.	O

Recent	O
studies	O
of	O
the	O
text4baby	O
program	O
have	O
found	O
that	O
it	O
changes	O
attitudes	O
and	O
beliefs	O
,	O
but	O
effects	O
on	O
behavior	O
have	O
not	O
previously	O
been	O
established	O
[	O
23	O
,	O
26	O
].	O

Conclusions	O
Traditional	O
interventions	O
for	O
child	O
and	O
adolescent	O
obesity	O
often	O
focus	O
on	O
the	O
individual	O
child	O
,	O
with	O
or	O
without	O
family	O
involvement	O
,	O
and	O
include	O
education	O
,	O
modification	O
of	O
diet	O
,	O
and	O
increases	O
in	O
physical	O
activity	O
.	O

Of	O
the	O
children	O
in	O
the	O
cohort	O
,	O
20	O
.	O
3	O
%	O
were	O
found	O
to	O
be	O
vitamin	O
D	O
deficient	O
,	O
as	O
defined	O
by	O
a	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
mL	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Child	O
Sociodemographics	O
and	O
Clinical	O
Characteristics	O
.	O
CharacteristicValue	O
n	O
=	O
133Race	O
/	O
Ethnicity	O
[	O
n	O
(%)]	O
Black41	O
(	O
30	O
.	O
8	O
)	O
White38	O
(	O
28	O
.	O
6	O
)	O
Hispanic54	O
(	O
40	O
.	O
6	O
)	O
Gender	O
[	O
n	O
(%)]	O
Female62	O
(	O
46	O
.	O
6	O
)	O
Male71	O
(	O
53	O
.	O
4	O
)	O
Age1	O
(	O
years	O
)	O
4	O
.	O
7	O
±	O
1	O
.	O
2	O
(	O
2	O
–	O
7	O
)	O
BMI116	O
.	O
1	O
±	O
2	O
.	O
5	O
(	O
12	O
.	O
1	O
–	O
28	O
.	O
8	O
)%	O
Fat125	O
.	O
5	O
±	O
6	O
.	O
1	O
(	O
14	O
.	O
6	O
–	O
42	O
.	O
9	O
)	O
No	O
.	O

The	O
system	O
will	O
also	O
generate	O
daily	O
reports	O
of	O
the	O
completed	O
interviews	O
and	O
enrolment	O
and	O
make	O
them	O
available	O
on	O
the	O
online	O
monitoring	O
interface	O
(	O
in	O
real	O
time	O
).	O

First	O
,	O
from	O
2007	O
–	O
2013	O
,	O
the	O
Government	O
of	O
Nicaragua	O
provided	O
influenza	O
vaccination	O
only	O
for	O
pregnant	O
women	O
with	O
chronic	O
conditions	O
[	O
34	O
].	O

The	O
importance	O
of	O
effective	O
3	O
-	O
way	O
communication	O
among	O
the	O
patient	O
,	O
asthma	O
specialist	O
,	O
and	O
obstetrician	O
cannot	O
be	O
overemphasized	O
.	O

UVB	O
in	O
the	O
290	O
-	O
315	O
nm	O
range	O
photolysis	O
7	O
-	O
dehydrocholesterol	O
in	O
the	O
skin	O
to	O
form	O
previtamin	O
D3	O
,	O
which	O
then	O
isomerizes	O
to	O
colecalciferol	O
.	O
6Colecalciferol	O
(	O
and	O
ergocalciferol	O
[	O
vitamin	O
D2	O
])	O
is	O
also	O
available	O
from	O
fortified	O
foods	O
(	O
e	O
.	O
g	O
.,	O
milk	O
,	O
cereal	O
,	O
and	O
some	O
orange	O
juice	O
and	O
cheeses	O
),	O
dark	O
fish	O
(	O
e	O
.	O
g	O
.,	O
salmon	O
and	O
tuna	O
),	O
and	O
vitamin	O
supplements	O
(	O
colecalciferol	O
).	O

Varying	O
observations	O
,	O
however	O
,	O
have	O
been	O
made	O
when	O
determining	O
whether	O
a	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
concentrations	O
exists	O
.	O

BAT	O
activity	O
is	O
well	O
known	O
to	O
mostly	O
rely	O
on	O
lipid	O
metabolism	O
,	O
UCP1	O
being	O
directly	O
activated	O
by	O
fatty	O
acids	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

Thus	O
,	O
this	O
suggests	O
that	O
BMI	O
is	O
not	O
transmitted	O
via	O
mitochondrial	O
DNA	O
or	O
,	O
if	O
so	O
,	O
only	O
weakly	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Association	O
of	O
LINE	O
-	O
1	O
(	O
A	O
)	O
and	O
AluYb8	O
(	O
B	O
)	O
methylation	O
with	O
bioinformatically	O
derived	O
CpG	O
class	O
methylation	O
.	O

Dietary	O
data	O
was	O
collected	O
using	O
a	O
validated	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

[	O
66	O
],	O
it	O
was	O
shown	O
that	O
the	O
manipulation	O
of	O
serotonin	O
during	O
early	O
development	O
in	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
models	O
disturbs	O
characteristic	O
chemoarchitectural	O
and	O
electrophysiological	O
brain	O
features	O
.	O

While	O
diet	O
can	O
impact	O
health	O
at	O
any	O
life	O
stage	O
,	O
it	O
is	O
likely	O
to	O
be	O
most	O
important	O
during	O
the	O
fetal	O
and	O
infancy	O
periods	O
,	O
when	O
the	O
immune	O
system	O
is	O
immature	O
.	O

No	O
genes	O
were	O
found	O
consistently	O
differentially	O
expressed	O
between	O
the	O
groups	O
along	O
all	O
examined	O
stages	O
.	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

There	O
were	O
fewer	O
deaths	O
than	O
we	O
predicted	O
in	O
both	O
groups	O
,	O
possibly	O
due	O
to	O
the	O
intense	O
health	O
surveillance	O
possible	O
during	O
our	O
study	O
.	O

The	O
evaluation	O
team	O
will	O
consist	O
of	O
135	O
data	O
collectors	O
,	O
five	O
field	O
supervisors	O
and	O
five	O
field	O
research	O
officers	O
.	O

The	O
approach	O
parents	O
take	O
to	O
feeding	O
their	O
children	O
reflects	O
their	O
goals	O
for	O
their	O
children	O
'	O
s	O
eating	O
and	O
health	O
,	O
and	O
these	O
goals	O
are	O
influenced	O
by	O
culture	O
and	O
socioeconomic	O
status	O
(	O
82	O
).	O

For	O
example	O
,	O
the	O
maternal	O
aMED	O
score	O
was	O
consistently	O
positively	O
and	O
negatively	O
associated	O
with	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
additionally	O
negatively	O
associated	O
with	O
the	O
species	O
Escherichia	O
coli	O
,	O
in	O
both	O
delivery	O
mode	O
strata	O
.	O

However	O
,	O
at	O
the	O
whole	O
-	O
body	O
level	O
adverse	O
consequences	O
of	O
restricted	O
intrauterine	O
supply	O
were	O
observed	O
[	O
15	O
].	O

Thus	O
,	O
during	O
the	O
late	O
fattening	O
stage	O
of	O
beef	O
cattle	O
,	O
marbling	O
adipocytes	O
may	O
grow	O
continuously	O
even	O
though	O
development	O
of	O
abdominal	O
,	O
intermuscular	O
,	O
and	O
subcutaneous	O
fat	O
may	O
slow	O
or	O
cease	O
.	O

3	O
.	O
3	O
.	O

Larger	B
observational	O-
studies	I
are	O
required	O
to	O
establish	O
a	O
true	O
link	O
between	O
the	O
use	O
of	O
SSRIs	O
and	O
autism	O
.	O

Children	O
'	O
s	O
heightened	O
preference	O
for	O
salty	O
tastes	O
(	O
29	O
)	O
attracts	O
them	O
to	O
necessary	O
minerals	O
,	O
and	O
rejecting	O
bitter	O
-	O
tasting	O
substances	O
protects	O
them	O
from	O
poisons	O
because	O
most	O
poisonous	O
compounds	O
taste	O
bitter	O
(	O
30	O
).	O

Though	O
,	O
because	O
of	O
its	O
immediate	O
bioavailability	O
,	O
it	O
may	O
result	O
in	O
a	O
more	O
rapid	O
rise	O
in	O
haemoglobin	O
level	O
in	O
anaemic	O
patients	O
compared	O
with	O
oral	O
iron	O
;	O
but	O
it	O
probably	O
does	O
not	O
confer	O
an	O
advantage	O
in	O
preventing	O
anaemia	O
in	O
pregnancy	O
[	O
25	O
,	O
38	O
].	O

The	O
lack	O
of	O
vitamin	O
A	O
supplementation	O
also	O
increased	O
marbling	O
compared	O
with	O
vitamin	O
A	O
supplementation	O
in	O
a	O
study	O
of	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

Exploratory	O
analyses	O
examined	O
whether	O
treatment	O
condition	O
(	O
intervention	O
versus	O
standard	O
care	O
)	O
interacted	O
with	O
dietary	O
variables	O
and	O
physical	O
activity	O
in	O
predicting	O
offspring	O
weight	O
status	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
13	O
Health	O
care	O
workers	O
-	O
Health	O
care	O
providers	O
as	O
champions	O
of	O
change	O
for	O
mothers	O
and	O
newborns	O
.	O

Providing	O
quality	O
care	O
involves	O
doing	O
the	O
right	O
thing	O
at	O
the	O
right	O
time	O
.	O

Thus	O
,	O
the	O
caloric	O
restriction	O
finished	O
at	O
GD	O
20	O
(	O
2	O
days	O
before	O
birth	O
),	O
and	O
all	O
dams	O
and	O
their	O
offspring	O
were	O
fed	O
ad	O
libitum	O
with	O
the	O
standard	O
chow	O
along	O
the	O
remaining	O
experimental	O
periods	O
(	O
lactation	O
and	O
postweaning	O
periods	O
).	O

Our	O
findings	O
suggest	O
that	O
analysis	O
of	O
SNPs	O
may	O
have	O
an	O
important	O
role	O
in	O
identifying	O
high	O
-	O
risk	O
categories	O
of	O
individuals	O
who	O
are	O
likely	O
to	O
require	O
higher	O
doses	O
of	O
vitamin	O
D	O
to	O
achieve	O
repletion	O
,	O
and	O
studies	B
are	I
needed	I
to	O
establish	O
clinical	O
approaches	O
to	O
vitamin	O
D	O
supplementation	O
that	O
are	O
centered	O
on	O
individual	O
characteristics	O
.	O

Although	O
transplacental	O
transport	O
has	O
not	O
been	O
studied	O
in	O
humans	O
,	O
vitamin	O
D	O
passage	O
from	O
the	O
mother	O
to	O
the	O
fetus	O
would	O
be	O
facilitated	O
by	O
serum	O
concentrations	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
being	O
higher	O
in	O
the	O
maternal	O
compared	O
to	O
the	O
fetal	O
circulations	O
.	O

Not	O
surprisingly	O
,	O
they	O
found	O
that	O
children	O
who	O
breastfed	O
longer	O
had	O
higher	O
levels	O
of	O
PFASs	O
in	O
their	O
blood	O
.	O

As	O
compared	O
to	O
mothers	O
with	O
suboptimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
,	O
mothers	O
with	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
had	O
heavier	O
newborns	O
(	O
P	O
=	O
0	O
.	O
010	O
),	O
but	O
this	O
positive	O
association	O
was	O
not	O
verified	O
in	O
linear	O
regression	O
(	O
B	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
00	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
16	O
).	O

In	O
two	O
separate	O
studies	O
,	O
early	O
-	O
weaned	O
steers	O
(	O
weaned	O
at	O
177	O
d	O
[	O
study	O
1	O
]	O
and	O
158	O
d	O
[	O
study	O
2	O
]	O
of	O
age	O
and	O
placed	O
on	O
a	O
finishing	O
diet	O
)	O
increased	O
MS	O
and	O
body	O
weight	O
gain	O
,	O
improved	O
feed	O
efficiency	O
,	O
and	O
improved	O
QG	O
of	O
the	O
beef	O
compared	O
with	O
normally	O
weaned	O
steers	O
or	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
[	O
51	O
].	O

Above	O
-	O
average	O
nutritional	O
knowledge	O
was	O
independently	O
associated	O
with	O
the	O
use	O
of	O
folic	O
acid	O
(	O
aOR	O
,	O
4	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
6	O
-	O
13	O
.	O
8	O
),	O
iron	O
(	O
aOR	O
,	O
2	O
.	O
6	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
5	O
.	O
7	O
)	O
and	O
multivitamins	O
(	O
aOR	O
,	O
2	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
6	O
.	O
8	O
).	O

Statistical	O
estimates	O
show	O
that	O
one	O
out	O
of	O
every	O
88	O
individuals	O
in	O
the	O
United	O
States	O
is	O
diagnosed	O
with	O
autism	O
.	O

These	O
effects	O
extended	O
to	O
lipid	O
and	O
cholesterol	O
metabolic	O
pathways	O
,	O
suggesting	O
the	O
existence	O
of	O
a	O
complex	O
pattern	O
alterations	O
derived	O
of	O
adaptation	O
to	O
maternal	O
malnutrition	O
.	O

There	O
are	O
a	O
number	O
of	O
limitations	O
inherent	O
in	O
the	O
design	O
of	O
the	O
present	O
study	O
that	O
should	B
be	I
acknowledged	O
.	O

[	O
12	O
]	O
Chailurkit	O
et	O
al	O
.	O

Considering	O
the	O
possible	O
losses	O
,	O
the	O
sample	O
size	O
was	O
set	O
at	O
74	O
people	O
in	O
each	O
group	O
finally	O
.	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
034	O
for	O
maternal	O
dairy	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
dairy	O
intake	O
tertiles	O
.	O

Thus	O
,	O
season	O
at	O
pregnancy	O
blood	O
sampling	O
and	O
at	O
birth	O
was	O
coded	O
using	O
dummy	O
variables	O
(	O
with	O
autumn	O
as	O
a	O
reference	O
)	O
in	O
ANCOVA	O
and	O
used	O
as	O
a	O
covariate	O
.	O

Using	O
data	O
from	O
the	O
general	O
Australian	O
population	O
,	O
we	O
anticipated	O
a	O
minimum	O
incidence	O
in	O
the	O
standard	O
care	O
group	O
of	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
of	O
approximately	O
25	O
%	O
[	O
35	O
].	O

For	O
example	O
,	O
research	O
has	O
suggested	O
that	O
Alu	O
sequences	O
often	O
flank	O
CGIs	O
(	O
Graff	O
et	O
al	O
.	O

All	O
measurements	O
are	O
done	O
twice	O
and	O
recorded	O
to	O
the	O
nearest	O
0	O
.	O
05	O
kg	O
for	O
weight	O
,	O
0	O
.	O
1	O
cm	O
for	O
MUAC	O
and	O
height	O
.	O

A	O
second	O
aim	O
was	O
to	O
determine	O
if	O
the	O
concentration	O
of	O
cathelicidin	O
and	O
vitamin	O
D	O
correlate	O
with	O
the	O
number	O
of	O
infections	O
a	O
child	O
experiences	O
during	O
childhood	O
and	O
as	O
a	O
function	O
of	O
age	O
.	O

In	O
a	O
nonrandomized	O
study	O
,	O
women	O
with	O
GDM	O
on	O
a	O
diet	O
comprising	O
less	O
than	O
42	O
%	O
carbohydrate	O
,	O
had	O
lower	O
post	O
-	O
prandial	O
glucose	O
levels	O
,	O
were	O
less	O
likely	O
to	O
require	O
insulin	O
,	O
and	O
had	O
a	O
lower	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
.	O
28A	O
small	O
study	O
which	O
randomized	O
pregnant	O
women	O
to	O
low	O
glycemic	O
index	O
(	O
GI	O
)	O
or	O
high	O
GI	O
diets	O
found	O
that	O
the	O
former	O
resulted	O
in	O
lower	O
glucose	O
levels	O
,	O
a	O
blunting	O
of	O
the	O
pregnancy	O
associated	O
rise	O
in	O
insulin	O
resistance	O
,	O
and	O
lower	O
birthweight	O
.	O
29In	O
another	O
study	O
of	O
GI	O
,	O
women	O
assigned	O
to	O
a	O
low	O
GI	O
diet	O
during	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
who	O
were	O
lighter	O
(	O
3408	O
±	O
78	O
g	O
vs	O
3644	O
±	O
90	O
g	O
)	O
and	O
had	O
a	O
lower	O
incidence	O
of	O
large	O
for	O
gestational	O
age	O
,	O
compared	O
to	O
women	O
given	O
a	O
high	O
GI	O
diet	O
.	O
30Both	O
diets	O
comprised	O
55	O
%	O
carbohydrate	O
.	O

Muscle	O
and	O
fat	O
cell	O
development	O
are	O
dependent	O
on	O
myogenesis	O
(	O
muscle	O
cell	O
formation	O
)	O
and	O
adipogenesis	O
(	O
fat	O
cell	O
formation	O
),	O
respectively	O
[	O
16	O
].	O

It	O
is	O
evident	O
that	O
the	O
major	O
transcripts	O
in	O
the	O
human	O
placenta	O
are	O
GR	O
α	O
and	O
GAS5	O
.	O

Despite	O
this	O
,	O
it	O
remains	O
important	O
to	O
continue	O
to	O
follow	O
-	O
up	O
the	O
children	O
whose	O
mothers	O
participated	O
in	O
this	O
intervention	O
trial	O
,	O
particularly	O
in	O
view	O
of	O
the	O
well	O
recognised	O
association	O
between	O
high	O
-	O
infant	O
birth	O
weight	O
and	O
subsequent	O
childhood	O
obesity	O
[	O
48	O
],	O
and	O
the	O
emerging	O
associations	O
between	O
maternal	O
obesity	O
and	O
impaired	O
childhood	O
neurodevelopmental	O
function	O
[	O
46	O
].	O

The	O
autumn	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
the	O
intervention	O
group	O
is	O
significantly	O
higher	O
than	O
that	O
of	O
control	O
group	O
.	O

At	O
the	O
same	O
time	O
,	O
it	O
decreases	O
serum	O
AMH	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
which	O
are	O
often	O
elevated	O
in	O
those	O
women	O
[	O
26	O
].	O

Hypothalamic	O
Gene	O
Expression	O
The	O
HV	O
but	O
not	O
HFol	O
pup	O
diet	O
brought	O
POMC	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
from	O
HV	O
dams	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
(	O
Figure	O
5a	O
).	O

Neonates	O
exposed	O
to	O
polytherapy	O
were	O
five	O
times	O
more	O
likely	O
to	O
present	O
with	O
PNA	O
signs	O
compared	O
with	O
those	O
exposed	O
to	O
monotherapy	O
.	O

All	O
the	O
mothers	O
completed	O
a	O
questionnaire	O
pertaining	O
to	O
their	O
diet	O
in	O
the	O
12	O
months	O
prior	O
to	O
pregnancy	O
.	O

In	O
the	O
USA	O
excessive	O
GWG	O
remains	O
of	O
predominant	O
concern	O
,	O
as	O
60	O
%	O
of	O
obese	O
women	O
gain	O
more	O
than	O
recommended	O
.	O

Infant	O
skin	O
prick	O
tests	O
are	O
performed	O
at	O
phases	O
7	O
and	O
8	O
by	O
a	O
medical	O
doctor	O
according	O
to	O
the	O
procedure	O
described	O
in	O
the	O
Allergy	O
Society	O
of	O
South	O
Africa	O
’	O
s	O
position	O
statement	O
on	O
skin	O
prick	O
testing	O
[	O
49	O
].	O

This	O
QFFQ	O
includes	O
a	O
list	O
of	O
typically	O
consumed	O
foods	O
and	O
minor	O
changes	O
were	O
made	O
to	O
the	O
questionnaire	O
according	O
to	O
vernacular	O
used	O
by	O
the	O
study	O
population	O
in	O
that	O
particular	O
area	O
.	O

The	O
25	O
(	O
OH	O
)	O
D	O
distribution	O
based	O
on	O
caries	O
-	O
status	O
appears	O
in	O
Table	O
2	O
.	O

Solid	O
gray	O
circles	O
and	O
solid	O
black	O
line	O
represent	O
MUSC	O
cohort	O
(	O
N	O
=	O
1064	O
)	O
and	O
open	O
circles	O
and	O
dashed	O
line	O
represent	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Sample	O
suspensions	O
were	O
sonicated	O
3	O
×	O
10	O
sec	O
at	O
40	O
%	O
intensity	O
and	O
centrifuged	O
at	O
14	O
,	O
000	O
×	O
g	O
for	O
20	O
min	O
at	O
15	O
°	O
C	O
.	O

In	O
a	O
study	O
by	O
Hovsepian	O
et	O
al	O
.,	O
in	O
men	O
and	O
women	O
with	O
average	O
age	O
of	O
41	O
.	O
4	O
years	O
in	O
Isfahan	O
,	O
45	O
%	O
of	O
men	O
and	O
52	O
.	O
4	O
%	O
of	O
women	O
had	O
vitamin	O
D	O
concentrations	O
lower	O
than	O
20	O
ng	O
/	O
mL	O
([	O
52	O
]).	O

They	O
sought	O
to	O
have	O
the	O
mother	O
and	O
family	O
members	O
identify	O
perceived	O
barriers	O
to	O
their	O
own	O
handwashing	O
,	O
to	O
address	O
those	O
barriers	O
through	O
behavioral	O
solutions	O
,	O
and	O
to	O
enhance	O
maternal	O
self	O
-	O
efficacy	O
for	O
handwashing	O
in	O
the	O
neonatal	O
period	O
.	O

Approximately	O
three	O
-	O
quarters	O
of	O
the	O
women	O
were	O
immigrants	O
(	O
75	O
%),	O
primarily	O
from	O
Mexico	O
and	O
Honduras	O
.	O

Methylation	O
levels	O
of	O
long	O
interspersed	O
nuclear	O
element	O
-	O
1	O
(	O
LINE	O
-	O
1	O
)	O
and	O
the	O
Alu	O
element	O
AluYb8	O
were	O
determined	O
in	O
380	O
placental	O
samples	O
from	O
term	O
deliveries	O
using	O
bisulfite	O
pyrosequencing	O
.	O

Recent	O
surveys	O
in	O
Bangladesh	O
indicate	O
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
IFA	O
supplements	O
in	O
their	O
last	O
pregnancy	O
,	O
but	O
this	O
falls	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
[	O
5	O
].	O

Early	O
weaning	O
(	O
141	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
high	O
-	O
starch	O
diet	O
improved	O
MS	O
compared	O
with	O
normal	O
weaning	O
(	O
222	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
starch	O
creep	O
-	O
feed	O
diet	O
.	O

A	O
second	O
person	O
checks	O
20	O
%	O
of	O
all	O
the	O
captured	O
data	O
randomly	O
and	O
notes	O
and	O
corrects	O
any	O
errors	O
.	O

The	O
serum	O
samples	O
were	O
used	O
to	O
measure	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
,	O
paratormone	O
(	O
PTH	O
),	O
calcium	O
and	O
phosphorus	O
.	O

[	O
34	O
]	O
Interestingly	O
,	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
also	O
associated	O
with	O
risks	O
of	O
health	O
problems	O
later	O
in	O
childhood	O
,	O
including	O
improper	O
bone	O
development	O
at	O
9	O
yrs	O
of	O
age	O
,	O
asthma	O
,[	O
36	O
]	O
dental	O
cavities	O
,	O
schizophrenia	O
,	O
and	O
type	O
I	O
diabetes	O
.	O

Afterwards	O
,	O
participating	O
mothers	O
were	O
matched	O
and	O
divided	O
into	O
groups	O
A	O
and	O
B	O
based	O
on	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
as	O
follows	O
:	O
normal	O
(	O
18	O
.	O
5	O
-	O
25	O
kg	O
/	O
m2	O
)	O
(	O
n	O
=	O
16	O
)	O
and	O
overweight	O
and	O
obese	O
(≥	O
25	O
kg	O
/	O
m2	O
)	O
(	O
n	O
=	O
25	O
).	O

Such	O
commonly	O
identified	O
,	O
prenatal	O
risk	O
factors	O
may	O
include	O
advanced	O
-	O
aged	O
parents	O
,	O
a	O
short	O
gestation	O
period	O
,	O
low	O
birth	O
weight	O
,	O
hyperbilirubinemia	O
,	O
and	O
breech	O
presentation	O
[	O
3	O
].	O

Children	O
born	O
to	O
women	O
who	O
smoke	O
during	O
pregnancy	O
typically	O
weigh	O
less	O
at	O
birth	O
,	O
and	O
they	O
often	O
have	O
a	O
catch	O
-	O
up	O
period	O
during	O
their	O
first	O
year	O
,	O
although	O
studies	O
have	O
not	O
consistently	O
found	O
a	O
link	O
between	O
catch	O
-	O
up	O
growth	O
and	O
greater	O
childhood	O
body	O
mass	O
index	O
(	O
BMI	O
).	O

The	O
smoking	O
evidence	O
is	O
particularly	O
compelling	O
as	O
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	O
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

Additionally	O
,	O
a	O
meta	O
-	O
analysis	O
by	O
Govarts	O
et	O
al	O
.	O

Improve	O
adherence	O
and	O
monitor	O
compliance	O
To	O
improve	O
adherence	O
,	O
a	O
local	O
pharmaceutical	O
company	O
(	O
Eskayef	O
Bangladesh	O
Limited	O
)	O
will	O
produce	O
IFA	O
supplements	O
in	O
an	O
attractive	O
capsule	O
shell	O
and	O
special	O
blister	O
package	O
.	O

Researchers	O
have	O
studied	O
the	O
relationship	O
between	O
low	O
serum	O
vitamin	O
D	O
concentration	O
and	O
perinatal	O
depression	O
,	O
although	O
no	O
clinical	O
trial	O
has	O
been	O
conducted	O
on	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
depression	O
related	O
to	O
childbirth	O
.	O

Black	O
line	O
represents	O
fitted	O
LOESS	O
curve	O
,	O
dark	O
gray	O
area	O
represents	O
1	O
standard	O
deviation	O
,	O
and	O
light	O
gray	O
area	O
represents	O
2	O
standard	O
deviations	O
.	O

2	O
.	O

The	O
animal	O
experiment	O
was	O
performed	O
as	O
described	O
[	O
15	O
].	O

Labor	O
induction	O
and	O
augmentation	O
appear	O
to	O
be	O
an	O
area	O
of	O
association	O
.	O

The	O
association	O
between	O
polytherapy	O
exposure	O
and	O
higher	O
rates	O
of	O
malformations	O
should	B
be	I
considered	B
in	O
the	O
context	O
of	O
the	O
small	O
sample	O
size	O
,	O
severity	O
of	O
the	O
baseline	O
disorder	O
that	O
required	O
polytherapy	O
,	O
associated	O
comorbidities	O
,	O
as	O
well	O
as	O
any	O
other	O
unknown	O
environmental	O
factors	O
that	O
were	O
not	O
assessed	O
in	O
this	O
study	O
.	O

Indeed	O
those	O
offspring	O
,	O
for	O
which	O
maternal	O
calorie	O
restriction	O
was	O
extended	O
into	O
lactation	O
,	O
did	O
not	O
show	O
obesity	O
as	O
adults	O
,	O
but	O
still	O
displayed	O
accelerated	O
reproductive	O
maturation	O
.	O

It	O
has	O
long	O
been	O
proposed	O
that	O
the	O
mother	O
should	B
avoid	O
such	O
foods	O
containing	O
potential	O
allergens	O
during	O
pregnancy	O
and	O
lactation	O
to	O
prevent	O
food	O
sensitization	O
in	O
the	O
child	O
.	O

It	O
is	O
also	O
relevant	O
to	O
note	O
that	O
Hibbeln	O
et	O
al	O
.	O

An	O
increase	O
in	O
serum	O
retinol	O
and	O
improved	O
anthropometric	O
status	O
(	O
weight	O
,	O
height	O
,	O
BMI	O
)	O
in	O
supplemented	O
girls	O
was	O
also	O
recorded	O
(	O
Hyder	O
et	O
al	O
2007	O
),	O
indicating	O
the	O
potential	O
benefits	O
of	O
MMN	O
supplementation	O
for	O
a	O
risk	O
group	O
attempting	O
to	O
satisfy	O
increased	O
nutritional	O
requirements	O
for	O
pubertal	O
growth	O
while	O
commonly	O
manifesting	O
a	O
substantial	O
degree	O
of	O
undernutrition	O
.	O

The	O
mean	O
BW	O
was	O
3008	O
g	O
(	O
Range	O
:	O
1400	O
to	O
4590	O
;	O
SD	O
=	O
605	O
g	O
)	O
with	O
birth	O
length	O
47	O
.	O
1	O
cm	O
(	O
Range	O
:	O
39	O
.	O
0	O
–	O
53	O
.	O
0	O
;	O
SD	O
=	O
3	O
.	O
28	O
cm	O
).	O

African	O
American	O
women	O
accounted	O
for	O
a	O
majority	O
(	O
69	O
%)	O
of	O
the	O
non	O
-	O
white	O
births	O
and	O
had	O
a	O
19	O
%	O
PTB	O
rate	O
.	O

It	O
is	O
well	O
known	O
that	O
male	O
heights	O
tend	O
to	O
be	O
greater	O
in	O
reported	O
than	O
measured	O
data	O
.	O
37Our	O
analysis	O
suggests	O
that	O
it	O
is	O
unlikely	O
that	O
correlations	O
were	O
affected	O
by	O
this	O
feature	O
.	O

Consenting	O
subjects	O
who	O
were	O
present	O
in	O
the	O
village	O
on	O
an	O
allotted	O
day	O
were	O
recruited	O
.	O

Identifying	O
mechanisms	O
of	O
these	O
conditions	O
,	O
and	O
strategies	B
for	O
early	O
detection	O
,	O
prevention	O
,	O
and	O
care	O
,	O
represent	O
an	O
important	O
need	O
for	O
reducing	O
the	O
global	O
burden	O
of	O
preterm	O
birth	O
.	O

Bridging	O
this	O
gap	O
will	O
be	O
critical	O
for	O
saving	O
premature	O
babies	O
globally	O
,	O
and	O
must	O
be	O
linked	O
to	O
implementation	O
research	O
and	O
context	O
specific	O
adaptation	O
and	O
innovation	O
.	O

The	O
increased	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
in	O
neonates	O
relative	O
to	O
maternal	O
BMI	O
level	O
were	O
seen	O
in	O
both	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
population	O
and	O
supports	O
similar	O
findings	O
seen	O
in	O
a	O
study	O
done	O
by	O
Bodnar	O
et	O
al	O
.	O
38Although	O
prenatal	O
vitamin	O
use	O
was	O
not	O
significantly	O
different	O
between	O
blacks	O
and	O
whites	O
in	O
our	O
study	O
,	O
prenatal	O
vitamin	O
use	O
was	O
significant	O
among	O
those	O
with	O
and	O
without	O
vitamin	O
D	O
deficiency	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Determinants	O
of	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
vitamins	O
Folic	O
acidIronVitamins	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
OR	O
(	O
95	O
%	O
CI	O
)#	O
OR	O
(	O
95	O
%	O
CI	O
)##	O
Urban	O
environment	O
1	O
.	O
47	O
(	O
1	O
.	O
18	O
;	O
1	O
.	O
48	O
)	O
1	O
.	O
46	O
(	O
0	O
.	O
83	O
;	O
2	O
.	O
54	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
55	O
;	O
1	O
.	O
34	O
)	O
0	O
.	O
72	O
(	O
0	O
.	O
44	O
;	O
1	O
.	O
19	O
)	O
1	O
.	O
66	O
(	O
1	O
.	O
01	O
;	O
2	O
.	O
73	O
)	O
1	O
.	O
58	O
(	O
0	O
.	O
90	O
;	O
2	O
.	O
78	O
)	O
Age	O
(	O
yrs	O
)	O
≤	O
1911111119	O
-	O
342	O
.	O
061	O
.	O
271	O
.	O
050	O
.	O
931	O
.	O
551	O
.	O
18	O
(	O
0	O
.	O
66	O
;	O
6	O
.	O
47	O
)(	O
0	O
.	O
39	O
;	O
4	O
.	O
19	O
)(	O
0	O
.	O
47	O
;	O
2	O
.	O
37	O
)(	O
0	O
.	O
41	O
;	O
2	O
.	O
14	O
)	O
0	O
.	O
67	O
;	O
3	O
.	O
580	O
.	O
50	O
;	O
2	O
.	O
78	O
≥	O
353	O
.	O
111	O
.	O
590	O
.	O
760	O
.	O
640	O
.	O
790	O
.	O
50	O
(	O
0	O
.	O
84	O
;	O
11	O
.	O
46	O
)(	O
0	O
.	O
41	O
;	O
6	O
.	O
17	O
)(	O
0	O
.	O
28	O
;	O
2	O
.	O
08	O
)(	O
0	O
.	O
23	O
;	O
1	O
.	O
79	O
)	O
0	O
.	O
28	O
;	O
2	O
.	O
250	O
.	O
17	O
;	O
1	O
.	O
47Schooling	O
(	O
grades	O
)	O
≤	O
8	O
9	O
-	O
12	O
11	O
1111	O
4	O
.	O
764	O
.	O
01	O
1	O
.	O
141	O
.	O
341	O
.	O
631	O
.	O
640	O
>	O
12	O
(	O
2	O
.	O
28	O
;	O
9	O
.	O
97	O
)(	O
1	O
.	O
88	O
;	O
8	O
.	O
56	O
)	O
(	O
0	O
.	O
66	O
;	O
1	O
.	O
98	O
)(	O
0	O
.	O
75	O
;	O
2	O
.	O
37	O
)(	O
0	O
.	O
93	O
;	O
2	O
.	O
88	O
)(	O
0	O
.	O
908	O
;	O
2	O
.	O
964	O
)	O
8	O
.	O
125	O
.	O
21	O
1	O
.	O
54	O
2	O
.	O
303	O
.	O
543	O
.	O
372	O
(	O
3	O
.	O
67	O
;	O
17	O
.	O
96	O
)(	O
2	O
.	O
12	O
;	O
12	O
.	O
82	O
)	O
(	O
0	O
.	O
82	O
;	O
2	O
.	O
90	O
)	O
(	O
1	O
.	O
08	O
;	O
4	O
.	O
86	O
)(	O
1	O
.	O
68	O
;	O
7	O
.	O
43	O
)(	O
1	O
.	O
432	O
;	O
7	O
.	O
940	O
)	O
Married	O
2	O
.	O
68	O
1	O
.	O
931	O
.	O
300	O
.	O
741	O
.	O
491	O
.	O
330	O
(	O
1	O
.	O
34	O
;	O
5	O
.	O
36	O
)	O
(	O
0	O
.	O
93	O
;	O
4	O
.	O
01	O
)(	O
0	O
.	O
75	O
;	O
2	O
.	O
25	O
)(	O
0	O
.	O
45	O
;	O
1	O
.	O
22	O
)(	O
0	O
.	O
83	O
;	O
2	O
.	O
68	O
)(	O
0	O
.	O
712	O
;	O
2	O
.	O
487	O
)	O
Wanted	O
pregnancy0	O
.	O
960	O
.	O
821	O
.	O
611	O
.	O
480	O
.	O
961	O
.	O
49	O
(	O
0	O
.	O
40	O
;	O
2	O
.	O
30	O
)(	O
0	O
.	O
32	O
;	O
2	O
.	O
08	O
)(	O
0	O
.	O
78	O
;	O
3	O
.	O
33	O
)(	O
0	O
.	O
71	O
;	O
3	O
.	O
09	O
)(	O
0	O
.	O
40	O
;	O
2	O
.	O
30	O
)(	O
0	O
.	O
68	O
;	O
3	O
.	O
26First	O
birth1	O
.	O
3540	O
.	O
9470	O
.	O
9130	O
.	O
8982	O
.	O
0361	O
.	O
79	O
(	O
0	O
.	O
706	O
;	O
2	O
.	O
599	O
)(	O
0	O
.	O
474	O
;	O
1	O
.	O
891	O
)(	O
0	O
.	O
519	O
;	O
1	O
.	O
604	O
)(	O
0	O
.	O
506	O
;	O
1	O
.	O
593	O
)(	O
1	O
.	O
128	O
;	O
3	O
.	O
673	O
)(	O
0	O
.	O
98	O
;	O
3	O
.	O
26	O
)≤	O
4	O
pregnancy	O
registration	O
3	O
.	O
763	O
.	O
41	O
1	O
.	O
070	O
.	O
920	O
.	O
482	O
.	O
02	O
(	O
1	O
.	O
19	O
;	O
11	O
.	O
89	O
)(	O
1	O
.	O
05	O
;	O
11	O
.	O
14	O
)	O
(	O
0	O
.	O
52	O
;	O
2	O
.	O
24	O
)(	O
0	O
.	O
48	O
;	O
1	O
.	O
93	O
)(	O
0	O
.	O
22	O
;	O
1	O
.	O
05	O
)(	O
0	O
.	O
91	O
;	O
4	O
.	O
46	O
)	O
No	O
.	O

In	O
agreement	O
with	O
our	O
findings	O
,	O
others	O
have	O
discovered	O
that	O
mothers	O
with	O
higher	O
vitamin	O
D	O
concentration	O
have	O
infants	O
with	O
smaller	O
head	O
circumference	O
at	O
birth	O
[	O
36	O
,	O
37	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Maternal	O
mean	O
plasma	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
g	O
glucose	O
challenge	O
.	O

After	O
gathering	O
information	O
,	O
we	O
divided	O
all	O
subjects	O
into	O
three	O
categories	O
on	O
the	O
base	O
of	O
their	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
serum	O
level	O
as	O
follows	O
:	O
vitamin	O
D	O
deficient	O
patients	O
(	O
serum	O
level	O
below	O
25	O
nmol	O
/	O
L	O
),	O
vitamin	O
D	O
insufficient	O
cases	O
(	O
serum	O
level	O
between	O
25	O
and	O
75	O
nmol	O
/	O
L	O
)	O
and	O
subjects	O
with	O
normal	O
or	O
higher	O
than	O
normal	O
vitamin	O
D	O
level	O
(	O
serum	O
level	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
).	O

Recent	O
research	O
has	O
confirmed	O
that	O
ALL	O
can	O
originate	O
in	O
utero	O
.	O

We	O
further	O
increased	O
the	O
desired	O
sample	O
to	O
200	O
per	O
arm	O
to	O
account	O
for	O
potential	O
loss	O
to	O
follow	O
-	O
up	O
,	O
and	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
maternal	O
or	O
neonatal	O
death	O
,	O
since	O
structured	O
observations	O
would	O
not	O
be	O
feasible	O
or	O
appropriate	O
in	O
such	O
cases	O
.	O

Particularly	O
,	O
we	O
evaluated	O
the	O
gene	O
expression	O
of	O
relevant	O
components	O
of	O
the	O
endocannabinoid	O
system	O
,	O
and	O
key	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
metabolically	O
relevant	O
tissues	O
,	O
such	O
as	O
the	O
hypothalamus	O
,	O
the	O
liver	O
,	O
and	O
the	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
),	O
of	O
male	O
and	O
female	O
adult	O
offspring	O
.	O

Maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
transfers	O
to	O
the	O
fetus	O
by	O
the	O
placenta	O
.	O

p	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Limited	O
previous	O
research	O
is	O
generally	O
consistent	O
with	O
our	O
findings	O
.	O

Of	O
the	O
recruited	O
eligible	O
families	O
,	O
29	O
%	O
(	O
987	O
/	O
3408	O
)	O
agreed	O
to	O
participate	O
in	O
the	O
VIDI	O
study	O
.	O

While	O
SGAs	O
readily	O
cross	O
the	O
placenta	O
,	O
14the	O
existing	O
studies	O
that	O
have	O
investigated	O
the	O
reproductive	O
safety	O
of	O
these	O
agents	O
did	O
not	O
reach	O
conclusive	O
results	O
due	O
to	O
the	O
methodological	O
limitations	O
,	O
small	O
sample	O
sizes	O
and	O
failure	O
to	O
assess	O
SGAs	O
in	O
monotherapy	O
.	O

Specifically	O
,	O
it	O
is	O
the	O
prescriptions	O
taken	O
during	O
pregnancy	O
,	O
the	O
length	O
of	O
labor	O
,	O
viral	O
infection	O
,	O
abnormal	O
presentation	O
at	O
delivery	O
,	O
and	O
finally	O
low	O
birth	O
weight	O
that	O
were	O
associated	O
with	O
autism	O
.	O

Therefore	O
,	O
expression	O
profiles	O
at	O
weaning	O
and	O
adult	O
stages	O
point	O
to	O
an	O
alarm	O
alert	O
(	O
activated	O
defence	O
)	O
in	O
LP	O
offspring	O
.	O

However	O
,	O
it	O
is	O
unclear	O
if	O
less	O
intensive	O
interventions	O
can	O
be	O
effective	O
in	O
this	O
population	O
.	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
to	O
participate	O
.	O

BMI	O
,	O
body	O
mass	O
index	O
;	O
MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

As	O
a	O
result	O
the	O
calculated	O
cost	O
per	O
woman	O
treated	O
is	O
USD	O
0	O
.	O
76	O
per	O
year	O
(	O
USD133900	O
/	O
175581	O
).	O

The	O
MS	O
generally	O
increases	O
with	O
slaughter	O
age	O
in	O
Korean	O
cattle	O
.	O

The	O
decrease	O
in	O
male	O
birth	O
weight	O
associated	O
with	O
Pb	O
exposure	O
was	O
roughly	O
double	O
the	O
associated	O
birth	O
weight	O
decrease	O
in	O
the	O
combined	O
analysis	O
(	O
94	O
g	O
decrease	O
compared	O
with	O
45	O
g	O
decrease	O
).	O

found	O
a	O
59	O
%	O
lower	O
risk	O
of	O
PTB	O
for	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
concentrations	O
≤	O
20	O
ng	O
/	O
mL	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
[	O
12	O
].	O

2	O
.	O
6	O
.	O

Using	O
data	O
from	O
a	O
U	O
.	O
S	O
.	O
national	O
study	O
on	O
the	O
health	O
effects	O
of	O
prenatal	O
diethylstilbestrol	O
exposure	O
,	O
a	O
team	O
of	O
researchers	O
reported	O
in	O
the	O
11	O
January	O
2008	O
advance	O
access	O
edition	O
of	O
the	O
American	O
Journal	O
of	O
Epidemiology	O
that	O
study	O
participants	O
who	O
had	O
never	O
smoked	O
cigarettes	O
but	O
had	O
been	O
prenatally	O
exposed	O
to	O
maternal	O
cigarette	O
smoke	O
experienced	O
earlier	O
-	O
onset	O
menopause	O
.	O

A	O
challenge	O
in	O
previous	O
studies	O
on	O
vitamin	O
D	O
status	O
and	O
GDM	O
has	O
been	O
the	O
lack	O
of	O
relevant	O
adjustments	O
,	O
for	O
example	O
adjustments	O
for	O
BMI	O
and	O
smoking	O
status	O
[	O
6	O
].	O

Results	O
For	O
a	O
10	O
-	O
fold	O
increase	O
in	O
chemical	O
concentration	O
,	O
the	O
mean	O
differences	O
in	O
birth	O
weights	O
(	O
95	O
%	O
credible	O
intervals	O
(	O
CI	O
))	O
were	O
1	O
g	O
(-	O
20	O
,	O
23	O
)	O
for	O
phthalates	O
,	O
-	O
11	O
g	O
(-	O
52	O
,	O
34	O
)	O
for	O
PFAS	O
,	O
0	O
.	O
2	O
g	O
(-	O
9	O
,	O
10	O
)	O
for	O
PCBs	O
,	O
-	O
4	O
g	O
(-	O
30	O
,	O
22	O
)	O
for	O
PBDEs	O
,	O
and	O
7	O
g	O
(-	O
25	O
,	O
40	O
)	O
for	O
OCPs	O
.	O

Two	O
mothers	O
(	O
1	O
Hispanic	O
,	O
1	O
Caucasian	O
)	O
reported	O
covering	O
their	O
face	O
and	O
body	O
due	O
to	O
their	O
religious	O
beliefs	O
.	O

We	O
employed	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
to	O
reflect	O
both	O
the	O
maternal	O
vitamin	O
D	O
status	O
at	O
the	O
end	O
of	O
pregnancy	O
and	O
the	O
newborn	O
’	O
s	O
vitamin	O
D	O
status	O
at	O
birth	O
[	O
1	O
].	O

Role	O
of	O
epigenetics	O
in	O
the	O
mammalian	O
life	O
cycle	O
Normal	O
mammalian	O
development	O
is	O
a	O
cyclical	O
series	O
of	O
events	O
that	O
enable	O
the	O
continued	O
production	O
of	O
multiple	O
generations	O
(	O
described	O
in	O
Gilbert2014	O
).	O

When	O
examined	O
by	O
gender	O
,	O
girls	O
were	O
only	O
weakly	O
correlated	O
with	O
the	O
mother	O
,	O
but	O
with	O
boys	O
the	O
correlation	O
was	O
much	O
stronger	O
.	O

However	O
,	O
the	O
existence	O
of	O
this	O
protein	O
and	O
its	O
role	O
in	O
humans	O
is	O
still	O
a	O
matter	O
of	O
debate	O
(	O
Elsen	O
et	O
al	O
.,	O
2014a	O
).	O

Although	O
the	O
95	O
%	O
CI	O
for	O
μβfor	O
PFAS	O
did	O
cover	O
zero	O
,	O
the	O
estimate	O
was	O
significantly	O
lower	O
than	O
zero	O
based	O
on	O
the	O
upper	O
limit	O
of	O
the	O
50	O
%	O
CI	O
(-	O
21	O
,	O
-	O
2	O
).	O

Results	O
We	O
identified	O
637	O
spots	O
in	O
DVD	O
deplete	O
samples	O
and	O
655	O
spots	O
in	O
Control	O
samples	O
(	O
seeFigure	O
1for	O
a	O
representative	O
gel	O
).	O

However	O
,	O
our	O
main	O
exposure	O
(	O
fish	O
/	O
fatty	O
acids	O
)	O
did	O
not	O
differ	O
between	O
those	O
who	O
participated	O
and	O
those	O
who	O
did	O
not	O
participate	O
in	O
the	O
study	O
.	O

Free	O
and	O
colleagues	O
[	O
11	O
]	O
systematically	O
reviewed	O
the	O
evidence	O
on	O
mHealth	O
interventions	O
and	O
found	O
that	O
antiretroviral	O
treatment	O
(	O
ART	O
)	O
and	O
smoking	O
cessation	O
interventions	O
had	O
sufficient	O
evidence	O
of	O
effectiveness	O
to	O
be	O
considered	B
for	O
inclusion	O
in	O
health	O
care	O
services	O
.	O

Gestational	O
age	O
at	O
delivery	O
and	O
data	O
collection	O
was	O
determined	O
by	O
routine	O
ultrasound	O
in	O
the	O
second	O
trimester	O
,	O
but	O
gestational	O
age	O
at	O
inclusion	O
was	O
based	O
on	O
the	O
date	O
of	O
the	O
last	O
menstrual	O
period	O
.	O

The	O
median	O
was	O
nine	O
and	O
the	O
mode	O
was	O
13	O
.	O

A	O
strength	O
of	O
the	O
present	O
study	O
lies	O
in	O
the	O
recruitment	O
of	O
subjects	O
,	O
which	O
took	O
place	O
in	O
a	O
single	O
hospital	O
,	O
enabled	O
standardised	O
data	O
collection	O
and	O
covered	O
all	O
seasons	O
.	O

In	O
response	O
,	O
Raju	O
helped	O
to	O
initiate	O
the	O
Breastfeeding	O
and	O
Human	O
Lactation	O
Research	O
Scientific	O
Interest	O
Group	O
,	O
a	O
group	O
of	O
scientists	O
organized	O
under	O
the	O
auspices	O
of	O
the	O
National	O
Institutes	O
of	O
Health	O
to	O
identify	O
and	O
discuss	O
research	O
gaps	O
.	O
43	O
“	O
The	O
intention	O
is	O
to	O
increase	O
dialogue	O
across	O
institutions	O
and	O
various	O
funding	O
agencies	O
to	O
stimulate	O
interest	O
in	O
breastfeeding	O
research	O
,”	O
says	O
Raju	O
.	O

The	O
data	O
were	O
then	O
assembled	O
using	O
BeadStudio	O
methylation	O
software	O
(	O
version	O
1	O
.	O
9	O
.	O
0	O
;	O
Illumina	O
),	O
without	O
normalization	O
,	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

Human	O
insulin	O
does	O
not	O
normally	O
cross	O
the	O
placenta	O
,	O
though	O
antibody	O
bound	O
animal	O
insulin	O
has	O
been	O
reported	O
to	O
do	O
so	O
.	O
35However	O
,	O
it	O
has	O
been	O
shown	O
by36Jovanovic	O
that	O
it	O
is	O
maternal	O
glucose	O
control	O
,	O
rather	O
than	O
maternal	O
anti	O
-	O
insulin	O
antibody	O
levels	O
which	O
influence	O
birthweight	O
.	O
36Human	O
insulin	O
is	O
considered	O
safe	O
in	O
pregnancy	O
as	O
years	O
of	O
experience	O
has	O
not	O
suggested	O
an	O
increase	O
in	O
fetal	O
complications	O
as	O
a	O
consequence	O
of	O
its	O
use	O
.	O

Feed	O
efficiency	O
decreases	O
as	O
animal	O
age	O
and	O
slaughter	O
weight	O
exceed	O
a	O
certain	O
level	O
.	O

The	O
total	O
number	O
of	O
glomeruli	O
was	O
evaluated	O
at	O
6	O
months	O
of	O
age	O
.	O

Respondents	O
rated	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
generally	O
as	O
satisfactory	O
.	O

The	O
higher	O
prevalence	O
of	O
PNA	O
signs	O
found	O
in	O
the	O
exposed	O
group	O
,	O
compared	O
with	O
the	O
controls	O
,	O
may	O
be	O
driven	O
by	O
concurrent	O
SSRI	O
exposure	O
,	O
as	O
12	O
of	O
the	O
15	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
also	O
exposed	O
to	O
an	O
SSRI	O
.	O

However	O
,	O
until	O
these	O
results	O
,	O
no	O
behavioral	O
effects	O
had	O
been	O
observed	O
.	O

Meanwhile	O
,	O
Jones	O
et	O
al	O
.	O

Total	O
GWG	O
was	O
computed	O
based	O
on	O
pregravid	O
weight	O
and	O
weight	O
at	O
the	O
last	O
clinic	O
visit	O
prior	O
to	O
delivery	O
.	O

The	O
present	O
report	O
is	O
one	O
of	O
the	O
first	O
to	O
compare	O
the	O
pregnancy	O
outcomes	O
of	O
women	O
receiving	O
SGA	O
monotherapy	O
with	O
those	O
receiving	O
SGAs	O
in	O
polytherapy	O
.	O

Two	O
clinical	O
trials	O
support	O
a	O
potential	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
prevention	O
of	O
preeclampsia	O
,	O
although	O
neither	O
of	O
these	O
treated	O
with	O
vitamin	O
D	O
supplements	O
alone	O
.	O

The	O
seasonal	O
variations	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
detected	O
in	O
these	O
subjects	O
are	O
consistent	O
with	O
natural	O
environmental	O
changes	O
in	O
the	O
area	O
of	O
residence	O
.	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Altogether	O
,	O
the	O
existing	O
literature	O
suggests	O
that	O
BAT	O
activation	O
is	O
not	O
only	O
involved	O
in	O
non	O
-	O
shivering	O
thermogenesis	O
,	O
but	O
also	O
in	O
the	O
regulation	O
of	O
insulin	O
-	O
mediated	O
glucose	O
disposal	O
.	O

Additional	O
details	O
about	O
study	O
eligibility	O
,	O
recruitment	O
,	O
and	O
follow	O
-	O
up	O
are	O
described	O
elsewhere	O
[	O
34	O
].	O

Moreover	O
,	O
a	O
more	O
detailed	O
investigation	B
into	O
maternal	O
mental	O
health	O
,	O
which	O
includes	O
measures	O
of	O
the	O
frequency	O
and	O
severity	O
of	O
specific	O
psychiatric	O
symptoms	O
during	O
pregnancy	O
,	O
would	O
allow	O
for	O
a	O
more	O
thorough	O
investigation	B
into	O
these	O
critical	O
confounding	O
variables	O
.	O

There	O
are	O
no	O
current	O
studies	O
that	O
can	O
give	O
real	O
good	O
answers	O
to	O
the	O
question	O
if	O
dietary	O
deficiency	O
interacts	O
with	O
genetic	O
vulnerability	O
for	O
schizophrenia	O
.	O

In	O
contrast	O
,	O
Newham	O
et	O
al	O
19found	O
that	O
neonates	O
exposed	O
to	O
SGAs	O
(	O
n	O
=	O
25	O
)	O
were	O
significantly	O
more	O
likely	O
to	O
be	O
LGA	O
compared	O
with	O
healthy	O
controls	O
.	O

Natriuretic	O
peptides	O
(	O
NP	O
),	O
which	O
are	O
important	O
in	O
cardiovascular	O
homeostasis	O
through	O
the	O
maintenance	O
of	O
blood	O
pressure	O
and	O
extracellular	O
fluid	O
volume	O
,	O
comprise	O
three	O
structurally	O
related	O
molecules	O
:	O
atrial	O
NP	O
,	O
brain	O
NP	O
,	O
and	O
C	O
-	O
type	O
NP	O
(	O
Potter	O
2011	O
).	O

In	O
addition	O
,	O
residual	O
confounding	O
due	O
to	O
genetic	O
backgrounds	O
could	O
not	O
be	O
excluded	O
,	O
although	O
we	O
controlled	O
some	O
important	O
potential	O
confounding	O
factors	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
those	O
born	O
with	O
low	O
or	O
high	O
birth	O
weight	O
have	O
impairment	O
of	O
the	O
arterial	O
vascular	O
system	O
with	O
modifications	O
in	O
both	O
functional	O
(	O
e	O
.	O
g	O
.,	O
endothelium	O
dysfunction	O
,	O
reduction	O
in	O
nitric	O
oxide	O
production	O
)	O
and	O
structural	O
/	O
mechanical	O
(	O
e	O
.	O
g	O
.,	O
higher	O
arterial	O
intima	O
-	O
media	O
thickness	O
,	O
elastin	O
synthesis	O
deficiency	O
,	O
increased	O
arterial	O
stiffness	O
)	O
properties	O
[	O
8	O
,	O
9	O
,	O
11	O
–	O
14	O
].	O

We	O
had	O
no	O
information	O
as	O
to	O
the	O
duration	O
of	O
use	O
or	O
the	O
vitamin	O
D	O
dose	O
in	O
the	O
PNV	O
which	O
typically	O
is	O
400	O
–	O
600	O
IU	O
per	O
tablet	O
,	O
but	O
can	O
vary	O
.	O

The	O
rationale	O
for	O
this	O
combination	O
is	O
to	O
meet	O
increased	O
folic	O
acid	O
requirements	O
in	O
pregnancy	O
brought	O
about	O
by	O
the	O
rapidly	O
dividing	O
cells	O
in	O
the	O
fetus	O
and	O
elevated	O
urinary	O
losses	O
[	O
7	O
].	O

Indoor	O
exposures	O
to	O
these	O
agents	O
frequently	O
occur	O
[	O
29	O
,	O
30	O
].	O

Environmental	O
factors	O
and	O
epigenetic	O
perturbation	O
Epigenetic	O
processes	O
are	O
susceptible	O
to	O
perturbation	O
throughout	O
an	O
individual	O
’	O
s	O
life	O
(	O
Figure	O
1	O
).	O

The	O
visfatin	O
regulation	O
mechanism	O
in	O
human	O
fetal	O
blood	O
circulation	O
is	O
unknown	O
(	O
12	O
).	O

Alternatively	O
,	O
cyclical	O
hypoxemia	O
with	O
re	O
-	O
oxygenation	O
,	O
similar	O
to	O
repeated	O
ischemia	O
-	O
reperfusion	O
damage	O
,	O
may	O
promote	O
the	O
formation	O
of	O
reactive	O
oxygen	O
species	O
that	O
may	O
then	O
elicit	O
the	O
release	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
including	O
interleukin	O
-	O
6	O
and	O
tumor	O
necrosis	O
factor	O
-	O
α	O
[	O
46	O
,	O
47	O
].	O

After	O
physiological	O
fluctuations	O
in	O
childhood	O
,	O
AMH	O
is	O
stabilized	O
at	O
the	O
age	O
of	O
eight	O
and	O
later	O
begins	O
to	O
decrease	O
from	O
about	O
the	O
25th	O
year	O
of	O
life	O
up	O
to	O
the	O
beginning	O
of	O
menopause	O
[	O
42	O
].	O

The	O
left	O
side	O
of	O
the	O
remaining	O
brain	O
was	O
used	O
for	O
folate	O
concentration	O
measurement	O
.	O

Mid	O
-	O
upper	O
arm	O
circumference	O
(	O
MUAC	O
)	O
was	O
measured	O
at	O
the	O
mid	O
-	O
point	O
of	O
the	O
left	O
arm	O
using	O
standard	O
tapes	O
(	O
TALC	O
,	O
UK	O
).	O

Models	O
adjusted	O
for	O
delivery	O
hospital	O
,	O
hospitalization	O
during	O
pregnancy	O
for	O
any	O
specific	O
complication	O
(	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
),	O
reporting	O
at	O
least	O
one	O
episode	O
of	O
influenza	O
-	O
like	O
illness	O
during	O
pregnancy	O
(	O
ILI	O
),	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
number	O
of	O
parturitions	O
,	O
sex	O
of	O
the	O
baby	O
,	O
and	O
influenza	O
circulation	O
.	O

Studies	O
suggest	O
that	O
the	O
effect	O
of	O
influenza	O
vaccination	O
on	O
birth	O
outcomes	O
may	O
be	O
better	O
observed	O
during	O
high	O
influenza	O
circulation	O
period	O
,	O
and	O
there	O
was	O
a	O
substantial	O
influenza	O
circulation	O
in	O
Nicaragua	O
in	O
2014	O
[	O
20	O
],[	O
21	O
],[	O
55	O
].	O

Lewis	O
and	O
colleagues	O
surveyed	O
1	O
,	O
304	O
residents	O
,	O
obtaining	O
basic	O
demographic	O
information	O
,	O
mapping	O
the	O
locations	O
of	O
their	O
homes	O
,	O
and	O
taking	O
samples	O
from	O
the	O
wells	O
where	O
they	O
obtained	O
their	O
drinking	O
water	O
.	O

and	O
Camargo	O
et	O
al	O
.	O

After	O
baseline	O
,	O
participants	O
in	O
both	O
groups	O
were	O
surveyed	O
again	O
after	O
4	O
weeks	O
,	O
at	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
at	O
the	O
time	O
of	O
first	O
postpartum	O
medical	O
appointment	O
.	O

However	O
,	O
measuring	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
in	O
early	O
pregnancy	O
is	O
common	O
and	O
potentially	O
clinically	O
useful	O
as	O
this	O
is	O
prior	O
to	O
when	O
many	O
of	O
the	O
pregnancy	O
complications	O
that	O
affect	O
late	O
gestation	O
manifest	O
.	O

The	O
intake	O
of	O
fatty	O
acids	O
and	O
vitamin	O
D	O
was	O
categorized	O
into	O
quartiles	O
,	O
with	O
the	O
lowest	O
quartile	O
as	O
the	O
reference	O
category	O
for	O
comparison	O
.	O

The	O
Shapiro	O
-	O
Wilk	O
and	O
Levene	O
tests	O
were	O
used	O
to	O
assess	O
normality	O
and	O
homogeneity	O
of	O
variance	O
of	O
data	O
,	O
respectively	O
.	O

Comparison	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
based	O
on	O
month	O
of	O
sampling	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
(	O
black	O
line	O
&	O
left	O
axis	O
)	O
and	O
average	O
hours	O
of	O
sunlight	O
per	O
day	O
in	O
Adelaide	O
(	O
grey	O
line	O
&	O
right	O
axis	O
).	O

)•	O
Create	O
and	O
implement	O
effective	O
community	O
-	O
based	O
approaches	O
(	O
e	O
.	O
g	O
.,	O
community	O
health	O
workers	O
home	O
visit	O
packages	O
,	O
women	O
'	O
s	O
'	O
groups	O
)	O
Typical	O
timeline	O
to	O
impactNear	O
-	O
term	O
to	O
Long	O
-	O
term	O
(	O
2	O
to	O
15	O
years	O
)	O
Long	O
-	O
term	O
(	O
5	O
to	O
15	O
years	O
)	O
Medium	O
-	O
term	O
(	O
5	O
to	O
10	O
years	O
)	O
Near	O
-	O
term	O
(	O
2	O
to	O
5	O
years	O
)	O
Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Pb	O
,	O
while	O
not	O
conventionally	O
considered	O
an	O
EDC	O
,	O
is	O
a	O
widespread	O
reproductive	O
[	O
38	O
]	O
toxin	O
that	O
impacts	O
neurodevelopment	O
[	O
6	O
]	O
and	O
birth	O
weight	O
at	O
very	O
low	O
exposure	O
levels	O
[	O
39	O
]	O
and	O
so	O
is	O
included	O
in	O
this	O
study	O
.	O

On	O
the	O
first	O
day	O
,	O
the	O
Baecke	O
questionnaire	O
was	O
administered	O
and	O
body	O
composition	O
was	O
assessed	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
recent	O
reports	O
of	O
increased	O
polytherapy	O
involving	O
antipsychotics	O
and	O
antidepressants	O
in	O
the	O
USA	O
,	O
20as	O
well	O
as	O
in	O
other	O
cohorts	O
of	O
pregnant	O
women	O
.	O
14161921	O
We	O
found	O
that	O
women	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
differed	O
significantly	O
with	O
respect	O
to	O
a	O
number	O
of	O
characteristics	O
and	O
behaviours	O
that	O
are	O
known	O
to	O
be	O
associated	O
with	O
increased	O
risks	O
for	O
adverse	O
pregnancy	O
outcomes	O
.	O

Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Author	O
'	O
s	O
manuscript	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Reviewer	O
comments	O
PubMed	O
Central	O
:	O

We	O
similarly	O
found	O
that	O
the	O
C	O
allele	O
was	O
associated	O
with	O
lower	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
following	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

A	O
summary	O
of	O
these	O
articles	O
and	O
their	O
quality	O
rating	O
is	O
presented	O
inTable	O
2	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t002_Table	O
2	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Summary	O
and	O
quality	O
rating	O
for	O
reviewed	O
articles	O
.	O
ReferenceDaniels	O
et	O
al	O
.	O

Ponderal	O
index	O
is	O
the	O
clinical	O
measure	O
normally	O
used	O
at	O
birth	O
.	O

Infant	O
anthropometric	O
measurements	O
Infant	O
growth	O
is	O
assessed	O
at	O
each	O
postnatal	O
visit	O
.	O

The	O
training	O
consisted	O
of	O
didactic	O
sessions	O
,	O
role	O
plays	O
,	O
and	O
field	O
pilots	O
and	O
was	O
delivered	O
over	O
16	O
days	O
.	O

C	O
–	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

Liver	O
samples	O
and	O
the	O
brains	O
were	O
also	O
collected	O
,	O
frozen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

When	O
dealing	O
with	O
MTC	O
,	O
we	O
should	O
always	O
bear	O
in	O
mind	O
that	O
these	O
patients	O
may	O
be	O
the	O
index	O
-	O
case	O
for	O
one	O
of	O
the	O
familial	O
forms	O
of	O
the	O
disease	O
:	O
presymptomatic	O
screening	O
of	O
relatives	O
of	O
MTC	O
patients	O
enables	O
early	O
diagnosis	O
of	O
this	O
malignancy	O
.	O

Priority	O
questions	O
:	O
What	O
is	O
the	O
‘	O
normal	O
’	O
epigenome	O
?	O

There	O
were	O
35	O
spots	O
that	O
were	O
significantly	O
altered	O
between	O
the	O
two	O
groups	O
,	O
22	O
were	O
down	O
-	O
regulated	O
and	O
13	O
up	O
-	O
regulated	O
(	O
Table	O
1	O
).	O

At	O
birth	O
,	O
umbilical	O
cord	O
blood	O
(	O
UCB	O
)	O
for	O
25	O
(	O
OH	O
)	O
D	O
measurement	O
was	O
obtained	O
at	O
gestational	O
weeks	O
37	O
to	O
42	O
between	O
January	O
2013	O
and	O
May	O
2014	O
[	O
hereafter	O
referred	O
to	O
as	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
].	O

Within	O
24	O
hours	O
of	O
delivery	O
,	O
each	O
litter	O
was	O
culled	O
to	O
10	O
pups	O
to	O
minimize	O
the	O
difference	O
in	O
milk	O
availability	O
.	O

However	O
,	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
alone	O
was	O
the	O
only	O
predicted	O
higher	O
probability	O
of	O
respiratory	O
infection	O
in	O
the	O
first	O
6	O
months	O
of	O
life	O
(	O
Table	O
4	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multiple	O
linear	O
regression	O
analysis	O
of	O
lung	O
function	O
outcome	O
(	O
Z	O
score	O
of	O
Rrs	O
).	O
Beta	O
(	O
s	O
.	O
e	O
.	O

We	O
will	O
only	O
share	O
datasets	O
with	O
all	O
personally	O
identifiable	O
information	O
removed	O
,	O
and	O
every	O
reasonable	O
effort	O
to	O
keep	O
the	O
identification	O
of	O
study	O
subjects	O
in	O
the	O
strictest	O
confidence	O
.	O

Subjects	O
in	O
this	O
study	O
reside	O
in	O
an	O
areas	O
from	O
39	O
″	O
26	O
’	O
N	O
to	O
41	O
″	O
03	O
’	O
N	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
was	O
lower	O
.	O

After	O
adjustments	O
(	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
),	O
no	O
significant	O
interactions	O
were	O
observed	O
in	O
normal	O
weight	O
or	O
overweight	O
/	O
obese	O
mothers	O
(	O
data	O
not	O
shown	O
).	O

Our	O
results	O
suggested	O
that	O
impaired	O
cardiac	O
autonomic	O
modulation	O
characterized	O
by	O
a	O
reduction	O
in	O
the	O
parasympathetic	O
activity	O
occurs	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

Inform	O
•	O
Improve	O
systems	O
for	O
collecting	O
,	O
evaluating	O
and	O
disseminating	O
data	O
on	O
preterm	O
birth	O
rates	O
,	O
mortality	O
,	O
disability	O
,	O
quality	O
of	O
life	O
and	O
equitable	O
coverage	O
of	O
evidence	O
-	O
based	O
interventions	O
to	O
track	O
progress	O
towards	O
MDGs	O
4	O
and	O
5	O
for	O
maternal	O
and	O
child	O
survival	O
.	O

Interestingly	O
,	O
GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	O
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
.	O

For	O
the	O
preterm	O
prevention	O
research	B
agenda	I
,	O
the	O
greatest	O
emphasis	O
is	O
on	O
discovery	O
and	O
descriptive	O
research	O
,	O
which	O
is	O
a	O
longer	O
-	O
term	O
investment	O
.	O

Participants	O
were	O
considered	O
to	O
have	O
quit	O
the	O
study	O
if	O
they	O
were	O
unreachable	O
after	O
7	O
recontact	O
attempts	O
,	O
and	O
no	O
further	O
follow	O
-	O
up	O
attempts	O
were	O
made	O
.	O

Of	O
note	O
is	O
that	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
a	O
southern	O
United	O
States	O
climate	O
are	O
low	O
despite	O
sunshine	O
exposure	O
year	O
round	O
at	O
the	O
latitude	O
in	O
Houston	O
.	O

Trafficking	O
of	O
cells	O
could	O
therefore	O
be	O
responsible	O
for	O
the	O
passing	O
of	O
allergy	O
risk	O
from	O
mother	O
to	O
fetus	O
.	O

So	O
in	O
this	O
survey	O
,	O
we	O
investigated	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
compared	O
it	O
with	O
controls	O
in	O
central	O
region	O
of	O
Iran	O
,	O
an	O
area	O
with	O
medium	O
to	O
high	O
risk	O
for	O
MS	O
disease	O
,	O
in	O
spite	O
of	O
high	O
sun	O
exposure	O
.	O

No	O
current	O
medical	O
illness	O
;	O
4	O
).	O

It	O
is	O
clear	O
that	O
the	O
processes	O
arising	O
during	O
fetal	O
development	O
can	O
influence	O
health	O
later	O
in	O
life	O
.	O

The	O
fieldworkers	O
obtained	O
written	O
informed	O
consent	O
from	O
the	O
mother	O
,	O
father	O
,	O
or	O
another	O
senior	O
family	O
member	O
before	O
recruitment	O
;	O
allocated	O
the	O
unique	O
identification	O
number	O
(	O
sequentially	O
);	O
and	O
gave	O
the	O
first	O
dose	O
of	O
vitamin	O
D3or	O
placebo	O
.	O

During	O
days	O
30	O
–	O
32	O
,	O
we	O
completed	O
3	O
-	O
hour	O
structured	O
observations	O
of	O
106	O
(	O
85	O
%)	O
control	O
and	O
112	O
(	O
90	O
%)	O
intervention	O
participants	O
(	O
Table	O
2	O
).	O

It	O
was	O
recently	O
shown	O
that	O
a	O
maternal	O
supplementation	O
of	O
2100	O
IU	O
vitamin	O
D	O
/	O
day	O
was	O
needed	O
,	O
when	O
administered	O
during	O
the	O
period	O
of	O
lactation	O
,	O
in	O
order	O
to	O
observe	O
an	O
increase	O
in	O
serum	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
breast	O
-	O
fed	O
infants	O
comparable	O
to	O
that	O
observed	O
in	O
children	O
given	O
400	O
IU	O
/	O
day	O
.	O

Reminder	O
texts	O
were	O
sent	O
1	O
week	O
before	O
each	O
follow	O
-	O
up	O
survey	O
prompting	O
online	O
or	O
in	O
-	O
clinic	O
survey	O
completion	O
.	O

The	O
proportion	O
of	O
children	O
without	O
an	O
episode	O
of	O
pneumonia	O
during	O
our	O
18	O
month	O
study	O
did	O
not	O
differ	O
between	O
the	O
groups	O
(	O
figure	O
2	O
).	O

The	O
annual	O
cost	O
of	O
USD0	O
.	O
76	O
per	O
woman	O
treated	O
is	O
consistent	O
with	O
a	O
cost	O
estimate	O
of	O
USD10	O
-	O
13	O
per	O
pregnancy	O
[	O
22	O
],[	O
23	O
],	O
since	O
pregnant	O
women	O
receive	O
more	O
tablets	O
.	O

Phthalates	O
are	O
used	O
as	O
plasticizers	O
[	O
1	O
,	O
4	O
,	O
5	O
,	O
8	O
]	O
and	O
also	O
found	O
in	O
personal	O
care	O
and	O
consumer	O
products	O
[	O
1	O
,	O
3	O
,	O
7	O
].	O

Priority	O
was	O
given	O
to	O
papers	O
that	O
presented	O
original	O
data	O
rather	O
than	O
reviews	O
or	O
meta	O
-	O
analyses	O
.	O

Female	O
rats	O
were	O
maintained	O
on	O
the	O
same	O
diet	O
paradigm	O
as	O
in	O
the	O
pregestational	O
period	O
up	O
to	O
the	O
gestational	O
day	O
20	O
(	O
GD	O
20	O
).	O

However	O
,	O
there	O
is	O
a	O
limitation	O
to	O
the	O
use	O
of	O
some	O
of	O
these	O
biochemical	O
indicators	O
of	O
iron	O
status	O
in	O
certain	O
settings	O
and	O
conditions	O
;	O
thus	O
,	O
necessitating	O
caution	O
in	O
their	O
interpretations	O
.	O

However	O
,	O
we	O
are	O
not	O
seeking	O
to	O
report	O
or	O
measure	O
adiposity	O
in	O
itself	O
in	O
this	O
analysis	O
;	O
for	O
comparator	O
purposes	O
,	O
we	O
report	O
BMI	O
at	O
the	O
three	O
time	O
points	O
in	O
order	O
to	O
compare	O
like	O
with	O
like	O
both	O
(	O
1	O
)	O
in	O
relation	O
to	O
the	O
child	O
over	O
time	O
and	O
(	O
2	O
)	O
in	O
relation	O
to	O
the	O
adults	O
.	O

Economic	O
situation	O
was	O
assessed	O
by	O
ownership	O
of	O
radio	O
and	O
/	O
or	O
bicycle	O
and	O
information	O
on	O
perceived	O
economic	O
status	O
.	O

However	O
,	O
these	O
changes	O
with	O
slaugther	O
age	O
were	O
not	O
observed	O
in	O
double	O
-	O
muscled	O
Belgian	O
Blue	O
bulls	O
[	O
24	O
].	O

Indeed	O
,	O
the	O
higher	O
leptin	O
levels	O
in	O
plasma	O
without	O
reduction	O
in	O
food	O
intake	O
suggest	O
leptin	O
resistance	O
and	O
,	O
therefore	O
,	O
an	O
altered	O
leptin	O
signaling	O
(	O
Friedman	O
and	O
Halaas	O
,	O
1998	O
).	O

The	O
results	O
of	O
this	O
observational	O
study	O
were	O
based	O
on	O
questionnaires	O
filled	O
out	O
by	O
the	O
mothers	O
after	O
childbirth	O
.	O

Methods	O
We	O
conducted	O
a	O
cross	O
-	O
sectional	O
study	O
on	O
a	O
sample	O
of	O
400	O
pregnant	O
women	O
admitted	O
to	O
the	O
Cuza	O
-	O
Vodă	O
Obstetrics	O
and	O
Gynaecology	O
Clinical	O
Hospital	O
in	O
Iaşi	O
,	O
Romania	O
,	O
during	O
August	O
-	O
September	O
2010	O
.	O

